Browse by UCL Department: listings for include files
- UCL (198993)
- UCL (198993)
- Provost and Vice Provost Offices (197752)
- School of Life and Medical Sciences (96774)
- Faculty of Medical Sciences (21915)
- Cancer Institute (4089)
- Research Department of Haematology (1269)
- Cancer Institute (4089)
- Faculty of Medical Sciences (21915)
- School of Life and Medical Sciences (96774)
- Provost and Vice Provost Offices (197752)
- UCL (198993)
Number of items at this level: 1269.
A
Aaboud, M;
Aad, G;
Abbott, B;
Abdinov, O;
Abeloos, B;
Abhayasinghe, DK;
Abidi, SH;
... Zwalinski, L; + view all
(2019)
Searches for scalar leptoquarks and differential cross-section measurements in dilepton-dijet events in proton-proton collisions at a centre-of-mass energy of root s=13TeV with the ATLAS experiment.
The European Physical Journal C
, 79
, Article 733. 10.1140/epjc/s10052-019-7181-x.
|
 |
|
Aad, G;
Abbott, B;
Abbott, DC;
Abdinov, O;
Abud, AA;
Abeling, K;
Abhayasinghe, DK;
... Pereira, RA; + view all
(2020)
Search for electroweak production of charginos and sleptons decaying into final states with two leptons and missing transverse momentum in √s=13 TeV pp collisions using the ATLAS detector.
European Physical Journal C
, 80
, Article 123. 10.1140/epjc/s10052-019-7594-6.
|
|
|
Abbosh, Christopher;
Frankell, Alexander M;
Harrison, Thomas;
Kisistok, Judit;
Garnett, Aaron;
Johnson, Laura;
Veeriah, Selvaraju;
... Swanton, Charles; + view all
(2023)
Tracking early lung cancer metastatic dissemination in TRACERx using ctDNA.
Nature
, 616
(7957)
pp. 553-562.
10.1038/s41586-023-05776-4.
|
|
Abbosh, C;
Birkbak, NJ;
Wilson, GA;
Jamal-Hanjani, M;
Constantin, T;
Salari, R;
Le Quesne, J;
... Dessimoz, C; + view all
(2017)
Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution.
Nature
, 545
pp. 446-451.
10.1038/nature22364.
|
|
Abdel-Gadir, A;
Berber, R;
Porter, JB;
Quinn, PD;
Suri, D;
Kellman, P;
Hart, AJ;
... Skinner, JA; + view all
(2016)
Detection of metallic cobalt and chromium liver deposition following failed hip replacement using T2* and R2 magnetic resonance.
Journal of Cardiovascular Magnetic Resonance
, 18
, Article 29. 10.1186/s12968-016-0248-z.
|
|
|
Abdel-Gadir, A;
Vorasettakarnkij, Y;
Ngamkasem, H;
Nordin, S;
Ako, EA;
Tumkosit, M;
Sucharitchan, P;
... Moon, JC; + view all
(2016)
Ultrafast Magnetic Resonance Imaging for Iron Quantification in Thalassemia Participants in the Developing World The TIC-TOC Study (Thailand and UK International Collaboration in Thalassaemia Optimising Ultrafast CMR).
Circulation
, 134
(5)
pp. 432-434.
10.1161/CIRCULATIONAHA.116.022803.
|
|
|
Abdul-Aziz, AM;
Shafat, MS;
Sun, Y;
Marlein, CR;
Piddock, RE;
Robinson, SD;
Edwards, DR;
... Rushworth, SA; + view all
(2018)
HIF1α drives chemokine factor pro-tumoral signaling pathways in acute myeloid leukemia.
Oncogene
, 37
(20)
pp. 2676-2686.
10.1038/s41388-018-0151-1.
|
|
|
AbdulJabbar, K;
Raza, SEA;
Rosenthal, R;
Jamal-Hanjani, M;
Veeriah, S;
Akarca, A;
Lund, T;
... Yuan, Y; + view all
(2020)
Geospatial immune variability illuminates differential evolution of lung adenocarcinoma.
Nature Medicine
, 26
pp. 1054-1062.
10.1038/s41591-020-0900-x.
|
|
Abeti, R;
Baccaro, A;
Giunti, P;
(2019)
Mitochondrial Dysfunction in Friedreich Ataxia.
In: Ahmad, SI, (ed.)
Handbook of Mitochondrial Dysfunction.
CRC Press: Boca Raton, FL, USA.
|
|
Abou-Alfa, GK;
Macarulla, T;
Javle, MM;
Kelley, RK;
Lubner, SJ;
Adeva, J;
Cleary, JM;
... Zhu, AX; + view all
(2020)
Ivosidenib in IDH1-mutant, chemotherapy-refractory cholangiocarcinoma (ClarIDHy): a multicentre, randomised, double-blind, placebo-controlled, phase 3 study.
The Lancet Oncology
, 21
(6)
pp. 796-807.
10.1016/S1470-2045(20)30157-1.
|
|
Abraham, BJ;
Hnisz, D;
Weintraub, AS;
Kwiatkowski, N;
Li, CH;
Li, Z;
Weichert-Leahey, N;
... Young, RA; + view all
(2017)
Small genomic insertions form enhancers that misregulate oncogenes.
Nature Communications
, 8
, Article 14385. 10.1038/ncomms14385.
|
|
|
Abrol, E;
Groszmann, M;
Pitman, A;
Hough, R;
Taylor, RM;
Aref-Adib, G;
(2017)
Exploring the digital technology preferences of teenagers and young adults (TYA) with cancer and survivors: a cross-sectional service evaluation questionnaire.
Journal of Cancer Survivorship
, 11
(6)
pp. 670-682.
10.1007/s11764-017-0618-z.
|
|
|
Afaq, A;
Fraioli, F;
Sidhu, H;
Wan, S;
Punwani, S;
Chen, S-H;
Akin, O;
... Kayani, I; + view all
(2017)
Comparison of PET/MRI With PET/CT in the Evaluation of Disease Status in Lymphoma.
Clinical Nuclear Medicine
, 42
(1)
e1-e7.
10.1097/RLU.0000000000001344.
|
|
Agbamu, DA;
Day, N;
Walsh, CJ;
Hendrickse, CW;
Langman, G;
Pallan, A;
Lowe, A;
... Lees, N; + view all
(2012)
Feasibility of preoperative chemotherapy for locally advanced, operable colon cancer: The pilot phase of a randomised controlled trial.
The Lancet Oncology
, 13
(11)
1152 - 1160.
10.1016/S1470-2045(12)70348-0.
|
 |
|
Agliardi, G;
Liuzzi, AR;
Hotblack, A;
De Feo, D;
Núñez, N;
Stowe, CL;
Friebel, E;
... Becher, B; + view all
(2021)
Intratumoral IL-12 delivery empowers CAR-T cell immunotherapy in a pre-clinical model of glioblastoma.
Nature Communications
, 12
, Article 444. 10.1038/s41467-020-20599-x.
|
|
|
Agliardi, Giulia;
(2017)
Development of a Chimeric Antigen Receptor (CAR) - based T cell therapy for glioblastoma.
Doctoral thesis (Ph.D), UCL (University College London).
|
|
Agostinelli, C;
Akarca, AU;
Ramsay, A;
Rizvi, H;
Rodriguez-Justo, M;
Pomplun, S;
Proctor, I;
... Marafioti, T; + view all
(2019)
Novel markers in pediatric-type follicular lymphoma.
Virchows Archiv
10.1007/s00428-019-02681-y.
(In press).
|
|
|
Aguiar, P;
Azevedo, O;
Pinto, R;
Marino, J;
Cardoso, C;
Sousa, N;
Cunha, D;
... Ducla Soares, JL; + view all
(2018)
Biomarkers of Myocardial Fibrosis: Revealing the Natural History of Fibrogenesis in Fabry Disease Cardiomyopathy.
Journal of the American Heart Association
, 7
(6)
10.1161/JAHA.117.007124.
|
|
|
Ahmed, F;
Ings, SJ;
Pizzey, AR;
Blundell, MP;
Thrasher, AJ;
Ye, HT;
Fahey, A;
... Yong, KL; + view all
(2004)
Impaired bone marrow homing of cytokine-activated CD34<sup>+</sup> cells in the NOD/SCID model.
Blood
, 103
(6)
pp. 2079-2087.
10.1182/blood-2003-06-1770.
|
|
|
Ahmedzai, SH;
Snowden, JA;
Ashcroft, AJ;
Cairns, DA;
Williams, C;
Hockaday, A;
Cavenagh, JD;
... Cook, G; + view all
(2019)
Patient-Reported Outcome Results From the Open-Label, Randomized Phase III Myeloma X Trial Evaluating Salvage Autologous Stem-Cell Transplantation in Relapsed Multiple Myeloma.
Journal of Clinical Oncology
, 37
(19)
pp. 1617-1628.
10.1200/jco.18.01006.
|
|
|
Ainley, L;
Chavda, SJ;
Counsell, N;
Cheesman, S;
Newrick, F;
Horder, J;
Kyriakou, C;
... Yong, K; + view all
(2021)
DT‐PACE/ESHAP chemotherapy regimens as salvage therapy for multiple myeloma prior to autologous stem cell transplantation.
British Journal of Haematology
, 192
(3)
e73-e77.
10.1111/bjh.17248.
|
|
Ako, EOI;
Barber, N;
Kowalik, G;
Steeden, JA;
Porter, J;
Walker, J;
Muthurangu, V;
(2016)
MR-Augmented Cardiopulmonary Exercise Testing - a proof of concept in Sickle Cell Disease.
Presented at: Society for Cardiovascular Magnetic Resonance: 19th Annual SCMR Scientific Sessions, Los Angeles, California, USA.
|
|
|
Al Bakir, Maise;
Huebner, Ariana;
Martínez-Ruiz, Carlos;
Grigoriadis, Kristiana;
Watkins, Thomas BK;
Pich, Oriol;
Moore, David A;
... Swanton, Charles; + view all
(2023)
The evolution of non-small cell lung cancer metastases in TRACERx.
Nature
10.1038/s41586-023-05729-x.
(In press).
|
|
Al-Obaidi, M.S.J.;
(2005)
Fluorescence-in-situ hybridization in adult all cytogenetic findings and clinical correlation.
Doctoral thesis , University of London.
|
|
|
Al-Yousuf, Hannah;
O'Nions, Jenny;
Wilson, Andrew J;
Gohil, Satyen;
Manson, Jessica J;
Payne, Elspeth M;
(2024)
Safety and efficacy of anakinra in hemophagocytic lymphohistiocytosis associated with acute leukemia.
Haematologica
10.3324/haematol.2023.283879.
|
|
Ali, A;
Gale, RE;
Shakoori, AR;
(2017)
Detection of FLT3/TKD and IDH1 Mutations in Pakistani Acute Myeloid Leukemia Patients by Denaturing HPLC.
Journal of Cellular Biochemistry
, 118
(5)
pp. 1174-1181.
10.1002/jcb.25761.
|
|
Ali, H;
Puccio, I;
Akarca, AU;
Bob, R;
Pomplun, S;
Keong Wong, W;
Gupta, R;
... Marafioti, T; + view all
(2020)
Megakaryocytes, erythropoietic and granulopoietic cells express CAL2 antibody in myeloproliferative neoplasms carrying CALR gene mutations.
International Journal of Experimental Pathology
10.1111/iep.12375.
|
|
|
Alimam, Samah;
Timms, Jessica Ann;
Harrison, Claire N;
Dillon, Richard;
Mare, Tracey;
DeLavallade, Hugues;
Radia, Deepti;
... McLornan, Donal P; + view all
(2021)
Altered immune response to the annual influenza A vaccine in patients with myeloproliferative neoplasms.
British Journal of Haematology
, 193
(1)
pp. 150-154.
10.1111/bjh.17096.
|
|
|
Allen, A.J.R.;
(2006)
Investigations into the pathogenesis of essential thrombocythemia.
Doctoral thesis , University of London.
|
|
|
Allsup, D;
Howard, D;
Emmerson, J;
Hockaday, A;
Rawstron, A;
Oughton, JB;
Bloor, A;
... Hillmen, P; + view all
(2021)
COSMIC, chemotherapy plus ofatumumab at standard or mega-dose in chronic lymphocytic leukaemia, a phase II randomised study.
British Journal of Haematology
, 194
(3)
pp. 646-650.
10.1111/bjh.17526.
|
|
|
Almarzouki, A;
Wilson, D;
Ambler, G;
Shakeshaft, C;
Cohen, H;
Yousry, T;
Al-Shahi Salman, R;
... Werring, DJ; + view all
(2021)
Publisher Correction: Sensitivity and specificity of blood-fluid levels for oral anticoagulant-associated intracerebral haemorrhage.
Scientific Reports
, 11
(1)
, Article 9485. 10.1038/s41598-021-88890-5.
|
|
|
Almarzouki, A;
Wilson, D;
Ambler, G;
Shakeshaft, C;
Cohen, H;
Yousry, T;
Salman, RA-S;
... Werring, DJ; + view all
(2020)
Sensitivity and specifcity of blood‑fuid levels for oral anticoagulant‑associated intracerebral haemorrhage.
Scientific Reports
, 10
(1)
, Article 15529. 10.1038/s41598-020-72504-7.
|
|
|
Alrasheed, N;
Lee, L;
Ghorani, E;
Henry, JY;
Conde, L;
Chin, M;
Galas-Filipowicz, D;
... Yong, KL; + view all
(2020)
Marrow-Infiltrating Regulatory T Cells Correlate with the Presence of Dysfunctional CD4⁺PD-1⁺ Cells and Inferior Survival in Patients with Newly Diagnosed Multiple Myeloma.
Clinical Cancer Research
, 26
(13)
pp. 3443-3454.
10.1158/1078-0432.CCR-19-1714.
|
|
Alzoubi, S;
Brody, L;
Rahman, S;
Mahul-Mellier, AL;
Mercado, N;
Ito, K;
El-Bahrawy, M;
... Hajji, N; + view all
(2016)
Synergy between histone deacetylase inhibitors and DNA-damaging agents is mediated by histone deacetylase 2 in colorectal cancer.
Oncotarget
, 7
(28)
pp. 44505-44521.
10.18632/oncotarget.9887.
|
|
|
Ancliff, PJ;
Gale, RE;
Watts, MJ;
Liesner, R;
Hann, IM;
Strobel, S;
Linch, DC;
(2002)
Paternal mosaicism proves the pathogenic nature of mutations in neutrophil elastase in severe congenital neutropenia.
Blood
, 100
(2)
pp. 707-709.
10.1182/blood-2002-01-0060.
|
|
|
Andre, T;
Boni, C;
Mounedji-Boudiaf, L;
Navarro, M;
Tabernero, J;
Hickish, T;
Topham, C;
... de Gramont, A; + view all
(2004)
Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer.
NEW ENGLAND JOURNAL OF MEDICINE
, 350
(23)
pp. 2343-2351.
10.1056/NEJMoa032709.
|
|
|
Aneke, JC;
Huntley, N;
Porter, J;
Eleftheriou, P;
(2016)
Effect of automated red cell exchanges on oxygen saturation on-air, blood parameters and length of hospitalization in sickle cell disease patients with acute chest syndrome.
Nigerian Medical Journal
, 57
(3)
pp. 190-193.
10.4103/0300-1652.184073.
|
|
|
Anguita, E;
Gupta, R;
Olariu, V;
Valk, PJ;
Peterson, C;
Delwel, R;
Enver, T;
(2016)
A somatic mutation of GFI1B identified in leukemia alters cell fate via a SPI1 (PU.1) centered genetic regulatory network.
Developmental Biology
, 411
(2)
pp. 277-286.
10.1016/j.ydbio.2016.02.002.
|
|
|
Ankcorn, MJ;
Fox, TA;
Ijaz, S;
Nicholas, C;
Houston, E;
Longair, I;
Suri, D;
... Sekhar, M; + view all
(2019)
Characterising the risk of Hepatitis E virus infection in haematological malignancies: a UK prospective prevalence study.
British Journal of Haematology
, 186
(1)
pp. 191-195.
10.1111/bjh.15796.
|
|
Ansari, T;
Lange, P;
Southgate, A;
Greco, K;
Carvalho, C;
Partington, L;
Bullock, A;
... Birchall, MA; + view all
(2017)
Stem Cell-Based Tissue-Engineered Laryngeal Replacement.
Stem Cells Translational Medicine
, 6
(2)
pp. 677-687.
10.5966/sctm.2016-0130.
|
|
|
Anthias, CN;
(2016)
Related haematopoietic progenitor cell donor care: the influence of current guidance, and pathways to improvement.
Doctoral thesis , UCL (University College London).
|
|
|
Appios, Anna;
Davies, James;
Sirvent, Sofia;
Henderson, Stephen;
Trzebanski, Sébastien;
Schroth, Johannes;
Law, Morven L;
... Bennett, Clare L; + view all
(2024)
Convergent evolution of monocyte differentiation in adult skin instructs Langerhans cell identity.
Science Immunology
, 9
(99)
, Article eadp0344. 10.1126/sciimmunol.adp0344.
|
|
Arachchillage, DRJ;
Mackie, IJ;
Efthymiou, M;
Chitolie, A;
Hunt, BJ;
Isenberg, DA;
Khamashta, M;
... Cohen, H; + view all
(2016)
Rivaroxaban limits complement activation compared with warfarin in antiphospholipid syndrome patients with venous thromboembolism.
Journal of Thrombosis and Haemostasis
, 14
(11)
pp. 2177-2186.
10.1111/jth.13475.
|
|
|
Arcangeli, Silvia;
Bove, Camilla;
Mezzanotte, Claudia;
Camisa, Barbara;
Falcone, Laura;
Manfredi, Francesco;
Bezzecchi, Eugenia;
... Casucci, Monica; + view all
(2022)
CAR T cell manufacturing from naive/stem memory T lymphocytes enhances antitumor responses while curtailing cytokine release syndrome.
The Journal of Clinical Investigation
, 132
(12)
, Article e150807. 10.1172/jci150807.
|
|
|
Aref, S;
Bailey, K;
Fielding, A;
(2016)
Measles to the Rescue: A Review of Oncolytic Measles Virus.
Viruses
, 8
(10)
10.3390/v8100294.
|
|
|
Aref, S;
Castleton, AZ;
Bailey, K;
Burt, R;
Dey, A;
Leongamornlert, D;
Mitchell, RJ;
... Fielding, AK; + view all
(2020)
Type-1 Interferon Responses Underlie Tumor-Selective Replication of Oncolytic Measles Virus.
Molecular Therapy
, 28
(4)
pp. 1043-1055.
10.1016/j.ymthe.2020.01.027.
|
|
Arellano-Ballestero, Helena;
Sabry, May;
Lowdell, Mark W;
(2023)
A Killer Disarmed: Natural Killer Cell Impairment in Myelodysplastic Syndrome.
Cells
, 12
(4)
, Article 633. 10.3390/cells12040633.
|
|
Arends, M;
Biegstraaten, M;
Hughes, DA;
Mehta, A;
Elliott, PM;
Oder, D;
Watkinson, OT;
... Hollak, CEM; + view all
(2017)
Retrospective study of long-term outcomes of enzyme replacement therapy in Fabry disease: Analysis of prognostic factors.
PLoS One
, 12
(8)
, Article e0182379. 10.1371/journal.pone.0182379.
|
|
|
Arends, M;
Biegstraaten, M;
Wanner, C;
Sirrs, S;
Mehta, A;
Elliott, PM;
Oder, D;
... Hollak, CEM; + view all
(2018)
Agalsidase alfa versus agalsidase beta for the treatment of Fabry disease: an international cohort study.
Journal of Medical Genetics
, 55
(5)
pp. 351-358.
10.1136/jmedgenet-2017-104863.
|
|
|
Arends, M;
Körver, S;
Hughes, DA;
Mehta, A;
Hollak, CEM;
Biegstraaten, M;
(2017)
Phenotype, disease severity and pain are major determinants of quality of life in Fabry disease: results from a large multicenter cohort study.
J Inherit Metab Dis
10.1007/s10545-017-0095-6.
(In press).
|
|
Arends, M;
Wanner, C;
Hughes, D;
Mehta, A;
Oder, D;
Watkinson, OT;
Elliott, PM;
... Hollak, CE; + view all
(2016)
Characterization of Classical and Nonclassical Fabry Disease: A Multicenter Study.
Journal of the American Society of Nephrology
, 28
(5)
pp. 1631-1641.
10.1681/ASN.2016090964.
|
|
|
Ariëns, RA;
Hunt, BJ;
Agbani, EO;
Ahnström, J;
Ahrends, R;
Alikhan, R;
Assinger, A;
... Zhou, J; + view all
(2022)
Illustrated State-of-the-Art Capsules of the ISTH 2022 Congress.
Research and Practice in Thrombosis and Haemostasis
, 6
(5)
, Article e12747. 10.1002/rth2.12747.
|
|
Artim-Esen, B;
Pericleous, C;
Mackie, I;
Ripoll, VM;
Latchman, D;
Isenberg, D;
Rahman, A;
... Giles, I; + view all
(2015)
Anti-factor Xa antibodies in patients with antiphospholipid syndrome and their effects upon coagulation assays.
Arthritis Research & Therapy
, 17
, Article 47. 10.1186/s13075-015-0568-7.
|
|
|
Artim-Esen, B;
Smoktunowicz, N;
McDonnell, T;
Ripoll, VM;
Pericleous, C;
Mackie, I;
Robinson, E;
... Giles, I; + view all
(2017)
Factor Xa Mediates Calcium Flux in Endothelial Cells and is Potentiated by Igg From Patients With Lupus and/or Antiphospholipid Syndrome.
Scientific Reports
, 7
(1)
, Article 10788. 10.1038/s41598-017-11315-9.
|
|
|
Ascierto, Paolo A;
Agarwala, Sanjiv S;
Blank, Christian;
Caraco, Corrado;
Carvajal, Richard D;
Ernstoff, Marc S;
Ferrone, Soldano;
... Thurin, Magdalena; + view all
(2022)
Perspectives in Melanoma: meeting report from the Melanoma Bridge (December 2nd – 4th, 2021, Italy).
Journal of Translational Medicine
, 20
, Article 391. 10.1186/s12967-022-03592-4.
|
|
Ascierto, PA;
Bifulco, C;
Galon, J;
Garbe, C;
Khleif, SN;
McQuade, J;
Odunsi, K;
... Puzanov, I; + view all
(2020)
The Great Debate at 'Immunotherapy Bridge', Naples, December 5, 2019.
Journal for ImmunoTherapy of Cancer
, 8
(2)
, Article e000921. 10.1136/jitc-2020-000921.
|
|
|
Ascierto, PA;
Blank, C;
Dummer, R;
Ernstoff, MS;
Ferrone, S;
Fox, BA;
Gajewski, TF;
... Thurin, M; + view all
(2021)
Perspectives in Melanoma: meeting report from the Melanoma Bridge (December 3rd-5th, 2020, Italy).
Journal of Translational Medicine
, 19
, Article 278. 10.1186/s12967-021-02951-x.
|
|
|
Ashby, C;
Boyle, EM;
Bauer, MA;
Mikulasova, A;
Wardell, CP;
Williams, L;
Siegel, A;
... Morgan, GJ; + view all
(2022)
Structural variants shape the genomic landscape and clinical outcome of multiple myeloma.
Blood Cancer Journal
, 12
(5)
, Article 85. 10.1038/s41408-022-00673-x.
|
|
|
Asher, Samir;
Kazantzi, Aikaterini;
Dekaj, Fatjon;
Steventon, Luke;
Khatun, Aisha;
Ainley, Louise;
McMillan, Annabel;
... Popat, Rakesh; + view all
(2022)
Under-representation of ethnic minorities in early phase clinical trials for multiple myeloma.
Haematologica
, 107
(12)
pp. 2961-2965.
10.3324/haematol.2022.281322.
|
|
Aswendt, M;
Vogel, S;
Schaefer, C;
Jathoul, A;
Pule, M;
Hoehn, M;
(2019)
Quantitative in vivo dual-color bioluminescence imaging in the mouse brain.
Neurophotonics
, 6
(2)
, Article 025006. 10.1117/1.NPh.6.2.025006.
|
|
|
Atkin, C;
Iqbal, G;
Planche, T;
Pratt, G;
Yong, K;
Wood, J;
Raynes, K;
... Trial Investigators; + view all
(2020)
Diagnostic pathways in multiple myeloma and their relationship to end organ damage: an analysis from the Tackling Early Morbidity and Mortality in Myeloma (TEAMM) trial.
British Journal of Haematology
10.1111/bjh.17044.
(In press).
|
|
|
Au, L;
Hatipoglu, E;
Robert de Massy, M;
Litchfield, K;
Beattie, G;
Rowan, A;
Schnidrig, D;
... TRACERx Renal Consortium; + view all
(2021)
Determinants of anti-PD-1 response and resistance in clear cell renal cell carcinoma.
Cancer Cell
, 39
pp. 1497-1518.
10.1016/j.ccell.2021.10.001.
|
|
|
Aubert, G.;
(2004)
Molecular detection, monitoring and modulation of antigen specific immune responses.
Doctoral thesis , University of London.
|
|
Augusto, JB;
Johner, N;
Shah, D;
Nordin, S;
Knott, KD;
Rosmini, S;
Lau, C;
... Namdar, M; + view all
(2020)
The myocardial phenotype of Fabry disease pre-hypertrophy and pre-detectable storage.
European Heart Journal: Cardiovascular Imaging
10.1093/ehjci/jeaa101.
(In press).
|
|
|
Augusto, JB;
Nordin, S;
Vijapurapu, R;
Baig, S;
Bulluck, H;
Castelletti, S;
Alfarih, M;
... Moon, JC; + view all
(2020)
Myocardial Edema, Myocyte Injury, and Disease Severity in Fabry Disease.
Circulation: Cardiovascular Imaging
, 13
(3)
, Article e010171. 10.1161/CIRCIMAGING.119.010171.
|
|
|
Auner, HW;
Yong, KL;
(2018)
More convenient proteasome inhibition for improved outcomes.
Lancet Oncology
, 19
(7)
pp. 856-858.
10.1016/S1470-2045(18)30411-X.
|
|
|
Avenali, M;
Caminiti, SP;
Gegg, M;
Cerri, S;
Mitrotti, P;
Bandirali, L;
Toffoli, M;
... Blandini, F; + view all
(2025)
Combined Assessment of Blood Glucocerebrosidase Activity and Α-Synuclein Levels in Gba1 Mutation Carriers: a Novel Potential Biomarker.
Parkinsonism and Related Disorders
, 135
, Article 107854. 10.1016/j.parkreldis.2025.107854.
|
|
Avenali, M;
Toffoli, M;
Mullin, S;
McNeil, A;
Hughes, DA;
Mehta, A;
Blandini, F;
(2019)
Evolution of prodromal parkinsonian features in a cohort of GBA mutation-positive individuals: a 6-year longitudinal study.
Journal of Neurology, Neurosurgery & Psychiatry
10.1136/jnnp-2019-320394.
(In press).
|
|
Avenoso, D;
Marsh, JCW;
Potter, V;
Pagliuca, A;
Slade, S;
Dignan, F;
Tholouli, E;
... Kulasekararaj, AG; + view all
(2021)
SARS-CoV-2 infection in aplastic anaemia.
Haematologica
10.3324/haematol.2021.279928.
(In press).
|
|
Awan, M;
Buriak, I;
Fleck, R;
Fuller, B;
Goltsev, A;
Kerby, J;
Lowdell, M;
... Stacey, GN; + view all
(2020)
Dimethyl sulfoxide: a central player since the dawn of cryobiology, is efficacy balanced by toxicity?
Regenerative Medicine
, 15
(3)
10.2217/rme-2019-0145.
|
|
|
Ayto, R.M.;
(2011)
Investigation of the linkage between Gaucher disease and BCell
disorders including multiple myeloma.
Doctoral thesis , UCL (University College London).
|
|
B
|
Backen, AC;
Lopes, A;
Wasan, H;
Palmer, DH;
Duggan, M;
Cunningham, D;
Anthoney, A;
... Valle, JW; + view all
(2018)
Circulating biomarkers during treatment in patients with advanced biliary tract cancer receiving cediranib in the UK ABC-03 trial.
British Journal of Cancer
, 119
pp. 27-35.
10.1038/s41416-018-0132-8.
|
|
|
Badar, A;
Kiru, L;
Kalber, TL;
Jathoul, A;
Straathof, K;
Årstad, E;
Lythgoe, MF;
(2015)
Fluorescence-guided development of a tricistronic vector encoding bimodal optical and nuclear genetic reporters for in vivo cellular imaging.
EJNMMI Res
, 5
, Article 18. 10.1186/s13550-015-0097-z.
|
|
Bailey, C;
Black, JRM;
Reading, JL;
Litchfield, K;
Turajlic, S;
McGranahan, N;
Jamal-Hanjani, M;
(2021)
Tracking Cancer Evolution through the Disease Course.
Cancer Discovery
, 11
(4)
pp. 916-932.
10.1158/2159-8290.CD-20-1559.
|
|
Bakhai, Ameet;
McCauley, Leah;
Stones, Liba;
Khalil, Saria;
Mehta, Jay;
Price, Nicola;
Krishnamurthy, Vinodh;
... Hughes, Derralynn; + view all
(2022)
Shining a light on an additional clinical burden: work-related digital communication survey study – COVID-19 impact on NHS staff wellbeing.
Humanities and Social Sciences Communications
, 9
, Article 414. 10.1057/s41599-022-01427-7.
|
|
Balbi, Gustavo GM;
Ahmadzadeh, Yasaman;
Tektonidou, Maria G;
Pengo, Vittorio;
Sciascia, Savino;
Ugarte, Amaia;
Belmont, H Michael;
... Oliveira de Andrade, Danieli Castro; + view all
(2024)
Damage measured by Damage Index for Antiphospholipid Syndrome (DIAPS) in antiphospholipid antibody-positive patients included in the APS ACTION registry.
Rheumatology
, 63
(3)
pp. 772-779.
10.1093/rheumatology/kead292.
|
|
Baldomero, Helen;
Neumann, Daniel;
Hamad, Nada;
Atsuta, Yoshiko;
Sureda, Anna;
Iida, Minako;
Karduss, Amado;
... Niederwieser, Dietger; + view all
(2024)
The role of registries in hematological disorders.
Best Practice & Research Clinical Haematology
, 37
(2)
, Article 101556. 10.1016/j.beha.2024.101556.
|
|
|
Balestrini, S;
Koepp, MJ;
Gandhi, S;
Rickman, HM;
Yen Shin, G;
Houlihan, CF;
Anders-Cannon, J;
... Sisodiya, SM; + view all
(2021)
Clinical outcomes of COVID-19 in long-term care facilities for people with epilepsy.
Epilepsy & Behavior
, 115
, Article 107602. 10.1016/j.yebeh.2020.107602.
|
|
Banales, JM;
Marin, JJG;
Lamarca, A;
Rodrigues, PM;
Khan, SA;
Roberts, LR;
Cardinale, V;
... Gores, GJ; + view all
(2020)
Cholangiocarcinoma 2020: the next horizon in mechanisms and management.
Nature Reviews Gastroenterology & Hepatology
10.1038/s41575-020-0310-z.
(In press).
|
|
|
Banerjee, G;
Ambler, G;
Wilson, D;
Hostettler, IC;
Shakeshaft, C;
Lunawat, S;
Cohen, H;
... CROMIS-2 collaborators, .; + view all
(2020)
Baseline factors associated with early and late death in intracerebral haemorrhage survivors.
European Journal of Neurology
, 27
(7)
pp. 1257-1263.
10.1111/ene.14238.
|
|
|
Banerjee, G;
Chan, E;
Ambler, G;
Wilson, D;
Cipolotti, L;
Shakeshaft, C;
Cohen, H;
... CROMIS‐2 Collaborators, *; + view all
(2020)
Cognitive Impairment Before Atrial Fibrillation-Related Ischemic Events: Neuroimaging and Prognostic Associations.
Journal of the American Heart Association
, 9
(1)
, Article e014537. 10.1161/JAHA.119.014537.
|
|
|
Banerjee, G;
Chan, E;
Ambler, G;
Wilson, D;
Cipolotti, L;
Shakeshaft, C;
Cohen, H;
... Vahidassr, D; + view all
(2019)
Effect of small-vessel disease on cognitive trajectory after atrial fibrillation-related ischaemic stroke or TIA.
Journal of Neurology
, 266
(5)
pp. 1250-1259.
10.1007/s00415-019-09256-6.
|
|
|
Banerjee, G;
Wilson, D;
Ambler, G;
Hostettler, IC;
Shakeshaft, C;
Cohen, H;
Yousry, T;
... CROMIS-2 collaborators; + view all
(2020)
Longer term stroke risk in intracerebral haemorrhage survivors.
Journal of Neurology, Neurosurgery and Psychiatry
10.1136/jnnp-2020-323079.
(In press).
|
|
|
Banerjee, G;
Wilson, D;
Ambler, G;
Osei-Bonsu Appiah, K;
Shakeshaft, C;
Lunawat, S;
Cohen, H;
... CROMIS-2 Collaborators; + view all
(2017)
Cognitive Impairment Before Intracerebral Hemorrhage Is Associated With Cerebral Amyloid Angiopathy.
Stroke
, 49
pp. 40-45.
10.1161/STROKEAHA.117.019409.
|
|
|
Barker, Dominic J;
Maccari, Giuseppe;
Georgiou, Xenia;
Cooper, Michael A;
Flicek, Paul;
Robinson, James;
Marsh, Steven GE;
(2023)
The IPD-IMGT/HLA Database.
Nucleic Acids Research
, 51
(D1)
D1053-D1060.
10.1093/nar/gkac1011.
|
|
Barnes, Josephine L;
Yoshida, Masahiro;
He, Peng;
Worlock, Kaylee B;
Lindeboom, Rik GH;
Suo, Chenqu;
Pett, J Patrick;
... Nikolić, Marko Z; + view all
(2023)
Early human lung immune cell development and its role in epithelial cell fate.
Science Immunology
, 8
(90)
, Article eadf9988. 10.1126/sciimmunol.adf9988.
|
|
Barry, A;
Apisarnthanarax, S;
O'Kane, GM;
Sapisochin, G;
Beecroft, R;
Salem, R;
Yoon, SM;
... Hawkins, MA; + view all
(2020)
Management of primary hepatic malignancies during the COVID-19 pandemic: recommendations for risk mitigation from a multidisciplinary perspective.
The Lancet Gastroenterology & Hepatology
10.1016/S2468-1253(20)30182-5.
(In press).
|
|
Bassiony, Sarah;
Harrison, Claire N;
McLornan, Donal P;
(2020)
Evaluating the Safety, Efficacy, and Therapeutic Potential of Momelotinib in the Treatment of Intermediate/High-Risk Myelofibrosis: Evidence to Date.
Therapeutics and Clinical Risk Management
, 16
pp. 889-901.
10.2147/TCRM.S258704.
|
|
|
Battipaglia, Giorgia;
Polverelli, Nicola;
Tuffnell, Joe;
Chiusolo, Patrizia;
Robin, Marie;
Gambella, Massimiliano;
Broers, Annoek;
... McLornan, Donal P; + view all
(2025)
Evaluation and management of hepatic dysfunction, portal hypertension and portal/splanchnic vein thrombosis in patients with myelofibrosis undergoing allogeneic haematopoietic cell transplantation: A practice based survey on behalf of the Chronic Malignancies Working Party of the EBMT.
Current Research in Translational Medicine
, 73
(1)
, Article 103476. 10.1016/j.retram.2024.103476.
|
|
|
Batty, P;
(2025)
Making sense of factor VIII's breakdown.
Blood
, 146
(18)
pp. 2155-2156.
10.1182/blood.2025030522.
|
|
Batty, P;
Lillicrap, D;
(2021)
Hemophilia Gene Therapy: Approaching the First Licensed Product.
HemaSphere
, 5
(3)
, Article E540. 10.1097/HS9.0000000000000540.
|
|
|
Batty, P;
Mo, AM;
Hurlbut, D;
Ishida, J;
Yates, B;
Brown, C;
Harpell, L;
... Lillicrap, D; + view all
(2022)
Long-term follow-up of liver-directed, adeno-associated vector-mediated gene therapy in the canine model of hemophilia A.
Blood
, 140
(25)
pp. 2672-2683.
10.1182/blood.2021014735.
|
|
|
Batty, Paul;
Fong, Sylvia;
Franco, Matteo;
Sihn, Choong-Ryoul;
Swystun, Laura L;
Afzal, Saira;
Harpell, Lori M;
... Lillicrap, David; + view all
(2024)
Vector integration and fate in the hemophilia dog liver multi-years following AAV-FVIII gene transfer.
Blood
10.1182/blood.2023022589.
(In press).
|
|
Batty, Paul;
Lillicrap, David;
(2024)
Adeno-associated viral vector integration: implications for long-term efficacy and safety.
Journal of Thrombosis and Haemostasis
, 22
(11)
pp. 2945-2960.
10.1016/j.jtha.2024.07.012.
|
|
Batty, Paul;
Riddell, Anne;
Kitchen, Steve;
Sardo Infirri, Sofia;
Walker, Isobel;
Woods, Tim;
Jennings, Ian;
(2021)
Factor VIII/IX inhibitor testing practices in the United Kingdom: Results of a UKHCDO and UKNEQAS national survey.
Haemophilia
, 27
(3)
pp. 490-499.
10.1111/hae.14158.
|
|
Bayraktutan, Hulya;
Symonds, Peter;
Brentville, Victoria A;
Moloney, Cara;
Galley, Charlotte;
Bennett, Clare L;
Mata, Alvaro;
... Gurnani, Pratik; + view all
(2024)
Sparsely PEGylated poly(beta-amino ester) polyplexes enhance antigen specific T-cell response of a bivalent SARS-CoV-2 DNA vaccine.
Biomaterials
, Article 122647. 10.1016/j.biomaterials.2024.122647.
|
|
|
Bazarbachi, A;
Boumendil, A;
Finel, H;
Mohty, M;
Castagna, L;
Blaise, D;
Peggs, KS;
... Sureda, A; + view all
(2019)
Brentuximab vedotin for recurrent Hodgkin lymphoma after allogeneic hematopoietic stem cell transplantation: A report from the EBMT Lymphoma Working Party.
Cancer
, 125
(1)
pp. 90-98.
10.1002/cncr.31755.
|
|
Bazarbachi, A;
Boumendil, A;
Finel, H;
Mohty, M;
Castagna, L;
Peggs, KS;
Blaise, D;
... Sureda, A; + view all
(2018)
Brentuximab vedotin prior to allogeneic stem cell transplantation in Hodgkin lymphoma: a report from the EBMT Lymphoma Working Party.
British Journal of Haematology
, 181
(1)
pp. 86-96.
10.1111/bjh.15152.
|
|
Beaton, B;
Hughes, DA;
(2024)
Soluble mannose receptor: A potential biomarker in Gaucher disease.
European Journal of Haematology
10.1111/ejh.14171.
(In press).
|
|
Beavan, M;
McNeill, A;
Proukakis, C;
Hughes, DA;
Mehta, A;
Schapira, AH;
(2015)
Evolution of prodromal clinical markers of Parkinson disease in a GBA mutation-positive cohort.
JAMA Neurol
, 72
(2)
201 - 208.
10.1001/jamaneurol.2014.2950.
|
|
|
Beck, Michael;
Ramaswami, Uma;
Hernberg-Stahl, Elizabeth;
Hughes, Derralynn A;
Kampmann, Christoph;
Mehta, Atul B;
Nicholls, Kathleen;
... Giugliani, Roberto; + view all
(2022)
Twenty years of the Fabry Outcome Survey (FOS): insights, achievements, and lessons learned from a global patient registry.
Orphanet Journal of Rare Diseases
, 17
, Article 238. 10.1186/s13023-022-02392-9.
|
|
Beck, M;
Hughes, D;
Kampmann, C;
Pintos-Morell, G;
Ramaswami, U;
West, ML;
Giugliani, R;
(2018)
Long-term outcomes with agalsidase alfa enzyme replacement therapy: Analysis using deconstructed composite events.
Molecular Genetics and Metabolism Reports
, 14
pp. 31-35.
10.1016/j.ymgmr.2017.10.008.
|
|
|
Beelen, Dietrich Wilhelm;
Iacobelli, Simona;
Koster, Linda;
Eikema, Dirk-Jan;
van Biezen, Anja;
Stoelzel, Friedrich;
Ciceri, Fabio;
... Mohty, Mohamad; + view all
(2024)
Fludarabine-treosulfan versus fludarabine-melphalan or busulfan-cyclophosphamide conditioning in older AML or MDS patients - A clinical trial to registry data comparison.
Bone Marrow Transplantation
, 59
(5)
pp. 670-679.
10.1038/s41409-024-02241-2.
|
|
|
Bekaii-Saab, TS;
Bridgewater, J;
Normanno, N;
(2021)
Practical considerations in screening for genetic alterations in cholangiocarcinoma.
Annals of Oncology
10.1016/j.annonc.2021.04.012.
(In press).
|
|
|
Bekaii-Saab, TS;
Valle, JW;
Cutsem, EV;
Rimassa, L;
Furuse, J;
Ioka, T;
Melisi, D;
... Vogel, A; + view all
(2020)
FIGHT-302: first-line pemigatinib vs gemcitabine plus cisplatin for advanced cholangiocarcinoma with FGFR2 rearrangements.
Future Oncology
10.2217/fon-2020-0429.
(In press).
|
|
|
Beksac, Meral;
Eikema, Diderik-Jan;
Koster, Linda;
Hulin, Cyrille;
Poire, Xavier;
Hamladji, Rose-Marie;
Gromek, Tomasz;
... McLornan, Donal P; + view all
(2024)
In the era of Bortezomib-based Induction, intensification of Melphalan-based conditioning with Bortezomib does not improve Survival Outcomes in newly diagnosed Multiple Myeloma: a study from the Chronic Malignancies Working Party of the EBMT.
Bone Marrow Transplantation
, 59
(4)
pp. 526-533.
10.1038/s41409-023-02160-8.
|
|
|
Belmatoug, N;
Di Rocco, M;
Fraga, C;
Giraldo, P;
Hughes, D;
Lukina, E;
Maison-Blanche, P;
... Cox, TM; + view all
(2017)
Management and monitoring recommendations for the use of eliglustat in adults with type 1 Gaucher disease in Europe.
[Review].
European Journal of Internal Medicine
, 37
pp. 25-32.
10.1016/j.ejim.2016.07.011.
|
|
|
Benjamin, ER;
Della Valle, MC;
Wu, X;
Katz, E;
Pruthi, F;
Bond, S;
Bronfin, B;
... Lockhart, DJ; + view all
(2017)
The validation of pharmacogenetics for the identification of Fabry patients to be treated with migalastat.
Genetics in Medicine
, 19
(4)
pp. 430-438.
10.1038/gim.2016.122.
|
 |
|
Benjamin, LA;
Paterson, RW;
Moll, R;
Pericleous, C;
Brown, R;
Mehta, PR;
Athauda, D;
... Efthymiou, M; + view all
(2021)
Antiphospholipid antibodies and neurological manifestations in acute COVID-19: A single-centre cross-sectional study.
EClinicalMedicine
, Article 101070. 10.1016/j.eclinm.2021.101070.
(In press).
|
|
|
Bennett, CL;
van Rijn, E;
Jung, S;
Inaba, K;
Steinman, RM;
Kapsenberg, ML;
Clausen, BE;
(2005)
Inducible ablation of mouse Langerhans cells diminishes but fails to abrogate contact hypersensitivity.
JOURNAL OF CELL BIOLOGY
, 169
(4)
pp. 569-576.
10.1083/jcb.200501071.
|
|
|
Bennett, Clare;
(2022)
Loss of T cell tolerance in the skin following immunopathology is linked to failed restoration of the dermal niche by recruited macrophages.
Cell Reports
, 39
(7)
, Article 110819. 10.1016/j.celrep.2022.110819.
|
|
Bennett, Clare L;
Perona-Wright, Georgia;
(2023)
Metabolic adaption of mucosal macrophages: Is metabolism a driver of persistence across tissues?
Mucosal Immunology
10.1016/j.mucimm.2023.06.006.
(In press).
|
|
Bennett, CL;
(2021)
Switching between tolerance and immunity: Do counter-acting gene networks dictate Langerhans cell function in the skin?
BioEssays
, 43
(5)
, Article 2100072. 10.1002/bies.202100072.
|
|
|
Bennett, CL;
Ambler, CA;
(2019)
Editorial: Langerhans Cells and How Skin Pathology Reshapes the Local Immune Environment.
Frontiers in Immunology
, 10
, Article 139. 10.3389/fimmu.2019.00139.
|
|
|
Bennett, CL;
Chakraverty, R;
(2012)
Dendritic cells in tissues: in situ stimulation of immunity and immunopathology.
Trends in Immunology
, 33
(1)
pp. 8-13.
10.1016/j.it.2011.09.008.
|
|
Benson, AB;
Kiss, I;
Bridgewater, J;
Eskens, FALM;
Sasse, C;
Vossen, S;
Chen, J;
... Krivoshik, A; + view all
(2016)
BATON-CRC: A Phase II Randomized Trial Comparing Tivozanib Plus mFOLFOX6 with Bevacizumab Plus mFOLFOX6 in Stage IV Metastatic Colorectal Cancer.
Clinical Cancer Research
, 22
(20)
pp. 5058-5067.
10.1158/1078-0432.CCR-15-3117.
|
|
Bentham, R;
Litchfield, K;
Watkins, TBK;
Lim, EL;
Rosenthal, R;
Martinez-Ruiz, C;
Hiley, CT;
... McGranahan, N; + view all
(2021)
Using DNA sequencing data to quantify T cell fraction and therapy response.
Nature
, 597
pp. 555-560.
10.1038/s41586-021-03894-5.
|
|
Bentzen, AK;
Marquard, AM;
Lyngaa, R;
Saini, SK;
Ramskov, S;
Donia, M;
Such, L;
... Hadrup, SR; + view all
(2016)
Large-scale detection of antigen-specific T cells using peptide-MHC-I multimers labeled with DNA barcodes.
Nature Biotechnology
, 34
(10)
pp. 1037-1045.
10.1038/nbt.3662.
|
|
|
Bergerhoff, KF;
(2016)
Cellular and molecular events controlling acquisition of cytotoxic activity by melanoma-reactive CD4⁺ T cells in vivo.
Doctoral thesis , UCL (University College London).
|
|
Berlato, C;
Khan, MN;
Schioppa, T;
Thompson, R;
Maniati, E;
Montfort, A;
Jangani, M;
... Balkwill, FR; + view all
(2017)
A CCR4 antagonist reverses the tumor-promoting microenvironment of renal cancer.
Journal of Clinical Investigation
, 127
(3)
pp. 801-813.
10.1172/JCI82976.
|
|
|
Best, JG;
Ambler, G;
Wilson, D;
Lee, K-J;
Lim, J-S;
Shiozawa, M;
Koga, M;
... Werring, DJ; + view all
(2021)
Development of imaging-based risk scores for prediction of intracranial haemorrhage and ischaemic stroke in patients taking antithrombotic therapy after ischaemic stroke or transient ischaemic attack: a pooled analysis of individual patient data from cohort studies.
The Lancet Neurology
, 20
(4)
pp. 294-303.
10.1016/S1474-4422(21)00024-7.
|
|
Best, Jonathan G;
Arram, Liz;
Ahmed, Norin;
Balogun, Maryam;
Bennett, Kate;
Bordea, Ekaterina;
Campos, Marta G;
... OPTIMAS investigators, .; + view all
(2022)
Optimal timing of anticoagulation after acute ischemic stroke with atrial fibrillation (OPTIMAS): Protocol for a randomized controlled trial.
International Journal of Stroke
, 17
(5)
pp. 583-589.
10.1177/17474930211057722.
|
|
Best, JG;
Barbato, C;
Ambler, G;
Du, H;
Banerjee, G;
Wilson, D;
Shakeshaft, C;
... Clinical Relevance of Microbleeds in Stroke (CROMIS-2) collabora; + view all
(2020)
Association of enlarged perivascular spaces and anticoagulant-related intracranial hemorrhage.
Neurology
10.1212/WNL.0000000000010788.
(In press).
|
|
|
Beyrouti, R;
Adams, ME;
Benjamin, L;
Cohen, H;
Farmer, SF;
Goh, YY;
Humphries, F;
... Werring, DJ; + view all
(2020)
Characteristics of ischaemic stroke associated with COVID-19.
[Letter].
Journal of Neurology, Neurosurgery and Psychiatry
10.1136/jnnp-2020-323586.
(In press).
|
|
|
Bharucha, T;
Rutherford, A;
Skeoch, S;
Alavi, A;
Brown, M;
Galloway, J;
FDG-PET/CT in fever of unknown origin working group;
(2017)
Diagnostic yield of FDG-PET/CT in fever of unknown origin: a systematic review, meta-analysis, and Delphi exercise.
Clinical Radiology
, 72
(9)
pp. 764-771.
10.1016/j.crad.2017.04.014.
|
|
Biasco, L;
Izotova, N;
Rivat, C;
Ghorashian, S;
Richardson, R;
Guvenel, A;
Hough, R;
... Amrolia, PJ; + view all
(2021)
Clonal expansion of T memory stem cells determines early anti-leukemic responses and long-term CAR T cell persistence in patients.
Nature Cancer
, 2
pp. 629-64.
10.1038/s43018-021-00207-7.
|
|
Bichet, DG;
Hopkin, RJ;
Aguiar, P;
Allam, SR;
Chien, YH;
Giugliani, R;
Kallish, S;
... Hughes, DA; + view all
(2023)
Consensus recommendations for the treatment and management of patients with Fabry disease on migalastat: a modified Delphi study.
Frontiers in Medicine
, 10
, Article 1220637. 10.3389/fmed.2023.1220637.
|
|
|
Bichet, DG;
Torra, R;
Wallace, E;
Hughes, D;
Giugliani, R;
Skuban, N;
Krusinska, E;
... Nicholls, K; + view all
(2021)
Long-term follow-up of renal function in patients treated with migalastat for Fabry disease.
Molecular Genetics and Metabolism Reports
, 28
, Article 100786. 10.1016/j.ymgmr.2021.100786.
|
|
|
Biegstraaten, M;
Cox, TM;
Belmatoug, N;
Berger, MG;
Collin-Histed, T;
Vom Dahl, S;
Di Rocco, M;
... Hollak, CE; + view all
(2018)
Management goals for type 1 Gaucher disease: An expert consensus document from the European working group on Gaucher disease.
Blood Cells, Molecules, and Diseases
, 68
pp. 203-208.
10.1016/j.bcmd.2016.10.008.
|
|
Bird, S;
Hadjimichael, E;
Mehta, A;
Ramaswami, U;
Hughes, D;
(2017)
Fabry disease and incidence of cancer.
Orphanet Journal of Rare Diseases
, 12
(1)
, Article 150. 10.1186/s13023-017-0701-6.
|
|
|
Biswas, D;
Birkbak, NJ;
Rosenthal, R;
Hiley, CT;
Lim, EL;
Papp, K;
Boeing, S;
... TRACERx Consortium; + view all
(2019)
A clonal expression biomarker associates with lung cancer mortality.
Nature Medicine
, 25
pp. 1540-1548.
10.1038/s41591-019-0595-z.
|
|
Bjorkqvist, M;
Wild, EJ;
Thiele, J;
Silvestroni, A;
Andre, R;
Lahiri, N;
Raibon, E;
... Tabrizi, SJ; + view all
(2008)
A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington's disease.
Journal of Experimental Medicine
, 205
(8)
1869 - 1877.
10.1084/jem.20080178.
|
|
|
Bochtler, W;
Gragert, L;
Patel, ZI;
Robinson, J;
Steiner, D;
Hofmann, JA;
Pingel, J;
... Mueller, CR; + view all
(2016)
A comparative reference study for the validation of HLA-matching algorithms in the search for allogeneic hematopoietic stem cell donors and cord blood units.
HLA
, 87
(6)
pp. 439-448.
10.1111/tan.12817.
|
|
|
Boire, A;
Coffelt, SB;
Quezada, SA;
Vander Heiden, MG;
Weeraratna, AT;
(2019)
Tumour Dormancy and Reawakening: Opportunities and Challenges.
Trends in Cancer
, 5
(12)
pp. 762-765.
10.1016/j.trecan.2019.10.010.
|
|
Borrello, T;
Tam, CH;
Shafat, M;
Rushworth, S;
Bowles, K;
Bailey, S;
Crabb, S;
... Douglas, L; + view all
(2020)
Synthesis of Carboxamides Tranylcypromine Analogues as LSD1 (KDM1A) Inhibitors for AML.
ChemRxiv: Cambridge, UK.
|
|
Boto, C;
Quartin, E;
Cai, Y;
Martin-Lorenzo, A;
Garcia Cenador, MB;
Pinto, S;
Gupta, R;
... Ferreira, L; + view all
(2017)
Prolonged intracellular accumulation of light-inducible nanoparticles in leukemia cells allows their remote activation.
Nature Communications
, 8
, Article 15204. 10.1038/ncomms15204.
|
|
Bove, Camilla;
Arcangeli, Silvia;
Falcone, Laura;
Camisa, Barbara;
El Khoury, Rita;
Greco, Beatrice;
De Lucia, Anna;
... Casucci, Monica; + view all
(2023)
CD4 CAR-T cells targeting CD19 play a key role in exacerbating cytokine release syndrome, while maintaining long-term responses.
Journal for ImmunoTherapy of Cancer
, 11
(1)
, Article e005878. 10.1136/jitc-2022-005878.
|
|
|
Bowcock, Stella;
Atkin, Catherine;
Iqbal, Gulnaz;
Pratt, Guy;
Yong, Kwee;
Neal, Richard D;
Planche, Tim;
... Drayson, Mark T; + view all
(2023)
Presenting Symptoms in Newly Diagnosed Myeloma, Relation to Organ Damage, and Implications for Symptom-Directed Screening: A Secondary Analysis from the Tackling Early Morbidity and Mortality in Myeloma (TEAMM) Trial.
Cancers
, 15
(13)
, Article 3337. 10.3390/cancers15133337.
|
|
|
Boyle, Eileen M;
Deshpande, Shayu;
Tytarenko, Ruslana;
Ashby, Cody;
Wang, Yan;
Bauer, Michael A;
Johnson, Sarah K;
... Walker, Brian A; + view all
(2021)
The molecular make up of smoldering myeloma highlights the evolutionary pathways leading to multiple myeloma.
Nature Communications
, 12
, Article 293. 10.1038/s41467-020-20524-2.
|
|
|
Braso-Maristany, F;
Filosto, S;
Catchpole, S;
Marlow, R;
Quist, J;
Francesch-Domenech, E;
Plumb, DA;
... Tutt, AN; + view all
(2016)
PIM1 kinase regulates cell death, tumor growth and chemotherapy response in triple-negative breast cancer.
Nature Medicine
, 22
(11)
pp. 1303-1313.
10.1038/nm.4198.
|
|
|
Bridgewater, John;
Fletcher, Peter;
Palmer, Daniel H;
Malik, Hassan Z;
Prasad, Raj;
Mirza, Darius;
Anthony, Alan;
... BILCAP study group, .; + view all
(2022)
Long-Term Outcomes and Exploratory Analyses of the Randomized Phase III BILCAP Study.
Journal of Clinical Oncology
, 40
(18)
pp. 2048-2057.
10.1200/JCO.21.02568.
|
|
Bridgewater, John;
Jiao, Xiaolong;
Parimi, Mounika;
Flach, Clare;
Stratford, Jeran;
Kamburov, Atanas;
Schmitz, Arndt A;
... Bazhenova, Lyudmila; + view all
(2022)
Prognosis and oncogenomic profiling of patients with tropomyosin receptor kinase fusion cancer in the 100,000 genomes project.
Cancer Treatment and Research Communications
, 33
, Article 100623. 10.1016/j.ctarc.2022.100623.
|
|
Bridgewater, J;
(2019)
Systemic treatment of biliary tract cancer: now we have evidence.
Annals of Oncology
, 30
(12)
pp. 1851-1852.
10.1093/annonc/mdz441.
|
|
Bridgewater, J;
Lopes, A;
Beare, S;
Duggan, M;
Lee, D;
Ricamara, M;
McEntee, D;
... Valle, JW; + view all
(2016)
A phase 1b study of Selumetinib in combination with Cisplatin and Gemcitabine in advanced or metastatic biliary tract cancer: the ABC-04 study.
BMC Cancer
, 16
(1)
p. 153.
10.1186/s12885-016-2174-8.
|
|
|
Bridgewater, JA;
Pugh, SA;
Maishman, T;
Eminton, Z;
Mellor, J;
Whitehead, A;
Stanton, L;
... New EPOC investigators; + view all
(2020)
Systemic chemotherapy with or without cetuximab in patients with resectable colorectal liver metastasis (New EPOC): long-term results of a multicentre, randomised, controlled, phase 3 trial.
The Lancet Oncology
, 21
(3)
pp. 398-411.
10.1016/S1470-2045(19)30798-3.
|
|
|
Brimble, MA;
Cheng, PH;
Winston, SM;
Reeves, IL;
Souquette, A;
Spence, Y;
Zhou, J;
... Davidoff, AM; + view all
(2022)
Preventing packaging of translatable P5-associated DNA contaminants in recombinant AAV vector preps.
Molecular Therapy - Methods and Clinical Development
, 24
pp. 280-291.
10.1016/j.omtm.2022.01.008.
(In press).
|
|
|
Brimble, Mark;
Morton, Christopher L;
Winston, Stephen M;
Reeves, Isaiah L;
Spence, Yunyu;
Cheng, Pei-Hsin;
Zhou, Jungfang;
... Davidoff, Andrew M; + view all
(2024)
Pre-existing immunity to a nucleic acid contaminant-derived antigen mediates transaminitis and resultant diminished transgene expression in a mouse model of hepatic rAAV-mediated gene transfer.
Human Gene Therapy
10.1089/hum.2023.188.
(In press).
|
|
Brimble, MA;
Zhou, J;
Morton, C;
Meagher, M;
Nathwani, AC;
Gray, JT;
Davidoff, AM;
(2016)
AAV Preparations Contain Contamination from DNA Sequences in Production Plasmids Directly Outside of the ITRs.
Presented at: 19th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT), Washington DC, USA.
|
|
|
Brown, S;
Hinsley, S;
Ballesteros, M;
Bourne, S;
McGarry, P;
Sherratt, D;
Flanagan, L;
... Myeloma UK Clinical Trials Network, .; + view all
(2016)
The MUK five protocol: a phase II randomised, controlled, parallel group, multi-centre trial of carfilzomib, cyclophosphamide and dexamethasone (CCD) vs. cyclophosphamide, bortezomib (Velcade) and dexamethasone (CVD) for first relapse and primary refractory multiple myeloma.
BMC Hematology
, 16
, Article 14. 10.1186/s12878-016-0053-9.
|
|
Buck, Caroline;
Castillo, Francisco Brenes;
Bettio, Elena;
Land, Joanne;
Mccourt, Orla;
Poole, Helen;
Tarling, Rachel;
... Sive, Jonathan; + view all
(2024)
The impact of continuous lenalidomide maintenance treatment on people living with multiple myeloma-a single-centre, qualitative service evaluation study.
Supportive Care in Cancer
, 32
(7)
, Article 479. 10.1007/s00520-024-08663-4.
|
|
|
Bultitude, Will P.;
(2020)
Generating full-length Killer-cell Immunoglobulin-like Receptor (KIR) gene sequences using Third Generation long-amplicon sequencing to assess the impact of KIR polymorphism on Haematopoietic Cell Transplantation outcomes.
Doctoral thesis (Ph.D), UCL (University College London).
|
|
Bultitude, WP;
Schellekens, J;
Szydlo, RM;
Anthias, C;
Cooley, SA;
Miller, JS;
Weisdorf, DJ;
... Marsh, SGE; + view all
(2020)
Presence of donor-encoded centromeric KIR B content increases the risk of infectious mortality in recipients of myeloablative, T-cell deplete, HLA-matched HCT to treat AML.
Bone Marrow Transplantation
, 55
pp. 1975-1984.
10.1038/s41409-020-0858-9.
|
|
Burlina, A;
Brand, E;
Hughes, D;
Kantola, I;
Krӓmer, J;
Nowak, A;
Tøndel, C;
... Spada, M; + view all
(2023)
An expert consensus on the recommendations for the use of biomarkers in Fabry disease.
Molecular Genetics and Metabolism
, 139
(2)
, Article 107585. 10.1016/j.ymgme.2023.107585.
|
|
|
Burnett, AK;
Das Gupta, E;
Knapper, S;
Khwaja, A;
Sweeney, M;
Kjeldsen, L;
Hawkins, T;
... Russell, NH; + view all
(2018)
The Addition Of The MTORr Inhibitor, Everolimus, To Consolidation Therapy In Acute Myeloid Leukaemia: Experience From The UK NCRI AML17 Trial.
Haematologica
10.3324/haematol.2018.189514.
(In press).
|
|
|
Burt, R;
Dey, A;
Aref, S;
Aguiar, M;
Akarca, A;
Bailey, K;
Day, W;
... Fielding, AK; + view all
(2019)
Activated stromal cells transfer mitochondria to rescue acute lymphoblastic leukemia cells from oxidative stress.
Blood
, 134
(17)
pp. 1415-1429.
10.1182/blood.2019001398.
|
|
Burt, R;
Warcel, D;
Fielding, AK;
(2019)
Blinatumomab, a bispecific B-cell and T-cell engaging antibody, in the treatment of B-cell malignancies.
Human Vaccines & Immunotherapeutics
, 15
(3)
pp. 594-602.
10.1080/21645515.2018.1540828.
|
|
Burt, Richard James;
(2020)
Defining the role of mesenchymal stromal cells in treatment resistance in acute lymphoblastic leukaemia.
Doctoral thesis (Ph.D), UCL (University College London).
|
|
|
Bustoros, Mark;
Anand, Shankara;
Sklavenitis-Pistofidis, Romanos;
Redd, Robert;
Boyle, Eileen M;
Zhitomirsky, Benny;
Dunford, Andrew J;
... Ghobrial, Irene M; + view all
(2022)
Genetic subtypes of smoldering multiple myeloma are associated with distinct pathogenic phenotypes and clinical outcomes.
Nature Communications
, 13
, Article 3449. 10.1038/s41467-022-30694-w.
|
|
Bustoros, M;
Sklavenitis-Pistofidis, R;
Park, J;
Redd, R;
Zhitomirsky, B;
Dunford, AJ;
Salem, K;
... Ghobrial, IM; + view all
(2020)
Genomic Profiling of Smoldering Multiple Myeloma Identifies Patients at a High Risk of Disease Progression.
Journal of Clinical Oncology
, 38
(21)
pp. 2380-2389.
10.1200/JCO.20.00437.
|
|
Butler, CR;
Hynds, RE;
Crowley, C;
Gowers, KH;
Partington, L;
Hamilton, NJ;
Carvalho, C;
... Janes, SM; + view all
(2017)
Vacuum-assisted decellularization: an accelerated protocol to generate tissue-engineered human tracheal scaffolds.
Biomaterials
, 124
pp. 95-105.
10.1016/j.biomaterials.2017.02.001.
|
|
|
Byrne, BJ;
Geberhiwot, T;
Barshop, BA;
Barohn, R;
Hughes, D;
Bratkovic, D;
Desnuelle, C;
... Walsh, L; + view all
(2017)
A study on the safety and efficacy of reveglucosidase alfa in patients with late-onset Pompe disease.
Orphanet Journal of Rare Diseases
, 12
, Article 144. 10.1186/s13023-017-0693-2.
|
|
C
|
C Sallan, Marta;
Filipsky, Filip;
Shi, Christina H;
Pontarini, Elena;
Terranova-Barberio, Manuela;
Beattie, Gordon;
Clear, Andrew;
... Braun, Andrejs; + view all
(2025)
Autophagy is an upstream mediator of chromatin dynamics in normal and autoimmune germinal centre B cells.
The Journal of Clinical Investigation
10.1172/jci178920.
(In press).
|
|
|
Calvisi, DF;
Boulter, L;
Vaquero, J;
Saborowski, A;
Fabris, L;
Rodrigues, PM;
Coulouarn, C;
... Saito, Y; + view all
(2023)
Criteria for preclinical models of cholangiocarcinoma: scientific and medical relevance.
Nature Reviews Gastroenterology and Hepatology
, 20
pp. 462-480.
10.1038/s41575-022-00739-y.
|
|
Camilleri, M;
Sive, J;
Wilson, W;
Pang, G;
Jenner, R;
Phillips, E;
Popat, R;
... Yong, K; + view all
(2021)
COVID-19 and myeloma clinical research - experience from the CARDAMON clinical trial.
British Journal of Haematology
, 192
(1)
E14-E16.
10.1111/bjh.17168.
|
|
Camilleri, M;
Cuadrado, M;
Phillips, E;
Wilson, W;
Jenner, R;
Pang, G;
Kamora, S;
... Yong, K; + view all
(2021)
Thrombotic microangiopathy in untreated myeloma patients receiving carfilzomib, cyclophosphamide and dexamethasone on the CARDAMON study.
British Journal of Haematology
10.1111/bjh.17377.
(In press).
|
|
|
Cappellini, MD;
Taher, AT;
Piga, A;
Shah, F;
Voskaridou, E;
Viprakasit, V;
Porter, JB;
... Oliva, EN; + view all
(2023)
Health-related quality of life in patients with β-thalassemia: Data from the phase 3 BELIEVE trial of luspatercept.
European Journal of Haematology
, 111
(1)
pp. 113-124.
10.1111/ejh.13975.
|
|
Cappellini, MD;
Cassiman, D;
Marinakis, T;
Rosenbaum, H;
Bauduer, F;
Bjerrum, OW;
Fraga, C;
... Villarrubia, J; + view all
(2016)
Investigating rare haematological disorders - A celebration of 10 years of the Sherlock Holmes symposia.
European Oncology and Haematology
, 12
(1)
pp. 55-61.
10.17925/EOH.2016.12.01.55.
|
|
|
Cappellini, MD;
Porter, J;
Origa, R;
Forni, GL;
Voskaridou, E;
Galacteros, F;
Taher, AT;
... Hermine, O; + view all
(2019)
Sotatercept, a novel transforming growth factor beta ligand trap, improves anemia in beta-thalassemia: a phase II, open-label, dose-finding study.
Haematologica
, 104
(3)
pp. 477-484.
10.3324/haematol.2018.198887.
|
|
|
Cappellini, MD;
Porter, JB;
Viprakasit, V;
Taher, AT;
(2018)
A paradigm shift on beta-thalassaemia treatment: How will we manage this old disease with new therapies?
Blood Reviews
, 32
(4)
pp. 300-311.
10.1016/j.blre.2018.02.001.
|
|
|
Cappellini, MD;
Viprakasit, V;
Taher, AT;
Georgiev, P;
Kuo, KHM;
Coates, T;
Voskaridou, E;
... BELIEVE Investigators; + view all
(2020)
A Phase 3 Trial of Luspatercept in Patients with Transfusion-Dependent β-Thalassemia.
The New England Journal of Medicine
, 382
(13)
pp. 1219-1231.
10.1056/NEJMoa1910182.
|
|
Carbó, JM;
León, TE;
Font-Díaz, J;
De la Rosa, JV;
Castrillo, A;
Picard, FR;
Staudenraus, D;
... Valledor, AF; + view all
(2021)
Pharmacologic Activation of LXR Alters the Expression Profile of Tumor-Associated Macrophages and the Abundance of Regulatory T Cells in the Tumor Microenvironment.
Cancer Research
, 81
(4)
pp. 968-985.
10.1158/0008-5472.CAN-19-3360.
|
|
Carpenter, BJM;
(2014)
Targeting Therapeutic T Cells To Tumour Niches.
Doctoral thesis , UCL (University College London).
|
|
Carpenter, JP;
Alpendurada, F;
Deac, M;
Maceira, A;
Garbowski, M;
Kirk, P;
Walker, JM;
... Pennell, DJ; + view all
(2010)
Right ventricular volumes and function in thalassemia major patients in the absence of myocardial iron overload.
Journal of Cardiovascular Magnetic Resonance
, 12
, Article 24. 10.1186/1532-429X-12-24.
|
|
|
Carter, TJ;
Agliardi, G;
Lin, F-Y;
Ellis, M;
Jones, C;
Robson, M;
Richard-Londt, A;
... Chester, K; + view all
(2021)
Potential of Magnetic Hyperthermia to Stimulate Localized Immune Activation.
Small
, Article e2005241. 10.1002/smll.202005241.
(In press).
|
|
|
Carty, F;
Corbett, JM;
Cunha, JPMCM;
Reading, JL;
Tree, TIM;
Ting, AE;
Stubblefield, SR;
(2018)
Multipotent Adult Progenitor Cells Suppress T Cell Activation in In Vivo Models of Homeostatic Proliferation in a Prostaglandin E2-Dependent Manner.
Frontiers In Immunology
, 9
, Article 645. 10.3389/fimmu.2018.00645.
|
|
|
Cashman, Helen;
Wilson, Andrew J;
Xu, Ke;
Nacheva, Elisabeth;
Baker, Robert;
Gupta, Rajeev;
(2024)
Untangling the clonal architecture in a case of acute myeloid leukaemia with multiple cytogenetically unrelated clones.
Clinical Hematology International
, 6
(4)
pp. 1-4.
10.46989/001c.124931.
|
|
Castet, Florian;
Fabregat-Franco, Carles;
Bridgewater, John;
Kim, Jin Won;
Rimini, Margherita;
La Casta, Adelaida;
Lamarca, Angela;
... DURVABTC Group, Group; + view all
(2025)
Association of candidate surrogate endpoints with overall survival in advanced biliary tract cancer.
Journal of Hepatology
10.1016/j.jhep.2025.05.020.
(In press).
|
|
Castillo, Simon P;
Galvez-Cancino, Felipe;
Liu, Jiali;
Pollard, Steven M;
Quezada, Sergio A;
Yuan, Yinyin;
(2023)
The tumour ecology of quiescence: Niches across scales of complexity.
Seminars in Cancer Biology
, 92
pp. 139-149.
10.1016/j.semcancer.2023.04.004.
|
|
Castillo, Stephania Contreras;
Montibus, Bertille;
Rocha, Azucena;
Duke, Will;
von Meyenn, Ferdinand;
McLornan, Donal;
Harrison, Claire;
... Oakey, Rebecca J; + view all
(2021)
Hydroxycarbamide effects on DNA methylation and gene expression in myeloproliferative neoplasms.
Genome Research
, 31
(8)
pp. 1381-1394.
10.1101/gr.270066.120.
|
|
|
Castleton, AZ;
(2014)
Oncolytic measles virus and mesenchymal stromal cells: A therapeutic model and a dissection of mechanisms of action.
Doctoral thesis , UCL (University College London).
|
 |
|
Cavenagh, J;
Oakervee, H;
Baetiong-Caguioa, P;
Davies, F;
Gharibo, M;
Rabin, N;
Kurman, M;
... Yong, K; + view all
(2017)
A phase I/II study of KW-2478, an Hsp90 inhibitor, in combination with bortezomib in patients with relapsed/refractory multiple myeloma.
British Journal of Cancer
, 117
(9)
pp. 1295-1302.
10.1038/bjc.2017.302.
|
|
|
Caxaria, SMGL;
(2016)
Induced pluripotent stem cells (iPSCs) for research and therapy: induction of hepatic differentiation in iPSCs and evaluation of their quality as a model of in vivo development in the context of coagulation.
Doctoral thesis , UCL (University College London).
|
|
|
Cecchi, Irene;
Radin, Massimo;
Foddai, Silvia Grazietta;
Barinotti, Alice;
Andrade, Danieli;
Tektonidou, Maria G;
Pengo, Vittorio;
... Sciascia, Savino; + view all
(2025)
ANA-positive versus ANA-negative Antiphospholipid Antibody-positive Patients: Results from the APS ACTION Clinical Database and Repository.
Rheumatology
, 64
(5)
pp. 2862-2867.
10.1093/rheumatology/keae583.
|
|
Chaganti, S;
Illidge, T;
Barrington, S;
Mckay, P;
Linton, K;
Cwynarski, K;
McMillan, A;
... British Committee for Standards in Haematology, British Committee for Standards in Haematology; + view all
(2016)
Guidelines for the management of diffuse large B-cell lymphoma.
Br J Haematol
, 174
(1)
pp. 43-56.
10.1111/bjh.14136.
|
|
|
Chakrabarti, S.;
Mackinnon, S.;
Chopra, R.;
Kottaridis, P.D.;
Peggs, K.;
O'Gorman, P.;
Chakraverty, R.;
... Milligan, D.W.; + view all
(2002)
High incidence of cytomegalovirus infection after nonmyeloablative stem cell transplantation: potential role of Campath-1H in delaying immune reconstitution.
Blood
, 99
(12)
pp. 4357-4363.
10.1182/blood.V99.12.4357.
|
|
|
Chakravarthy, A;
Furness, A;
Joshi, K;
Ghorani, E;
Ford, K;
Ward, MJ;
King, EV;
... Fenton, TR; + view all
(2018)
Author Correction: Pan-cancer deconvolution of tumour composition using DNA methylation.
[Corrigendum].
Nature Communications
, 9
, Article 4642. 10.1038/s41467-018-07155-4.
|
|
|
Chakravarthy, A;
Furness, A;
Joshi, K;
Ghorani, E;
Ford, K;
Ward, MJ;
King, EV;
... Fenton, TR; + view all
(2018)
Pan-cancer deconvolution of tumour composition using DNA methylation.
Nature Communications
, 9
, Article 3220. 10.1038/s41467-018-05570-1.
|
 |
|
Chakraverty, R;
Cote, D;
Buchli, J;
Cotter, P;
Hsu, R;
Zhao, GL;
Sachs, T;
... Sykes, M; + view all
(2006)
An inflammatory checkpoint regulates recruitment of graft-versus-host reactive T cells to peripheral tissues.
J EXP MED
, 203
(8)
2021 - 2031.
10.1084/jem.20060376.
|
|
|
Chalandon, Yves;
Eikema, Diderik-Jan;
Moiseev, Ivan;
Ciceri, Fabio;
Koster, Linda;
Vydra, Jan;
Passweg, Jakob;
... Robin, Marie; + view all
(2024)
Unrelated donor transplantation with posttransplant cyclophosphamide vs ATG for myelodysplastic neoplasms.
Blood Advances
, 8
(18)
pp. 4792-4802.
10.1182/bloodadvances.2024013468.
|
|
Chan, E;
Sammaraiee, Y;
Banerjee, G;
Martin, AF;
Farmer, S;
Cowley, P;
Sayal, P;
... Werring, DJ; + view all
(2021)
Neuropsychological and neuroimaging characteristics of classical superficial siderosis.
Journal of Neurology
, 268
pp. 4238-4247.
10.1007/s00415-021-10548-z.
|
|
Chan, WY;
Counsell, N;
de Tute, R;
De-Silva, D;
Phillips, EH;
Cavenagh, J;
Adedayo, T;
... Yong, KL; + view all
(2022)
Outcomes of relapse in patients with deferred autologous stem cell transplant after achieving at least very good partial response following bortezomib, adriamycin, dexamethasone chemotherapy for newly diagnosed multiple myeloma in the phase II PADIMAC trial.
British Journal of Haematology
, 196
(4)
e33-e37.
10.1111/bjh.17903.
|
|
Chan, WY;
Zhu, C;
Sanchez, E;
Gupta, R;
Fielding, AK;
Khwaja, A;
Payne, EM;
(2022)
Antibody responses to SARS-CoV-2 vaccination in patients with acute myeloid leukaemia and high risk MDS on active anti-cancer therapies.
British Journal of Haematology
, 198
(3)
pp. 478-481.
10.1111/bjh.18248.
|
|
Chan, JKY;
Gil-Farina, I;
Johana, N;
Rosales, C;
Tan, YW;
Ceiler, J;
Mcintosh, J;
... Mattar, CNZ; + view all
(2019)
Therapeutic expression of human clotting factors IX and X following adeno-associated viral vector-mediated intrauterine gene transfer in early-gestation fetal macaques.
FASEB Journal
, 33
(3)
pp. 3954-3967.
10.1096/fj.201801391R.
|
|
|
Chan, TA;
Yarchoan, M;
Jaffee, E;
Swanton, C;
Quezada, SA;
Stenzinger, A;
Peters, S;
(2019)
Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic.
Annals of Oncology
, 30
(1)
pp. 44-56.
10.1093/annonc/mdy495.
|
|
|
Chandran, S;
Watkins, J;
Abdul‐Aziz, A;
Shafat, M;
Calvert, PA;
Bowles, KM;
Flather, MD;
... Ryding, AD; + view all
(2017)
Inflammatory Differences in Plaque Erosion and Rupture in Patients With ST‐Segment Elevation Myocardial Infarction.
Journal of the American Heart Association
, 6
(5)
, Article e005868. 10.1161/JAHA.117.005868.
|
|
|
Chapman, MA;
Sive, J;
Ambrose, J;
Roddie, C;
Counsell, N;
Lach, A;
Abbasian, M;
... Yong, K; + view all
(2018)
RNA-Seq of newly diagnosed patients in the PADIMAC study leads to a bortezomib/lenalidomide decision signature.
Blood
, 132
(20)
pp. 2154-2165.
10.1182/blood-2018-05-849893.
|
|
Chari, A;
Samur, MK;
Martinez-Lopez, J;
Cook, G;
Biran, N;
Yong, KL;
Hungria, VTDM;
... Avet-Loiseau, H; + view all
(2020)
Clinical features associated with COVID-19 outcome in multiple myeloma: first results from the International Myeloma Society data set.
Blood
, 136
(26)
pp. 3033-3040.
10.1182/blood.2020008150.
|
|
Chau, I;
Joulain, F;
Iqbal, SU;
Bridgewater, J;
(2014)
A VELOUR post hoc subset analysis: prognostic groups and treatment outcomes in patients with metastatic colorectal cancer treated with aflibercept and FOLFIRI.
BMC Cancer
, 14
, Article 605. 10.1186/1471-2407-14-605.
|
 |
|
Chavda, SJ;
Maciocia, PM;
Mesiri, P;
Counsell, N;
Kothari, J;
Bird, A;
Mariner, C;
... Yong, K; + view all
(2019)
A new prognostic model for myeloma patients relapsing from upfront autologous transplantation based on ISS and PFS1.
British Journal of Haematology
, 185
(2)
pp. 350-353.
10.1111/bjh.15487.
|
|
Chavda, SJ;
Pocock, R;
Cheesman, S;
Lee, K-M;
Dowling, E;
Marks, DJB;
Kyriakou, C;
... Popat, R; + view all
(2020)
Association of hypertension and cardiac events in patients with multiple myeloma receiving carfilzomib: practical management recommendations.
British Journal of Haematology
10.1111/bjh.16889.
(In press).
|
|
|
Chemaly, RF;
Hill, JA;
Voigt, S;
Peggs, KS;
(2019)
In vitro comparison of currently available and investigational antiviral agents against pathogenic human double-stranded DNA viruses: A systematic literature review.
Antiviral Research
, 163
pp. 50-58.
10.1016/j.antiviral.2019.01.008.
|
|
|
Chemi, F;
Rothwell, DG;
McGranahan, N;
Gulati, S;
Abbosh, C;
Pearce, SP;
Zhou, C;
... TRACERx Consortium, .; + view all
(2019)
Pulmonary venous circulating tumor cell dissemination before tumor resection and disease relapse.
Nature Medicine
, 25
pp. 1534-1539.
10.1038/s41591-019-0593-1.
|
|
Cheminant, Morgane;
Fox, Thomas A;
Alligon, Mickael;
Bouaziz, Olivier;
Neven, Bénédicte;
Moshous, Despina;
Blanche, Stephane;
... Suarez, Felipe; + view all
(2023)
Allogeneic stem cell transplantation compared to conservative management in adults with inborn errors of immunity.
Blood
, 141
(1)
pp. 60-71.
10.1182/blood.2022015482.
|
|
Chen, Jingyu;
Sathiaseelan, Vijitha;
Reddy Chilamakuri, Chandra Sekkar;
Roamio Franklin, Valar Nila;
Jakwerth, Constanze A;
D'Santos, Clive;
Ringshausen, Ingo;
(2024)
ZAP-70 augments tonic B-cell receptor and CCR7 signaling in IGHV–unmutated chronic lymphocytic leukemia.
Blood Advances
, 8
(5)
pp. 1167-1178.
10.1182/bloodadvances.2022009557.
|
|
Chen, LY;
Keddie, S;
Lunn, MP;
Bomsztyk, J;
Vitsaras, E;
Gupta, R;
D'Sa, S;
(2020)
IgM paraprotein-associated peripheral neuropathy: small CD20-positive B-cell clones may predict a monoclonal gammopathy of neurological significance and rituximab responsiveness.
British Journal of Haematology
, 188
(4)
pp. 511-515.
10.1111/bjh.16210.
|
|
Cheok, Kathleen PL;
Kirkwood, Amy A;
Creasey, Thomas;
Tholouli, Eleni;
Chaganti, Sridhar;
Mathew, Amrith;
Dulobdas, Vaishali;
... Roddie, Claire; + view all
(2023)
Improved COVID-19 outcomes in CAR-T patients in the age of vaccination and preemptive pharmacotherapeutics.
Leukemia & Lymphoma
10.1080/10428194.2023.2248329.
(In press).
|
|
Cheok, Kathleen PL;
Kirkwood, Amy A;
Menne, Tobias;
Tholouli, Eleni;
Chaganti, Sridhar;
Mathew, Amrith;
Uttenthal, Ben;
... Roddie, Claire; + view all
(2022)
Severe presentations and high mortality from SARS-CoV-2 in patients undergoing chimeric antigen receptor (CAR-T) therapy: a UK NCCP analysis.
Leukemia & Lymphoma
, 63
(8)
pp. 1980-1984.
10.1080/10428194.2022.2057487.
|
|
Chicca, IJ;
Heaney, JLJ;
Iqbal, G;
Dunn, JA;
Bowcock, S;
Planche, T;
Pratt, G;
... Drayson, MT; + view all
(2020)
Stratifying risk of infection and response to therapy in patients with myeloma: a prognostic study.
Efficacy and Mechanism Evaluation
, 7
(10)
10.3310/eme07100.
|
|
|
Chicca, IJ;
Heaney, JLJ;
Iqbal, G;
Dunn, JA;
Bowcock, S;
Pratt, G;
Yong, KL;
... Drayson, MT; + view all
(2020)
Anti-bacterial antibodies in multiple myeloma patients at disease presentation, in response to therapy and in remission: implications for patient management.
Blood Cancer Journal
, 10
(11)
, Article 114. 10.1038/s41408-020-00370-7.
|
|
|
Chighizola, Cecilia B;
Pregnolato, Francesca;
Andrade, Danieli;
Tektonidou, Maria;
Pengo, Vittorio;
Ruiz-Irastorza, Guillermo;
Belmont, H Michael;
... AntiPhospholipid Syndrome Alliance For Clinical Trials and Inter, .; + view all
(2023)
Fluctuation of Anti-Domain 1 and Anti-Β2 Glycoprotein I Antibody Titers Over Time in Patients with Persistently Positive Antiphospholipid Antibodies.
Arthritis & Rheumatology
, 75
(6)
pp. 984-995.
10.1002/art.42459.
|
|
Chin, M;
Sive, JI;
Allen, C;
Roddie, C;
Chavda, SJ;
Smith, D;
Blombery, P;
... Yong, KL; + view all
(2017)
Prevalence and timing of TP53 mutations in del(17p) myeloma and effect on survival.
Blood Cancer Journal
, 7
, Article e610. 10.1038/bcj.2017.76.
|
|
|
Chojnacka, Monika;
Diamond, Benjamin;
Ziccheddu, Bachisio;
Rustad, Even;
Maclachlan, Kylee;
Papadimitriou, Marios;
Boyle, Eileen M;
... Maura, Francesco; + view all
(2024)
Impact of Rare Structural Variant Events in Newly Diagnosed Multiple Myeloma.
Clinical Cancer Research
, 30
(3)
pp. 575-585.
10.1158/1078-0432.CCR-23-1045.
|
|
Chowdary, P;
Agarwal, B;
Peralta, MR;
Bhagani, S;
Lee, S;
Goldring, J;
Lipman, M;
... Gomez, K; + view all
(2023)
Nebulized Recombinant Tissue Plasminogen Activator (rt-PA) for Acute COVID-19-Induced Respiratory Failure: An Exploratory Proof-of-Concept Trial.
Journal of Clinical Medicine
, 12
(18)
, Article 5848. 10.3390/jcm12185848.
|
|
|
Chowdary, P;
Nathwani, A;
(2022)
Phase 1-2 Trial of AAVS3 Gene Therapy in Patients with Hemophilia B: The authors reply.
New England Journal of Medicine
, 387
(14)
pp. 1336-1337.
10.1056/NEJMc2210918.
|
|
Chowdary, P;
Shapiro, S;
Makris, M;
Evans, G;
Boyce, S;
Talks, K;
Dolan, G;
... Nathwani, A; + view all
(2022)
Phase 1-2 Trial of AAVS3 Gene Therapy in Patients with Hemophilia B.
The New England Journal of Medicine
, 387
(3)
pp. 237-247.
10.1056/NEJMoa2119913.
|
|
Chowdary, Pratima;
Duran, Beatriz;
Batty, Paul;
Lowe, Gillian;
Jones, April;
Pollard, Debra;
Boyce, Sara;
... Shapiro, Susan; + view all
(2024)
UKHCDO gene therapy taskforce: Guidance for implementation of haemophilia gene therapy into routine clinical practice for adults.
Haemophilia
10.1111/hae.15125.
(In press).
|
|
|
Chowdary, Pratima;
Shapiro, Susan;
Makris, Mike;
Evans, Gillian;
Boyce, Sara;
Talks, Kate;
Dolan, Gerry;
... Nathwani, Amit; + view all
(2021)
Factor IX Expression within the Normal Range Prevents Spontaneous Bleeds Requiring Treatment Following FLT180a Gene Therapy in Patients with Severe Hemophilia B: Long-Term Follow- up Study of the B-Amaze Program.
Blood
, 138
(Supp 1)
, Article 3967. 10.1182/blood-2021-146546.
|
|
Chowdary, P;
Hamid, C;
Slatter, D;
Morris, R;
Foley, JH;
Gomez, K;
Brodkin, E;
... McVey, JH; + view all
(2020)
Impaired platelet-dependent thrombin generation associated with thrombocytopenia is improved by prothrombin complex concentrates in vitro.
Research and Practice in Thrombosis and Haemostasis
, 4
(2)
pp. 334-342.
10.1002/rth2.12310.
|
|
|
Christen, F;
Hoyer, K;
Yoshida, K;
Hou, H-A;
Waldhueter, N;
Heuser, M;
Hills, RK;
... Damm, F; + view all
(2019)
Genomic landscape and clonal evolution of acute myeloid leukemia with t(8;21): an international study on 331 patients.
Blood
, 133
(10)
pp. 1140-1151.
10.1182/blood-2018-05-852822.
|
|
Clark, RE;
Dodi, IA;
Hill, SC;
Lill, JR;
Aubert, G;
Macintyre, AR;
Rojas, J;
... Madrigal, JA; + view all
(2001)
Direct evidence that leukemic cells present HLA-associated immunogenic peptides derived from the BCR-ABL b3a2 fusion protein.
Blood
, 98
(10)
pp. 2887-2893.
|
|
|
Cleary, M;
Davison, J;
Gould, R;
Geberhiwot, T;
Hughes, D;
Mercer, J;
Morrison, A;
... Stepien, KM; + view all
(2021)
Impact of long-term elosulfase alfa treatment on clinical and patient-reported outcomes in patients with mucopolysaccharidosis type IVA: results from a Managed Access Agreement in England.
Orphanet Journal of Rare Diseases
, 16
, Article 38. 10.1186/s13023-021-01675-x.
|
|
|
Clements, Melanie;
Tang, Wenhao;
Florjanic Baronik, Zan;
Simpson Ragdale, Holly;
Oria, Roger;
Volteras, Dimitrios;
White, Ian J;
... Parrinello, Simona; + view all
(2025)
Axonal injury is a targetable driver of glioblastoma progression.
Nature
, 646
pp. 452-461.
10.1038/s41586-025-09411-2.
|
|
Clesham, K;
Rao, V;
Bartram, J;
Ancliff, P;
Ghorashian, S;
O'Connor, D;
Pavasovic, V;
... Vora, A; + view all
(2020)
Blinatumomab for infant acute lymphoblastic leukemia.
Blood
, 135
(17)
pp. 1501-1504.
10.1182/blood.2019004008.
|
|
Coats, T;
Bean, D;
Basset, A;
Sirkis, T;
Brammeld, J;
Johnson, S;
Thomas, I;
... Dillon, R; + view all
(2021)
A novel algorithmic approach to generate consensus treatment guidelines in adult acute myeloid leukaemia.
British Journal of Haematology
10.1111/bjh.18013.
(In press).
|
|
|
Cohen, H;
Efthymiou, M;
Devreese, KMJ;
(2021)
Monitoring of anticoagulation in thrombotic antiphospholipid syndrome.
Journal of Thrombosis and Haemostasis
, 19
(4)
pp. 892-908.
10.1111/jth.15217.
|
|
Cohen, H;
Isenberg, DA;
(2021)
How I treat anticoagulant-refractory thrombotic antiphospholipid syndrome.
Blood
, 137
(3)
pp. 299-309.
10.1182/blood.2020004942.
|
|
Cohen, Hannah;
Werring, David J;
Chandretheva, Arvind;
Mittal, Prabal;
Devreese, Katrien MJ;
Isenberg, David A;
ISTH SSC LA/aPL Subcommittee Study Group;
(2023)
Survey on antiphospholipid syndrome diagnosis and antithrombotic treatment in patients with ischemic stroke, other brain ischemic injury, or arterial thromboembolism in other sites: communication from ISTH SSC Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibodies.
Journal of Thrombosis and Haemostasis
, 21
(10)
pp. 2963-2976.
10.1016/j.jtha.2023.06.020.
|
|
Cohen, OC;
Brodermann, MH;
Dervin, A;
Raja, N;
Marafioti, T;
Otero, S;
Beale, T;
... Morley, S; + view all
(2021)
Lymph node core biopsies reliably permit diagnosis of lymphoproliferative diseases. Real‐World Experience from 554 sequential core biopsies from a single centre.
European Journal of Haematology
, 106
(2)
pp. 267-272.
10.1111/ejh.13545.
|
|
Cohen, H;
(1989)
Haemostatic changes in renal allograft recipients and the role of cyclosporin.
Masters thesis , University of Manchester.
|
|
Cohen, H;
Cuadrado, MJ;
Erkan, D;
Duarte-Garcia, A;
Isenberg, DA;
Knight, JS;
Ortel, TL;
... Andrade, D; + view all
(2020)
16th International Congress on Antiphospholipid Antibodies Task Force Report on Antiphospholipid Syndrome Treatment Trends.
Lupus
, 29
(12)
pp. 1571-1593.
10.1177/0961203320950461.
|
|
Cohen, H;
Doré, CJ;
Clawson, S;
Hunt, BJ;
Isenberg, D;
Khamashta, M;
Muirhead, N;
(2015)
Rivaroxaban in antiphospholipid syndrome (RAPS) protocol: a prospective, randomized controlled phase II/III clinical trial of rivaroxaban versus warfarin in patients with thrombotic antiphospholipid syndrome, with or without SLE.
Lupus
, 24
(10)
pp. 1087-1094.
10.1177/0961203315581207.
|
|
|
Cohen, H;
Efthymiou, M;
Gates, C;
Isenberg, D;
(2018)
Direct Oral Anticoagulants for Thromboprophylaxis in Patients with Antiphospholipid Syndrome.
Seminars in Thrombosis and Hemostasis
, 44
(05)
pp. 427-438.
10.1055/s-0036-1597902.
|
|
|
Cohen, H;
Efthymiou, M;
Isenberg, DA;
(2018)
Use of direct oral anticoagulants in antiphospholipid syndrome.
Journal of Thrombosis and Haemostasis
, 16
(6)
pp. 1028-1039.
10.1111/jth.14017.
|
|
Cohen, H;
Hunt, B;
Efythymiou, M;
Arachchillage, D;
Ruiz, M;
Clawson, S;
Muirhead, N;
... Collaborators, RAPST; + view all
(2015)
Raps (rivaroxaban in antiphospholipid syndrome): a prospective randomised controlled phase II/III clinical trial of rivaroxaban vs. warfarin in patients with thrombotic antiphospholipid syndrome, with or without SLE.
Journal of Thrombosis and Haemostasis
, 13
, Article LB003. DOI: 10.1111/jth.12993.
|
|
Cohen, H;
Hunt, BJ;
Efthymiou, M;
Arachchillage, DR;
Mackie, IJ;
Clawson, S;
Sylvestre, Y;
... RAPS trial investigators, .; + view all
(2016)
Rivaroxaban versus warfarin to treat patients with thrombotic antiphospholipid syndrome, with or without systemic lupus erythematosus (RAPS): a randomised, controlled, open-label, phase 2/3, non-inferiority trial.
Lancet Haematology
, 3
(9)
e426-e436.
10.1016/S2352-3026(16)30079-5.
|
|
|
Cohen, H;
Mackie, IJ;
Devreese, KMJ;
(2019)
Clinical and laboratory practice for lupus anticoagulant testing: An International Society of Thrombosis and Haemostasis Scientific and Standardization Committee survey.
Journal of Thrombosis and Haemostasis
, 17
(10)
pp. 1715-1732.
10.1111/jth.14560.
|
|
Cohen, H;
Sayar, Z;
Efthymiou, M;
Gaspar, P;
Richards, T;
Isenberg, D;
(2020)
Management of anticoagulant-refractory thrombotic antiphospholipid syndrome.
The Lancet Haematology
, 7
(8)
e613-e623.
10.1016/S2352-3026(20)30116-2.
|
|
Cohen, OC;
Brodermann, MH;
Blakeney, IJ;
Mahmood, S;
Sachchithanantham, S;
Ravichandran, S;
Law, S;
... Wechalekar, AD; + view all
(2020)
Rapid response to single agent daratumumab is associated with improved progression-free survival in relapsed/refractory AL amyloidosis.
Amyloid
, 27
(3)
pp. 200-205.
10.1080/13506129.2020.1765768.
|
|
Cohen, OC;
Counsell, N;
Rabin, N;
Popat, R;
Owen, RG;
Popova, B;
Schofield, O;
... Yong, KL; + view all
(2019)
Bortezomib consolidation post-ASCT as frontline therapy for multiple myeloma deepens disease response and MRD-negative rate whilst maintaining QOL and response to re-treatment at relapse.
[Letter].
British Journal of Haematology
, 185
(5)
pp. 948-951.
10.1111/bjh.15649.
|
|
Cohen, OC;
Sharpley, F;
Gillmore, JD;
Lachmann, HJ;
Sachchithanantham, S;
Mahmood, S;
Fontana, M;
... Wechalekar, AD; + view all
(2020)
Use of ixazomib, lenalidomide and dexamethasone in patients with relapsed amyloid light‐chain amyloidosis.
British Journal of Haematology
, 189
(4)
pp. 643-649.
10.1111/bjh.16401.
|
|
Comerford, AG;
Lucas, JAM;
Turner, TR;
Marsh, SGE;
Mayor, NP;
(2020)
The novel HLA-C*03:04:01:47 allele sequence identified using Pacific biosciences SMRT sequencing.
HLA: Immune Response Genetics
, 96
(4)
pp. 525-526.
10.1111/tan.14006.
|
|
|
Cook, G;
Ashcroft, AJ;
Cairns, DA;
Williams, CD;
Brown, JM;
Cavenagh, JD;
Snowden, JA;
... National Cancer Research Institute Haemato-oncology Clinical Stu, .; + view all
(2016)
The effect of salvage autologous stem-cell transplantation on overall survival in patients with relapsed multiple myeloma (final results from BSBMT/UKMF Myeloma X Relapse [Intensive]): a randomised, open-label, phase 3 trial.
Lancet Haematology
, 3
(7)
e340-e351.
10.1016/S2352-3026(16)30049-7.
|
|
|
Cook, G;
Royle, K-L;
O'Connor, S;
Cairns, DA;
Ashcroft, AJ;
Williams, CD;
Hockaday, A;
... National Cancer Research Institute Haemato-oncology Clinical Stu; + view all
(2019)
The impact of cytogenetics on duration of response and overall survival in patients with relapsed multiple myeloma (long-term follow-up results from BSBMT/UKMF Myeloma X Relapse [Intensive]): a randomised, open-label, phase 3 trial.
British Journal of Haematology
10.1111/bjh.15782.
(In press).
|
|
|
Cooke, EA;
Smith, NAS;
Thomas, SA;
Ruston, C;
Hothi, S;
Hughes, D;
(2022)
An integrated discrete event simulation and particle swarm optimisation model for optimising efficiency of cancer diagnosis pathways.
Healthcare Analytics
, 2
, Article 100082. 10.1016/j.health.2022.100082.
|
|
Cordoba, S;
Onuoha, S;
Thomas, S;
Pignataro, DS;
Hough, R;
Ghorashian, S;
Vora, A;
... Amrolia, PJ; + view all
(2021)
CAR T cells with dual targeting of CD19 and CD22 in pediatric and young adult patients with relapsed or refractory B cell acute lymphoblastic leukemia: a phase 1 trial.
Nature Medicine
, 27
pp. 1797-1805.
10.1038/s41591-021-01497-1.
|
|
|
Corrie, PG;
Qian, W;
Basu, B;
Valle, JW;
Falk, S;
Lwuji, C;
Wasan, H;
... Jodrell, DI; + view all
(2020)
Scheduling nab-paclitaxel combined with gemcitabine as first-line treatment for metastatic pancreatic adenocarcinoma.
British Journal of Cancer
10.1038/s41416-020-0846-2.
|
|
|
Costoya, Cristobal Javier Costoya;
(2023)
Role of FcγRs in anti-OX40 based immunotherapies.
Doctoral thesis (Ph.D), UCL (University College London).
|
|
Coughtrey, A;
Millington, A;
Bennett, S;
Christie, D;
Hough, R;
Su, M;
Constantinou, M;
(2018)
The Effectiveness of Psychosocial Interventions for Psychological Outcomes in Paediatric Oncology: A Systematic Review.
Journal of Pain and Symptom Management
, 55
(3)
pp. 1004-1017.
10.1016/j.jpainsymman.2017.09.022.
|
|
Coughtrey, AE;
Shafran, R;
Su, MT;
Allcott-Watson, H;
Christie, D;
Hough, R;
(2019)
Health Professionals' Perspectives on the Nature of Distress and Low Mood in Young People with Cancer.
Journal of Adolescent and Young Adult Oncology
, 8
(2)
pp. 190-196.
10.1089/jayao.2018.0082.
|
|
Cowan, Annie;
Ferrari, Federico;
Freeman, Samuel S;
Redd, Robert;
El-Khoury, Habib;
Perry, Jacqueline;
Patel, Vidhi;
... Ghobrial, Irene M; + view all
(2023)
Personalised progression prediction in patients with monoclonal gammopathy of undetermined significance or smouldering multiple myeloma (PANGEA): a retrospective, multicohort study.
The Lancet Haematology
, 10
(3)
e203-e212.
10.1016/S2352-3026(22)00386-6.
|
|
Cox, S;
Hurt, C;
Grenader, T;
Mukherjee, S;
Bridgewater, J;
Crosby, T;
(2017)
The prognostic value of derived neutrophil to lymphocyte ratio in oesophageal cancer treated with definitive chemoradiotherapy.
Radiotherapy and Oncology
, 125
(1)
pp. 154-159.
10.1016/j.radonc.2017.08.023.
|
|
Creary, LE;
Guerra, SG;
Chong, W;
Brown, CJ;
Turner, TR;
Robinson, J;
Bultitude, WP;
... Fernandez-Vina, MA; + view all
(2019)
Next-generation HLA typing of 382 International Histocompatibility Working Group reference B-lymphoblastoid cell lines: Report from the 17th International HLA and Immunogenetics Workshop.
Human Immunology
, 80
(7)
pp. 449-460.
10.1016/j.humimm.2019.03.001.
|
|
Creasey, T;
Barretta, E;
Ryan, SL;
Butler, E;
Kirkwood, AA;
Leongamornlert, D;
Papaemmanuil, E;
... Moorman, AV; + view all
(2021)
Genetic and genomic analysis of acute lymphoblastic leukaemia in older adults reveals a distinct profile of abnormalities: analysis of 210 patients from the UKALL14 and UKALL60+ clinical trials.
Haematologica
10.3324/haematol.2021.279177.
(In press).
|
|
|
Creasey, T;
Enshaei, A;
Nebral, K;
Schwab, C;
Watts, K;
Cuthbert, G;
Vora, A;
... Moorman, AV; + view all
(2021)
Single nucleotide polymorphism (SNP) array-based signature of low hypodiploidy in acute lymphoblastic leukemia.
Genes Chromosomes and Cancer
10.1002/gcc.22956.
(In press).
|
|
|
Crolley, VE;
Hanna, D;
Joharatnam-Hogan, N;
Chopra, N;
Bamac, E;
Desai, M;
Lam, YC;
... Khan, K; + view all
(2020)
COVID-19 in cancer patients on systemic anti-cancer therapies: outcomes from the CAPITOL (COVID-19 Cancer PatIenT Outcomes in North London) cohort study.
Therapeutic Advances in Medical Oncology
, 12
pp. 1-14.
10.1177/1758835920971147.
|
|
|
Crosby, T;
Hurt, CN;
Falk, S;
Gollins, S;
Staffurth, J;
Ray, R;
Bridgewater, JA;
... Mukherjee, S; + view all
(2017)
Long-term results and recurrence patterns from SCOPE-1: a phase II/III randomised trial of definitive chemoradiotherapy +/- cetuximab in oesophageal cancer.
British Journal of Cancer
, 116
pp. 709-716.
10.1038/bjc.2017.21.
|
|
|
Cuadrado, MM;
Szydlo, RM;
Watts, M;
Patel, N;
Renshaw, H;
Dorman, J;
Lowdell, M;
... Chakraverty, R; + view all
(2019)
Predictors of recovery following allogeneic CD34+-selected cell infusion without conditioning to correct poor graft function.
Haematologica
, 105
(11)
10.3324/haematol.2019.226340.
|
|
Cuadrado Collados, Maria Del Mar;
(2023)
Strategies to Improve Haematological Reconstitution Post-Allogeneic Haematopoietic Stem Cell Transplantation.
Doctoral thesis (M.D(Res)), UCL (University College London).
|
|
Cucchiaro, B;
Davies, NA;
Weekes, CE;
O'Reilly, M;
Roddie, C;
Slee, A;
(2024)
Malnutrition and cachexia are associated with poor CAR T-cell therapy
outcomes including survival.
Clinical Nutrition ESPEN
, 62
pp. 206-215.
10.1016/j.clnesp.2024.05.020.
|
|
|
Cuff, AO;
Sillito, F;
Dertschnig, S;
Hall, A;
Tu, VL;
Chakraverty, R;
Male, V;
(2019)
The Obese Liver Environment Mediates Conversion of NK Cells to a Less Cytotoxic ILC1-Like Phenotype.
Frontiers in Immunology
, 10
, Article 2180. 10.3389/fimmu.2019.02180.
|
|
|
Cwynarski, Kate;
Iacoboni, Gloria;
Tholouli, Eleni;
Menne, Tobias;
Irvine, David A;
Balasubramaniam, Nivetha;
Wood, Leigh;
... Pule, Martin; + view all
(2025)
TRBC1-CAR T cell therapy in peripheral T cell lymphoma: a phase 1/2 trial.
Nature Medicine
, 31
pp. 137-143.
10.1038/s41591-024-03326-7.
|
D
|
D'Amore, S;
Page, K;
Donald, A;
Taiyari, K;
Tom, B;
Deegan, P;
Tan, CY;
... MRC GAUCHERITE Consortium, .; + view all
(2021)
In-depth phenotyping for clinical stratification of Gaucher disease.
Orphanet Journal of Rare Diseases
, 16
(1)
, Article 431. 10.1186/s13023-021-02034-6.
|
|
|
D'Sa, S.P.;
(2007)
Immune reconstitution of B cell and T cell compartments following reduced intensity allogeneic stem cell transplantation for myeloma.
Doctoral thesis , University of London.
|
|
|
Dabrowska, A;
Venero, JL;
Iwasawa, R;
Hankir, MK;
Rahman, S;
Boobis, A;
Hajji, N;
(2015)
PGC-1α controls mitochondrial biogenesis and dynamics in lead-induced neurotoxicity.
Aging (Albany NY)
, 7
(9)
pp. 629-647.
10.18632/aging.100790.
|
|
|
Dagil, L;
Troelsen, KS;
Bolt, G;
Thim, L;
Wu, B;
Zhao, X;
Tuddenham, EGD;
... Hansen, DF; + view all
(2019)
Interaction Between the a3 Region of Factor VIII and the TIL'E’ Domains of the von Willebrand Factor.
Biophysical Journal
, 117
(3)
pp. 479-489.
10.1016/j.bpj.2019.07.007.
|
|
|
Dalmia, S;
Sharma, R;
Ramaswami, U;
Hughes, D;
Jahnke, N;
Cole, D;
Smith, S;
(2023)
Enzyme replacement therapy for late-onset Pompe disease.
Cochrane Database of Systematic Reviews
, 2023
(12)
, Article CD012993. 10.1002/14651858.CD012993.pub2.
|
|
Dardis, A;
Michelakakis, H;
Rozenfeld, P;
Fumic, K;
Wagner, J;
Pavan, E;
Fuller, M;
... Aerts, J; + view all
(2022)
Patient centered guidelines for the laboratory diagnosis of Gaucher disease type 1.
Orphanet Journal of Rare Diseases
, 17
, Article 442. 10.1186/s13023-022-02573-6.
|
|
das Neves, RP;
Jones, NS;
Andreu, L;
Gupta, R;
Enver, T;
Iborra, FJ;
(2010)
Connecting Variability in Global Transcription Rate to Mitochondrial Variability.
PLoS Biology
, 8
(12)
, Article e1000560. 10.1371/journal.pbio.1000560.
|
|
|
Das-Gupta, E;
Thomson, KJ;
Bloor, AJC;
Clark, AD;
Mackinnon, S;
Kayani, I;
Clifton-Hadley, L;
... Peggs, KS; + view all
(2019)
Allo-HSCT in transplant-naive patients with Hodgkin lymphoma: a single-arm, multicenter study.
Blood Advances
, 3
(24)
pp. 4264-4270.
10.1182/bloodadvances.2019001016.
|
|
Davidoff, AM;
Ng, CYC;
Zhou, J;
Spence, Y;
Nathwani, AC;
(2003)
Sex significantly influences transduction of murine liver by recombinant adeno-associated viral vectors through an androgen-dependent pathway.
Blood
, 102
(2)
pp. 480-488.
10.1182/blood-2002-09-2889.
|
|
|
Davies, Faith E;
Pawlyn, Charlotte;
Usmani, Saad Z;
San-Miguel, Jesus F;
Einsele, Hermann;
Boyle, Eileen M;
Corre, Jill;
... Morgan, Gareth J; + view all
(2022)
Perspectives on the Risk-Stratified Treatment of Multiple Myeloma.
Blood Cancer Discovery
, 3
(4)
pp. 273-284.
10.1158/2643-3230.BCD-21-0205.
|
|
|
Davies, J.;
(2005)
Selective depletion of alloreactive T cells to reduce graft-versus-host disease and enhance immune reconstitution post allogeneic haematopoietic stem cell transplantation.
Doctoral thesis , University of London.
|
|
|
Davis, BA;
Allard, S;
Qureshi, A;
Porter, JB;
Pancham, S;
Win, N;
Cho, G;
... British Society for Haematology, .; + view all
(2017)
Guidelines on red cell transfusion in sickle cell disease Part II: indications for transfusion.
British Journal of Haematology
, 176
(2)
pp. 192-209.
10.1111/bjh.14383.
|
|
|
Day, James W;
Fox, Thomas A;
Gupta, Rajeev;
Khwaja, Asim;
Wilson, Andrew J;
Kottaridis, Panagiotis D;
(2022)
Gilteritinib monotherapy as a transplant bridging option for high risk FLT3-mutated AML with t(6;9)(p23;q34.1);DEK-NUP214 in morphological but not cytogenetic or molecular remission following standard induction chemotherapy.
Leukemia Research Reports
, 17
, Article 100291. 10.1016/j.lrr.2022.100291.
|
|
|
Day, E;
Jones, L;
Langner, R;
Stirling, LC;
Hough, R;
Bluebond-Langner, M;
(2018)
"We just follow the patients' lead": Healthcare professional perspectives on the involvement of teenagers with cancer in decision-making.
Pediatric Blood and Cancer
, 65
(3)
, Article e26898. 10.1002/pbc.26898.
|
|
|
De Ascensao Santos e Sousa, P;
Shorrock, H;
Lomas, C;
Conlan, T;
Means, TK;
Plagnol, V;
Chakraverty, R;
(2014)
DC control of immunopathology: Interaction with tissue DC drives a unique transcriptional response in effector T cells.
Presented at: 13th International Symposium on Dendritic Cells (DC 2014), Tours, France.
|
|
|
De Ascensão Santos e Sousa, Pedro Miguel;
(2017)
A systems immunology approach to graft-versus-host disease.
Doctoral thesis , UCL (University College London).
|
|
|
de Botton, Stephane;
Fenaux, Pierre;
Yee, Karen;
Recher, Christian;
Wei, Andrew H;
Montesinos, Pau;
Taussig, David C;
... Cortes, Jorge; + view all
(2023)
Olutasidenib (FT-2102) induces durable complete remissions in patients with relapsed or refractory IDH1-mutated AML.
Blood Advances
, 7
(13)
pp. 3117-3127.
10.1182/bloodadvances.2022009411.
|
|
De Oliveira Canedo, Gustavo;
Roddie, Claire;
Amrolia, Persis J;
(2024)
Dual targeting CAR-T cells for B-cell acute lymphoblastic leukaemia and B-cell non-Hodgkin lymphoma.
Blood Advances
10.1182/bloodadvances.2024013586.
(In press).
|
|
|
Dertschnig, S;
Evans, P;
Santos e Sousa, P;
Manzo, T;
Ferrer, IR;
Stauss, HJ;
Bennett, CL;
(2020)
Graft-versus-host disease reduces lymph node display of tissue-restricted self-antigens and promotes autoimmunity.
The Journal of Clinical Investigation
10.1172/JCI133102.
(In press).
|
|
|
Dey, A;
(2016)
Enhancing the neutrophil-mediated anti-cancer response after oncolytic measles virus therapy in B cell malignancy: dissecting out the mechanism.
Doctoral thesis , UCL (University College London).
|
 |
|
Diamanti, Paraskevi;
Bailey, Bethan K;
Iheanacho, Obinna E;
Moppett, John P;
Nathwani, Amit C;
Blair, Allison;
(2025)
Expression and treatment of ROR1+ cells with bispecific T-cell engagers in pediatric acute lymphoblastic leukemia.
Blood Advances
, 9
(13)
pp. 3190-3201.
10.1182/bloodadvances.2024013814.
|
|
|
Dias, J;
Garcia, J;
Agliardi, G;
Roddie, C;
(2024)
CAR-T cell manufacturing landscape—Lessons from the past decade and considerations for early clinical development.
Molecular Therapy Methods and Clinical Development
, 32
(2)
, Article 101250. 10.1016/j.omtm.2024.101250.
|
|
|
Dias, J;
Axelband, F;
Lara, LS;
Muzi-Filho, H;
Vieyra, A;
(2017)
Is angiotensin-(3–4) (Val-Tyr), the shortest angiotensin II-derived peptide, opening new vistas on the renin–angiotensin system?
Journal of the Renin-Angiotensin-Aldosterone System
, 18
(1)
10.1177/1470320316689338.
|
|
|
Dickson, GJ;
Bustraan, S;
Hills, RK;
Ali, A;
Goldstone, AH;
Burnett, AK;
Linch, DC;
(2015)
The value of molecular stratification for CEBPA_DM and NPM1_MUT_FLT3_WT genotypes in older patients with acute myeloid leukaemia.
British Journal of Haematology
10.1111/bjh.13873.
|
|
|
Dillon, R;
Hills, RK;
Freeman, SD;
Potter, N;
Jovanovic, J;
Ivey, A;
Kanda, AS;
... Grimwade, D; + view all
(2020)
Molecular MRD status and outcome after transplantation in NPM1 mutated AML: results from the UK NCRI AML17 study.
Blood
, 135
(9)
pp. 680-688.
10.1182/blood.2019002959.
|
|
Dimopoulos, MA;
Leleu, X;
Moreau, P;
Richardson, PG;
Liberati, AM;
Harrison, SJ;
Miles Prince, H;
... Yong, K; + view all
(2020)
Isatuximab plus pomalidomide and dexamethasone in relapsed/refractory multiple myeloma patients with renal impairment: ICARIA-MM subgroup analysis.
Leukemia
10.1038/s41375-020-0868-z.
(In press).
|
|
Ding, Wen Y;
Kuzmuk, Valeryia;
Hunter, Sarah;
Lay, Abigail;
Hayes, Bryony;
Beesley, Matthew;
Rollason, Ruth;
... Saleem, Moin A; + view all
(2023)
Adeno-associated virus gene therapy prevents progression of kidney disease in genetic models of nephrotic syndrome.
Science Translational Medicine
, 15
(708)
, Article eabc8226. 10.1126/scitranslmed.abc8226.
|
|
|
Diot, A;
Agnew, T;
Sanderson, J;
Liao, C;
Carver, J;
Neves, RPD;
Gupta, R;
... Poulton, J; + view all
(2018)
Validating the RedMIT/GFP-LC3 Mouse Model by Studying Mitophagy in Autosomal Dominant Optic Atrophy Due to the OPA1Q285STOP Mutation.
Frontiers in Cell and Developmental Biology
, 6
, Article 103. 10.3389/fcell.2018.00103.
|
|
|
Djebbari, F;
Rampotas, A;
Vallance, G;
Panitsas, F;
Basker, N;
Sangha, G;
Salhan, B;
... Ramasamy, K; + view all
(2022)
Efficacy of Isatuximab with Pomalidomide and Dexamethasone in Relapsed Myeloma: Results of a UK-Wide Real-World Dataset.
HemaSphere
, 6
(6)
, Article e738. 10.1097/HS9.0000000000000738.
|
|
|
Dodagatta-Marri, E;
Meyer, DS;
Reeves, MQ;
Paniagua, R;
To, MD;
Binnewies, M;
Broz, ML;
... Akhurst, RJ; + view all
(2019)
α-PD-1 therapy elevates Treg/Th balance and increases tumor cell pSmad3 that are both targeted by α-TGFβ antibody to promote durable rejection and immunity in squamous cell carcinomas.
Journal for ImmunoTherapy of Cancer
, 7
, Article 62. 10.1186/s40425-018-0493-9.
|
|
|
Doki, Yuichiro;
Ajani, Jaffer A;
Kato, Ken;
Xu, Jianming;
Wyrwicz, Lucjan;
Motoyama, Satoru;
Ogata, Takashi;
... CheckMate 648 Trial Investigators; + view all
(2022)
Nivolumab Combination Therapy in Advanced Esophageal Squamous-Cell Carcinoma.
New England Journal of Medicine
, 386
(5)
pp. 449-462.
10.1056/NEJMoa2111380.
|
|
Domogala, A;
Blundell, M;
Thrasher, A;
Lowdell, MW;
Madrigal, JA;
Saudemont, A;
(2017)
Natural killer cells differentiated in vitro from cord blood CD34(+) cells are more advantageous for use as an immunotherapy than peripheral blood and cord blood natural killer cells.
Cytotherapy
, 19
(6)
pp. 710-720.
10.1016/j.jcyt.2017.03.068.
|
|
|
Donald, A;
Cizer, H;
Finnegan, N;
Collin-Histed, T;
Hughes, DA;
Davies, EH;
(2019)
Measuring disease activity and patient experience remotely using wearable technology and a mobile phone app: outcomes from a pilot study in Gaucher disease.
Orphanet Journal of Rare Diseases
, 14
, Article 212. 10.1186/s13023-019-1182-6.
|
|
|
Donnellan, C;
Cohen, H;
Werring, DJ;
(2022)
Cognitive dysfunction and associated neuroimaging biomarkers in antiphospholipid syndrome: a systematic review.
Rheumatology
, 61
(1)
pp. 24-41.
10.1093/rheumatology/keab452.
|
|
Dotti, G;
Savoldo, B;
Pule, M;
Straathof, KC;
Biagi, E;
Yvon, E;
Vigouroux, S;
... Rooney, CM; + view all
(2005)
lHuman cytotoxic T lymphocytes with reduced sensitivity to Fas-induced apoptosis.
BLOOD
, 105
(12)
4677 - 4684.
10.1182/blood-2004-08-3337.
|
|
|
Drayson, MT;
Bowcock, S;
Planche, T;
Iqbal, G;
Pratt, G;
Yong, K;
Wood, J;
... Dunn, JA; + view all
(2019)
Levofloxacin prophylaxis in patients with newly diagnosed myeloma (TEAMM): a multicentre, double-blind, placebo-controlled, randomised, phase 3 trial.
The Lancet Oncology
, 20
(12)
pp. 1760-1772.
10.1016/S1470-2045(19)30506-6.
|
|
|
Drayson, MT;
Bowcock, S;
Planche, T;
Iqbal, G;
Pratt, G;
Yong, K;
Wood, J;
... Dunn, JA; + view all
(2019)
Prophylactic levofloxacin to prevent infections in newly diagnosed symptomatic myeloma: the TEAMM RCT.
Health Technology Assessment
, 23
(62)
10.3310/hta23620.
|
|
|
Drozd-Sokolowska, Joanna;
Gras, Luuk;
Koster, Linda;
Martino, Rodrigo;
Salas, Maria Queralt;
Salmenniemi, Urpu;
Zudaire, Teresa;
... Mclornan, Donal P; + view all
(2024)
Autologous hematopoietic cell transplantation for T-cell prolymphocytic leukemia: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT.
Haematologica
, 109
(5)
pp. 1608-1613.
10.3324/haematol.2023.284359.
|
|
|
Du, H;
Wilson, D;
Ambler, G;
Banerjee, G;
Shakeshaft, C;
Cohen, H;
Yousry, T;
... Clinical Relevance of Microbleeds in Stroke (CROMIS-2) Collabora, .; + view all
(2021)
Small Vessel Disease and Ischemic Stroke Risk During Anticoagulation for Atrial Fibrillation After Cerebral Ischemia.
Stroke
, 52
(1)
pp. 91-99.
10.1161/STROKEAHA.120.029474.
|
|
Duggleby, Richard C;
Tsang, Hoi Pat;
Strange, Kathryn;
McWhinnie, Alasdair;
Lamikanra, Abigail A;
Roberts, David J;
Hernandez, Diana;
... Danby, Robert D; + view all
(2020)
Enumerating regulatory T cells in cryopreserved umbilical cord blood samples using FOXP3 methylation specific quantitative PCR.
PLoS ONE
, 15
(10)
, Article e0240190. 10.1371/journal.pone.0240190.
|
|
|
Duke, VM;
Gandini, D;
Sherrington, PD;
Lin, K;
Heelan, B;
Amlot, P;
Mehta, AB;
... Foroni, L; + view all
(2003)
V-H gene usage differs in germline and mutated B-cell chronic lymphocytic leukemia.
Haematologica
, 88
(11)
1259 - 1271.
|
|
|
Dumontet, Charles;
Demangel, Delphine;
Galia, Perrine;
Karlin, Lionel;
Roche, Laurent;
Fauvernier, Mathieu;
Golfier, Camille;
... Garderet, Laurent; + view all
(2023)
Clinical characteristics and outcome of 318 families with familial monoclonal gammopathy: A multicenter Intergroupe Francophone du Myélome study.
American Journal of Hematology
, 98
(2)
pp. 264-271.
10.1002/ajh.26785.
|
|
|
Duran, R;
Mencacci, NE;
Angeli, AV;
Shoai, M;
Deas, E;
Houlden, H;
Mehta, A;
... Foltynie, T; + view all
(2013)
The glucocerobrosidase E326K variant predisposes to Parkinson's disease, but does not cause Gaucher's disease.
Movement Disorders
, 28
(2)
232 - 236.
10.1002/mds.25248.
|
|
E
|
Edeline, Julien;
Bridgewater, John;
Campillo-Gimenez, Boris;
Neveu, Estelle;
Phelip, Jean-Marc;
Neuzillet, Cindy;
Boudjema, Karim;
... Lamarca, Angela; + view all
(2024)
Chemotherapy with or without selective internal radiation therapy for intrahepatic cholangiocarcinoma: Data from clinical trials.
Hepatology
, 79
(1)
pp. 96-106.
10.1097/HEP.0000000000000544.
|
|
Edwards, K;
Zaitseva, K;
Sayed, U;
Volpi, EV;
Nathwani, A;
Gribben, JG;
Lydyard, P;
... Porakishvili, N; + view all
(2021)
Expression patterns of CD180 in the lymph nodes of patients with chronic lymphocytic leukaemia.
British Journal of Haematology
, 195
(2)
E131-E134.
10.1111/bjh.17680.
|
|
|
Efthymiou, M;
Lane, PJ;
Isenberg, D;
Cohen, H;
Mackie, IJ;
(2022)
Comparison of acquired activated protein C resistance, using the CAT and ST-genesia® analysers and three thrombin generation methods, in APS and SLE patients.
Journal of Clinical Medicine
, 11
(1)
, Article 69. 10.3390/jcm11010069.
|
|
|
Efthymiou, Maria;
Bertolaccini, Maria Laura;
Cohen, Hannah;
(2024)
Viewpoint: Lupus anticoagulant detection and interpretation in antiphospholipid syndrome.
Rheumatology
, 63
(SI)
SI54-SI63.
10.1093/rheumatology/kead623.
|
|
|
Efthymiou, M;
Arachchillage, DRJ;
Lane, PJ;
O'Keeffe, AG;
McDonnell, T;
Cohen, H;
Mackie, IJ;
(2018)
Antibodies against TFPI and protein C are associated with a severe thrombotic phenotype in patients with and without antiphospholipid syndrome.
Thrombosis Research
, 170
pp. 60-68.
10.1016/j.thromres.2018.08.003.
|
|
Efthymiou, M;
Mackie, IJ;
Lane, P;
Erkan, D;
Cohen, H;
(2017)
High prevalence of activated protein C resistance associated with high avidity anti-protein C antibodies in various antiphospholipid syndrome clinical phenotypes.
In:
(Proceedings) ISTH 2017.
|
|
|
Efthymiou, M;
Mackie, IJ;
Lane, PJ;
Andrade, D;
Willis, R;
Erkan, D;
Sciascia, S;
... APS ACTION, .; + view all
(2019)
Comparison of real world and core laboratory lupus anticoagulant results from the Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) clinical database and repository.
Journal of Thrombosis and Haemostasis
, 17
(12)
pp. 2069-2080.
10.1111/jth.14596.
|
|
El-Galaly, Tarec Christoffer;
Gaidzik, Verena I;
Gaman, Mihnea-Alexandru;
Antic, Darko;
Okosun, Jessica;
Copland, Mhairi;
Sexl, Veronika;
... Grønbæk, Kirsten; + view all
(2023)
A Lack of Diversity, Equity, and Inclusion in Clinical Research Has Direct Impact on Patient Care.
Hemasphere
, 7
(3)
, Article e842. 10.1097/HS9.0000000000000842.
|
|
El-Sharkawi, D;
(2016)
Studies to Investigate Epigenetic Factors in Acute Myeloid Leukaemia.
Doctoral thesis , UCL (University College London).
|
|
El-Sharkawi, D;
Ng, C-H;
Payne, EMC;
Yong, KL;
Ardeshna, KM;
Khwaja, A;
Townsend, W;
(2019)
Clinical outcomes and survival of patients with myeloma and lymphoma enrolled into phase I clinical trials.
British Journal of Haematology
, 185
(2)
pp. 344-347.
10.1111/bjh.15457.
|
|
El-Sharkawi, D;
Sproul, D;
Allen, CG;
Feber, A;
Wright, M;
Hills, RK;
Linch, DC;
(2018)
Variable Outcome And Methylation Status According To CEBPA Mutant Type In Double-Mutated Acute Myeloid Leukemia Patients And The Possible Implications For Treatment.
Haematologica
, 103
(1)
pp. 91-100.
10.3324/haematol.2017.173096.
|
|
|
Elliott, MJ;
Butler, CR;
Varanou-Jenkins, A;
Partington, L;
Carvalho, C;
Samuel, E;
Crowley, C;
... Birchall, MA; + view all
(2017)
Tracheal Replacement Therapy with a Stem Cell-Seeded Graft: Lessons from Compassionate Use Application of a GMP-Compliant Tissue-Engineered Medicine.
Stem Cells Translational Medicine
, 6
(6)
pp. 1458-1464.
10.1002/sctm.16-0443.
|
|
|
Elstein, D;
Belmatoug, N;
Deegan, P;
Göker-Alpan, Ö;
Hughes, DA;
Schwartz, IVD;
Weinreb, N;
... Zimran, A; + view all
(2022)
Development and validation of Gaucher disease type 1 (GD1)-specific patient-reported outcome measures (PROMs) for clinical monitoring and for clinical trials.
Orphanet Journal of Rare Diseases
, 17
, Article 9. 10.1186/s13023-021-02163-y.
|
|
Enfield, Katey SS;
Colliver, Emma;
Lee, Claudia SY;
Magness, Alastair;
Moore, David A;
Sivakumar, Monica;
Grigoriadis, Kristiana;
... Angelova, Mihaela; + view all
(2024)
Spatial Architecture of Myeloid and T Cells Orchestrates Immune Evasion and Clinical Outcome in Lung Cancer.
Cancer Discovery
, 14
(1)
pp. 1-30.
10.1158/2159-8290.CD-23-1380.
|
|
Engelhardt, M;
Yong, K;
Bringhen, S;
Waesch, R;
(2019)
Carfilzomib combination treatment as first-line therapy in multiple myeloma: where do we go from the Carthadex (KTd)-trial update?
[Editorial comment].
Haematologica
, 104
(11)
pp. 2128-2131.
10.3324/haematol.2019.228684.
|
|
|
Engert, A;
Balduini, C;
Brand, A;
Coiffier, B;
Cordonnier, C;
Doehner, H;
de Wit, TD;
... Zieger, B; + view all
(2016)
The European Hematology Association Roadmap for European Hematology Research: a consensus document.
Haematologica
, 101
(2)
pp. 115-208.
10.3324/haematol.2015.136739.
|
|
Enshaei, A;
Joy, M;
Butler, E;
Kirkwood, AA;
Messina, M;
Pavoni, C;
Morgades, M;
... Moorman, AV; + view all
(2024)
A robust and validated integrated prognostic index for defining risk groups in adult acute lymphoblastic leukemia: an EWALL collaborative study.
Blood Advances
, 8
(5)
pp. 1155-1166.
10.1182/bloodadvances.2023011661.
|
|
Enshaei, A;
O'Connor, D;
Bartram, J;
Hancock, J;
Harrison, CJ;
Hough, R;
Samarasinghe, S;
... Moorman, AV; + view all
(2020)
A validated novel continuous prognostic index to deliver stratified medicine in pediatric acute lymphoblastic leukemia.
Blood
, 135
(17)
pp. 1438-1446.
10.1182/blood.2019003191.
|
|
Erton, Zeynep Belce;
Leaf, Rebecca K;
de Andrade, Danieli;
Clarke, Ann;
Tektonidou, Maria G;
Pengo, Vittorio;
Sciascia, Savino;
... Erkan, Doruk; + view all
(2025)
Thrombocytopenia and autoimmune hemolytic anemia in antiphospholipid antibody-positive patients: Descriptive analysis of the AntiPhospholipid syndrome alliance for clinical trials and InternatiOnal networking (APS ACTION) clinical database and repository (“Registry”).
Lupus
, 34
(6)
pp. 617-625.
10.1177/09612033251332258.
|
|
Evans, REC;
Taylor, SA;
Kalasthry, J;
Sakai, NS;
Miles, A;
Streamline investigators;
(2019)
Patient deprivation and perceived scan burden negatively impact the quality of whole-body MRI.
Clinical Radiology
10.1016/j.crad.2019.10.019.
(In press).
|
|
|
Everington, T.;
(2009)
Investigation of the molecular and functional pathophysiology of polycythaemia vera.
Doctoral thesis , UCL (University College London).
|
|
Everington, T.F.;
(2008)
Investigation of the molecular & functional pathophysiology of Polycythaemia Vera.
pp. 1-225.
|
|
|
Eyre, TA;
Kirkwood, AA;
Gohill, S;
Follows, G;
Walewska, R;
Walter, H;
Cross, M;
... the UK CLL Forum; + view all
(2019)
Efficacy of venetoclax monotherapy in patients with relapsed chronic lymphocytic leukaemia in the post-BCR inhibitor setting: a UK wide analysis.
British Journal of Haematology
, 185
(4)
pp. 656-669.
10.1111/bjh.15802.
|
|
Eyre, TA;
Phillips, EH;
Linton, KM;
Kassam, S;
Gibb, A;
Allibone, S;
Radford, J;
... Collins, GP; + view all
(2017)
Results of a multicentre UK-wide retrospective study evaluating the efficacy of brentuximab vedotin in relapsed, refractory classical Hodgkin lymphoma in the transplant naive setting.
British Journal of Haematology
, 179
(3)
pp. 471-479.
10.1111/bjh.14898.
|
F
|
Fanelli, G;
Romano, M;
Nova-Lamperti, E;
Werner Sunderland, M;
Nerviani, A;
Scottà, C;
Bombardieri, M;
... Becker, PD; + view all
(2021)
PD-L1 signaling on human memory CD4+ T cells induces a regulatory phenotype.
PLoS Biology
, 19
(4)
, Article e3001199. 10.1371/journal.pbio.3001199.
(In press).
|
|
|
Fang, Z;
Corbizi Fattori, G;
McKerrell, T;
Boucher, RH;
Jackson, A;
Fletcher, RS;
Forte, D;
... Méndez-Ferrer, S; + view all
(2023)
Tamoxifen for the treatment of myeloproliferative neoplasms: A Phase II clinical trial and exploratory analysis.
Nature Communications
, 14
, Article 7725. 10.1038/s41467-023-43175-5.
|
|
Farah, Nadine Hani Rashad;
(2021)
Identifying novel therapeutic targets and prognostic markers through analysis of allele specific alterations in T-cell acute lymphoblastic leukaemia.
Doctoral thesis (Ph.D), UCL (University College London).
|
|
Farah, N;
Burt, R;
Ibrahim, AR;
Baker, R;
Kottaridis, PD;
(2020)
Concerns about how to use established minimal residual disease monitoring in the treatment of NPM1-mutant acute myeloid leukaemia (AML) following reduced intensity chemotherapy protocols for AML given as a result of the COVID-19 pandemic.
British Journal of Haematology
, 190
(4)
E208-E210.
10.1111/bjh.16985.
|
|
Farah, N;
Kirkwood, AA;
Rahman, S;
Leon, T;
Jenkinson, S;
Gale, RE;
Patrick, K;
... Mansour, MR; + view all
(2018)
Prognostic impact of the absence of biallelic deletion at theTRGlocus for pediatric patients with T-cell acute lymphoblastic leukemia treated on the MRC UKALL2003 trial.
Haematologica
, 103
(7)
e288-e292.
10.3324/haematol.2017.185801.
|
|
|
Farmakis, Dimitrios;
Porter, John;
Taher, Ali;
Cappellini, Maria Domenica;
Angastiniotis, Michael;
Eleftheriou, Androulla;
(2022)
2021 Thalassaemia International Federation Guidelines for the Management of Transfusion-dependent Thalassemia.
HemaSphere
, 6
(8)
, Article e732. 10.1097/HS9.0000000000000732.
|
|
Fehniger, TA;
Miller, JS;
Stuart, RK;
Cooley, S;
Salhotra, A;
Curtsinger, J;
Westervelt, P;
... Rowinsky, E; + view all
(2018)
A Phase 1 Trial of CNDO-109-Activated Natural Killer Cells in Patients with High-Risk Acute Myeloid Leukemia.
Biology of Blood and Marrow Transplantation
, 24
(8)
pp. 1581-1589.
10.1016/j.bbmt.2018.03.019.
|
|
|
Feldt-Rasmussen, U;
Hughes, D;
Sunder-Plassmann, G;
Shankar, S;
Nedd, K;
Olivotto, I;
Ortiz, D;
... Nicholls, K; + view all
(2020)
Long-term efficacy and safety of migalastat treatment in Fabry disease: 30-month results from the open-label extension of the randomized, phase 3 ATTRACT study.
Molecular Genetics and Metabolism
, 131
(1-2)
pp. 219-228.
10.1016/j.ymgme.2020.07.007.
|
|
|
Fendler, A;
Au, L;
Shepherd, STC;
Byrne, F;
Cerrone, M;
Boos, LA;
Rzeniewicz, K;
... Wilkinson, RJ; + view all
(2021)
Functional antibody and T cell immunity following SARS-CoV-2 infection, including by variants of concern, in patients with cancer: the CAPTURE study.
Nature Cancer
10.1038/s43018-021-00275-9.
(In press).
|
|
|
Feriozzi, S;
Linhart, A;
Ramaswami, U;
Kalampoki, V;
Gurevich, A;
Hughes, D;
Fabry Outcome Survey Study Group;
(2020)
Effects of Baseline Left Ventricular Hypertrophy and Decreased Renal Function on Cardiovascular and Renal Outcomes in Patients with Fabry Disease Treated with Agalsidase Alfa: A Fabry Outcome Survey Study.
Clinical Therapeutics
10.1016/j.clinthera.2020.10.007.
(In press).
|
|
|
Fernandes, E;
Goold, HD;
Kissenpfennig, A;
Malissen, B;
Dyson, J;
Bennett, CL;
(2011)
The Role of Direct Presentation by Donor Dendritic Cells in Rejection of Minor Histocompatibility Antigen-Mismatched Skin and Hematopoietic Cell Grafts.
Transplantation
, 91
(2)
154 - 160.
10.1097/TP.0b013e318201ac27.
|
|
Ferrada, Marcela A;
Savic, Sinisa;
Ospina Cardona, Daniela;
Collins, Jason Charles;
Alessi, Hugh;
Gutierrez-Rodrigues, Fernanda;
Uthaya Kumar, Dinesh Babu;
... Beck, David B; + view all
(2022)
Translation of cytoplasmic UBA1 contributes to VEXAS syndrome pathogenesis.
Blood
, 140
(13)
pp. 1496-1506.
10.1182/blood.2022016985.
|
|
Ferrari, M;
Mekkaoui, L;
Ilca, FT;
Akbar, Z;
Bughda, R;
Lamb, K;
Ward, K;
... Onuoha, SC; + view all
(2021)
Characterisation of a novel ACE2-based therapeutic with enhanced rather than reduced activity against SARS-CoV-2 variants.
Journal of Virology
, 95
(19)
, Article e00685-21. 10.1128/JVI.00685-21.
|
|
Ferrari, Mathieu;
Parekh, Farhaan;
Maciocia, Paul;
Horna, Pedro;
Thomas, Simon;
Sewell, Andrew K;
Pule, Martin;
(2025)
Reply to: Oligoclonality of TRBC1 and TRBC2 in T cell lymphomas as mechanism of primary resistance to TRBC-directed CAR T cell therapies.
Nature Communications
, 16
, Article 1103. 10.1038/s41467-025-56396-7.
|
|
|
Ferrari, Mathieu;
Righi, Matteo;
Baldan, Vania;
Wawrzyniecka, Patrycja;
Bulek, Anna;
Kinna, Alexander;
Ma, Biao;
... Pule, Martin; + view all
(2024)
Structure-guided engineering of immunotherapies targeting TRBC1 and TRBC2 in T cell malignancies.
Nature Communications
, 15
, Article 1583. 10.1038/s41467-024-45854-3.
|
|
Ferrer, IR;
West, HC;
Henderson, S;
Ushakov, DS;
Santos E Sousa, P;
Strid, J;
Chakraverty, R;
... Bennett, CL; + view all
(2019)
A wave of monocytes is recruited to replenish the long-term Langerhans cell network after immune injury.
Science Immunology
, 4
(38)
, Article eaax8704. 10.1126/sciimmunol.aax8704.
|
|
|
Fielding, AK;
(2019)
Curing Ph+ ALL: assessing the relative contributions of chemotherapy, TKIs, and allogeneic stem cell transplant.
Hematology, the ASH Education Program
, 2019
(1)
pp. 24-29.
10.1182/hematology.2019000010.
|
|
Fielding, AK;
(2019)
En-Abl-ing treatment of “Ph-like” ALL?
Blood
, 134
(16)
pp. 1277-1278.
10.1182/blood.2019002621.
|
|
Fielding, AK;
Goldstone, AH;
(2020)
Acute lymphoblastic leukaemia (ALL) things come to those who wait: 60 years of progress in the treatment of adult ALL.
British Journal of Haematology
, 191
(4)
pp. 558-561.
10.1111/bjh.17166.
|
|
|
Fields, Paul Andrew;
(2002)
Towards gene therapy for haemophilia using muscle as a target: A study of vector transduction and the implications of the immune response.
Doctoral thesis (Ph.D), UCL (University College London).
|
|
|
Foley, JH;
Shehu, E;
Riddell, A;
Gray, E;
Goodale, A;
Yu, IM;
Verhoef, D;
... Nathwani, AC; + view all
(2023)
Differences in wild-type– and R338L-tenase complex formation are at the root of R338L-factor IX assay discrepancies.
Blood Advances
, 7
(3)
pp. 458-467.
10.1182/bloodadvances.2022007435.
|
|
Foley, JH;
Orfeo, T;
Undas, A;
McLean, KC;
Bernstein, IM;
Rivard, G-E;
Mann, KG;
... Brummel-Ziedins, KE; + view all
(2013)
From Principle to Practice: Bridging the Gap in Patient Profiling.
PLoS ONE
, 8
(1)
, Article e54728 . 10.1371/journal.pone.0054728.
|
|
|
Forrester, AM;
Berman, JN;
Payne, EM;
(2012)
Myelopoiesis and Myeloid Leukaemogenesis in the Zebrafish.
Advances in Hematology
, 2012
, Article 358518. 10.1155/2012/358518.
|
|
|
Fortmann, J;
Fisher, A;
Hough, R;
Gregory, A;
Pugh, G;
(2021)
Sleep Quality Among Teenagers and Young Adults With Cancer.
Cancer Nursing
, 44
(1/2)
pp. 13-19.
10.1097/NCC.0000000000000707.
|
|
Fortmann, J;
Fisher, A;
Hough, R;
Gregory, A;
Pugh, G;
(2018)
Sleep Quality, Fatigue and Quality of Life among Teenage and Young Adult Cancer Survivors.
Journal of Adolescent and Young Adult Oncology
10.1089/jayao.2018.0004.
|
|
Fox, TA;
Carpenter, B;
Taj, M;
Perisoglou, M;
Nicholson, E;
Castleton, A;
Elliot, J;
... Hough, R; + view all
(2021)
Utility of 18F-FDG-PET/CT in lymphoblastic lymphoma.
Leukemia & Lymphoma
, 62
(4)
pp. 1010-1012.
10.1080/10428194.2020.1855346.
|
|
Fox, TA;
Kirkwood, AA;
Enfield, L;
O'Reilly, M;
Arulogun, S;
D'Sa, S;
O'Nions, J;
... Morris, EC; + view all
(2021)
Low seropositivity and suboptimal neutralisation rates in patients fully vaccinated against COVID-19 with B-cell malignancies.
British Journal of Haematology
, 195
(5)
pp. 706-709.
10.1111/bjh.17836.
|
|
|
Fox, TA;
Troy-Barnes, E;
Kirkwood, AA;
Chan, WY;
Day, JW;
Chavda, SJ;
Kumar, EA;
... Ardeshna, KM; + view all
(2020)
Response to 'Impact of immunosuppression on mortality in critically ill COVID-19 patients'.
British Journal of Haematology
, 191
(3)
pp. 505-506.
10.1111/bjh.17110.
|
|
Fox, Thomas A;
Massey, Valerie;
Lever, Charley;
Pearce, Rachel;
Laurence, Arian;
Grace, Sarah;
Oliviero, Filippo;
... Morris, Emma C; + view all
(2025)
Correction to: Pre-Transplant Immune Dysregulation Predicts for
Poor Outcome Following Allogeneic Haematopoietic Stem Cell
Transplantation in Adolescents and Adults with Inborn Errors of
Immunity (IEI).
[Corrigendum].
Journal of Clinical Immunology
, 45
(1)
, Article 95. 10.1007/s10875-025-01893-z.
|
|
|
Fox, T;
Chakraverty, R;
Burns, S;
Carpenter, B;
Thomson, K;
Lowe, D;
Fielding, A;
... Morris, EC; + view all
(2018)
Successful outcome following allogeneic hematopoietic stem cell transplantation in adults with primary immunodeficiency.
Blood
, 131
(8)
pp. 917-931.
10.1182/blood-2017-09-807487.
|
|
Fox, TA;
Carpenter, B;
Khwaja, A;
Halsey, R;
Grandage, V;
Mansour, MR;
Fielding, AK;
(2019)
Utility of FDG-PET/CT in Lymphoblastic Lymphoma.
Presented at: 61st ASH Annual Meeting, Orlando, FL, USA.
|
|
Fox, TA;
Halsey, R;
Pomplun, S;
Gant, V;
Grandage, V;
Mansour, MR;
Hough, R;
(2020)
Rapid clinical response to adjuvant corticosteroids in chronic disseminated candidiasis complicated by granulomas and persistent fever in acute leukemia patients.
Leukemia & Lymphoma
, 61
(4)
pp. 944-949.
10.1080/10428194.2019.1691198.
|
|
Fox, TA;
Jager, R;
Ardeshna, KM;
(2018)
Cerebrospinal fluid leak after bone marrow biopsy.
British Journal of Haematology
, 180
(3)
p. 319.
10.1111/bjh.14963.
|
|
Fox, TA;
Troy-Barnes, E;
Kirkwood, AA;
Chan, WY;
Day, J;
Chavda, SJ;
Kumar, EA;
... Ardeshna, KM; + view all
(2020)
Clinical outcomes and risk factors for severe COVID‐19 infection in patients with haematological disorders receiving chemo‐ or immunotherapy.
British Journal of Haematology
, 191
(2)
pp. 194-206.
10.1111/bjh.17027.
|
|
Frankell, Alexander M;
Dietzen, Michelle;
Al Bakir, Maise;
Lim, Emilia L;
Karasaki, Takahiro;
Ward, Sophia;
Veeriah, Selvaraju;
... Swanton, Charles; + view all
(2024)
The evolution of lung cancer and impact of subclonal selection in TRACERx (vol 616, pg 525, 2023).
[Corrigendum].
Nature
, 631
, Article E15. 10.1038/s41586-024-07738-w.
|
|
|
Frankell, AM;
Dietzen, M;
Al Bakir, M;
Lim, EL;
Karasaki, T;
Ward, S;
Veeriah, S;
... Gilbert, K; + view all
(2023)
The evolution of lung cancer and impact of subclonal selection in TRACERx.
Nature
, 616
pp. 525-533.
10.1038/s41586-023-05783-5.
|
|
Franz Demane, Dafne Sofia;
(2019)
Defining and targeting combination immunotherapies in mouse models of cancer.
Doctoral thesis (Ph.D), UCL (University College London).
|
|
Freeman, SD;
Thomas, A;
Thomas, I;
Hills, RK;
Vyas, P;
Gilkes, A;
Metzner, M;
... Russell, NH; + view all
(2023)
Fractionated vs single-dose gemtuzumab ozogamicin with determinants of benefit in older patients with AML: the UK NCRI AML18 trial.
Blood
, 142
(20)
pp. 1697-1707.
10.1182/blood.2023020630.
|
|
Freeman, SD;
Hills, RK;
Virgo, P;
Khan, N;
Couzens, S;
Dillon, R;
Gilkes, A;
... Russell, NH; + view all
(2018)
Measurable Residual Disease at Induction Redefines Partial Response in Acute Myeloid Leukemia and Stratifies Outcomes in Patients at Standard Risk Without NPM1 Mutations.
Journal of Clinical Oncology
, 36
(15)
pp. 1486-1497.
10.1200/JCO.2017.76.3425.
|
|
Fu, X;
Zhao, Y;
Lopez, JI;
Rowan, A;
Au, L;
Fendler, A;
Hazell, S;
... Bates, PA; + view all
(2021)
Spatial patterns of tumour growth impact clonal diversification in a computational model and the TRACERx Renal study.
Nature Ecology & Evolution
10.1038/s41559-021-01586-x.
|
|
|
Furness, AJ;
Quezada, SA;
Peggs, KS;
(2016)
Neoantigen heterogeneity: a key driver of immune response and sensitivity to immune checkpoint blockade?
[Editorial comment].
Immunotherapy
, 8
(7)
pp. 763-766.
10.2217/imt-2016-0064.
|
|
Furness, CL;
Mansur, MB;
Weston, VJ;
Ermini, L;
van Delft, FW;
Jenkinson, S;
Gale, R;
... Greaves, M; + view all
(2018)
The subclonal complexity of STIL-TAL1+ T-cell acute lymphoblastic leukaemia.
Leukemia
, 32
pp. 1984-1993.
10.1038/s41375-018-0046-8.
|
|
Furness, CL;
Smith, L;
Morris, E;
Brocklehurst, C;
Daly, S;
Hough, RE;
(2017)
Cancer Patient Experience in the Teenage Young Adult Population-Key Issues and Trends Over Time: An Analysis of the United Kingdom National Cancer Patient Experience Surveys 2010-2014.
Journal of Adolescent and Young Adult Oncology
, 6
(3)
pp. 450-458.
10.1089/jayao.2016.0058.
|
G
|
Gagelmann, Nico;
Bose, Prithviraj;
Gupta, Vikas;
Mclornan, Donal P;
Vachhani, Pankit;
Al-Ali, Haifa-Kathrin;
Ali, Haris;
... Scott, Bart; + view all
(2024)
Consistency of Spleen and Symptom Reduction Regardless of Cytopenia in Patients With Myelofibrosis Treated With Pacritinib.
Clinical Lymphoma Myeloma and Leukemia
, 24
(11)
pp. 796-803.
10.1016/j.clml.2024.06.012.
|
|
|
Gale, RE;
Tawana, K;
Wang, J;
Renneville, A;
Bodor, C;
Hills, R;
Loveday, C;
... Fitzgibbon, J; + view all
(2015)
Disease evolution and outcomes in familial AML with germline CEBPA mutations.
Blood
, 126
(10)
pp. 1214-1223.
10.1182/blood-2015-05-647172.
|
|
Gale, RE;
Hills, R;
Kottaridis, PD;
Srirangan, S;
Wheatley, K;
Burnett, AK;
Linch, DC;
(2005)
No evidence that FLT3 status should be considered as an indicator for transplantation in acute myeloid leukemia (AML): an analysis of 1135 patients, excluding acute promyelocytic leukemia, from the UK MRC AML 10 and 12 trials.
BLOOD
, 106
(10)
3658 - 3665.
10.1182/blood-2005-03-1323.
|
|
|
Gale, RE;
Hills, R;
Pizzey, AR;
Kottaridis, PD;
Swirsky, D;
Gilkes, AF;
Nugent, E;
... NCRI Adult Leukaemia Working Party; + view all
(2005)
Relationship between FLT3 mutation status, biologic characteristics, and response to targeted therapy in acute promyelocytic leukemia.
BLOOD
, 106
(12)
3768 - 3776.
|
|
|
Gale, RE;
Lamb, K;
Allen, C;
El-Sharkawi, D;
Stowe, C;
Jenkinson, S;
Tinsley, S;
... Linch, DC; + view all
(2015)
Simpson's Paradox and the Impact of Different DNMT3A Mutations on Outcome in Younger Adults With Acute Myeloid Leukemia.
Journal of Clinical Oncology
, 33
(18)
pp. 2072-2083.
10.1200/JCO.2014.59.2022.
|
|
|
Gale, RE;
Popa, T;
Wright, M;
Khan, N;
Freeman, SD;
Burnett, AK;
Russell, NH;
... Linch, DC; + view all
(2018)
No evidence that CD33 splicing SNP impacts the response to GO in younger adults with AML treated on UK MRC/NCRI trials.
Blood
, 131
(4)
pp. 468-471.
10.1182/blood-2017-08-802157.
|
|
Galleu, A;
Riffo-Vasquez, Y;
Trento, C;
Lomas, C;
Dolcetti, L;
Cheung, TS;
von Bonin, M;
... Dazzi, F; + view all
(2017)
Apoptosis in mesenchymal stromal cells induces in vivo recipient-mediated immunomodulation.
Science Translational Medicine
, 9
(416)
, Article eaam7828. 10.1126/scitranslmed.aam7828.
|
|
|
Galvez-Cancino, Felipe;
Navarrete, Mariela;
Beattie, Gordon;
Puccio, Simone;
Conde-Gallastegi, Enrique;
Foster, Kane;
Morris, Yasmin;
... Quezada, Sergio A; + view all
(2025)
Correction:
Regulatory T cell depletion promotes myeloid cell activation and glioblastoma response to anti-PD1 and tumor-targeting antibodies.
[Corrigendum].
Immunity
, 58
(7)
pp. 1862-1864.
10.1016/j.immuni.2025.05.019.
|
|
Galvez-Cancino, Felipe;
Simpson, Alexander P;
Costoya, Cristobal;
Matos, Ignacio;
Qian, Danwen;
Peggs, Karl S;
Litchfield, Kevin;
(2023)
Fcγ receptors and immunomodulatory antibodies in cancer.
Nature Reviews Cancer
, 24
(1)
pp. 51-71.
10.1038/s41568-023-00637-8.
|
|
Ganeshan, B;
Miles, KA;
Babikir, S;
Shortman, R;
Afaq, A;
Ardeshna, KM;
Groves, AM;
(2017)
CT-based texture analysis potentially provides prognostic information complementary to interim fdg-pet for patients with hodgkin's and aggressive non-hodgkin's lymphomas.
European Radiology
, 27
(3)
pp. 1012-1020.
10.1007/s00330-016-4470-8.
|
|
Gangoso, E;
Southgate, B;
Bradley, L;
Rus, S;
Galvez-Cancino, F;
McGivern, N;
Güç, E;
... Pollard, SM; + view all
(2021)
Glioblastomas acquire myeloid-affiliated transcriptional programs via epigenetic immunoediting to elicit immune evasion.
Cell
10.1016/j.cell.2021.03.023.
(In press).
|
|
|
Garbowski, Maciej W;
Cabantchik, Ioav;
Hershko, Chaim;
Hider, Robert;
Porter, John B;
(2023)
The clinical relevance of detectable plasma iron species in iron overload states and subsequent to intravenous iron-carbohydrate administration.
American Journal of Hematology
, 98
(3)
pp. 533-540.
10.1002/ajh.26819.
|
|
Garbowski, Maciej W;
Porter, John B;
Hider, Robert;
(2021)
Response to Cabantchik and Hershko commentary "Plasma nontransferrin bound iron-nontransferrin bound iron revisited: Implications for systemic iron overload and in iv iron supplementation".
American Journal of Hematology
, 97
(2)
E58-E59.
10.1002/ajh.26419.
|
|
Garbowski, MW;
Ugidos, M;
Risueño, A;
Shetty, JK;
Schwickart, M;
Hermine, O;
Porter, JB;
... Vodala, S; + view all
(2023)
Luspatercept stimulates erythropoiesis, increases iron utilization, and redistributes body iron in transfusion-dependent thalassemia.
American Journal of Hematology
10.1002/ajh.27102.
(In press).
|
|
|
Garbowski, MW;
(2017)
Molecular and clinical factors affecting myocardial iron retention in transfusional haemosiderosis.
Doctoral thesis , UCL (University College London).
|
|
Garbowski, MW;
Bansal, S;
Porter, JB;
Mori, C;
Burckhardt, S;
Hider, RC;
(2020)
Intravenous iron preparations transiently generate non-transferrin-bound iron from two proposed pathways.
Haematologica
10.3324/haematol.2020.250803.
(In press).
|
|
Garbowski, MW;
Carpenter, JP;
Smith, G;
Roughton, M;
Alam, MH;
He, T;
Pennell, DJ;
(2014)
Biopsy-based calibration of T2* magnetic resonance for estimation of liver iron concentration and comparison with R2 Ferriscan.
Journal of Cardiovascular Magnetic Resonance
, 16
(40)
10.1186/1532-429X-16-40.
|
|
|
Garbowski, MW;
Evans, P;
Vlachodimitropoulou, E;
Hider, R;
Porter, JB;
(2017)
Residual erythropoiesis protects against myocardial hemosiderosis in transfusion-dependent thalassemia by lowering labile plasma iron via transient generation of apotransferrin.
Haematologica
, 102
pp. 1640-1649.
10.3324/haematol.2017.170605.
|
|
|
Garbowski, MW;
Ma, Y;
Fucharoen, S;
Srichairatanakool, S;
Hider, R;
Porter, JB;
(2016)
Clinical and methodological factors affecting non-transferrin-bound iron values using a novel fluorescent bead assay.
Translational Research
, 177
19-30.e5.
10.1016/j.trsl.2016.05.005.
|
|
|
García-Berrocoso, T;
Llombart, V;
Colàs-Campàs, L;
Hainard, A;
Licker, V;
Penalba, A;
Ramiro, L;
... Montaner, J; + view all
(2018)
Single Cell Immuno-Laser Microdissection Coupled to Label-Free Proteomics to Reveal the Proteotypes of Human Brain Cells After Ischemia.
Molecular & Cellular Proteomics
, 17
(1)
pp. 175-189.
10.1074/mcp.RA117.000419.
|
|
Garcia-Diaz, Claudia;
Mereu, Elisabetta;
Clements, Melanie;
Pöysti, Anni;
Galvez-Cancino, Felipe;
Castillo, Simon;
Courtot, Lilas;
... Parrinello, Simona; + view all
(2021)
Glioblastoma cell fate is differentially regulated by the microenvironments of the tumour bulk and infiltrative margin.
bioRxiv: Cold Spring Harbor, NY, USA.
|
|
|
Garcia-Diaz, Claudia;
Pöysti, Anni;
Mereu, Elisabetta;
Clements, Melanie P;
Brooks, Lucy J;
Galvez-Cancino, Felipe;
Castillo, Simon P;
... Parrinello, Simona; + view all
(2023)
Glioblastoma cell fate is differentially regulated by the microenvironments of the tumor bulk and infiltrative margin.
Cell Reports
, 42
(5)
, Article 112472. 10.1016/j.celrep.2023.112472.
|
|
|
Garderet, Laurent;
Gras, Luuk;
Koster, Linda;
Baaij, Laurien;
Hamad, Nada;
Dsouza, Anita;
Estrada-Merly, Noel;
... Niederwieser, Dietger; + view all
(2024)
Global characteristics and outcomes of autologous hematopoietic stem cell transplantation for newly diagnosed multiple myeloma: A study of the worldwide network for blood and marrow transplantation (WBMT).
American Journal of Hematology
, 99
(11)
pp. 2084-2095.
10.1002/ajh.27451.
|
|
Garderet, Laurent;
Gras, Luuk;
Koster, Linda;
de Wreede, Liesbeth;
Montserrat, Rovira;
Vincent, Laure;
Fenk, Roland;
... Mclornan, Donal; + view all
(2024)
Long-term outcomes and renal responses following autologous hematopoietic stem cell transplantation for light chain deposition disease: a retrospective study on behalf of the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation.
Haematologica
, 109
(8)
pp. 2619-2627.
10.3324/haematol.2023.284520.
|
|
|
Gardiner, C;
Hills, J;
Machin, SJ;
Cohen, H;
(2013)
Diagnosis of antiphospholipid syndrome in routine clinical practice.
Lupus
, 22
(1)
18 - 25.
10.1177/0961203312460722.
|
|
|
Gardiner, C;
Kiyoko, K;
Patel, I;
Lane, P;
Machin, SJ;
Mackie, I;
(2016)
A performance evaluation of a novel human recombinant tissue factor prothrombin time reagent.
Presented at: UNSPECIFIED.
|
|
|
Gardiner, C;
Kohama, K;
Patel, I;
Lane, P;
Dwyer, S;
Machin, SJ;
Mackie, IJ;
(2017)
A performance evaluation of a novel human recombinant tissue factor prothrombin time reagent (Revohem (TM) PT).
International Journal of Laboratory Hematology
, 39
(5)
pp. 532-538.
10.1111/ijlh.12691.
|
|
Gardiner, C;
Lane, P;
Chitolie, A;
Nunn, M;
Kurono, H;
Machin, S;
Mackie, I;
(2016)
AUTOMATED ASSESSMENT OF THE COMPLEMENT SYSTEM.
Presented at: UNSPECIFIED.
|
|
Gardiner, C;
Lane, P;
Tailor, H;
Mackie, IJ;
(2019)
A practical method for reducing the interference due to lipaemia in coagulation tests.
International Journal of Laboratory Hematology
, 42
(2)
pp. 140-144.
10.1111/ijlh.13129.
|
|
|
Gardiner, C;
Longair, I;
Pescott, MA;
Erwin, H;
Hills, J;
Machin, SJ;
Cohen, H;
(2009)
Self-monitoring of oral anticoagulation: does it work outside trial conditions?
Journal of Clinical Pathology
, 62
(2)
168 - 171.
10.1136/jcp.2008.059634.
|
|
Gardiner, C;
Patel, I;
Lane, P;
Kiyoko, K;
Machin, S;
Mackie, I;
(2016)
A NOVEL PROTHROMBIN TIME REAGENT THAT UTILISES TISSUE FACTOR GENERATED BY SILK-WORM-BACULOVIRUS TECHNOLOGY.
Presented at: UNSPECIFIED.
|
|
|
Gardiner, C.;
(2008)
Antiphospholipid antibodies and the protein C pathway.
Doctoral thesis , University of London.
|
|
|
Gardner, Oliver FW;
Agabalyan, Natacha;
Weil, Ben;
Ali, Mohammed HI;
Lowdell, Mark W;
Bulstrode, Neil W;
Ferretti, Patrizia;
(2023)
Human platelet lysate enhances proliferation but not chondrogenic differentiation of pediatric mesenchymal progenitors.
Cytotherapy
, 25
(3)
pp. 286-297.
10.1016/j.jcyt.2022.11.007.
|
|
Gaspar, Pedro;
Farinha, Filipa;
Sayar, Zara;
Efthymiou, Maria;
Cohen, Hannah;
Isenberg, David A;
(2022)
A one-point increase in the Damage Index for Antiphospholipid Syndrome (DIAPS) predicts mortality in thrombotic antiphospholipid syndrome.
Clinical and Experimental Rheumatology
10.55563/clinexprheumatol/0gs167.
(In press).
|
|
Gaspar, P;
Cohen, H;
Isenberg, DA;
(2020)
The assessment of patients with the antiphospholipid antibody syndrome: where are we now?
Rheumatology
, 59
(7)
pp. 1489-1494.
10.1093/rheumatology/keaa172.
|
|
Gassas, A;
Sivaprakasam, P;
Cummins, M;
Breslin, P;
Patrick, K;
Slatter, M;
Skinner, R;
... Amrolia, P; + view all
(2018)
High transplant-related mortality associated with haematopoietic stem cell transplantation for paediatric therapy-related acute myeloid leukaemia (t-AML). A study on behalf of the United Kingdom Paediatric Blood and Bone Marrow Transplant Group.
Bone Marrow Transplantation
, 53
(9)
pp. 1165-1169.
10.1038/s41409-018-0157-x.
|
|
|
Genadieva-Stavrik, S;
Boumendil, A;
Dreger, P;
Peggs, K;
Briones, J;
Corradini, P;
Bacigalupo, A;
... Sureda, A; + view all
(2016)
Myeloablative versus reduced intensity allogeneic stem cell transplantation for relapsed/refractory Hodgkin's lymphoma in recent years: a retrospective analysis of the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation.
Annals of Oncology
, 27
(12)
pp. 2251-2257.
10.1093/annonc/mdw421.
|
|
Germain, DP;
Arad, M;
Burlina, A;
Elliott, PM;
Falissard, B;
Feldt-Rasmussen, U;
Hilz, MJ;
... Spada, M; + view all
(2019)
The effect of enzyme replacement therapy on clinical outcomes in female patients with Fabry disease - A systematic literature review by a European panel of experts.
Molecular Genetics and Metabolism
, 126
(3)
pp. 224-235.
10.1016/j.ymgme.2018.09.007.
|
|
|
Germain, DP;
Hughes, DA;
Nicholls, K;
Bichet, DG;
Giugliani, R;
Wilcox, WR;
Feliciani, C;
... Schiffmann, R; + view all
(2016)
Treatment of Fabry’s Disease with the Pharmacologic Chaperone Migalastat.
New England Journal of Medicine
, 375
(6)
pp. 545-555.
10.1056/NEJMoa1510198.
|
|
|
Germain, DP;
Nicholls, K;
Giugliani, R;
Bichet, DG;
Hughes, DA;
Barisoni, LM;
Colvin, RB;
... Viereck, C; + view all
(2019)
Efficacy of the pharmacologic chaperone migalastat in a subset of male patients with the classic phenotype of Fabry disease and migalastat-amenable variants: data from the phase 3 randomized, multicenter, double-blind clinical trial and extension study.
Genetics in Medicine
10.1038/s41436-019-0451-z.
(In press).
|
|
|
Ghamlouch, Hussein;
Boyle, Eileen M;
Blaney, Patrick;
Wang, Yubao;
Choi, Jinyoung;
Williams, Louis;
Bauer, Michael;
... Morgan, Gareth J; + view all
(2021)
Insights into high-risk multiple myeloma from an analysis of the role of PHF19 in cancer.
Journal of Experimental & Clinical Cancer Research
, 40
, Article 380. 10.1186/s13046-021-02185-1.
|
|
Ghorani, Ehsan;
Swanton, Charles;
Quezada, Sergio A;
(2023)
Cancer cell-intrinsic mechanisms driving acquired immune tolerance.
Immunity
, 56
(10)
pp. 2270-2295.
10.1016/j.immuni.2023.09.004.
|
|
|
Ghorani, E;
Kaur, B;
Fisher, RA;
Short, D;
Joneborg, U;
Carlson, JW;
Akarca, A;
... Seckl, MJ; + view all
(2017)
Pembrolizumab is effective for drugresistant gestational trophoblastic neoplasia.
The Lancet
, 390
(10110)
pp. 2343-2345.
10.1016/S0140-6736(17)32894-5.
|
|
Ghorani, E;
Quezada, SA;
(2018)
Chromatin regulation and immune escape.
Science
, 359
(6377)
pp. 745-746.
10.1126/science.aat0383.
|
|
Ghorani, E;
Reading, JL;
Henry, JY;
Massy, MRD;
Rosenthal, R;
Turati, V;
Joshi, K;
... Quezada, SA; + view all
(2020)
The T cell differentiation landscape is shaped by tumour mutations in lung cancer.
Nature Cancer
, 1
(5)
pp. 546-561.
10.1038/s43018-020-0066-y.
|
|
Ghorani, E;
Rosenthal, R;
McGranahan, N;
Reading, JL;
Lynch, M;
Peggs, KS;
Swanton, C;
(2018)
Differential binding affinity of mutated peptides for MHC class I is a predictor of survival in advanced lung cancer and melanoma.
Annals of Oncology
, 29
(1)
pp. 271-279.
10.1093/annonc/mdx687.
|
|
|
Ghorashian, Sara;
Lucchini, Giovanna;
Richardson, Rachel;
Nguyen, Kyvi;
Terris, Craig;
Guvenel, Aleks;
Oporto Espuelas, Macarena;
... Amrolia, Persis J; + view all
(2024)
CD19/CD22 targeting with co-transduced CAR T-cells to prevent antigen negative relapse after CAR T-cell therapy of B-ALL.
Blood
, 143
(2)
pp. 118-123.
10.1182/blood.2023020621.
|
|
Ghorashian, S;
Kramer, AM;
Onuoha, S;
Wright, G;
Bartram, J;
Richardson, R;
Albon, SJ;
... Amrolia, PJ; + view all
(2019)
Enhanced CAR T cell expansion and prolonged persistence in pediatric patients with ALL treated with a low-affinity CD19 CAR.
Nature Medicine
, 25
pp. 1408-1414.
10.1038/s41591-019-0549-5.
|
|
Ghorashian, S;
Veliça, P;
Chua, I;
McNicol, AM;
Carpenter, B;
Holler, A;
Nicholson, E;
... Stauss, HJ; + view all
(2015)
CD8 T cell tolerance to a tumor-associated self-antigen is reversed by CD4 T cells engineered to express the same T cell receptor.
Journal of Immunology
, 194
(3)
1080 - 1089.
10.4049/jimmunol.1401703.
|
|
|
Giugliani, R;
Niu, DM;
Ramaswami, U;
West, M;
Hughes, D;
Kampmann, C;
Pintos-Morell, G;
... Beck, M; + view all
(2016)
A 15-year perspective of the fabry outcome survey.
Journal of Inborn Errors of Metabolism and Screening
, 4
10.1177/2326409816666298.
|
|
|
Gkrouzman, E;
Sevim, E;
Finik, J;
Andrade, D;
Pengo, V;
Sciascia, S;
Tektonidou, MG;
... APS ACTION+; + view all
(2021)
Antiphospholipid Antibody Profile Stability Over Time: Prospective Results from APS ACTION Clinical Database and Repository.
Journal of Rheumatology
, 48
(4)
pp. 541-547.
10.3899/jrheum.200513.
|
|
Gkrouzman, Elena;
Willis, Rohan;
Andrade, Danieli;
Tektonidou, Maria G;
Pengo, Vittorio;
Ruiz-Irastorza, Guillermo;
Belmont, H Michael;
... APS, ACTION; + view all
(2023)
Associations Among Antiphospholipid Antibody Types, Isotypes, and Titers: An AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Study.
Laboratory Investigation
, 103
(6)
, Article 100147. 10.1016/j.labinv.2023.100147.
|
|
Gleeson, M;
Counsell, N;
Cunningham, D;
Chadwick, N;
Lawrie, A;
Hawkes, EA;
McMillan, A;
... Linch, D; + view all
(2017)
Central nervous system relapse of diffuse large B-cell lymphoma in the rituximab era: results of the UK NCRI R-CHOP-14 versus 21 trial.
Annals of Oncology
, 28
(10)
pp. 2511-2516.
10.1093/annonc/mdx353.
|
|
|
Gleeson, M;
Counsell, N;
Cunningham, D;
Lawrie, A;
Clifton-Hadley, L;
Hawkes, E;
McMillan, A;
... Linch, D; + view all
(2021)
Prognostic indices in diffuse large B-cell lymphoma in the rituximab era: an analysis of the UK National Cancer Research Institute R-CHOP 14 versus 21 phase 3 trial.
British Journal of Haematology
, 192
(6)
pp. 1015-1019.
10.1111/bjh.16691.
|
|
Gleeson, M;
Hawkes, EA;
Cunningham, D;
Chadwick, N;
Counsell, N;
Lawrie, A;
Jack, A;
... Linch, D; + view all
(2016)
Rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone (R-CHOP) in the management of primary mediastinal B-cell lymphoma: a subgroup analysis of the UK NCRI R-CHOP 14 versus 21 trial.
British Journal of Haematology
, 175
(4)
pp. 668-672.
10.1111/bjh.14287.
|
|
Glynne, P;
Tahmasebi, N;
Gant, V;
Gupta, R;
(2021)
Long COVID following mild SARS-CoV-2 infection: characteristic T cell alterations and response to antihistamines.
Journal of Investigative Medicine
10.1136/jim-2021-002051.
(In press).
|
|
|
Glynne-Jones, R;
Hall, MR;
Lopes, A;
Pearce, S;
Goh, V;
Bosompem, S;
Bridgewater, J;
... Harrison, M; + view all
(2018)
BACCHUS: A randomised non-comparative phase II study of neoadjuvant chemotherapy (NACT) in patients with locally advanced rectal cancer (LARC).
Heliyon
, 4
(9)
, Article e00804. 10.1016/j.heliyon.2018.e00804.
|
|
|
Goekbuget, N;
Dombret, H;
Ribera, J-M;
Fielding, AK;
Advani, A;
Bassan, R;
Chia, V;
... Kantarjian, H; + view all
(2016)
International reference analysis of outcomes in adults with B-precursor Ph-negative relapsed/refractory acute lymphoblastic leukemia.
Haematologica
, 101
(12)
pp. 1524-1533.
10.3324/haematol.2016.144311.
|
|
Goel, A;
Christudoss, P;
George, R;
Ramakrishna, B;
Amirtharaj, GJ;
Keshava, SN;
Ramachandran, A;
... Eapen, CE; + view all
(2016)
Arsenicosis, possibly from contaminated groundwater, associated with noncirrhotic intrahepatic portal hypertension.
Indian J Gastroenterol
, 35
(3)
pp. 207-215.
10.1007/s12664-016-0660-1.
|
|
Goel, A;
Raghupathy, V;
Amirtharaj, GJ;
Chapla, A;
Venkatraman, A;
Ramakrishna, B;
Ramachandran, A;
... Eapen, CE; + view all
(2017)
ADAMTS13 missense variants associated with defective activity and secretion of ADAMTS13 in a patient with non-cirrhotic portal hypertension.
Indian Journal of Gastroenterology
, 36
(5)
pp. 380-389.
10.1007/s12664-017-0786-9.
|
|
Goh, PA;
Caxaria, S;
Casper, C;
Rosales, C;
Warner, TT;
Coffey, PJ;
Nathwani, AC;
(2013)
A Systematic Evaluation of Integration Free Reprogramming Methods for Deriving Clinically Relevant Patient Specific Induced Pluripotent Stem (iPS) Cells.
PLoS One
, 8
(11)
, Article e81622. 10.1371/journal.pone.0081622.
|
|
|
Gohil, Satyen Harish;
(2018)
Pre-clinical development of novel ROR1 chimeric antigen receptor T cells and bispecific T cell engagers.
Doctoral thesis (Ph.D), UCL (University College London).
|
|
Gohil, SH;
Maciocia, N;
Patrick, P;
Roberts, T;
Counsell, N;
Smith, P;
Clifton-Hadley, L;
... Nathwani, AC; + view all
(2018)
LenD: a study to establish the safety and efficacy of lenalidomide and dexamethasone in patients with relapsed or refractory chronic lymphocytic leukemia.
Leukemia & Lymphoma
, 59
(7)
pp. 1730-1733.
10.1080/10428194.2017.1399311.
|
|
Gohil, SH;
Paredes-Moscosso, SR;
Harrasser, M;
Vezzalini, M;
Scarpa, A;
Morris, E;
Davidoff, AM;
... Della Peruta, M; + view all
(2017)
An ROR1 bi-specific T-cell engager provides effective targeting and cytotoxicity against a range of solid tumors.
OncoImmunology
, 6
(7)
, Article e1326437. 10.1080/2162402X.2017.1326437.
|
|
|
Gökbuget, N;
Kantarjian, HM;
Brüggemann, M;
Stein, AS;
Bargou, RC;
Dombret, H;
Fielding, AK;
... Topp, MS; + view all
(2019)
Molecular response with blinatumomab in relapsed/refractory B-cell precursor acute lymphoblastic leukemia.
Blood Advances
, 3
(20)
pp. 3033-3037.
10.1182/bloodadvances.2019000457.
|
|
|
Gökbuget, N;
Kelsh, M;
Chia, V;
Advani, A;
Bassan, R;
Dombret, H;
Doubek, M;
... Kantarjian, H; + view all
(2016)
Blinatumomab vs historical standard therapy of adult relapsed/refractory acute lymphoblastic leukemia.
Blood Cancer J
, 6
(9)
, Article e473. 10.1038/bcj.2016.84.
|
|
|
Gomez-Escobar, Natalia;
Bennett, Clare;
Prieto-Lafuente, Lidia;
Aebischer, Toni;
Blackburn, Clare C;
Maizels, Rick M;
(2005)
Heterologous expression of the filarial nematode alt gene products reveals their potential to inhibit immune function.
BMC Biology
, 3
, Article 8. 10.1186/1741-7007-3-8.
|
|
|
Gómez-López, Sandra;
Alhendi, Ahmed SN;
Przybilla, Moritz J;
Bordeu, Ignacio;
Whiteman, Zoe E;
Butler, Timothy;
Rouhani, Maral J;
... Janes, Sam M; + view all
(2025)
Aberrant basal cell clonal dynamics shape early lung carcinogenesis.
Science
, 388
(6752)
, Article eads9145. 10.1126/science.ads9145.
|
|
Gonzalez Malagon, SG;
Melidoni, AN;
Hernandez, D;
Omar, BA;
Houseman, L;
Veeravalli, S;
Scott, F;
... Shephard, EA; + view all
(2015)
The phenotype of a knockout mouse identifies flavin-containing monooxygenase 5 (FMO5) as a regulator of metabolic ageing.
Biochemical Pharmacology
, 96
(3)
pp. 267-277.
10.1016/j.bcp.2015.05.013.
|
|
Gonzalez-McQuire, S;
Yong, K;
Leleu, H;
Mennini, FS;
Flinois, A;
Gazzola, C;
Schoen, P;
... Fink, L; + view all
(2018)
Healthcare resource utilization among patients with relapsed multiple myeloma in the UK, France, and Italy.
Journal of Medical Economics
, 21
(5)
pp. 450-467.
10.1080/13696998.2017.1421546.
|
|
Gooding, Sarah;
Ansari-Pour, Naser;
Kazeroun, Mohammad H;
Karagoz, Kubra;
Polonskaia, Ann;
Angulo Salazar, Mirian;
Fitzsimons, Evelyn;
... Thakurta, Anjan; + view all
(2022)
Loss of COP9 signalosome genes at 2q37 is associated with IMiD resistance in multiple myeloma.
Blood
, 140
(16)
pp. 1816-1821.
10.1182/blood.2022015909.
|
|
Goodship, THJ;
Pinto, F;
Weston-Davies, WH;
Silva, J;
Nishimura, J-I;
Nunn, MA;
Mackie, I;
... Veys, P; + view all
(2017)
Use of the complement inhibitor Coversin to treat HSCT-associated TMA.
Blood Advances
, 1
(16)
pp. 1254-1258.
10.1182/bloodadvances.2016002832.
|
|
|
Gootjes, EC;
Bakkerus, L;
ten Tije, AJ;
Witteveen, PO;
Buffart, TE;
Bridgewater, JA;
Primrose, JN;
... Verheul, HMW; + view all
(2018)
The value of tumour debulking for patients with extensive multi-organ metastatic colorectal cancer.
European Journal of Cancer Prevention
, 103
pp. 160-164.
10.1016/j.ejca.2018.07.012.
|
|
Gopal, AK;
Popat, R;
Mattison, RJ;
Menne, T;
Bloor, A;
Gaymes, T;
Khwaja, A;
... Mufti, GJ; + view all
(2021)
A Phase I trial of talazoparib in patients with advanced hematologic malignancies.
International Journal of Hematologic Oncology
, 10
(3)
10.2217/ijh-2021-0004.
|
|
|
Goswami, P;
Oliva, EN;
Ionova, T;
Else, R;
Kell, J;
Fielding, AK;
Jennings, DM;
... Salek, S; + view all
(2020)
Reliability of a Novel Hematological Malignancy Specific Patient-Reported Outcome Measure: HM-PRO.
Frontiers in Pharmacology
, 11
, Article 571066. 10.3389/fphar.2020.571066.
|
|
|
Goswami, P;
Oliva, EN;
Ionova, T;
Else, R;
Kell, J;
Fielding, AK;
Jennings, DM;
... Salek, S; + view all
(2020)
Hematological Malignancy Specific Patient-Reported Outcome Measure (HM-PRO): Construct Validity Study.
Frontiers in Pharmacology
, 11
, Article 1308. 10.3389/fphar.2020.01308.
|
|
|
Goswami, P;
Oliva, EN;
Ionova, T;
Else, R;
Kell, J;
Fielding, AK;
Jennings, DM;
... Salek, S; + view all
(2020)
Development of a Novel Hematological Malignancy Specific Patient-Reported Outcome Measure (HM-PRO): Content Validity.
Frontiers in Pharmacology
, 11
, Article 209. 10.3389/fphar.2020.00209.
|
|
|
Goswami, P;
Oliva, EN;
Ionova, T;
Else, R;
Kell, J;
Fielding, AK;
Jennings, DM;
... Salek, S; + view all
(2020)
Quality-of-life issues and symptoms reported by patients living with haematological malignancy: a qualitative study.
Therapeutic Advances in Hematology
, 11
pp. 1-14.
10.1177/2040620720955002.
|
|
|
Goswami, P;
Oliva, EN;
Ionova, T;
Else, R;
Kell, J;
Fielding, AK;
Jennings, DM;
... Salek, S; + view all
(2019)
Paper and electronic versions of HM-PRO, a novel patient-reported outcome measure for hematology: an equivalence study.
Journal Of Comparative Effectiveness Research
, 8
(7)
pp. 523-533.
10.2217/cer-2018-0108.
|
|
|
Goyal, L;
Kongpetch, S;
Crolley, VE;
Bridgewater, J;
(2021)
Targeting FGFR inhibition in cholangiocarcinoma.
Cancer Treatment Reviews
, 95
, Article 102170. 10.1016/j.ctrv.2021.102170.
|
|
Goyal, Lipika;
Meric-Bernstam, Funda;
Hollebecque, Antoine;
Valle, Juan W;
Morizane, Chigusa;
Karasic, Thomas B;
Abrams, Thomas A;
... FOENIX-CCA2 Study Investigators; + view all
(2023)
Futibatinib for FGFR2-Rearranged Intrahepatic Cholangiocarcinoma.
New England Journal of Medicine
, 388
(3)
pp. 228-239.
10.1056/NEJMoa2206834.
|
|
Grandage, V.L.;
(2007)
Investigation of aberrant signal transduction in acute myeloid leukaemia.
Doctoral thesis , University of London.
|
|
|
Greco, R;
Ruggeri, A;
McLornan, DP;
Snowden, JA;
Alexander, T;
Angelucci, E;
Averbuch, D;
... Sureda, A; + view all
(2025)
Indications for haematopoietic cell transplantation and CAR-T for haematological diseases, solid tumours and immune disorders: 2025 EBMT practice recommendations.
Bone Marrow Transplantation
, 60
pp. 1499-1525.
10.1038/s41409-025-02701-3.
|
|
|
Green, CL;
(2012)
Studies on CEBPA mutations in acute myeloid leukaemia.
Doctoral thesis , UCL (University College London).
|
|
|
Green, K;
Pavasovic, V;
Ghorashian, S;
Ancliff, P;
Bartram, J;
Rao, A;
Samarasinghe, S;
... O'Connor, D; + view all
(2021)
Clinical Utility of Radiologic Disease Reassessment in the Management of Pediatric B-Cell Non-Hodgkin Lymphoma.
Journal of Pediatric Hematology/Oncology
, 43
(3)
e380-e384.
10.1097/MPH.0000000000001781.
|
|
Green, K;
Pearce, K;
Sellar, RS;
Jardine, L;
Nicolson, PLR;
Nagra, S;
Bigley, V;
... Collin, M; + view all
(2017)
Impact of Alemtuzumab Scheduling on Graft-versus-Host Disease after Unrelated Donor Fludarabine and Melphalan Allografts.
Biology of Blood and Marrow Transplantation
, 23
(5)
pp. 805-812.
10.1016/j.bbmt.2017.02.007.
|
|
Green, L.;
(2011)
The impact of total hip/knee replacement surgery and chemical prophylaxis on thrombin generation.
Doctoral thesis , UCL (University College London).
|
|
Gregucci, Fabiana;
Spada, Sheila;
Barcellos-Hoff, Mary Helen;
Bhardwaj, Nina;
Hak, Charleen Chan Wah;
Fiorentino, Alba;
Guha, Chandan;
... Formenti, Silvia C; + view all
(2023)
Updates on radiotherapy-immunotherapy combinations: Proceedings of 6(th) annual ImmunoRad conference.
OncoImmunology
, 12
(1)
, Article 2222560. 10.1080/2162402X.2023.2222560.
|
|
Griffiths, PD;
Rothwell, E;
Raza, M;
Wilmore, S;
Doyle, T;
Harber, M;
O'Beirne, J;
... Emery, VC; + view all
(2017)
Correction: Randomized Controlled Trials to Define Viral Load Thresholds for Cytomegalovirus Pre-Emptive Therapy.
[Corrigendum].
PLOS ONo
, 12
(9)
, Article e0185298. 10.1371/journal.pone.0185298.
|
|
|
Griffiths, PD;
Rothwell, E;
Raza, M;
Wilmore, S;
Doyle, T;
Harber, M;
O'Beirne, J;
... Emery, VC; + view all
(2016)
Randomized Controlled Trials to Define Viral Load Thresholds for Cytomegalovirus Pre-Emptive Therapy.
PLoS One
, 11
(9)
, Article e0163722. 10.1371/journal.pone.0163722.
|
|
Groeneveldt, L;
Mein, G;
Garrod, R;
Jewell, AP;
Van Someren, K;
Stephens, R;
D'Sa, SP;
(2013)
A mixed exercise training programme is feasible and safe and may improve quality of life and muscle strength in multiple myeloma survivors.
BMC Cancer
, 13
, Article 31. 10.1186/1471-2407-13-31.
|
|
|
Gu, Z;
Churchman, M;
Roberts, K;
Li, Y;
Liu, Y;
Harvey, RC;
McCastlain, K;
... Mullighan, CG; + view all
(2016)
Genomic analyses identify recurrent MEF2D fusions in acute lymphoblastic leukaemia.
Nature Communications
, 7
, Article 13331. 10.1038/ncomms13331.
|
|
|
Gupta, Shweta;
Kaffo, Eleanor;
Baker, Robert;
Nacheva, Elisabeth;
O'Nions, Jenny;
Wilson, Andrew J;
Gupta, Rajeev;
(2023)
The Use of Targeted RNA- Sequencing Assay in the Diagnostic Evaluation of Acute Myeloid Leukaemia(AML).
Presented at: 65th ASH Annual Meeting, San Diego, CA, USA.
|
|
Gupta, R;
Gant, VA;
Williams, B;
Enver, T;
(2020)
Increased Complement Receptor-3 levels in monocytes and granulocytes distinguish COVID-19 patients with pneumonia from those with mild symptoms.
International Journal of Infectious Diseases
10.1016/j.ijid.2020.08.004.
(In press).
|
|
|
Gupta, R;
Turati, V;
Brian, D;
Thrussel, C;
Wilbourn, B;
May, G;
Enver, T;
(2020)
Nov/CCN3 Enhances Cord Blood Engraftment by Rapidly Recruiting Latent Human Stem Cell Activity.
Cell Stem Cell
10.1016/j.stem.2020.02.012.
(In press).
|
|
Gupta, RK;
Abdul-Jawad, S;
McCoy, LE;
Mok, HP;
Peppa, D;
Salgado, M;
Martinez-Picado, J;
... Olavarria, E; + view all
(2019)
HIV-1 remission following CCR5Δ32/Δ32 haematopoietic stem-cell transplantation.
Nature
, 568
pp. 244-249.
10.1038/s41586-019-1027-4.
|
|
Gurnari, Carmelo;
Koster, Linda;
Baaij, Laurien;
Heiblig, Mael;
Yakoub-Agha, Ibrahim;
Collin, Matthew;
Passweg, Jakob;
... McLornan, Donal P; + view all
(2024)
Allogeneic hematopoietic cell transplantation for VEXAS syndrome: results of a multicenter study of the EBMT.
Blood Advances
, 8
(6)
pp. 1444-1448.
10.1182/bloodadvances.2023012478.
|
|
H
|
Hachani, R;
Birchall, MA;
Lowdell, MW;
Kasparis, G;
Tung, LD;
Manshian, BB;
Soenen, SJ;
... Thanh, NTK; + view all
(2017)
Assessing cell-nanoparticle interactions by high content imaging of biocompatible iron oxide nanoparticles as potential contrast agents for magnetic resonance imaging.
Scientific Reports
, 7
(1)
, Article 7850. 10.1038/s41598-017-08092-w.
|
|
|
Hachani, R;
Lowdell, M;
Birchall, M;
Hervault, A;
Mertz, D;
Begin-Colin, S;
Thanh, NT;
(2016)
Polyol synthesis, functionalisation, and biocompatibility studies of superparamagnetic iron oxide nanoparticles as potential MRI contrast agents.
Nanoscale
, 8
(6)
pp. 3278-3287.
10.1039/c5nr03867g.
|
|
|
Hachani, R;
Lowdell, M;
Birchall, M;
Thanh, NT;
(2013)
Tracking stem cells in tissue-engineered organs using magnetic nanoparticles.
Nanoscale
, 5
(23)
pp. 11362-11373.
10.1039/c3nr03861k.
|
|
|
Hagos, YB;
Lecat, CSY;
Patel, D;
Lee, L;
Tran, TA;
Justo, MR;
Yong, K;
(2021)
Cell abundance aware deep learning for cell detection on highly imbalanced pathological data.
In:
2021 IEEE 18th International Symposium on Biomedical Imaging (ISBI).
(pp. pp. 1438-1442).
IEEE: Nice, France.
|
|
|
Hagos, Yeman B;
Akarca, Ayse U;
Ramsay, Alan;
Rossi, Riccardo L;
Pomplun, Sabine;
Ngai, Victoria;
Moioli, Alessia;
... Marafioti, Teresa; + view all
(2022)
High inter-follicular spatial co-localization of CD8+FOXP3+ with CD4+CD8+ cells predicts favorable outcome in follicular lymphoma.
Hematological Oncology
10.1002/hon.3003.
(In press).
|
|
Hagos, Yeman B;
Lecat, Catherine SY;
Patel, Dominic;
Mikolajczak, Anna;
Castillo, Simon P;
Lyon, Emma J;
Foster, Kane;
... Yuan, Yinyin; + view all
(2023)
Deep learning enables spatial mapping of the mosaic microenvironment of myeloma bone marrow trephine biopsies.
Cancer Research
10.1158/0008-5472.can-22-2654.
|
|
|
Hájek, R;
Masszi, T;
Petrucci, MT;
Palumbo, A;
Rosiñol, L;
Nagler, A;
Yong, KL;
... Ludwig, H; + view all
(2016)
A randomized phase III study of carfilzomib vs low-dose corticosteroids with optional cyclophosphamide in relapsed and refractory multiple myeloma (FOCUS).
Leukemia
, 31
(1)
pp. 107-114.
10.1038/leu.2016.176.
|
|
|
Hamerschlak, Nelson;
Gomez-Almaguer, David;
McLornan, Donal P;
(2023)
50 years of BMT: risk stratification, donor matching and stem cell collection for transplantation.
Frontiers in Oncology
, 13
, Article 1321334. 10.3389/fonc.2023.1321334.
|
|
|
Hamilton, N;
Hynds, R;
Gowers, K;
Tait, A;
Butler, C;
Hopper, C;
Burns, A;
... Janes, SM; + view all
(2019)
Using a 3D collagen matrix to deliver respiratory progenitor cells to decellularized trachea in vivo.
Tissue Engineering Part C: Methods
, 25
(2)
pp. 93-102.
10.1089/ten.TEC.2018.0241.
|
|
Hamilton, NJ;
Kanani, M;
Roebuck, DJ;
Hewitt, RJ;
Cetto, R;
Culme-Seymour, EJ;
Toll, E;
... Birchall, MA; + view all
(2015)
Tissue-engineered tracheal replacement in a child: a 4-year follow-up study.
Am J Transplant
, 15
(10)
pp. 2750-2757.
10.1111/ajt.13318.
|
|
|
Han, Y;
(2014)
Towards retinal repair: analysis of photoreceptor precursor cells and their cell surface molecules.
Doctoral thesis , UCL (University College London).
|
|
|
Haran, Shaun;
Chindera, Kantaraja;
Sabry, May;
Wilkinson, Nafisa;
Arora, Rupali;
Zubiak, Agnieszka;
Bartlett, Thomas E;
... Widschwendter, Martin; + view all
(2024)
Natural Killer Cell Dysfunction in Premenopausal BRCA1 Mutation Carriers: A Potential Mechanism for Ovarian Carcinogenesis.
Cancers
, 16
(6)
, Article 1186. 10.3390/cancers16061186.
|
|
Harding, James J;
Fan, Jia;
Oh, Do-Youn;
Choi, Hye Jin;
Kim, Jin Won;
Chang, Heung-Moon;
Bao, Lequn;
... HERIZON-BTC-01 study group; + view all
(2023)
Zanidatamab for HER2-amplified, unresectable, locally advanced or metastatic biliary tract cancer (HERIZON-BTC-01): a multicentre, single-arm, phase 2b study.
The Lancet Oncology
, 24
(7)
pp. 772-782.
10.1016/S1470-2045(23)00242-5.
|
|
Harrasser, Micaela;
Gohil, Satyen Harish;
Lau, Hiu;
Della Peruta, Marco;
Muczynski, Vincent;
Patel, Dominic;
Miranda, Elena;
... Nathwani, Amit Chunilal; + view all
(2022)
Inducible localized delivery of an anti-PD-1 scFv enhances anti-tumor activity of ROR1 CAR-T cells in TNBC.
Breast Cancer Research
, 24
(1)
, Article 39. 10.1186/s13058-022-01531-1.
|
|
Harrington, Patrick;
Doores, Katie J;
Radia, Deepti;
O'Reilly, Amy;
Lam, Ho Pui Jeff;
Seow, Jeffrey;
Graham, Carl;
... De Lavallade, Hugues; + view all
(2021)
Single dose of BNT162b2 mRNA vaccine against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) induces neutralising antibody and polyfunctional T-cell responses in patients with chronic myeloid leukaemia.
British Journal of Haematology
, 194
(6)
pp. 999-1006.
10.1111/bjh.17568.
|
|
|
Harrison, Claire N;
Mesa, Ruben;
Talpaz, Moshe;
Gupta, Vikas;
Gerds, Aaron T;
Perkins, Andrew;
Goh, Yeow Tee;
... Oh, Stephen T; + view all
(2025)
Longitudinal Assessment of Transfusion Intensity in Patients With JAK Inhibitor-Naive or-Experienced Myelofibrosis Treated With Momelotinib.
Clinical Lymphoma Myeloma and Leukemia
, 25
(3)
pp. 199-211.
10.1016/j.clml.2024.10.001.
|
|
|
Harrison, Claire N;
Mesa, Ruben;
Talpaz, Moshe;
Gupta, Vikas;
Gerds, Aaron T;
Perkins, Andrew;
Goh, Yeow Tee;
... Oh, Stephen T; + view all
(2025)
Longitudinal Assessment of Transfusion Intensity in Patients With JAK Inhibitor-Naive or-Experienced Myelofibrosis Treated With Momelotinib.
Clinical Lymphoma Myeloma and Leukemia
, 25
(3)
pp. 199-211.
10.1016/j.clml.2024.10.001.
|
|
|
Harrison, C.N.;
Donohoe, S.;
Carr, P.;
Dave, M.;
Mackie, I.;
Machin, S.J.;
(2002)
Patients with Essential thrombocythaemia have an increased prevalence of antiphospholipid antibodies which may be associated with thrombosis.
Thrombosis and haemostasis
, 87
(5)
pp. 802-807.
|
|
|
Harrison, SJ;
Perrot, A;
Alegre, A;
Simpson, D;
Wang, MC;
Spencer, A;
Delimpasi, S;
... Richardson, P; + view all
(2021)
Subgroup analysis of ICARIA-MM study in relapsed/refractory multiple myeloma patients with high-risk cytogenetics.
British Journal of Haematology
10.1111/bjh.17499.
(In press).
|
|
|
Hartwig, T;
Montinaro, A;
von Karstedt, S;
Sevko, A;
Surinova, S;
Chakravarthy, A;
Taraborrelli, L;
... Walczak, H; + view all
(2017)
The TRAIL-Induced Cancer Secretome Promotes a Tumor-Supportive Immune Microenvironment via CCR2.
Molecular Cell
, 65
(4)
pp. 730-742.
10.1016/j.molcel.2017.01.021.
|
|
Hatcher, J;
Gil, E;
Storey, N;
Brown, JR;
Hartley, JC;
Breuer, J;
Lucchini, G;
... Dunn, H; + view all
(2022)
Reactivation/relapse of SARS-CoV-2 in a child following haematopoietic stem cell transplantation, confirmed by whole genome sequencing, following apparent viral clearance.
Journal of Infection
10.1016/j.jinf.2022.05.043.
(In press).
|
|
Hatipoglu, Emine;
(2022)
Deciphering the Immune Landscape in Renal Cell Carcinoma and in Anti-PD-1 Therapy.
Doctoral thesis (Ph.D), UCL (University College London).
|
|
Hayden, PJ;
Roddie, C;
Bader, P;
Basak, GW;
Bonig, H;
Bonini, C;
Chabannon, C;
... Yakoub-Agha, I; + view all
(2021)
Management of Adults and Children receiving CAR T-cell therapy: 2021 Best Practice Recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE) and the European Haematology Association (EHA).
Annals of Oncology
10.1016/j.annonc.2021.12.003.
(In press).
|
|
|
Heide, Timon;
Househam, Jacob;
Cresswell, George D;
Spiteri, Inmaculada;
Lynn, Claire;
Mossner, Maximilian;
Kimberley, Chris;
... Sottoriva, Andrea; + view all
(2022)
The co-evolution of the genome and epigenome in colorectal cancer.
Nature
10.1038/s41586-022-05202-1.
(In press).
|
|
Heinrich, M;
Fisher, A;
Paton, B;
McCourt, O;
Beeken, RJ;
Hackshaw, A;
Wardle, J;
(2016)
Lifestyle in Multiple Myeloma - a longitudinal cohort study protocol.
BMC Cancer
, 16
, Article 387. 10.1186/s12885-016-2407-x.
|
|
|
Hendriksz, CJ;
Berger, KI;
Parini, R;
AlSayed, MD;
Raiman, J;
Giugliani, R;
Mitchell, JJ;
... Harmatz, PR; + view all
(2016)
Impact of long-term elosulfase alfa treatment on respiratory function in patients with Morquio A syndrome.
Journal of Inherited Metabolic Disease
, 39
(6)
pp. 839-847.
10.1007/s10545-016-9973-6.
|
|
|
Hendriksz, CJ;
Parini, R;
AlSayed, MD;
Raiman, J;
Giugliani, R;
Mitchell, JJ;
Burton, BK;
... Harmatz, PR; + view all
(2018)
Impact of long-term elosulfase alfa on activities of daily living in patients with Morquio A syndrome in an open-label, multi-center, phase 3 extension study.
Molecular Genetics and Metabolism
, 123
(2)
pp. 127-134.
10.1016/j.ymgme.2017.11.015.
|
|
|
Hendriksz, CJ;
Parini, R;
AlSayed, MD;
Raiman, J;
Giugliani, R;
Solano Villarreal, ML;
Mitchell, JJ;
... Harmatz, PR; + view all
(2016)
Long-term endurance and safety of elosulfase alfa enzyme replacement therapy in patients with Morquio A syndrome.
Molecular Genetics and Metabolism
, 119
(1-2)
pp. 131-143.
10.1016/j.ymgme.2016.05.018.
|
|
|
Henninger, B;
Alustiza, J;
Garbowski, M;
Gandon, Y;
(2019)
Practical guide to quantification of hepatic iron with MRI.
European Radiology
10.1007/s00330-019-06380-9.
|
|
|
Henoun Loukili, Noureddine;
Gras, Luuk;
Koster, Linda;
Blaise, Didier;
Gedde-Dahl, Tobias;
Maertens, Johan;
Friis, Lone Smidstrup;
... Yakoub-Agha, Ibrahim; + view all
(2025)
Conditioning intensity in myelodysplastic patients aged ≥ 50 years undergoing allogeneic hematopoietic cell transplantation (allo-HCT): a study on behalf of the chronic malignancies working party of the EBMT.
Bone Marrow Transplantation
, 60
pp. 1487-1495.
10.1038/s41409-025-02682-3.
|
|
|
Henry, Jake Yarren;
(2019)
Innate lymphoid-macrophage crosstalk promotes lung cancer regression in response to IL-12 therapy.
Doctoral thesis (Ph.D), UCL (University College London).
|
|
|
Hernandez, Diana;
Danby, Robert David;
Querol, Sergio;
(2022)
Editorial: Umbilical cord blood and tissue in novel therapies and haematopoiesis research.
Frontiers in Cell and Developmental Biology
, 10
, Article 979306. 10.3389/fcell.2022.979306.
|
|
|
Hernández-Boluda, JC;
Mosquera-Orgueira, A;
Gras, L;
Koster, L;
Tuffnell, J;
Kröger, N;
Gambella, M;
... McLornan, DP; + view all
(2025)
Use of machine learning techniques to predict poor survival after hematopoietic cell transplantation for myelofibrosis.
Blood
, 145
(26)
pp. 3139-3152.
10.1182/blood.2024027287.
|
|
|
Hernandez-Boluda, Juan Carlos;
Sheth, Vipul;
Iacobelli, Simona;
Koster, Linda;
Kroger, Nicolaus;
Chiusolo, Patrizia;
Schroeder, Thomas;
... Mclornan, Donal P; + view all
(2025)
Impact of Donor Type on Outcomes After Allogeneic Hematopoietic Cell Transplantation in Myelofibrosis: A Study on Behalf of the Chronic Malignancies Working Party of the EBMT.
American Journal of Hematology
, 100
(11)
pp. 2028-2039.
10.1002/ajh.70049.
|
|
|
Hill, AG;
Findlay, M;
Burge, M;
Jackson, C;
García Alfonso, P;
Samuel, L;
Ganju, V;
... Tabernero, J; + view all
(2018)
Phase II study of the dual EGFR/HER3 inhibitor duligotuzumab (MEHD7945A) vs. cetuximab in combination with FOLFIRI in RAS wild-type metastatic colorectal cancer.
Clinical Cancer Research
, 42
(10)
pp. 2276-2284.
10.1158/1078-0432.CCR-17-0646.
|
|
Hobor, S;
Al Bakir, M;
Hiley, CT;
Skrzypski, M;
Frankell, AM;
Bakker, B;
Watkins, TBK;
... Clipson, A; + view all
(2024)
Mixed responses to targeted therapy driven by chromosomal instability through p53 dysfunction and genome doubling.
Nature Communications
, 15
, Article 4871. 10.1038/s41467-024-47606-9.
|
|
Hockings, C;
Gohil, S;
Dowse, R;
Hoade, Y;
Mansour, MR;
Gale, RE;
Linch, DC;
... Payne, EM; + view all
(2020)
In trans early mosaic mutational escape and novel phenotypic features of germline SAMD9 mutation.
British Journal of Haematology
, 188
(4)
e53-e57.
10.1111/bjh.16322.
|
|
Hodder, Angus;
Mishra, Avijeet K;
Enshaei, Amir;
Baird, Susan;
Elbeshlawi, Ismail;
Bonney, Denise;
Clesham, Katherine;
... Vora, Ajay; + view all
(2024)
Blinatumomab for First-Line Treatment of Children and Young Persons With B-ALL.
Journal of Clinical Oncology
, 42
(8)
pp. 907-914.
10.1200/JCO.23.01392.
|
|
Hoelzer, D;
Bassan, R;
Boissel, N;
Roddie, C;
Ribera, JM;
Jerkeman, M;
ESMO Guidelines Committee;
(2024)
ESMO Clinical Practice Guideline interim update on the use of targeted therapy in acute lymphoblastic leukaemia.
Annals of Oncology
, 35
(1)
pp. 15-28.
10.1016/j.annonc.2023.09.3112.
|
|
Hoffman, HI;
Guo, JA;
Hawkins, MA;
Bridgewater, JA;
Wo, JY;
Hong, TS;
Hwang, WL;
(2020)
Silver Linings: An Opportunity to Improve Clinical Paradigms After the COVID-19 Pandemic.
JCO Oncology Practice
10.1200/OP.20.00335.
(In press).
|
|
Holler, A;
Zech, M;
Ghorashian, S;
Pike, R;
Hotblack, A;
Velica, P;
Xue, S-A;
... Stauss, HJ; + view all
(2016)
Expression of a dominant T-cell receptor can reduce toxicity and enhance tumor protection of allogeneic T-cell therapy.
Haematologica
, 101
(4)
pp. 482-490.
10.3324/haematol.2015.132712.
|
|
|
Holm, Jeppe Sejerø;
Funt, Samuel A;
Borch, Annie;
Munk, Kamilla Kjærgaard;
Bjerregaard, Anne-Mette;
Reading, James L;
Maher, Colleen;
... Hadrup, Sine Reker; + view all
(2022)
Neoantigen-specific CD8 T cell responses in the peripheral blood following PD-L1 blockade might predict therapy outcome in metastatic urothelial carcinoma.
Nature Communications
, 13
, Article 1935. 10.1038/s41467-022-29342-0.
|
|
|
Horna, Pedro;
Weybright, Matthew J;
Ferrari, Mathieu;
Jungherz, Dennis;
Peng, YaYi;
Akbar, Zulaikha;
Tudor Ilca, F;
... Olteanu, Horatiu; + view all
(2024)
Dual T-cell constant β chain (TRBC)1 and TRBC2 staining for the identification of T-cell neoplasms by flow cytometry.
Blood Cancer Journal
, 14
(1)
, Article 34. 10.1038/s41408-024-01002-0.
|
|
Hostettler, IC;
Schwarz, G;
Ambler, G;
Wilson, D;
Banerjee, G;
Seiffge, D;
Shakeshaft, C;
... Werring, DJ; + view all
(2021)
Cerebral Small Vessel Disease and Functional Outcome Prediction after Intracerebral Haemorrhage.
Neurology
, 96
(15)
e1954-e1965.
10.1212/WNL.0000000000011746.
|
|
Hostettler, Isabel Charlotte;
Seiffge, David;
Wong, Andrew;
Ambler, Gareth;
Wilson, Duncan;
Shakeshaft, Clare;
Banerjee, Gargi;
... Werring, David; + view all
(2022)
APOE and Cerebral Small Vessel Disease Markers in Patients With Intracerebral Hemorrhage.
Neurology
, 99
(12)
e1290-e1298.
10.1212/WNL.0000000000200851.
|
|
Hostettler, IC;
Bernal-Quiros, M;
Wong, A;
Sharma, N;
Wilson, D;
Seiffge, D;
Shakeshaft, C;
... Houlden, H; + view all
(2019)
C9orf72 and intracerebral haemorrhage.
Neurobiology of Aging
, 84
237.e1-237.e3.
10.1016/j.neurobiolaging.2019.07.007.
|
|
Hostettler, IC;
Morton, MJ;
Ambler, G;
Kazmi, N;
Gaunt, T;
Wilson, D;
Shakeshaft, C;
... CROMIS-2 collaborators; + view all
(2020)
Haptoglobin genotype and outcome after spontaneous intracerebral haemorrhage.
Journal of Neurology, Neurosurgery and Psychiatry
, 91
(3)
pp. 298-304.
10.1136/jnnp-2019-321774.
|
|
|
Hotblack, A;
Kokalaki, EK;
Palton, MJ;
Cheung, GW-K;
Williams, IP;
Manzoor, S;
Grothier, TI;
... Pule, M; + view all
(2021)
Tunable control of CAR T cell activity through tetracycline mediated disruption of protein-protein interaction.
Scientific Reports
, 11
(1)
, Article 21902. 10.1038/s41598-021-01418-9.
|
|
|
Hotblack, A;
Holler, A;
Piapi, A;
Ward, S;
Strauss, HJ;
Bennett, CL;
(2018)
Tumor-resident dendritic cells and macrophages modulate the accumulation of TCR-engineered T cells in melanoma.
Molecular Therapy
, 26
(6)
pp. 1471-1481.
10.1016/j.ymthe.2018.03.011.
|
|
|
Hotblack, A;
Seshadri, S;
Zhang, L;
Hamrang-Yousefi, S;
Chakraverty, R;
Escors, D;
Bennett, CL;
(2016)
Dendritic Cells Cross-Present Immunogenic Lentivector-Encoded Antigen from Transduced Cells to Prime Functional T Cell Immunity.
Molecular Therapy
, 25
(2)
pp. 504-511.
10.1016/j.ymthe.2016.11.001.
|
|
Hotblack, AC;
(2017)
Characterising the role of dendritic cells in TCR gene therapy.
Doctoral thesis , UCL (University College London).
|
|
Hough, R;
Lopes, A;
Patrick, P;
Russell, N;
Raj, K;
Tholouli, E;
Snowden, JA;
... Marks, D; + view all
(2022)
Primary graft failure, but not relapse, may be identified by early chimerism following double cord blood unit transplantation.
Blood Advances
, 6
(7)
pp. 2414-2426.
10.1182/bloodadvances.2021005106.
|
|
Hough, R;
Sandhu, S;
Khan, M;
Moran, A;
Feltbower, R;
Stiller, C;
Stevens, MCG;
... McCabe, MG; + view all
(2017)
Are survival and mortality rates associated with recruitment to clinical trials in teenage and young adult patients with acute lymphoblastic leukaemia? A retrospective observational analysis in England.
BMJ Open
, 7
(10)
, Article e017052. 10.1136/bmjopen-2017-017052.
|
|
|
Househam, Jacob;
Heide, Timon;
Cresswell, George D;
Spiteri, Inmaculada;
Kimberley, Chris;
Zapata, Luis;
Lynn, Claire;
... Graham, Trevor A; + view all
(2022)
Phenotypic plasticity and genetic control in colorectal cancer evolution.
Nature
10.1038/s41586-022-05311-x.
|
|
Howard, J;
Hemmaway, CJ;
Telfer, P;
Layton, DM;
Porter, J;
Awogbade, M;
Mant, T;
... Lehrer-Graiwer, J; + view all
(2019)
A phase 1/2 ascending dose study and open-label extension study of voxelotor in patients with sickle cell disease.
Blood
, 133
(17)
pp. 1865-1875.
10.1182/blood-2018-08-868893.
|
|
Howell, Rowan;
Clarke, Matthew A;
Reuschl, Ann-Kathrin;
Chen, Tianyi;
Abbott-Imboden, Sean;
Singer, Mervyn;
Lowe, David M;
... Fisher, Jasmin; + view all
(2022)
Executable network of SARS-CoV-2-host interaction predicts drug combination treatments.
npj Digital Medicine
, 5
(1)
, Article 18. 10.1038/s41746-022-00561-5.
|
|
|
Howell, Rowan;
Davies, James;
Clarke, Matthew A;
Appios, Anna;
Mesquita, Inês;
Jayal, Yashoda;
Ringham-Terry, Ben;
... Bennett, Clare L; + view all
(2023)
Localized immune surveillance of primary melanoma in the skin deciphered through executable modeling.
Science Advances
, 9
(15)
, Article eadd1992. 10.1126/sciadv.add1992.
|
|
|
Hubig, L;
Sussex, AK;
MacCulloch, A;
Hughes, D;
Graham, R;
Morris, L;
Raza, S;
... Gallop, K; + view all
(2023)
Quality of Life with Late-Onset Pompe Disease: Qualitative Interviews and General Public Utility Estimation in the United Kingdom.
Journal of Health Economics and Outcomes Research
, 10
(1)
pp. 41-50.
10.36469/001c.68157.
|
|
Huerga Encabo, H;
Aramburu, IV;
Garcia-Albornoz, M;
Piganeau, M;
Wood, H;
Song, A;
Ferrelli, A;
... Bonnet, D; + view all
(2023)
Loss of TET2 in human hematopoietic stem cells alters the development and function of neutrophils.
Cell Stem Cell
, 30
(6)
781-799.e9.
10.1016/j.stem.2023.05.004.
|
|
|
Hughes, D;
Gonzalez, D;
Maegawa, G;
Bernat, JA;
Holida, M;
Giraldo, P;
Atta, MG;
... Goker-Alpan, O; + view all
(2023)
Long-term safety and efficacy of pegunigalsidase alfa: A multicenter 6-year study in adult patients with Fabry disease.
Genetics in Medicine
, 25
(12)
, Article 100968. 10.1016/j.gim.2023.100968.
(In press).
|
|
|
Hughes, D;
Lenny, A;
Shah, K;
Longworth, L;
Devercelli, G;
Ayodele, O;
(2023)
Estimation of Health State Utility Values in Fabry Disease Using Vignette Development and Valuation.
Journal of Health Economics and Outcomes Research
, 10
(1)
pp. 80-88.
10.36469/001c.71344.
|
|
|
Hughes, D;
Linhart, A;
Gurevich, A;
Kalampoki, V;
Jazukeviciene, D;
Feriozzi, S;
(2021)
Prompt Agalsidase Alfa Therapy Initiation is Associated with Improved Renal and Cardiovascular Outcomes in a Fabry Outcome Survey Analysis.
Drug Design, Development and Therapy
, 15
pp. 3561-3572.
10.2147/DDDT.S313789.
|
|
|
Hughes, DA;
Deegan, P;
Giraldo, P;
Göker-Alpan, Ö;
Lau, H;
Lukina, E;
Revel-Vilk, S;
... Zimran, A; + view all
(2023)
Reply to Mistry et al. The Two Substrate Reduction Therapies for Type 1 Gaucher Disease Are Not Equivalent. Comment on “Hughes et al. Switching between Enzyme Replacement Therapies and Substrate Reduction Therapies in Patients with Gaucher Disease: Data from the Gaucher Outcome Survey (GOS). J. Clin. Med. 2022, 11, 5158”.
Journal of Clinical Medicine
, 12
(12)
, Article 4017. 10.3390/jcm12124017.
|
|
Hughes, Derralynn A;
Aguiar, Patrício;
Lidove, Olivier;
Nicholls, Kathleen;
Nowak, Albina;
Thomas, Mark;
Torra, Roser;
... Feriozzi, Sandro; + view all
(2022)
Do clinical guidelines facilitate or impede drivers of treatment in Fabry disease?
Orphanet Journal of Rare Diseases
, 17
(1)
, Article 42. 10.1186/s13023-022-02181-4.
|
|
|
Hughes, Derralynn A;
Bichet, Daniel G;
Giugliani, Roberto;
Hopkin, Robert J;
Krusinska, Eva;
Nicholls, Kathleen;
Olivotto, Iacopo;
... Wilcox, William R; + view all
(2022)
Long-term multisystemic efficacy of migalastat on Fabry-associated clinical events, including renal, cardiac and cerebrovascular outcomes.
Journal of Medical Genetics
10.1136/jmg-2022-108669.
(In press).
|
|
Hughes, Derralynn A;
Deegan, Patrick;
Giraldo, Pilar;
Goker-Alpan, Ozlem;
Lau, Heather;
Lukina, Elena;
Revel-Vilk, Shoshana;
... Zimran, Ari; + view all
(2022)
Switching between Enzyme Replacement Therapies and Substrate Reduction Therapies in Patients with Gaucher Disease: Data from the Gaucher Outcome Survey (GOS).
Journal of Clinical Medicine
, 11
(17)
, Article 5158. 10.3390/jcm11175158.
|
|
Hughes, Derralynn A;
Ferrante, Francesca;
(2023)
GALILEO-1: a Phase I/II safety and efficacy study of FLT201 gene therapy for Gaucher disease type 1.
Future Rare Diseases
10.2217/frd-2022-0019.
|
|
Hughes, D;
Giugliani, R;
Guffon, N;
Jones, SA;
Mengel, KE;
Parini, R;
Matousek, R;
... Quartel, A; + view all
(2017)
Clinical outcomes in a subpopulation of adults with Morquio A syndrome: results from a long-term extension study of elosulfase alfa.
Orphanet Journal of Rare Diseases
, 12
, Article 98. 10.1186/s13023-017-0634-0.
|
|
Hughes, D;
Mikosch, P;
Belmatoug, N;
Carubbi, F;
Cox, T;
Goker-Alpan, O;
Kindmark, A;
... Deegan, P; + view all
(2019)
Gaucher Disease in Bone: From Pathophysiology to Practice.
Journal of Bone and Mineral Research
, 34
(6)
pp. 996-1013.
10.1002/jbmr.3734.
|
|
|
Hughes, DA;
(2016)
Fabry disease: will markers of early disease enable early treatment and better outcomes?
Current Opinion in Cardiology
, 31
(4)
pp. 434-439.
10.1097/HCO.0000000000000308.
|
|
Hughes, DA;
Aguiar, P;
Deegan, PB;
Ezgu, F;
Frustaci, A;
Lidove, O;
Linhart, A;
... Feriozzi, S; + view all
(2020)
Early indicators of disease progression in Fabry disease that may indicate the need for disease-specific treatment initiation: findings from the opinion-based PREDICT-FD modified Delphi consensus initiative.
BMJ Open
, 10
(10)
, Article e035182. 10.1136/bmjopen-2019-035182.
|
|
|
Hughes, DA;
Nicholls, K;
Shankar, SP;
Sunder-Plassmann, G;
Koeller, D;
Nedd, K;
Vockley, G;
... Feldt-Rasmussen, U; + view all
(2017)
Oral pharmacological chaperone migalastat compared with enzyme replacement therapy in Fabry disease: 18-month results from the randomised phase III ATTRACT study.
Journal of Medical Genetics
, 54
(4)
pp. 288-296.
10.1136/jmedgenet-2016-104178.
|
|
|
Hughes, DA;
Nicholls, K;
Sunder-Plassmann, G;
Jovanovic, A;
Feldt-Rasmussen, U;
Schiffmann, R;
Giugliani, R;
... Bichet, DG; + view all
(2019)
Safety of switching to Migalastat from enzyme replacement therapy in Fabry disease: Experience from the Phase 3 ATTRACT study.
American Journal of Medical Genetics: Part A
10.1002/ajmg.a.61105.
(In press).
|
|
|
Hussain, W;
Moens, N;
Veraitch, FS;
Hernandez, D;
Mason, C;
Lye, GJ;
(2013)
Reproducible culture and differentiation of mouse embryonic stem cells using an automated microwell platform.
Biochem Eng J
, 77
(100)
246 - 257.
10.1016/j.bej.2013.05.008.
|
|
|
Hutachok, N;
Angkasith, P;
Chumpun, C;
Fucharoen, S;
Mackie, IJ;
Porter, JB;
Srichairatanakool, S;
(2020)
Anti-Platelet Aggregation and Anti-Cyclooxygenase Activities for a Range of Coffee Extracts (Coffea arabica).
Molecules
, 26
, Article 10. 10.3390/molecules26010010.
|
|
|
Hwang, Angela;
Mehra, Vedika;
Chhetri, Jyoti;
Ali, Samira;
Tran, Maxine;
Roddie, Claire;
(2024)
Current Treatment Options for Renal Cell Carcinoma: Focus on
Cell-Based Immunotherapy.
Cancers
, 16
(6)
, Article 1209. 10.3390/cancers16061209.
|
|
Hynds, Robert E;
Huebner, Ariana;
Pearce, David R;
Hil, Mark S;
Akarca, Ayse U;
Moore, David A;
Ward, Sophia;
... Swanton, Charles; + view all
(2024)
Representation of genomic intratumor heterogeneity in multi-region non-small cell lung cancer patient-derived xenograft models.
Nature Communications
, 15
, Article 4653. 10.1038/s41467-024-47547-3.
|
|
|
Hynds, RE;
Ben Aissa, A;
Gowers, KHC;
Watkins, TBK;
Bosshard-Carter, L;
Rowan, AJ;
Veeriah, S;
... Janes, SM; + view all
(2018)
Expansion of airway basal epithelial cells from primary human non-small cell lung cancer tumors.
International Journal of Cancer
, 143
(1)
pp. 160-166.
10.1002/ijc.31383.
|
|
I
|
Iacobelli, Simona;
Schoenland, Stefan;
Koster, Linda;
Blaise, Didier;
Nicholson, Emma;
Broers, AEC;
Chevallier, Patrice;
... Kroeger, Nicolaus; + view all
(2025)
Outcomes following different upfront stem cell transplantation strategies for multiple myeloma: a statistical perspective on behalf of the Chronic Malignancies Working Party of the EBMT.
Bone Marrow Transplant
, 60
(10)
pp. 1361-1368.
10.1038/s41409-025-02675-2.
|
|
|
Iacoboni, Gloria;
Navarro, Víctor;
Martín-López, Ana África;
Rejeski, Kai;
Kwon, Mi;
Jalowiec, Katarzyna Aleksandra;
Amat, Paula;
... Barba, Pere; + view all
(2024)
Recent Bendamustine Treatment Before Apheresis Has a Negative Impact on Outcomes in Patients With Large B-Cell Lymphoma Receiving Chimeric Antigen Receptor T-Cell Therapy.
Journal of Clinical Oncology
, 42
(2)
pp. 205-217.
10.1200/JCO.23.01097.
|
|
Iland, Harry J;
Russell, Nigel;
Dillon, Richard;
Schuh, Andre C;
Tedjaseputra, Aditya;
Wei, Andrew;
Khwaja, Asim;
... Tholoui, Eleni; + view all
(2023)
Characteristics and outcomes of patients with acute promyelocytic leukemia and extreme hyperleukocytosis at presentation.
Blood Advances
, 7
(11)
pp. 2580-2585.
10.1182/bloodadvances.2022007126.
|
|
Irshad, S;
Flores-Borja, F;
Lawler, K;
Monypenny, J;
Evans, R;
Male, V;
Gordon, P;
... Ng, T; + view all
(2017)
RORγt+ innate lymphoid cells promote lymph node metastasis of breast cancers.
Cancer Research
, 77
(5)
pp. 1083-1096.
10.1158/0008-5472.CAN-16-0598.
|
|
Iskander, Deena;
Roy, Noémi BA;
Payne, Elspeth;
Drasar, Emma;
Hennessy, Kelly;
Harrington, Yvonne;
Christodoulidou, Chrysi;
... De la Fuente, Josu; + view all
(2023)
Diamond-Blackfan anemia in adults: In pursuit of a common approach for a rare disease.
Blood Reviews
, 61
, Article 101097. 10.1016/j.blre.2023.101097.
|
|
Iveson, T;
Boyd, KA;
Kerr, RS;
Robles-Zurita, J;
Saunders, MP;
Briggs, AH;
Cassidy, J;
... Paul, J; + view all
(2019)
3-month versus 6-month adjuvant chemotherapy for patients with high-risk stage II and III colorectal cancer: 3-year follow-up of the SCOT non-inferiority RCT.
Health Technology Assessment
, 23
(64)
pp. 1-88.
10.3310/hta23640.
|
|
|
Iveson, TJ;
Kerr, RS;
Saunders, MP;
Cassidy, J;
Henrik Hollander, N;
Tabernero, J;
Haydon, A;
... Paul, J; + view all
(2018)
3 versus 6 months of adjuvant oxaliplatin-fluoropyrimidine combination therapy for colorectal cancer (SCOT): an international, randomised, phase 3, non-inferiority trial.
Lancet Oncology
, 19
(4)
pp. 562-578.
10.1016/S1470-2045(18)30093-7.
|
|
|
Ivey, A;
Hills, RK;
Simpson, MA;
Jovanovic, JV;
Gilkes, A;
Grech, A;
Patel, Y;
... Grimwade, D; + view all
(2016)
Assessment of Minimal Residual Disease in Standard-Risk AML.
The New England Journal Medicine
, 374
(5)
pp. 422-433.
10.1056/NEJMoa1507471.
|
|
Iyer, RV;
Acquisto, SG;
Bridgewater, JA;
Choti, MA;
Hong, TS;
Kis, B;
Mead, PA;
... Valle, JW; + view all
(2020)
Guidelines for Management of Urgent Symptoms in Patients with Cholangiocarcinoma and Biliary Stents or Catheters Using the Modified RAND/UCLA Delphi Process.
Cancers
, 12
(9)
, Article 2375. 10.3390/cancers12092375.
|
|
J
|
Jackson, LH;
Vlachodimitropoulou, E;
Shangaris, P;
Roberts, TA;
Ryan, TM;
Campbell-Washburn, AE;
David, AL;
... Stuckey, DJ; + view all
(2017)
Non-invasive MRI biomarkers for the early assessment of iron overload in a humanized mouse model of β-thalassemia.
Scientific Reports
, 7
, Article 43439. 10.1038/srep43439.
|
|
|
Jaffer, S;
Goh, P;
Abbasian, M;
Nathwani, AC;
(2018)
Mbd3 Promotes Reprogramming of Primary Human Fibroblasts.
International Journal of Stem Cells
, 11
(2)
pp. 235-241.
10.15283/ijsc18036.
|
|
|
Jakupovic, I.;
Grandage, V.L.;
Linch, D.C.;
Khwaja, A.;
(2004)
Lack of effect of the human GM-CSF analog E21R on the survival of primary human acute myeloid leukemia cells.
Blood
, 103
(8)
pp. 3230-3232.
10.1182/blood-2003-06-1985.
|
|
|
Jamal-Hanjani, M;
Thanopoulou, E;
Peggs, KS;
Quezada, SA;
Swanton, C;
(2013)
Tumour heterogeneity and immune-modulation.
Curr Opin Pharmacol
, 13
(4)
497 - 503.
10.1016/j.coph.2013.04.006.
|
|
|
Jamal-Hanjani, M;
Wilson, GA;
McGranahan, N;
Birkbak, NJ;
Watkins, TBK;
Veeriah, S;
Shafi, S;
... Swanton, C; + view all
(2017)
Tracking the Evolution of Non-Small-Cell Lung Cancer.
New England Journal of Medicine
, 376
(22)
pp. 2109-2121.
10.1056/NEJMoa1616288.
|
|
Jamili, E;
Nathwani, AC;
Dua, V;
(2025)
Model-based dose selection for gene therapy for haemophilia B.
Physical Sciences Reviews
, 10
(4)
pp. 463-488.
10.1515/psr-2024-0057.
|
|
|
Jathoul, Amit P;
Grounds, Helen;
Anderson, James C;
Pule, Martin A;
(2014)
A Dual Color Far-Red to Near-Infrared Firefly Luciferin Analogue Designed for Multi-Parametric Bioluminescence Imaging.
Angewandte Chemie
, 53
(48)
pp. 13059-13063.
10.1002/anie.201405955.
|
|
Jeevaratnam, P;
(2013)
Early manifestations of Anderson Fabry disease.
Doctoral thesis , UCL (University College London).
|
|
|
Jenkinson, S;
Kirkwood, AA;
Goulden, N;
Vora, A;
Linch, DC;
Gale, RE;
(2015)
Impact of PTEN abnormalities on outcome in pediatric patients with T-cell acute lymphoblastic leukemia treated on the MRC UKALL2003 trial.
Leukemia
10.1038/leu.2015.206.
(In press).
|
|
|
Jeyakumar, Jey M;
Kia, Azadeh;
Tam, Lawrence CS;
McIntosh, Jenny;
Spiewak, Justyna;
Mills, Kevin;
Heywood, Wendy;
... Nathwani, Amit; + view all
(2023)
Preclinical evaluation of FLT190, a liver-directed AAV gene therapy for Fabry disease.
Gene Therapy
10.1038/s41434-022-00381-y.
(In press).
|
|
Jha, R;
Kinna, A;
Hotblack, A;
Bughda, R;
Bulek, A;
Gannon, I;
Ilca, T;
... Pule, M; + view all
(2023)
Designer Small-Molecule Control System Based on Minocycline-Induced Disruption of Protein–Protein Interaction.
ACS Chemical Biology
, 19
(2)
pp. 308-324.
10.1021/acschembio.3c00521.
|
|
Joharatnam-Hogan, N;
Cafferty, F;
Hubner, R;
Swinson, D;
Sothi, S;
Gupta, K;
Falk, S;
... Add-Aspirin Trial Management Group; + view all
(2019)
Aspirin as an adjuvant treatment for cancer: feasibility results from the Add-Aspirin randomised trial.
The Lancet Gastroenterology & Hepatology
, 4
(11)
pp. 854-862.
10.1016/S2468-1253(19)30289-4.
|
|
Joharatnam-Hogan, N;
Hochhauser, D;
Shiu, K-K;
Rush, H;
Crolley, V;
Wilson, W;
Sharma, A;
... Khan, K; + view all
(2020)
Outcomes of the 2019 novel coronavirus in patients with or without a history of cancer: a multi-centre North London experience.
Therapeutic Advances in Medical Oncology
pp. 1-9.
10.1177/1758835920956803.
|
|
Joharatnam-Hogan, N;
Wilson, W;
Shiu, KK;
Fusai, GK;
Davidson, B;
Hochhauser, D;
Bridgewater, J;
(2020)
Multimodal Treatment in Metastatic Colorectal Cancer (mCRC) Improves Outcomes—The University College London Hospital (UCLH) Experience.
Cancers
, 12
(12)
, Article 3545. 10.3390/cancers12123545.
|
|
|
Jones, DT;
Ganeshaguru, K;
Virchis, AE;
Folarin, NI;
Lowdell, MW;
Mehta, AB;
Prentice, HG;
... Wickremasinghe, RG; + view all
(2001)
Caspase 8 activation independent of Fas (CD95/APO-1) signaling may mediate killing of B-chronic lymphocytic leukemia cells by cytotoxic drugs or gamma radiation.
Blood
, 98
(9)
pp. 2800-2807.
10.1182/blood.v98.9.2800.
|
|
|
Jones, CM;
Radhakrishna, G;
Aitken, K;
Bridgewater, J;
Corrie, P;
Eatock, M;
Goody, R;
... Mukherjee, S; + view all
(2020)
Considerations for the treatment of pancreatic cancer during the COVID-19 pandemic: the UK consensus position.
British Journal of Cancer
, 123
pp. 709-713.
10.1038/s41416-020-0980-x.
|
|
Jones, DT;
Addison, E;
North, JM;
Lowdell, MW;
Hoffbrand, AV;
Mehta, AB;
Ganeshaguru, K;
... Wickremasinghe, RG; + view all
(2004)
Geldanamycin and herbimycin A induce apoptotic killing of B chronic lymphocytic leukemia cells and augment the cells' sensitivity to cytotoxic drugs.
Blood
, 103
(5)
pp. 1855-1861.
10.1182/blood-2003-05-1603.
|
|
|
Joshi, K;
Chain, BM;
Peggs, KS;
Quezada, SA;
(2017)
The "Achilles Heel" of Cancer and Its Implications for the Development of Novel Immunotherapeutic Strategies.
Cold Spring Harbor Perspectives in Medicine
10.1101/cshperspect.a027086.
(In press).
|
|
|
Joshi, K;
Robert de Massy, M;
Ismail, M;
Reading, JL;
Uddin, I;
Woolston, A;
Hatipoglu, E;
... Chain, B; + view all
(2019)
Spatial heterogeneity of the T cell receptor repertoire reflects the mutational landscape in lung cancer.
Nature Medicine
, 25
pp. 1549-1559.
10.1038/s41591-019-0592-2.
|
K
|
Kalam, S;
Beale, R;
Hughes, D;
Kulasekararaj, A;
Srirangalingam, U;
(2020)
Coombs-positive Paroxysmal Nocturnal Haemoglobinuria.
Oxford Medical Case Reports
(3)
, Article omz125. 10.1093/omcr/omz125.
|
|
|
Kamel, Kirollos;
Sardo Infirri, Sofia;
Riddell, Anne;
Chowdary, Pratima;
Batty, Paul;
(2025)
Factor VIII Antibodies Demonstrate Type I or Type II Kinetics in Acquired Haemophilia A.
Haemophilia
10.1111/hae.15144.
(In press).
|
|
|
Kantaris, X;
Shevlin, M;
Porter, J;
Myers, L;
(2020)
Development of the Thalassaemia Adult Life Index (ThALI).
Health and Quality of Life Outcomes
, 18
, Article 180. 10.1186/s12955-020-01437-6.
|
|
|
Kantarjian, H;
Stein, A;
Goekbuget, N;
Fielding, AK;
Schuh, AC;
Ribera, J-M;
Wei, A;
... Topp, MS; + view all
(2017)
Blinatumomab versus Chemotherapy for Advanced Acute Lymphoblastic Leukemia.
New England Journal of Medicine
, 376
(9)
pp. 836-847.
10.1056/NEJMoa1609783.
|
|
Karda, R;
Rahim, AA;
Wong, AMS;
Suff, N;
Diaz, JA;
Perocheau, DP;
Tijani, M;
... Waddington, SN; + view all
(2020)
Generation of light-producing somatic-transgenic mice using adeno-associated virus vectors.
Scientific Reports
, 10
(1)
, Article 2121. 10.1038/s41598-020-59075-3.
|
|
|
Karwacz, K;
Bricogne, C;
MacDonald, D;
Arce, F;
Bennett, CL;
Collins, M;
Escors, D;
(2011)
PD-L1 co-stimulation contributes to ligand-induced T cell receptor down-modulation on CD8(+) T cells.
EMBO Molecular Medicine
, 3
(10)
581 - 592.
10.1002/emmm.201100165.
|
|
|
Kasperavičiute, D;
Catarino, CB;
Chinthapalli, K;
Clayton, LMS;
Thom, M;
Martinian, L;
Cohen, H;
... Sisodiya, SM; + view all
(2011)
Uncovering genomic causes of co-morbidity in epilepsy: Gene-driven phenotypic characterization of rare microdeletions.
PLoS ONE
, 6
(8)
, Article e23182. 10.1371/journal.pone.0023182.
|
|
|
Kasprzyk, A.;
(1998)
Investigation of clonality and minimal residual
disease in haematological malignancy using
fluorescent in situ hybridization.
Doctoral thesis , University of London.
|
|
|
Katipally, Rohan R;
Martinez, Carlos A;
Pugh, Siân A;
Bridgewater, John A;
Primrose, John N;
Domingo, Enric;
Maughan, Timothy S;
... with the S:CORT Consortium; + view all
(2023)
Integrated Clinical-Molecular Classification of Colorectal Liver Metastases: A Biomarker Analysis of the Phase 3 New EPOC Randomized Clinical Trial.
JAMA Oncology
10.1001/jamaoncol.2023.2535.
(In press).
|
|
Kato, I;
Nishinaka, Y;
Nakamura, M;
Akarca, AU;
Niwa, A;
Ozawa, H;
Yoshida, K;
... Enver, T; + view all
(2017)
Hypoxic adaptation of leukemic cells infiltrating the CNS affords a therapeutic strategy targeting VEGFA.
Blood
, 129
(23)
pp. 3126-3129.
10.1182/blood-2016-06-721712.
|
|
Keddie, S;
Foldes, D;
Caimari, F;
Baldeweg, SE;
Bomsztyk, J;
Ziff, OJ;
Fehmi, J;
... Lunn, MP; + view all
(2020)
Clinical characteristics, risk factors, and outcomes of POEMS syndrome: A longitudinal cohort study.
Neurology
, 95
(3)
e268-e279.
10.1212/WNL.0000000000009940.
|
|
Kefas, Joanna;
Bridgewater, John;
Vogel, Arndt;
Stein, Alexander;
Primrose, John;
(2023)
Adjuvant therapy of biliary tract cancers.
Therapeutic Advances in Medical Oncology
, 15
10.1177/17588359231163785.
|
|
Keh, Ryan Yann Shern;
Lilleker, James B;
Lavin, Tim;
Sive, Jonathan;
D'Sa, Shirley;
Ramdharry, Gita;
Carr, Aisling S;
(2022)
Rasch-built overall disability scale for POEMS syndrome (POEMS-RODS).
Journal of the Peripheral Nervous System
, 27
(4)
pp. 302-310.
10.1111/jns.12516.
|
|
|
Kelley, RK;
Bridgewater, J;
Gores, GJ;
Zhu, AX;
(2020)
Systemic therapies for intrahepatic cholangiocarcinoma.
Journal of Hepatology
, 72
(2)
pp. 353-363.
10.1016/j.jhep.2019.10.009.
|
|
Kenten, C;
Ngwenya, N;
Gibson, F;
Flatley, M;
Jones, L;
Pearce, S;
Wong, G;
... Whelan, J; + view all
(2019)
Understanding care when cure is not likely for young adults who face cancer: a realist analysis of data from patients, families and healthcare professionals.
BMJ Open
, 9
(1)
, Article e024397. 10.1136/bmjopen-2018-024397.
|
|
|
Khan, Abdullah O;
Rodriguez-Romera, Antonio;
Reyat, Jasmeet S;
Olijnik, Aude-Anais;
Colombo, Michela;
Wang, Guanlin;
Wen, Wei Xiong;
... Psaila, Bethan; + view all
(2023)
Human bone marrow organoids for disease modelling, discovery and validation of therapeutic targets in hematological malignancies.
Cancer Discovery
, 13
(2)
pp. 364-385.
10.1158/2159-8290.CD-22-0199.
|
|
Khan, AB;
Carpenter, B;
Sousa, PSE;
Pospori, C;
Khorshed, R;
Griffin, J;
Veliça, P;
... Chakraverty, R; + view all
(2018)
Redirection to the bone marrow improves T cell persistence and antitumor functions.
The Journal of Clinical Investigation
, 128
(5)
pp. 2010-2024.
10.1172/JCI97454.
|
|
|
Khwaja, Jahanzaib;
Bomsztyk, Joshua;
Mahmood, Shameem;
Wisniowski, Brendan;
Shah, Raakhee;
Tailor, Anish;
Yong, Kwee;
... Wechalekar, Ashutosh D; + view all
(2022)
High response rates with single-agent belantamab mafodotin in relapsed systemic AL amyloidosis.
Blood Cancer Journal
, 12
(9)
, Article 128. 10.1038/s41408-022-00717-2.
|
|
Khwaja, Jahanzaib;
Vos, Josephine MI;
Pluimers, Tessa E;
Japzon, Nicole;
Patel, Aisha;
Salter, Simon;
Kwakernaak, Arjan J;
... D'Sa, Shirley; + view all
(2024)
Clinical and clonal characteristics of monoclonal immunoglobulin M-associated type I cryoglobulinaemia.
British Journal of Haematology
, 204
(1)
pp. 177-185.
10.1111/bjh.19112.
|
|
Kiladjian, Jean-Jacques;
Vannucchi, Alessandro M;
Gerds, Aaron T;
Gupta, Vikas;
Verstovsek, Srdan;
Egyed, Miklos;
Platzbecker, Uwe;
... Mesa, Ruben; + view all
(2023)
Momelotinib in Myelofibrosis Patients With Thrombocytopenia: Post Hoc Analysis From Three Randomized Phase 3 Trials.
Hemasphere
, 7
(11)
, Article e963. 10.1097/HS9.0000000000000963.
|
|
|
Killick, SB;
Ingram, W;
Culligan, D;
Enright, H;
Kell, J;
Payne, EM;
Krishnamurthy, P;
... Bowen, D; + view all
(2021)
Guidelines for the management of adult myelodysplastic syndromes.
British Journal of Haematology
, 194
(2)
pp. 267-281.
10.1111/bjh.17612.
|
|
Killick, SB;
Wiseman, DH;
Quek, L;
Cargo, C;
Culligan, D;
Enright, H;
Green, S;
... Haematology, BSF; + view all
(2021)
Guidelines for the diagnosis and evaluation of prognosis of adult myelodysplastic syndromes.
British Society of Haematology
, 194
(2)
pp. 282-293.
10.1111/bjh.17621.
|
|
Kim, M;
Torrealdea, F;
Adeleke, O;
Rega, M;
Evans, V;
Beeston, T;
Soteriou, K;
... Golay, X; + view all
(2019)
Challenges in glucoCEST MR body imaging at 3 Tesla.
Quantitative Imaging in Medicine and Surgery
, 9
(10)
pp. 1628-1640.
10.21037/qims.2019.10.05.
|
|
|
Kirk, P;
Sheppard, M;
Carpenter, J-P;
Anderson, L;
He, T;
St Pierre, T;
Galanello, R;
... Pennell, DJ; + view all
(2017)
Post-mortem study of the association between cardiac iron and fibrosis in transfusion dependent anaemia.
Journal of Cardiovascular Magnetic Resonance
, 19
(1)
, Article 36. 10.1186/s12968-017-0349-3.
|
|
|
Kirkeby, Agnete;
Nelander, Jenny;
Hoban, Deirdre B;
Rogelius, Nina;
Bjartmarz, Hjálmar;
Novo Nordisk Cell Therapy R&D;
Storm, Petter;
... Parmar, Malin; + view all
(2023)
Preclinical quality, safety, and efficacy of a human embryonic stem cell-derived product for the treatment of Parkinson’s disease, STEM-PD.
Cell Stem Cell
, 30
(10)
1299-1314.E9.
10.1016/j.stem.2023.08.014.
|
|
|
Kistler, AD;
Siwy, J;
Breunig, F;
Jeevaratnam, P;
Scherl, A;
Mullen, W;
Warnock, DG;
... Serra, AL; + view all
(2011)
A Distinct Urinary Biomarker Pattern Characteristic of Female Fabry Patients That Mirrors Response to Enzyme Replacement Therapy.
PLOS ONE
, 6
(6)
, Article e20534. 10.1371/journal.pone.0020534.
|
|
|
Klebanoff, CA;
Chandran, SS;
Baker, BM;
Quezada, SA;
Ribas, A;
(2023)
T cell receptor therapeutics: immunological targeting of the intracellular cancer proteome.
Nature Reviews Drug Discovery
, 22
(12)
pp. 996-1017.
10.1038/s41573-023-00809-z.
|
|
|
Klopp, A;
Schreiber, S;
Kosinska, AD;
Pule, M;
Protzer, U;
Wisskirchen, K;
(2021)
Depletion of T cells via Inducible Caspase 9 Increases Safety of Adoptive T-Cell Therapy Against Chronic Hepatitis B.
Frontiers in Immunology
, 12
, Article 734246. 10.3389/fimmu.2021.734246.
|
|
|
Knapper, S;
Russell, N;
Gilkes, A;
Hills, RK;
Gale, RE;
Cavenagh, JD;
Jones, G;
... Burnett, AK; + view all
(2017)
A randomised assessment of adding the kinase inhibitor lestaurtinib to 1st-line chemotherapy for FLT3-mutated AML.
Blood
, 129
(9)
pp. 1143-1154.
10.1182/blood-2016-07-730648.
|
|
Knight, A;
Arnouk, H;
Britt, W;
Gillespie, GY;
Cloud, GA;
Harkins, L;
Su, Y;
... Lamb, LS; + view all
(2013)
CMV-Independent Lysis of Glioblastoma by Ex Vivo Expanded/Activated Vδ1+ γδ T Cells.
PLoS One
, 8
(8)
, Article e68729. 10.1371/journal.pone.0068729.
|
|
|
Knott, KD;
Augusto, JB;
Nordin, S;
Kozor, R;
Camaioni, C;
Xue, H;
Hughes, RK;
... Moon, JC; + view all
(2019)
Quantitative Myocardial Perfusion in Fabry Disease.
Circulation: Cardiovascular Imaging
, 12
(7)
, Article e008872. 10.1161/CIRCIMAGING.119.008872.
|
|
Kokalaki, E;
Ma, B;
Ferrari, M;
Grothier, T;
Hazelton, W;
Manzoor, S;
Costu, E;
... Pule, M; + view all
(2023)
Dual targeting of CD19 and CD22 against B-ALL using a novel high-sensitivity aCD22 CAR.
Molecular Therapy
, 31
(7)
pp. 2089-2104.
10.1016/j.ymthe.2023.03.020.
|
|
Kokalaki, Evangelia;
Ma, Biao;
Ferrari, Mathieu;
Grothier, Thomas;
Hazelton, Warren;
Manzoor, Somayya;
Costu, Eren;
... Pule, Martin; + view all
(2024)
Dual targeting of CD19 and CD22 against B-ALL using a novel high-sensitivity aCD22 CAR.
[Corrigendum].
Molecular Therapy
, 32
(2)
pp. 556-558.
10.1016/j.ymthe.2023.12.006.
|
|
|
Kokiçi, Jonida;
Arellano-Ballestero, Helena;
Hammond, Benjamin;
Preechanukul, Anucha;
Hussain, Noshin;
Da Costa, Kelly;
Davies, Jessica;
... Peppa, Dimitra; + view all
(2025)
Expanded adaptive NKG2C+ NK cells exhibit potent ADCC and functional responses against HBV-infected hepatoma cell lines.
Cytotherapy
10.1016/j.jcyt.2025.10.006.
(In press).
|
|
|
Kolovos, S;
Nador, G;
Kishore, B;
Streetly, M;
Rabin, NK;
Chantry, AD;
Yong, K;
... Pinedo-Villanueva, R; + view all
(2019)
Unplanned admissions for patients with myeloma in the UK: Low frequency but high costs.
Journal of Bone Oncology
, 17
, Article 100243. 10.1016/j.jbo.2019.100243.
|
|
|
Koonyosying, P;
Uthaipibull, C;
Fucharoen, S;
Koumoutsea, EV;
Porter, JB;
Srichairatanakool, S;
(2019)
Decrement in Cellular Iron and Reactive Oxygen Species, and Improvement of Insulin Secretion in a Pancreatic Cell Line Using Green Tea Extract.
Pancreas
, 48
(5)
pp. 636-643.
10.1097/MPA.0000000000001320.
|
|
|
Kos, K;
Aslam, MA;
van de Ven, R;
Wellenstein, MD;
Pieters, W;
van Weverwijk, A;
Duits, DEM;
... de Visser, KE; + view all
(2022)
Tumor-educated Tregs drive organ-specific metastasis in breast cancer by impairing NK cells in the lymph node niche.
Cell Reports
, 38
(9)
, Article 110447. 10.1016/j.celrep.2022.110447.
|
|
|
Kottaridis, P.D.;
(2006)
Investigations of FLT3 internal tandem duplications in patients with acute myeloid leukaemia.
Doctoral thesis , University of London.
|
|
|
Kottaridis, P.D.;
Gale, R.E.;
Frew, M.E.;
Harrison, G.;
Langabeer, S.E.;
Belton, A.A;
Walker, H.;
... Linch, D.C.; + view all
(2001)
The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12 trials.
Blood
, 98
(6)
pp. 1752-1759.
10.1182/blood.V98.6.1752.
|
|
|
Kottaridis, P.D.;
Gale, R.E.;
Langabeer, S.E.;
Frew, M.E.;
Bowen, D.T.;
Linch, D.C.;
(2002)
Studies of FLT3 mutations in paired presentation and relapse samples from patients with acute myeloid leukemia: implications for the role of FLT3 mutations in leukemogenesis, minimal residual disease detection, and possible therapy with FLT3 inhibitors.
Blood
, 100
(7)
pp. 2393-2398.
10.1182/blood-2002-02-0420.
|
|
|
Kottaridis, PD;
North, J;
Tsirogianni, M;
Marden, C;
Samuel, ER;
Jide-Banwo, S;
Grace, S;
(2015)
Two-Stage Priming of Allogeneic Natural Killer Cells for the Treatment of Patients with Acute Myeloid Leukemia: A Phase I Trial.
PLoS One
, 10
(6)
, Article e0123416. 10.1371/journal.pone.0123416.
|
|
|
Koumoutsea, EV;
Garbowski, M;
Porter, J;
(2015)
Synergistic intracellular iron chelation combinations: mechanisms and conditions for optimizing iron mobilization.
British Journal of Haematology
, 170
(6)
pp. 874-883.
10.1111/bjh.13512.
|
|
|
Koutoukidis, DA;
Land, J;
Hackshaw, A;
Heinrich, M;
McCourt, O;
Beeken, RJ;
Philpott, S;
... Yong, KL; + view all
(2020)
Fatigue, quality of life and physical fitness following an exercise intervention in multiple myeloma survivors (MASCOT): an exploratory randomised Phase 2 trial utilising a modified Zelen design.
British Journal of Cancer
10.1038/s41416-020-0866-y.
(In press).
|
|
|
Koutoukidis, DA;
Land, J;
Hackshaw, A;
Heinrich, M;
McCourt, O;
Beeken, RJ;
Philpott, S;
... Yong, KL; + view all
(2020)
Fatigue, quality of life and physical fitness following an exercise intervention in multiple myeloma survivors (MASCOT): an exploratory randomised Phase 2 trial utilising a modified Zelen design.
British Journal of Cancer
10.1038/s41416-020-0866-y.
(In press).
|
|
|
Kozor, R;
Nordin, S;
Treibel, TA;
Rosmini, S;
Castelletti, S;
Fontana, M;
Captur, G;
... Moon, JC; + view all
(2017)
Insight into hypertrophied hearts: a cardiovascular magnetic resonance study of papillary muscle mass and T1 mapping.
European Heart Journal - Cardiovascular Imaging
, 18
(9)
pp. 1034-1040.
10.1093/ehjci/jew187.
|
|
|
Kramer, AM;
(2017)
Delineating the impact of binding-domain affinity and kinetic properties on Chimeric Antigen Receptor T-cell function.
Doctoral thesis , UCL (University College London).
|
|
Krishnan, B;
Ganeshaguru, K;
Baker, R;
Richfield, L;
Mehta, AB;
(2003)
Multidrug resistance and myelomonocytic leukaemia in gaucher's disease.
Haematologica
, 88
(2)
ECR02-.
|
|
|
Kroeger, Nicolaus;
Sbianchi, Giulia;
Sirait, Tiarlan;
Wolschke, Christine;
Beelen, Dietrich;
Passweg, Jakob;
Robin, Marie;
... Yakoub-Agha, Ibrahim; + view all
(2021)
Impact of prior JAK-inhibitor therapy with ruxolitinib on outcome after allogeneic hematopoietic stem cell transplantation for myelofibrosis: a study of the CMWP of EBMT.
Leukemia
, 35
pp. 3551-3560.
10.1038/s41375-021-01276-4.
|
|
|
Kuhnl, A;
Kirkwood, AA;
Roddie, C;
Menne, T;
Tholouli, E;
Bloor, A;
Besley, C;
... Townsend, W; + view all
(2023)
CAR T in patients with large B-cell lymphoma not fit for autologous transplant.
British Journal of Haematology
, 202
(1)
pp. 65-73.
10.1111/bjh.18810.
|
|
Kuhnl, A;
Roddie, C;
Kirkwood, AA;
Chaganti, S;
Norman, J;
Lugthart, S;
Osborne, W;
... Mikhaeel, NG; + view all
(2024)
Outcome and feasibility of radiotherapy bridging in large B-cell lymphoma patients receiving CD19 CAR T in the UK.
British Journal of Haematology
, 205
(2)
pp. 483-494.
10.1111/bjh.19453.
|
|
Kuhnl, A;
Roddie, C;
Kirkwood, AA;
Menne, T;
Cuadrado, MM;
Marzolini, MAV;
Osborne, W;
... Kayani, I; + view all
(2021)
Early FDG PET response predicts CAR-T failure in large B-cell lymphoma.
Blood Advances
10.1182/bloodadvances.2021005807.
(In press).
|
|
|
Kuhnl, Andrea;
Roddie, Claire;
Kirkwood, Amy A;
Tholouli, Eleni;
Menne, Tobias;
Patel, Amit;
Besley, Caroline;
... McMillan, Andrew; + view all
(2022)
A national service for delivering CD19 CAR-Tin large B-cell lymphoma – The UK real-world experience.
British Journal of Haematology
, 198
(3)
pp. 492-502.
10.1111/bjh.18209.
|
|
Kühnl, A;
Cunningham, D;
Counsell, N;
Hawkes, EA;
Qian, W;
Smith, P;
Chadwick, N;
... Linch, D; + view all
(2017)
Outcome of Elderly Patients with Diffuse Large B-cell Lymphoma Treated with R-CHOP: Results from the UK NCRI R-CHOP14v21 trial with combined analysis of molecular characteristics with the DSHNHL RICOVER-60 trial.
Annals of Oncology
, 28
(7)
pp. 1540-1546.
10.1093/annonc/mdx128.
|
|
Kumar, AJ;
Gimotty, PA;
Gelfand, J;
Buck, G;
Rowe, JM;
Goldstone, AH;
Fielding, A;
... Loren, AW; + view all
(2016)
Delays in postremission chemotherapy for Philadelphia chromosome negative acute lymphoblastic leukemia are associated with inferior outcomes in patients who undergo allogeneic transplant: An analysis from ECOG 2993/MRC UK ALLXII.
American Journal of Hematology
, 91
(11)
pp. 1107-1112.
10.1002/ajh.24497.
|
|
L
|
Laethem, J-LV;
Riess, H;
Jassem, J;
Haas, M;
Martens, UM;
Weekes, C;
Peeters, M;
... Childs, BH; + view all
(2016)
Phase I/II Study of Refametinib (BAY 86-9766) in Combination with Gemcitabine in Advanced Pancreatic cancer.
Targeted Oncology
, 12
(1)
pp. 97-109.
10.1007/s11523-016-0469-y.
|
|
|
Lai, AG;
Pasea, L;
Banerjee, A;
Hall, G;
Denaxas, S;
Chang, WH;
Katsoulis, M;
... Hemingway, H; + view all
(2020)
Estimated impact of the COVID-19 pandemic on cancer services and excess 1-year mortality in people with cancer and multimorbidity: near real-time data on cancer care, cancer deaths and a population-based cohort study.
BMJ Open
, 10
(11)
, Article e043828. 10.1136/bmjopen-2020-043828.
|
|
|
Lamarca, A;
Edeline, J;
McNamara, MG;
Hubner, RA;
Nagino, M;
Bridgewater, J;
Primrose, J;
(2020)
Current standards and future perspectives in adjuvant treatment for biliary tract cancers.
Cancer Treatment Reviews
, 84
, Article 101936. 10.1016/j.ctrv.2019.101936.
|
|
Lamarca, A;
Palmer, DH;
Wasan, HS;
Ross, PJ;
Ma, YT;
Arora, A;
Falk, S;
... Advanced Biliary Cancer Working Group; + view all
(2021)
Second-line FOLFOX chemotherapy versus active symptom control for advanced biliary tract cancer (ABC-06): a phase 3, open-label, randomised, controlled trial.
The Lancet Oncology
10.1016/S1470-2045(21)00027-9.
(In press).
|
|
|
Lamarca, A;
Ross, P;
Wasan, HS;
Hubner, RA;
McNamara, MG;
Lopes, A;
Manoharan, P;
... Valle, JW; + view all
Advanced intrahepatic cholangiocarcinoma: post-hoc analysis of the ABC-01, -02 and -03 clinical trials.
Journal of the National Cancer Institute
10.1093/jnci/djz071.
(In press).
|
|
|
Lambert, J.R.;
(2011)
Investigations into the molecular pathogenesis of essential thrombocythaemia.
Doctoral thesis , UCL (University College London).
|
|
|
Land, J;
McCourt, O;
Heinrich, M;
Beeken, RJ;
Koutoukidis, DA;
Paton, B;
Yong, K;
... Fisher, A; + view all
(2020)
The adapted Zelen was a feasible design to trial exercise in myeloma survivors.
Journal of Clinical Epidemiology
, 125
pp. 76-83.
10.1016/j.jclinepi.2020.04.004.
|
|
|
Latifoltojar, A;
Duncan, MKJ;
Klusmann, M;
Sidhu, H;
Bainbridge, A;
Neriman, D;
Fraioli, F;
... Punwani, S; + view all
(2020)
Whole Body 3.0 T Magnetic Resonance Imaging in Lymphomas: Comparison of Different Sequence Combinations for Staging Hodgkin's and Diffuse Large B Cell Lymphomas.
Journal of Personalized Medicine
, 10
(4)
, Article 284. 10.3390/jpm10040284.
|
|
|
Latifoltojar, A;
Hall-Craggs, M;
Bainbridge, A;
Rabin, N;
Popat, R;
Rismani, A;
D'Sa, S;
... Punwani, S; + view all
(2017)
Whole-body MRI quantitative biomarkers are associated significantly with treatment response in patients with newly diagnosed symptomatic multiple myeloma following bortezomib induction.
European Radiology
10.1007/s00330-017-4907-8.
(In press).
|
|
|
Latifoltojar, A;
Hall-Craggs, M;
Rabin, N;
Popat, R;
Bainbridge, A;
Dikaios, N;
Sokolska, M;
... Yong, K; + view all
(2017)
Whole body magnetic resonance imaging in newly diagnosed multiple myeloma: early changes in lesional signal fat fraction predict disease response.
British Journal of Haematology
, 176
(2)
pp. 222-233.
10.1111/bjh.14401.
|
|
Lavalle, L;
Thomas, AS;
Beaton, B;
Ebrahim, H;
Reed, M;
Ramaswami, U;
Elliott, P;
... Hughes, DA; + view all
(2018)
Phenotype and biochemical heterogeneity in late onset Fabry disease defined by N215S mutation.
PLoS One
, 13
(4)
, Article e0193550. 10.1371/journal.pone.0193550.
|
|
|
Lawrie, AS;
Kitchen, S;
Efthymiou, M;
Mackie, IJ;
Machin, SJ;
(2013)
Determination of APTT factor sensitivity - the misguiding guideline.
Int J Lab Hematol
, 35
(6)
pp. 652-657.
10.1111/ijlh.12109.
|
|
|
Lawrie, AS;
Lane, PJ;
Mackie, IJ;
Machin, SJ;
Kobayashi, K;
(2014)
The automation of routine light transmission platelet aggregation.
International Journal of Laboratory Hematology
, 36
(4)
431 - 438.
10.1111/ijlh.12161.
|
|
|
Le Quellec, S;
Dane, A;
Enjolras, N;
McIntosh, J;
Rosales, C;
Negrier, C;
Nathwani, A;
(2019)
Potential limits of AAV-based gene therapy with the use of new transgenes expressing factor IX fusion proteins.
Haemophilia
, 25
(1)
E11-E18.
10.1111/hae.13651.
|
|
Lebrusant-Fernandez, Marta;
Reading, James L;
(2025)
Beta papillomaviruses: From foe to friend in skin cancer immunity.
Cancer Cell
, 43
(1)
pp. 6-7.
10.1016/j.ccell.2024.12.005.
|
|
Lecat, Catherine;
Boyle, Eileen M;
Hughes, Daniel;
Lee, Lydia;
Smith, Dean;
Bygrave, Ceri;
Ramasamy, Karthik;
(2024)
Challenges in designing and running smouldering myeloma interventional clinical trials.
eJHaem
10.1002/jha2.880.
(In press).
|
|
Lecat, Catherine SY;
Bristogiannis, Sotirios;
Mehta, Dipal;
Lwin, Yadanar;
Land, Joanne;
McCourt, Orla;
Dowling, Emma;
... Kyriakou, Charalampia; + view all
(2025)
Current quality of life questionnaires are not relevant for assessing QOL issues in multiple myeloma patients in the era of modern therapies: results from a survey with myeloma patients and myeloma healthcare professionals.
Frontiers in Oncology
, 15
, Article 1656912. 10.3389/fonc.2025.1656912.
|
|
|
Lecat, CSY;
Besley, C;
Hough, RE;
Khwaja, A;
Furness, C;
Marks, DI;
Fielding, AK;
(2020)
Inotuzumab ozogamicin versus FLAG-Ida in the treatment of relapsed or refractory B-cell acute lymphoblastic leukemia – real-world resource use data.
Leukemia & Lymphoma
, 61
(2)
pp. 491-493.
10.1080/10428194.2019.1672057.
|
|
Lecat, CSY;
McCourt, O;
Land, J;
Yong, K;
Fisher, A;
(2021)
Multiple myeloma and physical activity.
BMC Research Notes
, 14
(1)
, Article 171. 10.1186/s13104-021-05591-y.
|
|
|
Lecat, CSY;
Taube, JBB;
Wilson, W;
Carmichael, J;
Parrish, C;
Wallis, G;
Kyriakou, C;
... Popat, R; + view all
(2021)
Defining Unmet Need Following Lenalidomide Refractoriness: Real-World Evidence of Outcomes in Patients With Multiple Myeloma.
Frontiers in Oncology
, 11
, Article 703233. 10.3389/fonc.2021.703233.
|
|
|
Lechner, M;
Schartinger, VH;
Steele, CD;
Nei, WL;
Ooft, ML;
Schreiber, L-M;
Pipinikas, CP;
... Lund, VJ; + view all
(2021)
Somatostatin receptor 2 expression in nasopharyngeal cancer is induced by Epstein Barr virus infection: impact on prognosis, imaging and therapy.
Nature Communications
, 12
(1)
, Article 117. 10.1038/s41467-020-20308-8.
|
|
|
Lee, Lydia;
Lim, Wen Chean;
Galas-Filipowicz, Daria;
Fung, Kent;
Taylor, Julia;
Patel, Dominic;
Akbar, Zulaikha;
... Popat, Rakesh; + view all
(2023)
Limited efficacy of APRIL CAR in patients with multiple myeloma indicate challenges in the use of natural ligands for CAR T-cell therapy.
Journal for ImmunoTherapy of Cancer
, 11
(6)
, Article e006699. 10.1136/jitc-2023-006699.
|
|
Lee, Doyoung;
(2017)
Investigation of mechanisms for enhancing expression of human FVIII in vitro; application to therapeutic protein production.
Doctoral thesis , UCL (University College London).
|
|
Lee, DW;
Santomasso, BD;
Locke, FL;
Ghobadi, A;
Turtle, CJ;
Brudno, JN;
Maus, MV;
... Neelapu, SS; + view all
(2018)
ASBMT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells.
Biology of Blood and Marrow Transplantation
10.1016/j.bbmt.2018.12.758.
(In press).
|
|
|
Lee, E;
Milan, A;
Urbani, L;
De Coppi, P;
Lowdell, MW;
(2017)
Decellularized material as scaffolds for tissue engineering studies in long gap esophageal atresia.
Expert Opinion on Biological Therapy
, 17
(5)
pp. 573-584.
10.1080/14712598.2017.1308482.
|
|
Lee, KCL;
Baker, L;
Mallett, S;
Riddell, A;
Chowdary, P;
Alibhai, H;
Chang, Y-M;
... Agarwal, B; + view all
(2017)
Hypercoagulability progresses to hypocoagulability during evolution of acetaminophen-induced acute liver injury in pigs.
Scientific Reports
, 7
(1)
, Article 9347. 10.1038/s41598-017-09508-3.
|
|
|
Lee, L;
Alrasheed, N;
Khandelwal, G;
Fitzsimons, E;
Richards, H;
Wilson, W;
Chavda, SJ;
... Yong, K; + view all
(2021)
Increased Immune-Regulatory Receptor Expression on Effector T Cells as Early Indicators of Relapse Following Autologous Stem Cell Transplantation for Multiple Myeloma.
Frontiers Immunology
, 12
, Article 618610. 10.3389/fimmu.2021.618610.
|
|
|
Lee, L;
Draper, B;
Chaplin, N;
Philip, B;
Chin, M;
Galas-Filipowicz, D;
Onuoha, S;
... Pule, M; + view all
(2017)
An APRIL based chimeric antigen receptor for dual targeting of BCMA and TACI in Multiple Myeloma.
Blood
, 2017
(5)
, Article 781351. 10.1182/blood-2017-05-781351.
|
|
Lee, LSH;
(2017)
APRIL based therapeutic strategies to target BCMA and TACI in multiple myeloma.
Doctoral thesis , UCL (University College London).
|
|
Leen, G;
Stein, JE;
Robinson, J;
Maldonado Torres, H;
Marsh, SGE;
(2020)
The HLA diversity of the Anthony Nolan register.
HLA
, 97
(1)
pp. 15-29.
10.1111/tan.14127.
|
|
|
Leija-Salazar, M;
Sedlazeck, FJ;
Toffoli, M;
Mullin, S;
Mokretar, K;
Athanasopoulou, M;
Donald, A;
... Proukakis, C; + view all
(2019)
Evaluation of the detection of GBA missense mutations and other variants using the Oxford Nanopore MinION.
Molecular Genetics & Genomic Medicine
10.1002/mgg3.564.
(In press).
|
|
Leng, H;
Zhang, H;
Li, L;
Zhang, S;
Wang, Y;
Chavda, SJ;
Galas-Filipowicz, D;
... Horwood, NJ; + view all
(2022)
Modulating glycosphingolipid metabolism and autophagy improves outcomes in pre-clinical models of myeloma bone disease.
Nature Communications
, 13
(1)
, Article 7868. 10.1038/s41467-022-35358-3.
|
|
Lenogue, K;
Walencik, A;
Laulagnier, K;
Molens, J-P;
Benlalam, H;
Dreno, B;
Coulie, P;
... Plumas, J; + view all
(2021)
Engineering a Human Plasmacytoid Dendritic Cell-Based Vaccine to Prime and Expand Multispecific Viral and Tumor Antigen-Specific T-Cells.
Vaccines
, 9
(2)
, Article 141. 10.3390/vaccines9020141.
|
|
|
Leon, TE;
Rapoz-D'Silva, T;
Bertoli, C;
Rahman, S;
Magnussen, M;
Philip, B;
Farah, N;
... Mansour, MR; + view all
(2020)
EZH2 deficient T-cell acute lymphoblastic leukemia is sensitized to CHK1 inhibition through enhanced replication stress.
Cancer Discovery
, 10
(7)
10.1158/2159-8290.CD-19-0789.
|
|
Leone, Gianmarco;
Wong, Yien Ning Sophia;
Jones, Robert J;
Sankey, Peter;
Josephs, Debra H;
Crabb, Simon J;
Harris, Louise;
... Linch, Mark D; + view all
(2025)
Nivolumab and Ipilimumab for Metastatic Castration-Resistant Prostate Cancer With an Immunogenic Signature: The Multicenter, Two-Cohort, Phase II NEPTUNES Study.
Journal of Clinical Oncology
10.1200/JCO-24-02637.
(In press).
|
|
Leong, S;
Inglott, S;
Papaleonidopoulou, F;
Orfinada, K;
Ancliff, P;
Bartram, J;
Carpenter, B;
... O'Connor, D; + view all
(2020)
CD1a is rarely expressed in pediatric or adult relapsed/refractory T-ALL: implications for immunotherapy.
Blood Advances
, 4
(19)
pp. 4665-4668.
10.1182/bloodadvances.2020002502.
|
|
Leongamornlert, Daniel;
Gutiérrez-Abril, Jesús;
Lee, Soo Wah;
Barretta, Emilio;
Creasey, Tom;
Gundem, Gunes;
Levine, Max Fine;
... Papaemmanuil, Elli; + view all
(2023)
Diagnostic utility of whole genome sequencing in adults with B-other acute lymphoblastic leukemia.
Blood Advances
10.1182/bloodadvances.2022008992.
(In press).
|
|
Li, Z;
Abraham, BJ;
Berezovskaya, A;
Farah, N;
Liu, Y;
Leon, T;
Fielding, A;
... Look, AT; + view all
(2017)
APOBEC signature mutation generates an oncogenic enhancer that drives LMO1 expression in T-ALL.
Leukemia
10.1038/leu.2017.75.
|
|
|
Li, Z;
Lamb, R;
Coles, MC;
Bennett, CL;
Ambler, CA;
(2021)
Inducible ablation of CD11c⁺ cells to determine their role in skin wound repair.
Immunology
, 163
(1)
pp. 105-111.
10.1111/imm.13312.
|
|
|
Lidove, O;
Barbey, F;
Niu, DM;
Brand, E;
Nicholls, K;
Bizjajeva, S;
Hughes, DA;
(2016)
Fabry in the older patient: Clinical consequences and possibilities for treatment.
Molecular Genetics and Metabolism
, 118
(4)
pp. 319-325.
10.1016/j.ymgme.2016.05.009.
|
|
|
Lin, W-Y;
Fordham, SE;
Hungate, E;
Sunter, NJ;
Elstob, C;
Xu, Y;
Park, C;
... Allan, JM; + view all
(2021)
Genome-wide association study identifies susceptibility loci for acute myeloid leukemia.
Nature Communications
, 12
(1)
, Article 6233. 10.1038/s41467-021-26551-x.
|
|
|
Linch, DC;
Hills, RK;
Burnett, AK;
Russell, N;
Gale, RE;
(2021)
Therapy for isocitrate dehydrogenase 2 (IDH2)(R172)-mutant acute myeloid leukaemia.
British Journal of Haematology
10.1111/bjh.17981.
(In press).
|
|
|
Linch, DC;
Hills, RK;
Gilkes, A;
Burnett, AK;
Russell, N;
Gale, RE;
(2021)
Additional impact of mutational genotype on prognostic determination in resistant and relapsed acute myeloid leukaemia.
Leukemia Research
, 108
, Article 106553. 10.1016/j.leukres.2021.106553.
|
|
Linch, D;
(2020)
Developments over the last 60 years in diffuse large B-cell lymphomas.
British Journal of Haematology
, 191
(4)
pp. 552-557.
10.1111/bjh.17154.
|
|
|
Linch, DC;
Hills, RK;
Burnett, AK;
Russell, N;
Gale, RE;
(2020)
Analysis of the clinical impact of NPM1 mutant allele burden in a large cohort of younger adult patients with acute myeloid leukaemia.
British Journal of Haematology
, 188
(6)
pp. 852-859.
10.1111/bjh.16239.
|
|
Linch, M;
Goh, G;
Hiley, C;
Shanmugabavan, Y;
McGranahan, N;
Rowan, A;
Wong, YNS;
... Swanton, C; + view all
(2017)
Intratumoural evolutionary landscape of high-risk prostate cancer: the PROGENY study of genomic and immune parameters.
Annals of Oncology
, 28
(10)
pp. 2472-2480.
10.1093/annonc/mdx355.
|
|
Ling, G;
Nathwani, AC;
Tuddenham, EGD;
(2018)
Recent advances in developing specific therapies for haemophilia.
British Journal of Haematology
, 181
(2)
pp. 161-172.
10.1111/bjh.15084.
|
|
Linhart, A;
Dostálová, G;
Nicholls, K;
West, ML;
Tøndel, C;
Jovanovic, A;
Giraldo, P;
... Hughes, D; + view all
(2023)
Safety and efficacy of pegunigalsidase alfa in patients with Fabry disease who were previously treated with agalsidase alfa: results from BRIDGE, a phase 3 open-label study.
Orphanet Journal of Rare Diseases
, 18
(1)
, Article 332. 10.1186/s13023-023-02937-6.
|
|
|
Linhart, A;
Germain, DP;
Olivotto, I;
Akhtar, MM;
Anastasakis, A;
Hughes, D;
Namdar, M;
... Elliott, P; + view all
(2020)
An Expert Consensus Document on the Management of Cardiovascular Manifestations of Fabry Disease.
European Journal of Heart Failure
, 22
(7)
pp. 1076-1096.
10.1002/ejhf.1960.
|
|
|
Litchfield, K;
Reading, JL;
Lim, EL;
Xu, H;
Liu, P;
Al-Bakir, M;
Wong, YNS;
... Swanton, C; + view all
(2020)
Escape from nonsense-mediated decay associates with anti-tumor immunogenicity.
Nature Communications
, 11
, Article 3800. 10.1038/s41467-020-17526-5.
|
|
|
Litchfield, K;
Reading, JL;
Puttick, C;
Thakkar, K;
Abbosh, C;
Bentham, R;
Watkins, TBK;
... Swanton, C; + view all
(2021)
Meta-analysis of tumor- and T cell-intrinsic mechanisms of sensitization to checkpoint inhibition.
Cell
, 184
(3)
596-614.e14.
10.1016/j.cell.2021.01.002.
|
|
|
Litchfield, K;
Stanislaw, S;
Spain, L;
Gallegos, LL;
Rowan, A;
Schnidrig, D;
Rosenbaum, H;
... Turajlic, S; + view all
(2020)
Representative Sequencing: Unbiased Sampling of Solid Tumor Tissue.
Cell Reports
, 31
(5)
p. 107550.
10.1016/j.celrep.2020.107550.
|
|
Liu, S;
Razon, L;
Ritchie, O;
Sihn, CR;
Handyside, B;
Berguig, G;
Woloszynek, J;
... Fong, S; + view all
(2022)
Application of in-vitro-cultured primary hepatocytes to evaluate species translatability and AAV transduction mechanisms of action.
Molecular Therapy Methods and Clinical Development
, 26
pp. 61-71.
10.1016/j.omtm.2022.05.008.
|
|
|
Liu, Zhuang;
Bian, Xiaowei;
Luo, Lihua;
Björklund, Åsa K;
Li, Li;
Zhang, Letian;
Chen, Yongjian;
... Landén, Ning Xu; + view all
(2024)
Spatiotemporal single-cell roadmap of human skin wound healing.
Cell Stem Cell
10.1016/j.stem.2024.11.013.
(In press).
|
|
|
Liu, ZJ;
Deschmann, E;
Ramsey, HE;
Feldman, HA;
Psaila, B;
Cooper, N;
Vlachodimitropoulou, E;
... Sola-Visner, M; + view all
(2022)
Iron status influences the response of cord blood megakaryocyte progenitors to eltrombopag in vitro.
Blood Advances
, 6
(1)
pp. 13-27.
10.1182/bloodadvances.2021004207.
|
|
|
Llombart, V;
Mansour, MR;
(2022)
Therapeutic targeting of "undruggable" MYC.
EBioMedicine
, 75
, Article 103756. 10.1016/j.ebiom.2021.103756.
|
|
|
Llombart, V;
Alejandro Trejo, S;
Bronsoms, S;
Morancho, A;
Ma, F;
Faura, J;
Garcia-Berrocoso, T;
... Montaner, J; + view all
(2017)
Profiling and identification of new proteins involved in brain ischemia using MALDI-imaging-mass-spectrometry.
Journal of Proteomics
, 152
pp. 243-253.
10.1016/j.jprot.2016.11.014.
|
|
|
Lloyd, Emma;
(2025)
Biogenic activity of peripheral sensory nerves during homeostasis and regeneration.
Doctoral thesis (Ph.D), UCL (University College London).
|
|
Lloyd, AJ;
Gallop, K;
Ali, S;
Hughes, D;
MacCulloch, A;
(2016)
Social preference weights for treatments in Fabry disease in the UK: a discrete choice experiment.
Current Medical Research and Opinion
, 33
(1)
pp. 23-29.
10.1080/03007995.2016.1232704.
|
|
|
Lo, Jonathan W;
Schroeder, Jan-Hendrik;
Roberts, Luke B;
Mohamed, Rami;
Cozzetto, Domenico;
Beattie, Gordon;
Omer, Omer S;
... Lord, Graham M; + view all
(2024)
CTLA-4 expressing innate lymphoid cells modulate mucosal homeostasis in a microbiota dependent manner.
Nature Communications
, 15
(1)
, Article 9520. 10.1038/s41467-024-51719-6.
|
|
|
Löhle, M;
Hughes, D;
Milligan, A;
Richfield, L;
Reichmann, H;
Mehta, A;
Schapira, AH;
(2015)
Clinical prodromes of neurodegeneration in Anderson-Fabry disease.
Neurology
, 84
(14)
1454 - 1464.
10.1212/WNL.0000000000001450.
|
|
Loke, J;
Lowe, DM;
Miller, LJ;
Morton, S;
Roy, NBA;
Sekhar, M;
Stanworth, SJ;
(2020)
Supportive care in the management of patients with acute myeloid leukaemia: where are the research needs?
British Journal of Haematology
10.1111/bjh.16708.
(In press).
|
|
|
Lopez, Ernesto;
Karattil, Rajesh;
Nannini, Francesco;
Weng-Kit Cheung, Gordon;
Denzler, Lilian;
Galvez-Cancino, Felipe;
Quezada, Sergio;
(2023)
Inhibition of lactate transport by MCT-1 blockade improves chimeric antigen receptor T-cell therapy against B-cell malignancies.
Journal for ImmunoTherapy of Cancer
, 11
(6)
, Article e006287. 10.1136/jitc-2022-006287.
|
|
López, S;
Lim, EL;
Horswell, S;
Haase, K;
Huebner, A;
Dietzen, M;
Mourikis, TP;
... McGranahan, N; + view all
(2020)
Interplay between whole-genome doubling and the accumulation of deleterious alterations in cancer evolution.
Nature Genetics
, 52
(3)
pp. 283-293.
10.1038/s41588-020-0584-7.
|
|
López Cabrera, Ernesto;
(2024)
Metabolic transport blockade enhances chimeric antigen receptors T cell therapy against B cell lymphoma.
Doctoral thesis (Ph.D), UCL (University College London).
|
|
Lowdell, Mark W;
Weil, Ben;
(2023)
Bringing function to the forefront of cell therapy: how do we demonstrate potency?
Frontiers in Immunology
, 14
, Article 1226841. 10.3389/fimmu.2023.1226841.
|
|
Lowdell, MW;
Thomas, A;
(2017)
The expanding role of the clinical haematologist in the new world of advanced therapy medicinal products.
British Journal of Haematology
, 176
(1)
pp. 9-15.
10.1111/bjh.14384.
|
|
Lubin, A;
Otterstrom, J;
Hoade, Y;
Bjedov, I;
Stead, E;
Whelan, M;
Gestri, G;
... Payne, E; + view all
(2021)
A versatile, automated and high-throughput drug screening platform for zebrafish embryos.
Biology Open
, 10
(9)
, Article bio058513. 10.1242/bio.058513.
|
|
Lucas, JAM;
Marsh, SGE;
Mayor, NP;
(2025)
An In-Depth Review of the Genetics of the Non-Classical HLA Class I Gene HLA-E and Its Effects on Haematopoietic Cell Transplant Outcomes.
HLA
, 106
(2)
, Article e70344. 10.1111/tan.70344.
|
|
|
Lukina, E;
Balwani, M;
Belmatoug, N;
Watman, N;
Hughes, D;
Gaemers, SJM;
Foster, MC;
... Peterschmitt, MJ; + view all
(2021)
Pregnancy outcome in women with Gaucher disease type 1 who had unplanned pregnancies during eliglustat clinical trials.
JIMD Reports
, 57
(1)
pp. 76-84.
10.1002/jmd2.12172.
|
|
|
Lum, SH;
James, B;
Ottaviano, G;
Ewins, AM;
Patrick, K;
Ali, S;
Carpenter, B;
... Wynn, R; + view all
(2023)
Alemtuzumab, Dual Graft-versus-Host Disease Prophylaxis, and Lower CD3+ T Cell Doses Equalize Rates of Acute and Chronic Graft-versus-Host Disease in Pediatric Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation with Matched Unrelated Donor Peripheral Blood Stem Cells or Bone Marrow Grafts.
Transplantation and Cellular Therapy
10.1016/j.jtct.2023.12.005.
(In press).
|
|
Lyndon, D;
Davagnanam, I;
Wilson, D;
Jichi, F;
Merwick, A;
Bolsover, F;
Jager, HR;
... Werring, DJ; + view all
(2021)
MRI-visible perivascular spaces as an imaging biomarker in Fabry disease.
Journal of Neurology
, 268
pp. 872-878.
10.1007/s00415-020-10209-7.
|
M
|
M F Silva, J;
Ladomenou, F;
Carpenter, B;
Chandra, S;
Sedlacek, P;
Formankova, R;
Grandage, V;
... Veys, P; + view all
(2018)
Allogeneic hematopoietic stem cell transplantation for severe, refractory juvenile idiopathic arthritis.
Blood Adv
, 2
(7)
pp. 777-786.
10.1182/bloodadvances.2017014449.
|
|
Mac Lochlainn, DJ;
McKechnie, DGJ;
Mehta, AB;
Hughes, DA;
(2018)
The utility of the FIPI score in predicting long-term clinical outcomes in patients with Fabry disease receiving enzyme replacement therapy with agalsidase alfa.
Molecular Genetics and Metabolism
, 123
(2)
pp. 154-158.
10.1016/j.ymgme.2017.10.001.
|
|
Maccari, G;
Robinson, J;
Ballingall, K;
Guethlein, LA;
Grimholt, U;
Kaufman, J;
Ho, CS;
... Marsh, SG; + view all
(2017)
IPD-MHC 2.0: an improved inter-species database for the study of the major histocompatibility complex.
Nucleic Acids Research
, 45
(D1)
D860-D864.
10.1093/nar/gkw1050.
|
|
Macias, Rocio IR;
Cardinale, Vincenzo;
Kendall, Timothy J;
Avila, Matias A;
Guido, Maria;
Coulouarn, Cedric;
Braconi, Chiara;
... Carpino, Guido; + view all
(2022)
Clinical relevance of biomarkers in cholangiocarcinoma: critical revision and future directions.
Gut
10.1136/gutjnl-2022-327099.
(In press).
|
|
Maciocia, N;
Spencer, D;
Maciocia, P;
Childerhouse, A;
O’Reilly, M;
Payne, E;
Roddie, C;
(2024)
Late onset pancytopenia post chimeric antigen receptor T cell therapy triggered by a COVID-19 vaccination: a case report.
Frontiers in Hematology
, 3
10.3389/frhem.2024.1435584.
(In press).
|
|
|
Maciocia, Nicola;
Hoekx, Malika;
Acuna, Ciaran;
Wade, Brandon;
Burley, Amy;
Ramanayake, Saumya;
Nannini, Francesco;
... Maciocia, Paul; + view all
(2025)
Preclinical development of anti-CD21 chimeric antigen receptor T cells to treat T cell acute lymphoblastic leukemia.
Science Translational Medicine
, 17
(794)
, Article eadr1476. 10.1126/scitranslmed.adr1476.
|
|
Maciocia, Nicola;
Wade, Brandon;
Maciocia, Paul;
(2025)
CAR T-cell therapies for T-cell malignancies: does cellular immunotherapy represent the best chance of cure?
Blood Advances
, 9
(4)
pp. 913-923.
10.1182/bloodadvances.2023012263.
|
|
|
Maciocia, Nicola Christina;
(2022)
Anti-CD21 Chimeric Antigen Receptor Therapy for the Treatment of T-cell Acute Lymphoblastic Leukaemia.
Doctoral thesis (Ph.D), UCL (University College London).
|
|
Maciocia, Paul Michael;
Wawrzyniecka, Patrycja A;
Maciocia, Nicola C;
Burley, Amy;
Karpanasamy, Thaneswari;
Devereaux, Sam;
Hoekx, Malika;
... Mansour, Marc R; + view all
(2022)
Anti-CCR9 chimeric antigen receptor T cells for T-cell acute lymphoblastic leukemia.
Blood
, 140
(1)
pp. 25-37.
10.1182/blood.2021013648.
|
|
Maciocia, N;
Melville, A;
Cheesman, S;
Sharpley, F;
Ramasamy, K;
Streetly, M;
Jenner, M;
... Rabin, N; + view all
(2017)
Real-world use of pomalidomide and dexamethasone in double refractory multiple myeloma suggests benefit in renal impairment and adverse genetics: a multi-centre UK experience.
British Journal of Haematology
, 176
(6)
pp. 908-917.
10.1111/bjh.14547.
|
|
|
Maciocia, N;
Wechalekar, A;
Yong, K;
(2016)
Monoclonal gammopathy of undetermined significance and smoldering myeloma (SMM): a practical guide to management.
Hematological Oncology
, 35
(4)
pp. 432-439.
10.1002/hon.2345.
|
|
|
Maciocia, PM;
(2017)
Targeting the T-cell Receptor Beta Constant Region for Investigation and Immunotherapy of T-cell Malignancies.
Doctoral thesis , UCL (University College London).
|
|
Maciocia, PM;
Wawrzyniecka, P;
Philip, B;
Akarca, A;
Marafioti, T;
Pule, MA;
(2016)
Targeting the TCR beta-constant region for specific immunotherapy of T-cell malignancies.
Presented at: Conference on Changing the Face of Modern Medicine - Stem Cells and Gene Therapy, Florence, ITALY.
|
|
|
Maciocia, PM;
Wawrzyniecka, PA;
Akarca, AU;
Philip, B;
Ricciardelli, I;
Somja, J;
Onuoha, SC;
... Pule, MA; + view all
(2017)
Targeting T-cell receptor β-constant region for immunotherapy of T-cell malignancies.
Nature Medicine
, 23
(12)
pp. 1416-1423.
10.1038/nm.4444.
|
|
Mackie, I;
Mancini, I;
Muia, J;
Kremer Hovinga, J;
Nair, S;
Machin, S;
Baker, R;
(2020)
International Council for Standardization in Haematology (ICSH) recommendations for laboratory measurement of ADAMTS13.
International Journal of Laboratory Hematology
, 42
(6)
pp. 685-696.
10.1111/ijlh.13295.
|
|
|
Mahdi, J;
Dietrich, J;
Straathof, K;
Roddie, C;
Scott, BJ;
Davidson, TB;
Prolo, LM;
... Monje, M; + view all
(2023)
Tumor inflammation-associated neurotoxicity.
Nature Medicine
, 29
(4)
pp. 803-810.
10.1038/s41591-023-02276-w.
|
|
Mahmood, Umair;
Muhamad Faizul, Elisya;
Howlett, Sarah;
Amin, Zahir;
Hochhauser, Daniel;
Shiu, Kai-Keen;
Bridgewater, John;
(2024)
Comprehensive Examination of Cholangiocarcinoma Patients Treated with Novel Targeted Therapies after Extended Molecular Profiling on Liquid Biopsies.
Cancers
, 16
(4)
, Article 697. 10.3390/cancers16040697.
|
|
Mainwaring, P.N.;
Cunningham, D.;
Gregory, W.;
Hoskin, P.;
Hancock, B.;
Norton, A.J.;
MacLennan, K.;
... Linch, D.; + view all
(2001)
Mitoxantrone is superior to doxorubicin in a multiagent weekly regimen for patients older than 60 with high-grade lymphoma: results of a BNLI randomized trial of PAdriaCEBO versus PMitCEBO.
Blood
, 97
(10)
pp. 2991-2997.
10.1182/blood.V97.10.2991.
|
|
|
Majumder, B;
(2012)
An investigation into the role of platelet- monocyte interaction and inflammation in coronary artery disease.
Doctoral thesis , UCL (University College London).
|
|
|
Majumder, B;
Koganti, S;
Lowdell, MW;
Rakhit, RD;
(2016)
Intracoronary platelet and monocyte activation status within platelet-monocyte complexes are determinants of inflammation in ST elevation myocardial infarction1.
Clinical Hemorheology and Microcirculation
, 64
(1)
pp. 35-46.
10.3233/CH-162040.
|
|
|
Makker, Shania;
Galley, Charlotte;
Bennett, Clare L;
(2024)
Cancer vaccines: from an immunology perspective.
Immunotherapy Advances
, 4
(1)
, Article ltad030. 10.1093/immadv/ltad030.
|
|
Malhotra, K;
Butler, JS;
Yu, HM;
Selvadurai, S;
D'Sa, S;
Rabin, N;
Kyriakou, C;
... Molloy, S; + view all
(2016)
Spinal disease in myeloma: cohort analysis at a specialist spinal surgery centre indicates benefit of early surgical augmentation or bracing.
BMC Cancer
, 16
, Article 444. 10.1186/s12885-016-2495-7.
|
|
|
Mansour, MR;
He, S;
Li, Z;
Lobbardi, R;
Abraham, BJ;
Hug, C;
Rahman, S;
... Look, TA; + view all
(2018)
JDP2: An oncogenic bZIP transcription factor in T cell acute lymphoblastic leukemia.
Journal of Experimental Medicine
, 215
(7)
, Article 1929. 10.1084/jem.20170484.
|
|
Manwani, R;
Hegenbart, U;
Mahmood, S;
Sachchithanantham, S;
Kyriakou, C;
Yong, K;
Popat, R;
... Wechalekar, A; + view all
(2018)
Deferred autologous stem cell transplantation in systemic AL amyloidosis.
Blood Cancer Journal
, 8
, Article 101. 10.1038/s41408-018-0137-9.
|
|
|
Manwani, R;
Mahmood, S;
Sachchithanantham, S;
Lachmann, HJ;
Gillmore, JD;
Yong, K;
Rabin, N;
... Wechalekar, AD; + view all
(2019)
Carfilzomib is an effective upfront treatment in AL amyloidosis patients with peripheral and autonomic neuropathy.
British Journal of Haematology
, 187
(5)
pp. 638-641.
10.1111/bjh.16122.
|
|
Marin, JJG;
Prete, MG;
Lamarca, A;
Tavolari, S;
Landa-Magdalena, A;
Brandi, G;
Segatto, O;
... Braconi, C; + view all
(2020)
Current and novel therapeutic opportunities for systemic therapy in biliary cancer.
British Journal of Cancer
, 123
pp. 1047-1059.
10.1038/s41416-020-0987-3.
|
|
Marks, David I;
Clifton-Hadley, Laura;
Copland, Mhairi;
Hussain, Jiaull;
Menne, Tobias F;
McMillan, Andrew;
Moorman, Anthony V;
... Fielding, Adele K; + view all
(2022)
In-vivo T-cell depleted reduced-intensity conditioned allogeneic haematopoietic stem-cell transplantation for patients with acute lymphoblastic leukaemia in first remission: results from the prospective, single-arm evaluation of the UKALL14 trial.
Lancet Haematol
, 9
(4)
e276-e288.
10.1016/S2352-3026(22)00036-9.
|
|
Marks, David I;
Kirkwood, Amy A;
Rowntree, Clare J;
Aguiar, Melanie;
Bailey, Katharine E;
Beaton, Brendan;
Cahalin, Paul;
... Fielding, Adele K; + view all
(2022)
Addition of four doses of rituximab to standard induction chemotherapy in adult patients with precursor B-cell acute lymphoblastic leukaemia (UKALL14): a phase 3, multicentre, randomised controlled trial.
Lancet Haematology
, 9
(4)
e262-e275.
10.1016/S2352-3026(22)00038-2.
|
|
Marks, A.J.;
(2005)
Targeting of cytotoxic peptides to haematological malignancies.
Doctoral thesis , University of London.
|
|
|
Marlein, CR;
Zaitseva, L;
Piddock, RE;
Robinson, SD;
Edwards, DR;
Shafat, MS;
Zhou, Z;
... Rushworth, SA; + view all
(2017)
NADPH oxidase-2 derived superoxide drives mitochondrial transfer from bone marrow stromal cells to leukemic blasts.
Blood
, 130
(14)
pp. 1649-1660.
10.1182/blood-2017-03-772939.
|
|
|
Marra, Andrea;
Akarca, Ayse U;
Martino, Giovanni;
Ramsay, Alan;
Ascani, Stefano;
Perriello, Vincenzo Maria;
O'Nions, Jenny;
... Marafioti, Teresa; + view all
(2023)
CD47 expression in acute myeloid leukemia varies according to genotype.
Haematologica
, 108
(12)
pp. 3491-3495.
10.3324/haematol.2023.283154.
|
|
Marshall, A;
Kasturiarachchi, J;
Datta, P;
Guo, Y;
Deltcheva, E;
James, C;
Brown, J;
... Nimmo, R; + view all
(2020)
Mir142 loss unlocks IDH2R140-dependent leukemogenesis through antagonistic regulation of HOX genes.
Scientific Reports
, 10
, Article 19390. 10.1038/s41598-020-76218-8.
|
|
Martin, Thomas;
Dimopoulos, Meletios-Athanasios;
Mikhael, Joseph;
Yong, Kwee;
Capra, Marcelo;
Facon, Thierry;
Hajek, Roman;
... Moreau, Philippe; + view all
(2023)
Isatuximab, carfilzomib, and dexamethasone in patients with relapsed multiple myeloma: updated results from IKEMA, a randomized Phase 3 study.
Blood Cancer Journal
, 13
, Article 72. 10.1038/s41408-023-00797-8.
|
|
|
Martinelli, G;
Boissel, N;
Chevallier, P;
Ottmann, O;
Goekbuget, N;
Topp, MS;
Fielding, AK;
... Stein, A; + view all
(2017)
Complete Hematologic and Molecular Response in Adult Patients With Relapsed/Refractory Philadelphia Chromosome-Positive B-Precursor Acute Lymphoblastic Leukemia Following Treatment With Blinatumomab: Results From a Phase II, Single-Arm, Multicenter Study.
Journal of Clinical Oncology
, 35
(16)
pp. 1795-1802.
10.1200/JCO.2016.69.3531.
|
|
Martinez, C;
Gayoso, J;
Canals, C;
Finel, H;
Peggs, K;
Dominietto, A;
Castagna, L;
... Sureda, A; + view all
(2017)
Post-Transplantation Cyclophosphamide-Based Haploidentical Transplantation as Alternative to Matched Sibling or Unrelated Donor Transplantation for Hodgkin Lymphoma: A Registry Study of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation.
Journal of Clinical Oncology
, 35
(30)
pp. 3425-3432.
10.1200/JCO.2017.72.6869.
|
|
Marzolini, Maria AV;
Kayani, Irfan;
Carpenter, Ben;
Laurence, Arian;
McLornan, Donal;
Raj, Kavita;
O'Reilly, Maeve;
... Peggs, Karl S; + view all
(2024)
The Effect of the Pre-Transplant Disease Status on the Outcome for Recipients of T-Cell Depleted Allogeneic Haematopoietic Stem Cell Transplants for Large B Cell Lymphomas.
European Journal of Haematology
10.1111/ejh.14361.
|
|
Marzolini, Maria AV;
Neill, Lorna;
O'Reilly, Maeve;
Peggs, Karl S;
Roddie, Claire;
(2022)
Lymphocyte morphology in a patient receiving CD19 chimeric antigen receptor T-cell therapy for mantle cell lymphoma.
eJHaem
, 3
(1)
pp. 245-246.
10.1002/jha2.334.
|
|
Marzolini, MAV;
Wilson, AJ;
Sanchez, E;
Carpenter, B;
Chakraverty, R;
Hough, R;
Kottaridis, P;
... Peggs, KS; + view all
(2021)
Natural History of Epstein-Barr Virus Replication and Viral Load Dynamics after Alemtuzumab-Based Allogeneic Stem Cell Transplantation.
Transplantation and Cellular Therapy
, 27
(8)
682.e1-682.e12.
10.1016/j.jtct.2021.04.020.
|
|
Marzolini, Maria Ann Veronica;
(2019)
The characterisation and manipulation of a novel subset of tumour-reactive CD4+ cytotoxic T lymphocytes in human cancer.
Doctoral thesis (Ph.D), UCL (University College London).
|
|
Marzolini, MAV;
Akarca, A;
Teng, K;
Marafioti, T;
Gohil, S;
Nathwani, A;
Newell, E;
... Peggs, K; + view all
(2018)
Cytotoxic CD4+ Cells in Chronic Lymphocytic Leukaemia: An Extended Immunophenotypic Analysis Examining Their Association with Cytomegalovirus Serostatus and Similarities with Cytotoxic CD8+ Cells.
Blood
, 132
(suppl 1)
p. 3130.
10.1182/blood-2018-99-116798.
|
|
Marzolini, MAV;
Jaunmuktane, Z;
Roddie, C;
O'Reilly, M;
Chiodini, P;
Peggs, KS;
(2019)
Toxoplasmosis initially presenting as neurological sequelae of chimeric antigen receptor T-cell therapy.
The Lancet Infectious Diseases
, 19
(7)
p. 788.
10.1016/S1473-3099(19)30119-7.
|
|
|
Matalonga, J;
Glaria, E;
Bresque, M;
Escande, C;
Carbó, JM;
Kiefer, K;
Vicente, R;
... Valledor, AF; + view all
(2017)
The Nuclear Receptor LXR Limits Bacterial Infection of Host Macrophages through a Mechanism that Impacts Cellular NAD Metabolism.
Cell Reports
, 18
(5)
pp. 1241-1255.
10.1016/j.celrep.2017.01.007.
|
|
|
Mateos, M-V;
Ludwig, H;
Bazarbachi, A;
Beksac, M;
Bladé, J;
Boccadoro, M;
Cavo, M;
... Sonneveld, P; + view all
(2019)
Insights on Multiple Myeloma Treatment Strategies.
HemaSphere
, 3
(1)
, Article e163. 10.1097/HS9.0000000000000163.
|
|
|
Mathew, NR;
Baumgartner, F;
Braun, L;
O'Sullivan, D;
Thomas, S;
Waterhouse, M;
Mueller, TA;
... Zeiser, R; + view all
(2018)
Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells.
Nature Medicine
, 24
(3)
pp. 282-291.
10.1038/nm.4484.
|
|
Mattar, CNZ;
Gil-Farina, I;
Rosales, C;
Johana, N;
Tan, YYW;
McIntosh, J;
Kaeppel, C;
... Chan, JKY; + view all
(2017)
In Utero Transfer of Adeno-Associated Viral Vectors Produces Long-Term Factor IX Levels in a Cynomolgus Macaque Model.
Molecular Therapy
, 25
(8)
pp. 1843-1853.
10.1016/j.ymthe.2017.04.003.
|
|
|
Maughan, EF;
Hynds, RE;
Proctor, TJ;
Janes, SM;
Elliott, M;
Birchall, MA;
Lowdell, MW;
(2017)
Autologous Cell Seeding in Tracheal Tissue Engineering.
Current Stem Cell Reports
, 3
(4)
pp. 279-289.
10.1007/s40778-017-0108-2.
|
|
|
Mavroudis, CA;
Eleftheriou, D;
Hong, Y;
Majumder, B;
Koganti, S;
Sapsford, R;
North, J;
... Rakhit, RD; + view all
(2017)
Microparticles in acute coronary syndrome.
Thrombosis Research
, 156
pp. 109-116.
10.1016/j.thromres.2017.06.003.
|
|
Maybury, B;
Cook, G;
Pratt, G;
Yong, K;
Ramasamy, K;
(2016)
Augmenting Autologous Stem Cell Transplantation to Improve Outcomes in Myeloma.
Biology of Blood and Marrow Transplantation
, 22
(11)
pp. 1926-1937.
10.1016/j.bbmt.2016.06.004.
|
|
|
Mayor, NP;
Hayhurst, JD;
Turner, TR;
Szydlo, RM;
Shaw, BE;
Bultitude, WP;
Sayno, J-R;
... Marsh, SGE; + view all
(2019)
Recipients Receiving Better HLA-Matched Hematopoietic Cell Transplantation Grafts, Uncovered by a Novel HLA Typing Method, Have Superior Survival: A Retrospective Study.
Biology of Blood and Marrow Transplantation
, 25
(3)
pp. 443-450.
10.1016/j.bbmt.2018.12.768.
|
|
|
Mayor, NP;
Wang, T;
Lee, SJ;
Kuxhausen, M;
Vierra-Green, C;
Barker, DJ;
Auletta, J;
... Marsh, SGE; + view all
(2021)
Impact of Previously Unrecognized HLA Mismatches Using Ultrahigh Resolution Typing in Unrelated Donor Hematopoietic Cell Transplantation.
Journal of Clinical Oncology
10.1200/JCO.20.03643.
(In press).
|
|
|
Mc Lernon, S;
Schwarz, G;
Wilson, D;
Ambler, G;
Goodwin, R;
Shakeshaft, C;
Cohen, H;
... CROMIS-2 Collaborators; + view all
(2020)
Association between critical care admission and 6-month functional outcome after spontaneous intracerebral haemorrhage.
Journal of the Neurological Sciences
, 418
, Article 117141. 10.1016/j.jns.2020.117141.
|
|
McCourt, Orla;
Cairns, David Allan;
Moore, Sally;
Parrish, Christopher;
Pawlyn, Charlotte;
Seymour, Frances;
Ethan, R Senior;
... Cook, Gordon; + view all
(2023)
Health-Related Quality of Life (HRQoL) in Fit, Unfit and Frail Patients Enrolled in Fitness (UK-MRA Myeloma XIV): A Cross Sectional Study.
Presented at: 65th Annual Meeting of the American-Society-of-Hematology (ASH), CA, San Diego.
|
|
|
McCourt, Orla;
Fisher, Abigail;
Land, Joanne;
Ramdharry, Gita;
Roberts, Anna L;
Bekris, Georgios;
Yong, Kwee;
(2023)
"What I wanted to do was build myself back up and prepare": qualitative findings from the PERCEPT trial of prehabilitation during autologous stem cell transplantation in myeloma.
BMC Cancer
, 23
(1)
, Article 348. 10.1186/s12885-023-10799-1.
|
|
McCourt, Orla;
Fisher, Abigail;
Land, Joanne;
Ramdharry, Gita;
Yong, Kwee;
(2023)
The views and experiences of people with myeloma referred for autologous stem cell transplantation, who declined to participate in a physiotherapist-led exercise trial: a qualitative study.
Physiotherapy Theory and Practice
pp. 1-13.
10.1080/09593985.2023.2244068.
(In press).
|
|
McCourt, Orla;
Fisher, Abigail;
Ramdharry, Gita;
Land, Joanne;
Roberts, Anna L;
Rabin, Neil;
Yong, Kwee;
(2023)
Exercise prehabilitation for people with myeloma undergoing autologous stem cell transplantation: results from PERCEPT pilot randomised controlled trial.
Acta Oncologica
, 62
(7)
pp. 696-705.
10.1080/0284186X.2023.2178326.
|
|
McCourt, O;
Fisher, A;
Ramdharry, G;
Roberts, AL;
Land, J;
Rabin, N;
Yong, K;
(2020)
PERCEPT myeloma: a protocol for a pilot randomised controlled trial of exercise prehabilitation before and during autologous stem cell transplantation in patients with multiple myeloma.
BMJ Open
, 10
(1)
, Article e033176. 10.1136/bmjopen-2019-033176.
|
|
|
McCourt, O;
Heinrich, M;
Fisher, A;
Paton, B;
Beeken, R;
Hackshaw, A;
Rismani, A;
... Yong, K; + view all
(2016)
Use of an 'adapted Zelen' design in a randomised controlled trial of a physiotherapist-led exercise intervention in patients with myeloma.
Presented at: th European Congress of the European Region of the World Confederation of Physical Therapy (ER-WCPT), Liverpool, UK.
|
|
McCourt, O;
Yong, K;
Ramdharry, G;
Fisher, A;
(2021)
Physical Activity During and After Haematological Cancer Treatment: A Cross-Sectional Survey of Haematology Healthcare Professionals in the United Kingdom.
Journal of Multidisciplinary Healthcare
, 14
pp. 1659-1671.
10.2147/JMDH.S295888.
|
|
|
McCulloch, R;
Lewis, D;
Crosbie, N;
Eyre, TA;
Bolam, S;
Arasaretnam, A;
Creasey, T;
... Rule, S; + view all
(2021)
Ibrutinib for mantle cell lymphoma at first relapse: a United Kingdom real-world analysis of outcomes in 211 patients.
British Journal of Haematology
10.1111/bjh.17363.
|
|
|
McDonnell, T;
Wincup, C;
Buchholz, I;
Pericleous, C;
Giles, I;
Ripoll, V;
Cohen, H;
... Rahman, A; + view all
(2019)
The role of beta-2-glycoprotein I in health and disease associating structure with function: More than just APS.
Blood Reviews
, Article 100610. 10.1016/j.blre.2019.100610.
|
|
|
McGranahan, N;
Rosenthal, R;
Hiley, CT;
Rowan, AJ;
Watkins, TBK;
Wilson, GA;
Birkbak, NJ;
... Swanton, C; + view all
(2017)
Allele-Specific HLA Loss and Immune Escape in Lung Cancer Evolution.
Cell
10.1016/j.cell.2017.10.001.
(In press).
|
|
|
McGuckin, S;
Westwood, JP;
Webster, H;
Collier, D;
Leverett, D;
Scully, M;
(2014)
Characterization of the complications associated with plasma exchange for thrombotic thrombocytopaenic purpura and related thrombotic microangiopathic anaemias: a single institution experience.
Vox Sang
, 106
(2)
161 - 166.
10.1111/vox.12090.
|
|
|
McIlroy, G;
Lax, S;
Gaskell, C;
Jackson, A;
Rhodes, M;
Seale, T;
Fox, S;
... Bishton, M; + view all
(2024)
Investigator choice of standard therapy versus sequential novel therapy arms in the treatment of relapsed follicular lymphoma (REFRACT): study protocol for a multi-centre, open-label, randomised, phase II platform trial.
BMC Cancer
, 24
(1)
, Article 370. 10.1186/s12885-024-12112-0.
|
|
McIntosh, J.H.;
(2005)
Investigations of the thrombin generation test for the measurement of factor VIII.
Doctoral thesis , University of London.
|
|
|
McKenzie, Callum;
El-Kholy, Mohamed;
Parekh, Farhaan;
Robson, Mathew;
Lamb, Katarina;
Allen, Christopher;
Sillibourne, James;
... Pule, Martin; + view all
(2023)
Novel Fas-TNFR chimeras that prevent Fas ligand-mediated kill and signal synergistically to enhance CAR T cell efficacy.
Molecular Therapy - Nucleic Acids
, 32
pp. 603-621.
10.1016/j.omtn.2023.04.017.
|
|
|
McMillan, AK;
Phillips, EH;
Kirkwood, AA;
Barrans, S;
Burton, C;
Rule, S;
Patmore, R;
... Linch, DC; + view all
(2020)
Favourable outcomes for high-risk diffuse large B-cell lymphoma (IPI 3–5) treated with front-line R-CODOX-M/R-IVAC chemotherapy: results of a phase 2 UK NCRI trial.
Annals of Oncology
10.1016/j.annonc.2020.05.016.
(In press).
|
|
|
McNamara, Mairéad G;
Bridgewater, John;
Goyal, Lipika;
Jacobs, Timothy;
Wagner, Anna D;
Goldstein, David;
Shroff, Rachna;
... Valle, Juan; + view all
(2022)
What is the gender representation in authorship in later phase systemic clinical trials in biliary tract cancer (BTC)? - a retrospective review of the published literature.
BMJ Open
, 12
(10)
, Article e064954. 10.1136/bmjopen-2022-064954.
|
|
McNamara, MG;
Bridgewater, J;
Palmer, DH;
Faluyi, O;
Wasan, H;
Patel, A;
Ryder, WD;
... Valle, JW; + view all
(2021)
A Phase Ib Study of NUC-1031 in Combination with Cisplatin for the First-Line Treatment of Patients with Advanced Biliary Tract Cancer (ABC-08).
The Oncologist
, 26
(4)
e669-e678.
10.1002/onco.13598.
|
|
McNamara, MG;
Bridgewater, J;
Lopes, A;
Wasan, H;
Malka, D;
Jensen, LH;
Okusaka, T;
... Valle, JW; + view all
(2017)
Systemic therapy in younger and elderly patients with advanced biliary cancer: sub-analysis of ABC-02 and twelve other prospective trials.
BMC Cancer
, 17
, Article 262. 10.1186/s12885-017-3266-9.
|
|
|
McNamara, MG;
Lopes, A;
Wasan, H;
Malka, D;
Goldstein, D;
Shannon, J;
Okusaka, T;
... Valle, JW; + view all
(2020)
Landmark survival analysis and impact of anatomic origin in prospective clinical trials of biliary tract cancer.
Journal of Hepatology
, 73
(5)
pp. 1109-1117.
10.1016/j.jhep.2020.05.014.
|
|
McNeill, A;
Duran, R;
Hughes, DA;
Mehta, A;
Schapira, AH;
(2012)
A clinical and family history study of Parkinson's disease in heterozygous glucocerebrosidase mutation carriers.
[Letter].
Journal of Neurology, Neurosurgery & Psychiatry
, 83
(8)
853 -854.
10.1136/jnnp-2012-302402.
|
|
|
McNeill, A;
Magalhaes, J;
Shen, C;
Chau, KY;
Hughes, D;
Mehta, A;
Foltynie, T;
... Schapira, AH; + view all
(2014)
Ambroxol improves lysosomal biochemistry in glucocerebrosidase mutation-linked Parkinson disease cells.
Brain
, 137
(5)
pp. 1481-1495.
10.1093/brain/awu020.
|
|
|
McNeill, A;
Roberti, G;
Lascaratos, G;
Hughes, D;
Mehta, A;
Garway-Heath, DF;
Schapira, AH;
(2013)
Retinal thinning in Gaucher disease patients and carriers: results of a pilot study.
Molecular Genetics and Metabolism
, 109
(2)
221 - 223.
10.1016/j.ymgme.2013.04.001.
|
|
|
Mead, A.J.;
(2009)
The clinical and biological consequences of different FLT3 mutations in patients with AML.
Doctoral thesis , UCL (University College London).
|
|
|
Megias, D;
Phillips, M;
Clifton-Hadley, L;
Harron, E;
Eaton, DJ;
Sanghera, P;
Whitfield, G;
(2017)
Dose specification for hippocampal sparing whole brain radiotherapy (HS WBRT): considerations from the UK HIPPO trial QA programme.
British Journal Of Radiology
, 90
(1071)
, Article 20160829. 10.1259/bjr.20160829.
|
|
|
Mehra, Vedika;
(2023)
Modulating Akt signalling to enhance CAR T-cell therapy.
Doctoral thesis (Ph.D), UCL (University College London).
|
|
Mehra, Vedika;
Agliardi, Giulia;
Dias Alves Pinto, Juliana;
Shafat, Manar S;
Garai, Amaia Cadinanos;
Green, Louisa;
Hotblack, Alastair;
... Roddie, Claire; + view all
(2023)
AKT inhibition generates potent polyfunctional clinical grade AUTO1 CAR T-cells, enhancing function and survival.
Journal for ImmunoTherapy of Cancer
, 11
(9)
, Article e007002. 10.1136/jitc-2023-007002.
|
|
Mehra, Vedika;
Chhetri, Jyoti Bikram;
Ali, Samira;
Roddie, Claire;
(2023)
The Emerging Role of Induced Pluripotent Stem Cells as Adoptive Cellular Immunotherapeutics.
Biology
, 12
(11)
, Article 1419. 10.3390/biology12111419.
|
|
Mehrban, N;
Bowen, J;
Tait, A;
Darbyshire, A;
Virasami, AK;
Lowdell, MW;
Birchall, MA;
(2018)
Silsesquioxane polymer as a potential scaffold for laryngeal reconstruction.
Materials Science and Engineering C
, 92
pp. 565-574.
10.1016/j.msec.2018.07.003.
|
|
|
Mehta, Dipal;
Gabriel, Maria;
Adu-Poku, Nathan;
Kanellias, Nikolaos;
Papanikolaou, Xenofon;
Sive, Jonathan;
Rabin, Neil;
... Kyriakou, Charalampia; + view all
(2025)
The Role of Radiotherapy for Patients With Multiple Myeloma in the Modern Era: A Real World Single-Centre Experience.
eJHaem
, 6
(5)
, Article e70141. 10.1002/jha2.70141.
|
|
|
Mehta, A;
Belmatoug, N;
Bembi, B;
Deegan, P;
Elstein, D;
Göker-Alpan, Ö;
Lukina, E;
... Hughes, D; + view all
(2017)
Exploring the patient journey to diagnosis of Gaucher disease from the perspective of 212 patients with Gaucher disease and 16 Gaucher expert physicians.
Molecular Genetics and Metabolism
, 122
(3)
pp. 122-129.
10.1016/j.ymgme.2017.08.002.
|
|
|
Mehta, A;
Kuter, DJ;
Salek, SS;
Belmatoug, N;
Bembi, B;
Bright, J;
vom Dahl, S;
... Zimran, A; + view all
(2019)
Presenting signs and patient co-variables in Gaucher disease: outcome of the Gaucher Earlier Diagnosis Consensus (GED-C) Delphi initiative.
Internal Medicine Journal
, 49
(5)
pp. 578-591.
10.1111/imj.14156.
|
|
|
Mehta, A;
Rivero-Arias, O;
Abdelwahab, M;
Campbell, S;
McMillan, A;
Rolfe, MJ;
Bright, JR;
(2020)
Scoring system to facilitate diagnosis of Gaucher disease.
Internal Medicine Journal
, 50
(12)
pp. 1538-1546.
10.1111/imj.14942.
|
|
|
Mekkaoui, L;
Bentley, EM;
Ferrari, M;
Lamb, K;
Ward, K;
Karattil, R;
Akbar, Z;
... Pule, M; + view all
(2021)
Incorrect DOI - please do not claim.
Bio-protocol
, 11
(16)
, Article e4128. 10.21769/BioProtoc.4128.
|
|
Mekkaoui, L;
Bentley, EM;
Ferrari, M;
Lamb, K;
Ward, K;
Karattil, R;
Akbar, Z;
... Pule, M; + view all
(2021)
Optimised Method for the Production and Titration of Lentiviral Vectors Pseudotyped with the SARS-CoV-2 Spike.
Bio Protocol
, 11
(16)
, Article e4194. 10.21769/BioProtoc.4194.
|
|
|
Mekkaoui, Leila;
Tejerizo, Jose G;
Abreu, Sara;
Rubat, Lydie;
Nikoniuk, Aleksandra;
Macmorland, William;
Horlock, Claire;
... Pule, Martin; + view all
(2023)
Efficient clinical-grade γ-retroviral vector purification by high-speed centrifugation for CAR T cell manufacturing.
Molecular Therapy - Methods and Clinical Development
, 28
pp. 116-128.
10.1016/j.omtm.2022.12.006.
|
|
Mekkaoui, L;
Ferrari, M;
Mattiuzzo, G;
Ma, B;
Nannini, F;
Onuoha, S;
Kotsopoulou, E;
... Pule, M; + view all
(2019)
Generation of a neutralizing antibody against RD114-pseudotyped viral vectors.
Journal of General Virology
10.1099/jgv.0.001309.
(In press).
|
|
|
Mekkaoui, L;
Parekh, F;
Kotsopoulou, E;
Darling, D;
Dickson, G;
Cheung, G;
Chan, L;
... Pule, M; + view all
(2018)
Lentiviral Vector Purification Using Genetically Encoded Biotin Mimic in Packaging Cell.
Molecular Therapy: Methods and Clinical Development
, 11
pp. 155-165.
10.1016/j.omtm.2018.10.008.
|
|
|
Mekkaoui, Leila;
(2018)
Lentiviral vector purification using genetically encoded biotin mimic in packaging cell.
Doctoral thesis (Ph.D), UCL (University College London).
|
|
Melotti, Dario;
Asher, Samir;
Troy-Barnes, Ethan;
Nesr, George;
Wilson, William;
Camilleri, Marquita;
Popat, Rakesh;
... Kyriakou, Chara; + view all
(2024)
Outcomes of melphalan 140 mg/m2 followed by autologous stem cell transplantation in multiple myeloma patients with co-morbidities: Single-centre experience.
eJHaem
, 5
(5)
10.1002/jha2.977.
|
|
|
Menares, E;
Gálvez-Cancino, F;
Cáceres-Morgado, P;
Ghorani, E;
López, E;
Díaz, X;
Saavedra-Almarza, J;
... Lladser, A; + view all
(2019)
Tissue-resident memory CD8⁺ T cells amplify anti-tumor immunity by triggering antigen spreading through dendritic cells.
Nature Communications
, 10
(1)
, Article 4401. 10.1038/s41467-019-12319-x.
|
|
Mendel, R;
Abdelhameed, N;
Salman, RAS;
Cohen, H;
Dowlatshahi, D;
Freemantle, N;
Paciaroni, M;
... Werring, DJ; + view all
(2023)
Prevention of venous thromboembolism in acute spontaneous intracerebral haemorrhage: A survey of opinion.
Journal of the Neurological Sciences
, 454
, Article 120855. 10.1016/j.jns.2023.120855.
|
|
|
Menezes, S;
Melandri, D;
Anselmi, G;
Perchet, T;
Loschko, J;
Dubrot, J;
Patel, R;
... Guermonprez, P; + view all
(2016)
The Heterogeneity of Ly6C(hi) Monocytes Controls Their Differentiation into iNOS(+) Macrophages or Monocyte-Derived Dendritic Cells.
Immunity
, 45
(6)
pp. 1205-1218.
10.1016/j.immuni.2016.12.001.
|
|
|
Menger, L;
Sledzinska, A;
Bergerhoff, K;
Vargas, FA;
Smith, J;
Poirot, L;
Pule, M;
... Quezada, SA; + view all
(2016)
TALEN-Mediated Inactivation of PD-1 in Tumor-Reactive Lymphocytes Promotes Intratumoral T-cell Persistence and Rejection of Established Tumors.
Cancer Research
, 76
(8)
pp. 2087-2093.
10.1158/0008-5472.CAN-15-3352.
|
|
|
Meric-Bernstam, F;
Bahleda, R;
Hierro, C;
Sanson, M;
Bridgewater, J;
Arkenau, H-T;
Tran, B;
... Goyal, L; + view all
(2021)
Futibatinib, an irreversible FGFR1-4 inhibitor, in patients with advanced solid tumors harboring FGF/FGFR aberrations: a phase I dose-expansion study.
Cancer Discovery
10.1158/2159-8290.CD-21-0697.
(In press).
|
|
|
Mesa, Ruben;
Harrison, Claire;
Oh, Stephen T;
Gerds, Aaron T;
Gupta, Vikas;
Catalano, John;
Cervantes, Francisco;
... Verstovsek, Srdan; + view all
(2022)
Overall survival in the SIMPLIFY-1 and SIMPLIFY-2 phase 3 trials of momelotinib in patients with myelofibrosis.
Leukemia
, 36
pp. 2261-2268.
10.1038/s41375-022-01637-7.
|
|
|
Michelozzi, Ilaria M;
Gomez-Castaneda, Eduardo;
Pohle, Ruben VC;
Cardoso Rodriguez, Ferran;
Sufi, Jahangir;
Puigdevall-Costa, Pau;
Subramaniyam, Meera;
... Giustacchini, Alice; + view all
(2022)
Activation priming and cytokine polyfunctionality modulate the enhanced functionality of low-affinity CD19 CAR T cells.
Blood Advances
10.1182/bloodadvances.2022008490.
(In press).
|
|
Miesbach, Wolfgang;
Batty, Paul;
Chowdary, Pratima;
Fong, Sylvia;
Kaczmarek, Radoslaw;
Leebeek, Frank WG;
Long, Brian;
... Peyvandi, Flora; + view all
(2025)
Adeno-associated virus-based gene therapy for hemophilia- addressing the gaps.
Research and Practice in Thrombosis and Haemostasis
, 9
(1)
, Article e102673. 10.1016/j.rpth.2024.102673.
|
|
|
Mikhaeel, NG;
Cunningham, D;
Counsell, N;
McMillan, A;
Radford, JA;
Ardeshna, KM;
Lawrie, A;
... Barrington, SF; + view all
(2021)
FDG‐PET/CT after two cycles of R‐CHOP in DLBCL predicts complete remission but has limited value in identifying patients with poor outcome – final result of a UK National Cancer Research Institute prospective study.
British Journal of Haematology
, 192
(3)
pp. 504-513.
10.1111/bjh.16875.
|
|
Miles, A;
Evans, RE;
Halligan, S;
Beare, S;
Bridgewater, J;
Goh, V;
Janes, SM;
... STREAMLINE investigators; + view all
(2020)
Predictors of patient preference for either whole body magnetic resonance imaging (WB-MRI) or CT/ PET-CT for staging colorectal or lung cancer.
Journal of Medical Imaging and Radiation Oncology
10.1111/1754-9485.13038.
(In press).
|
|
|
Miles, A;
Taylor, SA;
Evans, REC;
Halligan, S;
Beare, S;
Bridgewater, J;
Goh, V;
... Yu, D; + view all
(2019)
Patient preferences for whole-body MRI or conventional staging pathways in lung and colorectal cancer: a discrete choice experiment.
European Radiology
, 29
(7)
pp. 3889-3900.
10.1007/s00330-019-06153-4.
|
|
|
Milius, RP;
Mack, SJ;
Hollenbach, JA;
Pollack, J;
Heuer, ML;
Gragert, L;
Spellman, S;
... Maiers, M; + view all
(2013)
Genotype List String: a grammar for describing HLA and KIR genotyping results in a text string.
Tissue Antigens
, 82
(2)
pp. 106-112.
10.1111/tan.12150.
|
|
|
Miller, PDE;
de Silva, T;
Skinner, R;
Gilleece, M;
Peniket, A;
Hamblin, A;
Greenfield, D;
... Snowden, JA; + view all
(2017)
Routine vaccination practice after adult and paediatric allogeneic haematopoietic stem cell transplant: a survey of UK NHS programmes.
Bone Marrow Transplantation
, 52
pp. 775-777.
10.1038/bmt.2016.362.
|
|
|
Miller, PDE;
Forster, AS;
de Silva, TI;
Leonard, H;
Anthias, C;
Mayhew, M;
Klammer, M;
... A Snowden, J; + view all
(2018)
Sociodemographic and psychological determinants of influenza vaccine intention among recipients of autologous and allogeneic haematopoietic stem cell transplant: a cross-sectional survey of UK transplant recipients using a modified health belief model.
BMJ Open
, 8
(8)
, Article e021222. 10.1136/bmjopen-2017-021222.
|
|
|
Mishra, Avijeet Kumar;
Burridge, Saskia;
Espuelas, Macarena Oporto;
O'Reilly, Maeve;
Cummins, Michelle;
Nicholson, Emma;
Wheldon, Sophie;
... Ghorashian, Sara; + view all
(2024)
Practice guideline: Preparation for CAR T-cell therapy in children and young adults with B-acute lymphoblastic leukaemia.
British Journal of Haematology
10.1111/bjh.19381.
(In press).
|
|
Mitchell, RJ;
Kirkwood, AA;
Barretta, E;
Clifton-Hadley, L;
Lawrie, E;
Lee, S;
Leongamornlert, D;
... Fielding, AK; + view all
(2021)
IKZF1 alterations are not associated with outcome in 498 adults with B-precursor ALL enrolled in the UKALL14 trial.
Blood Advances
, 5
(17)
pp. 3322-3332.
10.1182/bloodadvances.2021004430.
|
|
|
Mittal, Prabal;
Gafoor, Rafael;
Sayar, Zara;
Efthymiou, Maria;
Tohidi-Esfahani, Ibrahim;
Appiah-Cubi, Stella;
Arachchillage, Deepa J;
... Cohen, Hannah; + view all
(2024)
Rivaroxaban for stroke patients with antiphospholipid syndrome (RISAPS): protocol for a randomized controlled, phase IIb proof-of-principle trial.
Research and Practice in Thrombosis and Haemostasis
, 8
(5)
, Article e102468. 10.1016/j.rpth.2024.102468.
|
|
|
Mlcochova, P;
Sutherland, KA;
Watters, SA;
Bertoli, C;
de Bruin, RAM;
Rehwinkel, J;
Neil, SJ;
... Gupta, RK; + view all
(2017)
A G1-like state allows HIV-1 to bypass SAMHD1 restriction in macrophages.
The EMBO Journal
, 36
(5)
pp. 604-616.
10.15252/embj.201696025.
|
|
|
Mock, U;
Nickolay, L;
Philip, B;
Cheung, GW;
Zhan, H;
Johnston, IC;
Kaiser, AD;
... Qasim, W; + view all
(2016)
Automated manufacturing of chimeric antigen receptor T cells for adoptive immunotherapy using CliniMACS prodigy.
Cytotherapy
, 18
(8)
pp. 1002-1011.
10.1016/j.jcyt.2016.05.009.
|
|
Mohty, M;
Cavo, M;
Fink, L;
Gonzalez-McQuire, S;
Leleu, H;
Mateos, M-V;
Raab, MS;
... Yong, K; + view all
(2019)
Understanding mortality in multiple myeloma: Findings of a European retrospective chart review.
European Journal of Haematology
, 103
(2)
pp. 107-115.
10.1111/ejh.13264.
|
|
|
Molinaro, R;
Sellar, RS;
Vromman, A;
Sausen, G;
Folco, E;
Sukhova, GK;
McConke, ME;
... Libby, P; + view all
(2024)
The clonal hematopoiesis mutation Jak2V617F aggravates endothelial injury and thrombosis in arteries with erosion-like intimas.
International Journal of Cardiology
, 409
, Article 132184. 10.1016/j.ijcard.2024.132184.
|
|
|
Monda, Emanuele;
Bakalakos, Athanasios;
Lachmann, Robin;
Syrris, Petros;
Limongelli, Giuseppe;
Murphy, Elaine;
Hughes, Derralynn;
(2024)
Incidence and risk factors for development of left ventricular hypertrophy in Fabry disease.
Heart
, 110
(12)
pp. 846-853.
10.1136/heartjnl-2023-323783.
|
|
|
Monypenny, J;
Milewicz, H;
Flores-Borja, F;
Weitsman, G;
Cheung, A;
Chowdhury, R;
Burgoyne, T;
... Ng, T; + view all
(2018)
ALIX Regulates Tumor-Mediated Immunosuppression by Controlling EGFR Activity and PD-L1 Presentation.
Cell Reports
, 24
(3)
pp. 630-641.
10.1016/j.celrep.2018.06.066.
|
|
|
Moorman, Anthony;
Butler, Ellie;
Barretta, Emilio;
Kirkwood, Amy A;
Schwab, Claire;
Creasey, Thomas;
Leongamornlert, Daniel A;
... Enshaei, Amir; + view all
(2021)
Prognostic impact of chromosomal abnormalities and copy number alterations in adult B-cell precursor acute lymphoblastic leukaemia: a UKALL14 study.
Leukemia
10.1038/s41375-021-01448-2.
(In press).
|
|
|
Moreau, P;
Kumar, SK;
Miguel, JS;
Davies, F;
Zamagni, E;
Bahlis, N;
Ludwig, H;
... Richardson, PG; + view all
(2021)
Treatment of relapsed and refractory multiple myeloma: recommendations from the International Myeloma Working Group.
The Lancet Oncology
, 22
(3)
E105-E118.
10.1016/S1470-2045(20)30756-7.
|
|
Moreau, P;
Dimopoulos, MA;
Yong, K;
Mikhael, J;
Risse, M-L;
Asset, G;
Martin, T;
(2020)
Isatuximab plus carfilzomib/dexamethasone versus carfilzomib/dexamethasone in patients with relapsed/refractory multiple myeloma: IKEMA Phase III study design.
Future Oncology
, 16
(2)
pp. 4347-4358.
10.2217/fon-2019-0431.
|
|
|
Moreno Martínez, D;
Aguiar, P;
Auray-Blais, C;
Beck, M;
Bichet, D;
Burlina, A;
Cole, D;
... Hughes, D; + view all
(2021)
Standardising clinical outcomes measures for adult clinical trials in Fabry Disease: A global Delphi Consensus.
Molecular Genetics and Metabolism
, 132
(4)
pp. 234-243.
10.1016/j.ymgme.2021.02.001.
|
|
Morgan, Huw J;
Rees, Elise;
Lanfredini, Simone;
Powell, Kate A;
Gore, Jasmine;
Gibbs, Alex;
Lovatt, Charlotte;
... Patel, Girish K; + view all
(2022)
CD200 ectodomain shedding into the tumor microenvironment leads to NK cell dysfunction and apoptosis.
Journal of Clinical Investigation
, 132
(21)
, Article e150750. 10.1172/JCI150750.
|
|
Morris, E.;
Thomson, K.;
Craddock, C.;
Mahendra, P.;
Milligan, D.;
Cook, G.;
Smith, G.M.;
... Mackinnon, S.; + view all
(2004)
Outcomes after alemtuzumab-containing reduced-intensity allogeneic transplantation regimen for relapsed and refractory non-Hodgkin lymphoma.
Blood
, 104
(13)
pp. 3865-3871.
10.1182/blood-2004-03-1105.
|
|
|
Morris, EC;
Fox, T;
Chakraverty, R;
Tendeiro, R;
Snell, K;
Rivat, C;
Grace, S;
... Thrasher, AJ; + view all
(2017)
Gene therapy for Wiskott-Aldrich syndrome in a severely affected adult.
Blood
, 130
pp. 1327-1335.
10.1182/blood-2017-04-777136.
|
|
Morris, EC;
Tendeiro-Rego, R;
Richardson, R;
Fox, TA;
Sillito, F;
Holler, A;
Thomas, S;
... Stauss, H; + view all
(2019)
A Phase I Study Evaluating the Safety and Persistence of Allorestricted WT1-TCR Gene Modified Autologous T Cells in Patients with High-Risk Myeloid Malignancies Unsuitable for Allogeneic Stem Cell Transplantation.
Presented at: 61st ASH Annual Meeting, Orlando, FL, USA.
|
|
Muczynski, Vincent;
Christophe, Olivier D;
Tanner, Lewis;
Vayssiere, Charlotte;
Guérin, Alice;
Casari, Caterina;
McIntosh, Jenny Hazel;
... Nathwani, Amit C; + view all
(2025)
Alternative AAV gene therapy for hemophilia A using expression of Bi8, a novel single-chain FVIII-mimetic antibody.
Blood
, Article blood.2024027709. 10.1182/blood.2024027709.
|
|
Mukherjee, Somnath;
Qi, Cathy;
Shaw, Rachel;
Jones, Christopher M;
Bridgewater, John A;
Radhakrishna, Ganesh;
Patel, Neel;
... Corrie, Pippa; + view all
(2024)
Standard or high dose chemoradiotherapy, with or without the protease inhibitor nelfinavir, in patients with locally advanced pancreatic cancer: The phase 1/randomised phase 2 SCALOP-2 trial.
European Journal of Cancer
, 209
, Article 114236. 10.1016/j.ejca.2024.114236.
|
|
|
Mullanfiroze, K;
Jones, C;
Williams, D;
Vieira, M;
Wechalekar, A;
Papanikolaou, X;
Popat, R;
... Xu, K; + view all
(2024)
Management of multiple myeloma presenting as malignant spinal cord compression during pregnancy: a case report.
Clinical Hematology International
, 6
(4)
pp. 89-92.
10.46989/001c.124664.
|
|
|
Mullin, S;
Hughes, D;
Mehta, A;
Schapira, AHV;
(2019)
Neurological effects of glucocerebrosidase gene mutations.
European Journal of Neurology
, 26
(3)
389-e29.
10.1111/ene.13837.
|
|
Mullin, S;
Beavan, M;
Bestwick, J;
McNeill, A;
Proukakis, C;
Cox, T;
Hughes, D;
... Schapira, AHV; + view all
(2019)
Evolution and clustering of prodromal parkinsonian features in GBA1 carriers.
Movement Disorders
, 34
(9)
pp. 1365-1373.
10.1002/mds.27775.
|
|
|
Mullin, S;
Stokholm, MG;
Hughes, D;
Mehta, A;
Parbo, P;
Hinz, R;
Pavese, N;
... Schapira, AH; + view all
(2020)
Brain Microglial Activation Increased in Glucocerebrosidase (GBA) Mutation Carriers without Parkinson's disease.
Movement Disorders
10.1002/mds.28375.
|
|
|
Mundee, Y.;
(2001)
Red cell adhesion molecules, foetal haemoglobin and endothelial factors in sickle cell disorders.
Doctoral thesis , University of London.
|
|
|
Munis, AM;
Tijani, M;
Hassall, M;
Mattiuzzo, G;
Collins, MK;
Takeuchi, Y;
(2018)
Characterisation of Antibody Interactions with the G Protein of Vesicular Stomatitis Virus Indiana Strain and Other Vesiculovirus G Proteins.
Journal of Virology
10.1128/JVI.00900-18.
|
|
|
Munoz, CM;
Ahmed, K;
Thomas, M;
Cohen, H;
Alijotas-Reig, J;
Giles, I;
(2021)
Comparing pregnancy outcomes in patients with criteria and non-criteria autoimmune disease: A systematic review.
Lupus
10.1177/09612033211061850.
(In press).
|
  |
|
Muñoz-Martínez, S;
Sapena, V;
Forner, A;
Nault, J-C;
Sapisochin, G;
Rimassa, L;
Sangro, B;
... Reig, M; + view all
(2021)
Assessing the impact of COVID-19 on liver cancer management (CERO-19).
JHEP Reports
, Article 100260. 10.1016/j.jhepr.2021.100260.
(In press).
|
|
|
Musallam, KM;
Taher, AT;
Cappellini, MD;
Hermine, O;
Kuo, KHM;
Sheth, S;
Viprakasit, V;
(2022)
Untreated Anemia in Nontransfusion-dependent β-thalassemia: Time to Sound the Alarm.
HemaSphere
, 6
(12)
, Article e806. 10.1097/HS9.0000000000000806.
|
|
Mussert, Caroline MA;
Miesbach, Wolfgang;
Chowdary, Pratima;
Lillicrap, David;
Mahlangu, Johnny;
Peyvandi, Flora;
Pipe, Steven W;
... Leebeek, Frank WG; + view all
(2025)
A comprehensive care pathway of gene therapy for hemophilia based on current guideline documents and Summary of Product Characteristics (SMPCs); Communication from the ISTH SSC Working Group on Gene Therapy.
Journal of Thrombosis and Haemostasis
10.1016/j.jtha.2025.09.041.
(In press).
|
|
N
|
Nacheva, EP;
Grace, CD;
Gancheva, K;
Rai, L;
Brazma, D;
Howard-Reeves, J;
Kottaridis, PD;
... Russell, N; + view all
(2013)
Does BCR/ABL1 positive Acute Myeloid Leukaemia Exist?
British Journal of Haematology
, 161
(4)
541 - 550.
10.1111/bjh.12301.
|
|
|
Nannini, F;
Parekh, F;
Wawrzyniecka, P;
Mekkaoui, L;
Righi, M;
Dastjerdi, FV;
Yeung, J;
... Pule, M; + view all
(2020)
A primer set for the rapid isolation of scFv fragments against cell surface antigens from immunised rats.
Scientific Reports
, 10
, Article 19168. 10.1038/s41598-020-76069-3.
|
|
|
Nannini, F;
Senicar, L;
Parekh, F;
Kong, KJ;
Kinna, A;
Bughda, R;
Sillibourne, J;
... Onuoha, SC; + view all
(2021)
Combining phage display with SMRTbell next-generation sequencing for the rapid discovery of functional scFv fragments.
MAbs
, 13
(1)
, Article 1864084. 10.1080/19420862.2020.1864084.
|
|
|
Nash, Philip S;
Best, Jonathan G;
Ambler, Gareth;
Wilson, Duncan;
Banerjee, Gargi;
Hostettler, Isabel C;
Seiffge, David;
... CROMIS-2 collaborators; + view all
(2023)
Associations of renal function with cerebral small vessel disease and functional outcome in acute intracerebral haemorrhage: A hospital-based prospective cohort study.
Journal of Neurological Sciences
, 452
, Article 120743. 10.1016/j.jns.2023.120743.
|
|
Nash, PS;
Dehbi, HM;
Ahmed, N;
Arram, L;
Best, JG;
Balogun, M;
Bennett, K;
... OPTIMAS Investigators; + view all
(2025)
Anticoagulation Timing in Acute Stroke With Atrial Fibrillation According to Chronic Kidney Disease: The OPTIMAS Trial.
Stroke
, 56
(8)
pp. 1970-1979.
10.1161/STROKEAHA.125.051457.
|
|
|
Nathwani, AC;
Davidoff, AM;
Hanawa, H;
Hu, Y;
Hoffer, FA;
Nikanorov, A;
Slaughter, C;
... Nienhuis, AW; + view all
(2002)
Sustained high-level expression of human factor IX (hFIX) after liver-targeted delivery of recombinant adeno-associated virus encoding the hFIX gene in rhesus macaques.
Blood
, 100
(5)
pp. 1662-1669.
10.1182/blood-2002-02-0589.
|
|
|
Nathwani, AC;
Tuddenham, EGD;
(2020)
Haemophilia, the journey in search of a cure. 1960–2020.
British Journal of Haematology
, 191
(4)
pp. 573-578.
10.1111/bjh.17155.
|
|
Nathwani, Amit C;
McIntosh, Jennifer;
Sheridan, Rose;
(2022)
Liver Gene Therapy.
Human Gene Therapy
, 33
(17-18)
pp. 879-888.
10.1089/hum.2022.169.
|
|
Nathwani, AC;
Davidoff, A;
Hanawa, H;
Zhou, JF;
Vanin, EF;
Nienhuis, AW;
(2001)
Factors influencing in vivo transduction by recombinant adeno-associated viral vectors expressing the human factor IX cDNA.
Blood
, 97
(5)
pp. 1258-1265.
10.1182/blood.v97.5.1258.
|
|
|
Nathwani, AC;
Davidoff, AM;
Tuddenham, EGD;
(2017)
Gene Therapy for Hemophilia.
Hematology/Oncology Clinics of North America
, 31
(5)
pp. 853-868.
10.1016/j.hoc.2017.06.011.
|
|
Nathwani, AC;
Davidoff, AM;
Tuddenham, EGD;
(2017)
Advances in Gene Therapy for Haemophilia.
Hum Gene Ther
10.1089/hum.2017.167.
|
|
Nathwani, AC;
Down, JF;
Goldstone, J;
Yassin, J;
Dargan, PI;
Virchis, A;
Gent, N;
... Harrison, JD; + view all
(2016)
Polonium-210 poisoning: a first-hand account.
The Lancet
, 388
(10049)
pp. 1075-1080.
10.1016/S0140-6736(16)00144-6.
|
|
|
Navarrete Sanchez, Mariela Ivonne;
(2025)
Deciphering the role of the lung tumour microenvironment in the activity of regulatory T cell-depleting antibodies.
Doctoral thesis (Ph.D), UCL (University College London).
|
|
Nesr, George;
Shah, Raakhee;
Kyriakou, Charalampia;
Sive, Jonathan;
Popat, Rakesh;
Yong, Kwee;
Wisniowski, Brendan;
... Rabin, Neil; + view all
(2023)
Impact of timing of stem cell return following high dose melphalan in multiple myeloma patients with renal impairment: a single center experience.
Leukemia & Lymphoma
10.1080/10428194.2023.2216817.
(In press).
|
|
|
Ngwenya, N;
Kenten, C;
Jones, L;
Gibson, F;
Pearce, S;
Flatley, M;
Hough, R;
... Whelan, J; + view all
(2017)
Experiences and Preferences for End-of-Life Care for Young Adults with Cancer and Their Informal Carers: A Narrative Synthesis.
Journal of Adolescent and Young Adult Oncology
, 6
(2)
pp. 200-212.
10.1089/jayao.2016.0055.
|
|
|
Niederwieser, Christian;
Iacobelli, Simona;
Franke, Georg-Nikolaus;
Koster, Linda;
van Os, Marleen;
Platzbecker, Uwe;
Hübel, Kai;
... Kröger, Nicolaus; + view all
(2024)
Reduced intensity versus myeloablative conditioning for MDS: long-term results of an EBMT phase III study (RICMAC).
Bone Marrow Transplantation
, 59
pp. 1084-1091.
10.1038/s41409-024-02282-7.
|
|
|
Nienhuis, AW;
Nathwani, AC;
Davidoff, AM;
(2017)
Gene Therapy for Hemophilia.
[Review].
Molecular Therapy
, 25
(5)
pp. 1163-1167.
10.1016/j.ymthe.2017.03.033.
|
|
|
Nooijen, Lynn E;
van der Snee, Lizzel;
Ten Haaft, Britte;
Kazemier, Geert;
Klümpen, Heinz-Josef;
Bridgewater, John;
Primrose, John;
(2023)
A critical appraisal of the potential benefit of post-operative structured follow-up after resection for biliary tract cancer.
HPB
10.1016/j.hpb.2023.10.004.
(In press).
|
|
|
Nordin, S;
Kozor, R;
Baig, S;
Abdel-Gadir, A;
Medina-Menacho, K;
Rosmini, S;
Captur, G;
... Moon, JC; + view all
(2018)
Cardiac Phenotype of Prehypertrophic Fabry Disease.
Circulation: Cardiovascular Imaging
, 11
(6)
, Article e007168. 10.1161/CIRCIMAGING.117.007168.
|
|
|
Nordin, S;
Kozor, R;
Bulluck, H;
Castelletti, S;
Rosmini, S;
Abdel-Gadir, A;
Baig, S;
... Moon, JC; + view all
(2016)
Cardiac Fabry Disease With Late Gadolinium Enhancement Is a Chronic Inflammatory Cardiomyopathy.
[Letter].
Journal of the American College of Cardiology
, 68
(15)
pp. 1707-1708.
10.1016/j.jacc.2016.07.741.
|
|
|
Nordin, S;
Kozor, R;
Medina-Menacho, K;
Abdel-Gadir, A;
Baig, S;
Sado, DM;
Lobascio, I;
... Moon, JC; + view all
(2019)
Proposed Stages of Myocardial Phenotype Development in Fabry Disease.
JACC Cardiovasc Imaging
, 12
(8)
pp. 1673-1683.
10.1016/j.jcmg.2018.03.020.
|
|
Nordin, S;
Kozor, R;
Vijapurapu, R;
Augusto, JB;
Knott, KD;
Captur, G;
Treibel, TA;
... Moon, JC; + view all
(2019)
Myocardial Storage, Inflammation, and Cardiac Phenotype in Fabry Disease After One Year of Enzyme Replacement Therapy.
Circulation: Cardiovascular Imaging
, 12
(12)
, Article e009430. 10.1161/CIRCIMAGING.119.009430.
|
|
|
Northend, M;
Wilson, W;
Osborne, W;
Fox, CP;
Davies, AJ;
El-Sharkawi, D;
Phillips, EH;
... Townsend, WM; + view all
(2022)
Results of a United Kingdom real-world study of polatuzumab vedotin, bendamustine, and rituximab for relapsed/refractory DLBCL.
Blood Advances
, 6
(9)
pp. 2920-2926.
10.1182/bloodadvances.2021005953.
|
|
Notaridou, M;
(2013)
Functional analysis of low-moderate risk susceptibility genes emerging from pathway based approaches and genome wide association studies in epithelial ovarian cancer.
Doctoral thesis , UCL (University College London).
|
|
|
Nuttall Musson, Ellen;
(2026)
Analysis of the association of lipid-lowering therapy on clonal dynamics in clonal haematopoiesis of indeterminate potential: insights from the English Longitudinal Study of Ageing.
Leukemia
10.1038/s41375-025-02822-0.
(In press).
|
|
Nuttall Musson, Ellen;
Miller, Rowan E;
Mansour, Marc R;
Lockley, Michelle;
Ledermann, Jonathan A;
Payne, Elspeth M;
(2023)
Monitoring clone dynamics and reversibility in clonal haematopoiesis and myelodysplastic neoplasm associated with PARP inhibitor therapy-a role for early monitoring and intervention.
Leukemia
10.1038/s41375-023-02040-6.
(In press).
|
O
|
O'Connor, David;
Demeulemeester, Jonas;
Conde, Lucia;
Kirkwood, Amy;
Fung, Kent;
Papaleonidopoulou, Foteini;
Bloye, Gianna;
... Mansour, Marc R; + view all
(2023)
The Clinicogenomic Landscape of Induction Failure in Childhood and Young Adult T-Cell Acute Lymphoblastic Leukemia.
Journal of Clinical Oncology
10.1200/JCO.22.02734.
|
|
O'Connor, David;
Espejo Valle-Inclán, Jose;
Conde, Lucia;
Bloye, Gianna;
Rahman, Sunniyat;
Costa, Joana R;
Bartram, Jack;
... Mansour, Marc R; + view all
(2024)
Non-coding mutations drive persistence of a founder pre-leukemic clone which initiates late relapse in T-ALL.
Blood
, 143
(10)
pp. 933-937.
10.1182/blood.2023021906.
|
|
O'Connor, David;
Joy, Melvin;
Enshaei, Amir;
Kirkwood, Amy A;
Kearns, Pamela R;
Samarasinghe, Sujith;
Moppett, John P;
... Vora, Ajay; + view all
(2023)
Cranial radiotherapy has minimal benefit in children with central nervous system involvement in T-ALL.
Blood Advances
, 7
(23)
7231-7234..
10.1182/bloodadvances.2023011267.
|
|
O'Connor, D;
Enshaei, A;
Bartram, J;
Hancock, J;
Harrison, CJ;
Hough, R;
Samarasinghe, S;
... Goulden, N; + view all
(2018)
Genotype-Specific Minimal Residual Disease Interpretation Improves Stratification in Pediatric Acute Lymphoblastic Leukemia.
Journal of Clinical Oncology
, 36
(1)
pp. 34-43.
10.1200/JCO.2017.74.0449.
|
|
|
O'Connor, D;
Moorman, AV;
Wade, R;
Hancock, J;
Tan, RMR;
Bartram, J;
Moppett, J;
... Samarasinghe, S; + view all
(2017)
Use of Minimal Residual Disease Assessment to Redefine Induction Failure in Pediatric Acute Lymphoblastic Leukemia.
Journal of Clinical Oncology
, 35
(6)
pp. 660-667.
10.1200/JCO.2016.69.6278.
|
|
|
O'Donnell, M.W.;
(2005)
Lipidic peptide dendrimers: Potential gene delivery agents for the treatment of haemophilia B.
Doctoral thesis , University of London.
|
|
|
O'Neill, AT;
Hockey, J;
O'Brien, P;
Williams, A;
Morris, TP;
Khan, T;
Hardwick, E;
(2016)
Knowledge of pelvic floor problems: a study of third trimester, primiparous women.
International Urogynecology Journal
, 28
(1)
pp. 125-129.
10.1007/s00192-016-3087-4.
|
|
O'Nions, J;
Muir, L;
Zheng, J;
Rees-Spear, C;
Rosa, A;
Roustan, C;
Earl, C;
... McCoy, L; + view all
(2021)
SARS-CoV-2 antibody responses in patients with acute leukemia.
Leukemia
, 35
pp. 289-292.
10.1038/s41375-020-01103-2.
|
|
O'Reilly, Maeve A;
Neill, Lorna;
Collin, Simon M;
Stone, Neil;
Springell, Deborah;
Mensah, Jeremy;
Cheok, Kathleen PL;
... Sanderson, Robin; + view all
(2024)
High pretreatment disease burden as a risk factor for infectious complications following CD19 chimeric antigen receptor T-cell therapy for large B-cell lymphoma.
HemaSphere
, 8
(1)
, Article e29. 10.1002/hem3.29.
|
|
O'Reilly, MA;
Govender, D;
Kirkwood, AA;
Vora, A;
Samarasinghe, S;
Khwaja, A;
Grandage, V;
... O'Connor, D; + view all
(2019)
The incidence of invasive fungal infections in children, adolescents and young adults with acute lymphoblastic leukaemia/lymphoma treated with the UKALL2011 protocol: a multicentre retrospective study.
[Letter].
British Journal of Haematology
, 186
(2)
pp. 327-329.
10.1111/bjh.15798.
|
|
O'Rourke, Colm J;
Salati, Massimiliano;
Rae, Colin;
Carpino, Guido;
Leslie, Holly;
Pea, Antonio;
Prete, Maria G;
... Braconi, Chiara; + view all
(2023)
Molecular portraits of patients with intrahepatic cholangiocarcinoma who diverge as rapid progressors or long survivors on chemotherapy.
Gut
10.1136/gutjnl-2023-330748.
(In press).
|
|
|
O’Connell, N.M.;
(2011)
Factor XI Deficiency: a study of clinical, laboratory and molecular modifiers of bleeding phenotype.
Doctoral thesis , UCL (University College London).
|
|
|
Ogunlade, O;
Stowe, C;
Jathoul, A;
Kalber, T;
Lythgoe, MF;
Beard, P;
Pule, M;
(2020)
In vivo photoacoustic imaging of a nonfluorescent E2 crimson genetic reporter in mammalian tissues.
Journal of Biomedical Optics
, 25
(04)
, Article 046004. 10.1117/1.jbo.25.4.046004.
|
|
|
Oh, Stephen T;
Verstovsek, Srdan;
Gupta, Vikas;
Platzbecker, Uwe;
Devos, Timothy;
Kiladjian, Jean-Jacques;
McLornan, Donal P;
... Mesa, Ruben; + view all
(2024)
Changes in bone marrow fibrosis during momelotinib or ruxolitinib therapy do not correlate with efficacy outcomes in patients with myelofibrosis.
eJHaem
, 5
(1)
pp. 105-116.
10.1002/jha2.854.
|
|
|
Ohs, I;
van den Broek, M;
Nussbaum, K;
Munz, C;
Arnold, SJ;
Quezada, SA;
Tugues, S;
(2016)
Interleukin-12 bypasses common gamma-chain signalling in emergency natural killer cell lymphopoiesis.
Nature Communications
, 7
, Article 13708. 10.1038/ncomms13708.
|
|
|
Onida, Francesco;
Gras, Luuk;
Ge, Junran;
Koster, Linda;
Hamladji, Rose-Marie;
Byrne, Jenny;
Avenoso, Daniele;
... Chalandon, Yves; + view all
(2024)
Mismatched related donor allogeneic haematopoietic cell transplantation compared to other donor types for Ph plus chronic myeloid leukaemia: A retrospective analysis from the Chronic Malignancies Working Party of the EBMT.
British Journal of Haematology
, 204
(6)
pp. 2365-2377.
10.1111/bjh.19448.
|
|
|
Orf, K;
Rogosic, S;
Dexter, D;
Ancliff, P;
Badle, S;
Brierley, J;
Cheng, D;
... Bartram, J; + view all
(2020)
Remdesivir during induction chemotherapy for newly diagnosed paediatric acute lymphoblastic leukaemia with concomitant SARS-CoV-2 infection.
British Journal of Haematology
, 190
(5)
E274-E276.
10.1111/bjh.17014.
|
|
Ortí, Guillermo;
Peczynski, Christophe;
Boreland, William;
O'Reilly, Maeve;
von Bonin, Malte;
Balduzzi, Adriana;
Besley, Caroline;
... Peric, Zinaida; + view all
(2025)
Graft-versus-host disease after anti-CD19 chimeric antigen receptor T-cell therapy following allogeneic hematopoietic cell transplantation: a transplant complications and paediatric diseases working parties joint EBMT study.
Leukemia
, 39
pp. 431-437.
10.1038/s41375-024-02467-5.
|
|
Othman, J;
Tiong, IS;
O'Nions, J;
Dennis, M;
Mokretar, K;
Ivey, A;
Austin, M;
... Dillon, R; + view all
(2024)
Molecular MRD is strongly prognostic in patients with NPM1-mutated AML receiving venetoclax-based nonintensive therapy.
Blood
, 143
(4)
pp. 336-341.
10.1182/blood.2023021579.
|
|
Ottaviano, G;
Baird, S;
Bonney, D;
Connor, P;
Cummins, M;
Evans, P;
Gibson, B;
... Vora, A; + view all
(2021)
The role of immunotherapy in relapse/refractory precursor-B acute lymphoblastic leukaemia: real-life UK/Ireland experience in children and young adults.
British Journal of Haematology
, 192
(2)
e42-e44.
10.1111/bjh.17198.
|
|
Otterstrom, Jason J;
Lubin, Alexandra;
Payne, Elspeth M;
Paran, Yael;
(2022)
Technologies bringing young Zebrafish from a niche field to the limelight.
SLAS Technology
10.1016/j.slast.2021.12.005.
(In press).
|
|
|
Ovcinnikovs, V;
Ross, EM;
Petersone, L;
Edner, NM;
Heuts, F;
Ntavli, E;
Kogimtzis, A;
... Walker, LSK; + view all
(2019)
CTLA-4-mediated transendocytosis of costimulatory molecules primarily targets migratory dendritic cells.
Science Immunology
, 4
(35)
, Article eaaw0902. 10.1126/sciimmunol.aaw0902.
|
P
|
Pacheco, R;
Quezada, SA;
Kalergis, AM;
Becker, MI;
Ferreira, J;
De Ioannes, AE;
(2021)
Allergens of the urushiol family promote mitochondrial dysfunction by inhibiting the electron transport at the level of cytochromes b and chemically modify cytochrome c1.
Biological Research
, 54
(1)
, Article 35. 10.1186/s40659-021-00357-z.
|
|
|
Paietta, E;
Roberts, KG;
Wang, V;
Gu, Z;
Buck, G;
Pei, D;
Cheng, C;
... Litzow, MR; + view all
(2021)
Molecular classification improves risk assessment in adult BCR-ABL1–negative B-ALL.
Blood
, 138
(11)
pp. 948-958.
10.1182/blood.2020010144.
|
|
Panayi, C;
Akarca, AU;
Ramsay, AD;
Shankar, AG;
Falini, B;
Piris, MA;
Linch, D;
(2023)
Microenvironmental immune cell alterations across the spectrum of nodular lymphocyte predominant Hodgkin lymphoma and T-cell/histiocyte-rich large B-cell lymphoma.
Frontiers in Oncology
, 13
, Article 1267604. 10.3389/fonc.2023.1267604.
|
|
|
Paradee, N;
Utama-Ang, N;
Uthaipibull, C;
Porter, JB;
Garbowski, MW;
Srichairatanakool, S;
(2020)
Extracts of Thai Perilla frutescens nutlets attenuate tumour necrosis factor-α-activated generation of microparticles, ICAM-1 and IL-6 in human endothelial cells.
Bioscience Reports
, 40
(5)
, Article BSR20192110. 10.1042/BSR20192110.
|
|
|
Paredes-Moscosso, Solange R;
Nathwani, Amit C;
(2024)
10 years of BiTE immunotherapy: an overview with a focus on pancreatic cancer.
Frontiers in Oncology
, 14
, Article 1429330. 10.3389/fonc.2024.1429330.
|
|
|
Passweg, Jakob R;
Baldomero, Helen;
Alexander, Tobias;
Angelucci, Emanuele;
Averbuch, Dina;
Bazarbachi, Ali;
Ciceri, Fabio;
... Sureda, Anna; + view all
(2025)
Utilization of hematopoietic cell transplantation and cellular therapy technology in Europe and associated Countries. Using the 2022 activity survey data to correlate with economic and demographic factors. A report from the EBMT.
Bone Marrow Transplantation
, 60
pp. 227-236.
10.1038/s41409-024-02459-0.
|
|
|
Passweg, Jakob R;
Baldomero, Helen;
Atlija, Marina;
Kleovoulou, Iliana;
Witaszek, Aleksandra;
Alexander, Tobias;
Angelucci, Emanuele;
... Sureda, Anna; + view all
(2025)
The 2023 EBMT report on hematopoietic cell transplantation and cellular therapies. Increased use of allogeneic HCT for myeloid malignancies and of CAR-T at the expense of autologous HCT.
Bone Marrow Transplantation
, 60
pp. 519-528.
10.1038/s41409-025-02524-2.
|
|
|
Passweg, Jakob RR;
Baldomero, Helen;
Ciceri, Fabio;
Corbacioglu, Selim;
De la Camara, Rafael;
Dolstra, Harry;
Glass, Bertram;
... Sureda, Anna; + view all
(2023)
Hematopoietic cell transplantation and cellular therapies in Europe 2021. The second year of the SARS-CoV-2 pandemic. A Report from the EBMT Activity Survey.
Bone Marrow Transplantation
, 58
pp. 647-658.
10.1038/s41409-023-01943-3.
|
|
|
Paston, S.J.;
(2006)
CMV epitope selection and its use in T cell reconstitution in patients undergoing haematopoietic stem cell transplantation.
Doctoral thesis , University of London.
|
|
Pastores, GM;
Hughes, DA;
(2020)
Lysosomal Acid Lipase Deficiency: Therapeutic Options.
Drug Design, Development and Therapy
, 2020
(14)
pp. 591-601.
10.2147/DDDT.S149264.
|
|
|
Pastores, GM;
Hughes, DA;
(2017)
Lysosomal Storage Disorders and Malignancy.
Diseases
, 5
(1)
10.3390/diseases5010008.
|
|
|
Patel, Parth Mrugeshkumar;
(2025)
Exploring the Endothelial and Neuroinflammatory Facets of Spinal
Muscular Atrophy and the Role of
MicroRNAs as Biomarkers and Therapeutic
Targets.
Doctoral thesis (Ph.D), UCL (University College London).
|
|
Patel, B;
Kirkwood, AA;
Dey, A;
Marks, DI;
McMillan, AK;
Menne, TF;
Micklewright, L;
... Fielding, AK; + view all
(2016)
Pegylated-asparaginase during induction therapy for adult acute lymphoblastic leukaemia: toxicity data from the UKALL14 trial.
Leukemia
10.1038/leu.2016.219.
|
|
Paterson, RW;
Benjamin, LA;
Mehta, PR;
Brown, RL;
Athauda, D;
Ashton, NJ;
Leckey, CA;
... Schott, JM; + view all
(2021)
Serum and cerebrospinal fluid biomarker profiles in acute SARS-CoV-2-associated neurological syndromes.
Brain Communications
, 3
(3)
, Article fcab099. 10.1093/braincomms/fcab099.
|
|
|
Patrick, PS;
Kolluri, KK;
Zaw Thin, M;
Edwards, A;
Sage, EK;
Sanderson, T;
Weil, BD;
... Kalber, TL; + view all
(2020)
Lung delivery of MSCs expressing anti-cancer protein TRAIL visualised with ⁸⁹Zr-oxine PET-CT.
Stem Cell Research & Therapy
, 11
, Article 256. 10.1186/s13287-020-01770-z.
|
|
|
Paul, DS;
Jones, A;
Sellar, RS;
Mayor, NP;
Feber, A;
Webster, AP;
Afonso, N;
... Beck, S; + view all
(2015)
A donor-specific epigenetic classifier for acute graft-versus-host disease severity in hematopoietic stem cell transplantation.
Genome Medicine
, 7
(1)
, Article 128. 10.1186/s13073-015-0246-z.
|
|
|
Paul-Smith, MC;
Pytel, KM;
Gelinas, J-F;
McIntosh, J;
Pringle, I;
Davies, L;
Chan, M;
... Griesenbach, U; + view all
(2018)
The murine lung as a factory to produce secreted intrapulmonary and circulatory proteins.
Gene Therapy
, 35
pp. 345-358.
10.1038/s41434-018-0025-8.
|
|
|
Paulk, NK;
Pekrun, K;
Zhu, E;
Nygaard, S;
Li, B;
Xu, J;
Chu, K;
... Kay, MA; + view all
(2018)
Bioengineered AAV Capsids with Combined High Human Liver Transduction In Vivo and Unique Humoral Seroreactivity.
Molecular Therapy
, 26
(1)
pp. 289-303.
10.1016/j.ymthe.2017.09.021.
|
|
|
Peggs, K;
Verfuerth, S;
Pizzey, A;
Ainsworth, J;
Moss, P;
Mackinnon, S;
(2002)
Characterization of human cytomegalovirus peptide-specific CD8<sup>+</sup> T-cell repertoire diversity following in vitro restimulation by antigen-pulsed dendritic cells.
Blood
, 99
(1)
pp. 213-223.
10.1182/blood.V99.1.213.
|
|
|
Peggs, K.S.;
Thomson, K.;
Hart, D.P.;
Geary, J.;
Morris, E.C.;
Yong, K.;
Goldstone, A.H.;
... Mackinnon, S.; + view all
(2003)
Dose-escalated donor lymphocyte infusions following reduced intensity transplantation: toxicity, chimerism, and disease responses.
Blood
, 103
(4)
pp. 1548-1556.
10.1182/blood-2003-05-1513.
|
 |
|
Peña, OA;
Lubin, A;
Hockings, C;
Rowell, J;
Jung, Y;
Hoade, Y;
Dace, P;
... Payne, EM; + view all
(2021)
TLR7 ligation augments hematopoiesis in Rps14 (uS11) deficiency via paradoxical suppression of inflammatory signaling.
Blood Advances
, 5
(20)
pp. 4112-4124.
10.1182/bloodadvances.2020003055.
|
|
|
Peña, OA;
Lubin, A;
Rowell, J;
Hoade, Y;
Khokhar, N;
Lemmik, H;
Mahony, C;
... Payne, EM; + view all
(2021)
Differential Requirement of Gata2a and Gata2b for Primitive and Definitive Myeloid Development in Zebrafish.
Frontiers in Cell and Developmental Biology
, 9
, Article 708113. 10.3389/fcell.2021.708113.
|
|
|
Pennell, DJ;
Porter, JB;
Cappellini, MD;
Chan, LL;
El-Beshlawy, A;
Aydinok, Y;
Ibrahim, H;
... Taher, A; + view all
(2011)
Continued improvement in myocardial T2(star) over two years of deferasirox therapy in beta-thalassemia major patients with cardiac iron overload.
Haematologica - The Hematology Journal
, 96
(1)
48 - 54.
10.3324/haematol.2010.031468.
|
|
|
Pennycuick, A;
Teixeira, VH;
AbdulJabbar, K;
Raza, SEA;
Lund, T;
Akarca, AU;
Rosenthal, R;
... Janes, SM; + view all
(2020)
Immune surveillance in clinical regression of pre-invasive squamous cell lung cancer.
Cancer Discovery
, 10
(10)
pp. 1489-1499.
10.1158/2159-8290.CD-19-1366.
|
|
Pereira, SP;
Jitlal, M;
Duggan, M;
Lawrie, E;
Beare, S;
O'Donoghue, P;
Wasan, HS;
... PHOTOSTENT-02 investigators, .; + view all
(2018)
PHOTOSTENT-02: porfimer sodium photodynamic therapy plus stenting versus stenting alone in patients with locally advanced or metastatic biliary tract cancer.
ESMO Open
, 3
(5)
, Article e000379. 10.1136/esmoopen-2018-000379.
|
|
|
Philip, B;
Kokalaki, E;
Mekkaoui, L;
Thomas, S;
Straathof, K;
Flutter, B;
Marin, V;
... Pule, M; + view all
(2014)
A highly compact epitope-based marker/suicide gene for easier and safer T-cell therapy.
Blood
, 124
(8)
1277 - 1287.
10.1182/blood-2014-01-545020.
|
|
Philip, BM;
(2015)
RQR8: A universal safety switch for cellular therapies.
Doctoral thesis , UCL (University College London).
|
|
Philip, BM;
Pule, MP;
(2013)
Polypeptide useful in adoptive cell therapy.
WO/2013/153391.
|
|
Phillips, EH;
Westwood, JP;
Brocklebank, V;
Wong, EKS;
Tellez, JO;
Marchbank, KJ;
Mcguckin, S;
... Scully, MA; + view all
(2015)
The role of ADAMTS-13 activity and complement mutational analysis in differentiating acute thrombotic microangiopathies.
Journal of Thrombosis and Haemostasis
, 14
(1)
pp. 175-185.
10.1111/jth.13189.
|
|
|
Phillips, EH;
Fox, CP;
Cwynarski, K;
(2014)
Primary CNS Lymphoma.
Current Hematologic Malignancy Reports
, 9
(3)
243 - 253.
10.1007/s11899-014-0217-2.
|
|
|
Phyu, P;
Merwick, A;
Davagnanam, I;
Bolsover, F;
Jichi, F;
Wheeler-Kingshott, C;
Golay, X;
... Werring, DJ; + view all
(2018)
Increased resting cerebral blood flow in adult Fabry disease: MRI arterial spin labeling study.
Neurology
, 90
(16)
e1379-e1385.
10.1212/WNL.0000000000005330.
|
|
Pica, S;
Sado, DM;
Maestrini, V;
Fontana, M;
White, SK;
Treibel, T;
Captur, G;
... Moon, JC; + view all
(2014)
Reproducibility of native myocardial T1 mapping in the assessment of Fabry disease and its role in early detection of cardiac involvement by cardiovascular magnetic resonance.
Journal of Cardiovascular Magnetic Resonance
, 16
, Article 99. 10.1186/s12968-014-0099-4.
|
|
|
Piddock, RE;
Marlein, CR;
Abdul-Aziz, A;
Shafat, MS;
Auger, MJ;
Bowles, KM;
Rushworth, SA;
(2018)
Myeloma-derived macrophage inhibitory factor regulates bone marrow stromal cell-derived IL-6 via c-MYC.
[Letter].
Journal of Hematology & Oncology
, 11
(1)
, Article 66. 10.1186/s13045-018-0614-4.
|
|
|
Pihan, M;
Keddie, S;
D'Sa, S;
Church, AJ;
Yong, KL;
Reilly, MM;
Lunn, MP;
(2018)
Raised VEGF: High sensitivity and specificity in the diagnosis of POEMS syndrome.
Neurology, Neuroimmunology & Neuroinflammation
, 5
(5)
, Article e486. 10.1212/NXI.0000000000000486.
|
|
|
Pillinger, G;
Loughran, NV;
Piddock, RE;
Shafat, MS;
Zaitseva, L;
Abdul-Aziz, A;
Lawes, MJ;
... Rushworth, SA; + view all
(2016)
Targeting PI3Kδ and PI3Kγ signalling disrupts human AML survival and bone marrow stromal cell mediated protection.
Oncotarget
, 7
(26)
pp. 39784-39795.
10.18632/oncotarget.9289.
|
|
|
Pipis, Menelaos;
Jaunmuktane, Zane;
Marafioti, Teresa;
Brandner, Sebastian;
Smith, Elaine C;
D'Sa, Shirley;
Lunn, Michael P;
... Reilly, Mary M; + view all
(2024)
Nerve biopsy in T-cell lymphoma with neurolymphomatosis: where and when.
Practical Neurology
10.1136/pn-2023-003992.
(In press).
|
 |
|
Pocock, R;
Farah, N;
Richardson, SE;
Mansour, MR;
(2021)
Current and emerging therapeutic approaches for T-cell acute lymphoblastic leukaemia.
British Journal of Haematology
10.1111/bjh.17310.
(In press).
|
|
|
Popat, R;
Counsell, N;
De Tute, R;
De-Silva, D;
Phillips, EH;
Cavenagh, JD;
Adedayo, T;
... Yong, K; + view all
(2021)
Using depth of response to stratify patients to front line Autologous Stem Cell Transplant: results of the phase II PADIMAC Myeloma Trial.
British Journal of Haematology
, 193
(3)
e19-e22.
10.1111/bjh.17391.
|
|
Popat, R;
Brown, SR;
Flanagan, L;
Hall, A;
Gregory, W;
Kishore, B;
Streetly, M;
... Cavenagh, J; + view all
(2019)
Extended follow‐up and the feasibility of Panobinostat maintenance for patients with Relapsed Multiple Myeloma treated with Bortezomib, Thalidomide, Dexamethasone plus Panobinostat (MUK six open label, multi‐centre phase I/II Clinical Trial).
British Journal of Haematology
, 185
(3)
pp. 573-578.
10.1111/bjh.15551.
|
|
Popat, R;
Brown, SR;
Flanagan, L;
Hall, A;
Gregory, W;
Kishore, B;
Streetly, M;
... Myeloma UK Early Phase Clinical Trial Network, .; + view all
(2016)
Bortezomib, thalidomide, dexamethasone, and panobinostat for patients with relapsed multiple myeloma (MUK-six): a multicentre, open-label, phase 1/2 trial.
The Lancet Haematology
, 3
(12)
e572-e580.
10.1016/S2352-3026(16)30165-X.
|
|
|
Popat, R;
Warcel, D;
O'Nions, J;
Cowley, A;
Smith, S;
Tucker, WR;
Yong, K;
(2020)
Characterization of response and corneal events with extended follow-up after belantamab mafodotin (GSK2857916) monotherapy for patients with relapsed multiple myeloma: a case series from the first-time-in-human clinical trial.
Haematologica
, 105
(5)
E261-E263.
10.3324/haematol.2019.235937.
|
|
|
Porter, Hayley;
Li, Yang;
Neguembor, Maria Victoria;
Beltran, Manuel;
Varsally, Wazeer;
Martin, Laura;
Cornejo, Manuel Tavares;
... Hadjur, Suzana; + view all
(2023)
Cohesin-independent STAG proteins interact with RNA and localise to R-loops to promote complex loading.
bioRxiv: Cold Spring Harbor, NY, USA.
|
|
|
Porter, J;
Taher, A;
Viprakasit, V;
Kattamis, A;
Coates, TD;
Garbowski, M;
Durrenberger, F;
... Cappellini, MD; + view all
(2021)
Oral ferroportin inhibitor vamifeport for improving iron homeostasis and erythropoiesis in β-thalassemia: current evidence and future clinical development.
Expert Review of Hematology
, 14
(7)
pp. 633-644.
10.1080/17474086.2021.1935854.
|
|
|
Porter, JB;
Scrimgeour, A;
Martinez, A;
James, L;
Aleku, M;
Wilson, R;
Muckenthaler, M;
... Campion, GV; + view all
(2023)
SLN124, a GalNAc conjugated 19-mer siRNA targeting tmprss6, reduces plasma iron and increases hepcidin levels of healthy volunteers.
American Journal of Hematology
, 98
(9)
pp. 1425-1435.
10.1002/ajh.27015.
|
|
Porter, JB;
(2020)
Iron Through the Prism of Haematology.
British Journal of Haematology
, 191
(4)
pp. 587-592.
10.1111/bjh.17164.
|
|
|
Porter, JB;
Cappellini, MD;
Kattamis, A;
Viprakasit, V;
Musallam, KM;
Zhu, Z;
Taher, AT;
(2017)
Iron overload across the spectrum of non-transfusion-dependent thalassaemias: role of erythropoiesis, splenectomy and transfusions.
British Journal of Haematology
, 176
(2)
pp. 288-299.
10.1111/bjh.14373.
|
|
|
Porter, JB;
Elalfy, M;
Taher, A;
Aydinok, Y;
Lee, SH;
Sutcharitchan, P;
El-Ali, A;
... El-Beshlawy, A; + view all
(2017)
Limitations of serum ferritin to predict liver iron concentration responses to deferasirox therapy in patients with transfusion-dependent thalassaemia.
European Journal of Haematology
, 98
(3)
pp. 280-288.
10.1111/ejh.12830.
|
|
|
Porter, JB;
Garbowski, M;
(2014)
The Pathophysiology of Transfusional Iron Overload.
Hematology/Oncology Clinics of North America
, 28
(4)
pp. 683-701.
10.1016/j.hoc.2014.04.003.
|
|
|
Porter, JB;
Garbowski, MW;
(2018)
Interaction of Transfusion and Iron Chelation in Thalassemias.
Hematology/Oncology Clinics of North America
, 32
(2)
pp. 247-259.
10.1016/j.hoc.2017.11.010.
|
|
Porter, JB;
Walter, PB;
Neumayr, LD;
Evans, P;
Bansal, S;
Garbowski, M;
Weyhmiller, MG;
... Vichinsky, E; + view all
(2014)
Mechanisms of plasma non-transferrin bound iron generation: insights from comparing transfused diamond blackfan anaemia with sickle cell and thalassaemia patients.
British Journal of Haematology
, 167
(5)
pp. 692-696.
10.1111/bjh.13081.
|
|
Porter, JB;
Wood, J;
Olivieri, N;
Vichinsky, EP;
Taher, A;
Neufeld, E;
Giardina, P;
... Trachtenberg, F; + view all
(2013)
Treatment of heart failure in adults with thalassemia major: response in patients randomised to deferoxamine with or without deferiprone.
Journal of Cardiovascular Magnetic Resonance
, 15
, Article 38. 10.1186/1532-429X-15-38.
|
|
|
Post, M;
Cuapio, A;
Osl, M;
Lehmann, D;
Resch, U;
Davies, DM;
Bilban, M;
... Hofer, E; + view all
(2017)
The Transcription Factor ZnF683/hOBiT regulates human NK-cell Development.
Frontiers in Immunology
, 8
, Article 535. 10.3389/fimmu.2017.00535.
|
|
|
Pourcet, B;
Gage, MC;
León, TE;
Waddington, KE;
Pello, OM;
Steffensen, KR;
Castrillo, A;
... Pineda-Torra, I; + view all
(2016)
The nuclear receptor LXR modulates interleukin-18 levels in macrophages through multiple mechanisms.
Scientific Reports
, 6
, Article 25481. 10.1038/srep25481.
|
|
|
Prasanna, KS;
Goel, A;
Amirtharaj, GJ;
Ramachandran, A;
Balasubramanian, KA;
Mackie, I;
Zachariah, U;
... Eapen, CE; + view all
(2016)
Plasma von Willebrand factor levels predict in-hospital survival in patients with acute-on-chronic liver failure.
Indian Journal of Gastroenterology
, 35
(6)
pp. 432-440.
10.1007/s12664-016-0708-2.
|
|
Primrose, JN;
Fox, RP;
Palmer, DH;
Malik, HZ;
Prasad, R;
Mirza, D;
Anthony, A;
... Bridgewater, J; + view all
(2019)
Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study.
Lancet Oncology
, 20
(5)
pp. 663-673.
10.1016/S1470-2045(18)30915-X.
|
|
Privolizzi, R;
Chu, WS;
Tijani, M;
Ng, J;
(2021)
Viral gene therapy for paediatric neurological diseases: progress to clinical reality.
Developmental Medicine & Child Neurology
10.1111/dmcn.14885.
(In press).
|
|
|
Proctor, Toby Joseph;
(2019)
Translational process engineering for tissue engineered hollow organ advanced therapy investigational medicinal products.
Doctoral thesis (Eng.D), UCL (University College London).
|
|
Prommaban, A;
Utama-Ang, N;
Chaikitwattana, A;
Uthaipibull, C;
Porter, JB;
Srichairatanakool, S;
(2020)
Phytosterol, Lipid and Phenolic Composition, and Biological Activities of Guava Seed Oil.
Molecules
, 25
(11)
, Article 2474. 10.3390/molecules25112474.
|
|
|
Pugh, G;
Petrella, A;
Pabary, A;
Cross, A;
Hough, R;
Soanes, L;
Sabiston, C;
(2020)
Health Professionals' Views on Lifestyle Advice Delivery to Teenage and Young Adult Cancer Patients: A Qualitative Study.
Cancer Nursing
10.1097/NCC.0000000000000906.
(In press).
|
|
Pugh, G;
Gravestock, HL;
Hough, RE;
King, WM;
Wardle, J;
Fisher, A;
(2016)
Health Behavior Change Interventions for Teenage and Young Adult Cancer Survivors: A Systematic Review.
Journal of Adolescent and Young Adult Oncology
, 5
(2)
pp. 91-105.
10.1089/jayao.2015.0042.
|
|
Pugh, G;
Hough, R;
Gravestock, H;
Davies, C;
Horder, R;
Fisher, A;
(2019)
The development and user evaluation of health behaviour change resources for teenage and young adult Cancer survivors.
Research Involvement and Engagement
, 5
, Article 9. 10.1186/s40900-019-0142-6.
|
|
|
Pugh, G;
Hough, R;
Gravestock, H;
Fisher, A;
(2019)
The health behaviour status of teenage and young adult cancer patients and survivors in the United Kingdom.
Support Care Cancer
10.1007/s00520-019-04719-y.
(In press).
|
|
|
Pugh, G;
Hough, R;
Gravestock, H;
Haddrell, JB;
Beeken, RJ;
Fisher, A;
(2018)
The Lifestyle Information and Intervention Preferences of Teenage and Young Adult Cancer Survivors: A Qualitative Study.
Cancer Nursing
, 41
(5)
pp. 389-398.
10.1097/NCC.0000000000000508.
|
|
Pugh, G;
Hough, R;
Gravestock, H;
Williams, K;
Fisher, A;
(2017)
Lifestyle advice provision to teenage and young adult cancer patients: the perspective of health professionals in the UK.
Support Care in Cancer
, 25
(12)
pp. 3823-3832.
10.1007/s00520-017-3814-5.
|
|
Pugh, G;
Hough, R;
Hubbard, G;
Banks, E;
Fisher, A;
(2019)
Sun exposure among teenage and young adult cancer survivors in the United Kingdom.
Pediatric Blood & Cancer
, 66
(1)
, Article e27424. 10.1002/pbc.27424.
|
|
Pugh, G;
Hough, RE;
Gravestock, HL;
Jackson, SE;
Fisher, A;
(2017)
The Health Behavior Information Needs and Preferences of Teenage and Young Adult Cancer Survivors.
Journal of Adolescent and Young Adult Oncology
, 6
(2)
pp. 318-326.
10.1089/jayao.2016.0089.
|
|
Pugh, S;
Thiébaut, R;
Bridgewater, J;
Grisoni, ML;
Moutasim, K;
Rousseau, F;
Thomas, GJ;
... Laurent-Puig, P; + view all
(2017)
Association between miR-31-3p expression and cetuximab efficacy in patients with KRAS wild-type metastatic colorectal cancer: A post-hoc analysis of the New EPOC trial.
Oncotarget
, 8
(55)
pp. 93856-93866.
10.18632/oncotarget.21291.
|
|
|
Pugh, SA;
Bowers, M;
Ball, A;
Falk, S;
Finch-Jones, M;
Valle, JW;
O'Reilly, DA;
... Primrose, JN; + view all
(2016)
Patterns of progression, treatment of progressive disease and post-progression survival in the New EPOC study.
British Journal of Cancer
, 115
(4)
pp. 420-424.
10.1038/bjc.2016.208.
|
|
|
Puttick, Clare;
Jones, Thomas P;
Leung, Michelle M;
Galvez-Cancino, Felipe;
Liu, Jiali;
Varas-Godoy, Manuel;
Rowan, Andrew;
... Mcgranahan, Nicholas; + view all
(2024)
MHC Hammer reveals genetic and non-genetic HLA disruption in cancer evolution.
Nature Genetics
, 56
(10)
pp. 2121-2131.
10.1038/s41588-024-01883-8.
|
|
Q
|
Qasim, W;
Zhan, H;
Samarasinghe, S;
Adams, S;
Amrolia, P;
Stafford, S;
Butler, K;
... Veys, P; + view all
(2017)
Molecular remission of infant B-ALL after infusion of universal TALEN gene-edited CAR T cells.
Science Translational Medicine
, 9
(374)
, Article eaaj2013. 10.1126/scitranslmed.aaj2013.
|
|
Quek, L;
Otto, GW;
Garnett, C;
Lhermitte, L;
Karamitros, D;
Stoilova, B;
Lau, I-J;
... Vyas, P; + view all
(2016)
Genetically distinct leukemic stem cells in human CD34(-) acute myeloid leukemia are arrested at a hemopoietic precursor-like stage.
Journal of Experimental Medicine
, 213
(8)
pp. 1513-1535.
10.1084/jem.20151775.
|
|
Quezada, SA;
Peggs, KS;
(2018)
Lost in Translation: Deciphering the mechanism of action of anti-human CTLA-4.
Clinical Cancer Research
10.1158/1078-0432.CCR-18-2509.
(In press).
|
|
Quezada, SA;
Peggs, KS;
(2013)
Exploiting CTLA-4, PD-1 and PD-L1 to reactivate the host immune response against cancer.
British Journal of Cancer
, 108
(8)
1560 -1565.
10.1038/bjc.2013.117.
|
|
|
Quezada, SA;
Peggs, KS;
Curran, MA;
Allison, JP;
(2006)
CTLA4 blockade and GM-CSF combination immunotherapy alters the intratumor balance of effector and regulatory T cells.
J CLIN INVEST
, 116
(7)
1935 - 1945.
10.1172/JCI27745.
|
|
R
|
Raab, MS;
Cavo, M;
Delforge, M;
Driessen, C;
Fink, L;
Flinois, A;
Gonzalez-McQuire, S;
... Yong, K; + view all
(2016)
Multiple myeloma: practice patterns across Europe.
British Journal of Haematology
, 175
(1)
pp. 66-76.
10.1111/bjh.14193.
|
|
|
Raab, MS;
Fink, L;
Schoen, P;
Gonzalez-McQuire, S;
Flinois, A;
Cavo, M;
Mateos, M-V;
(2019)
Evolution of multiple myeloma treatment practices in Europe from 2014 to 2016.
British Journal of Haematology
, 185
(5)
pp. 981-984.
10.1111/bjh.15680.
|
|
Radford, J;
McKay, P;
Malladi, R;
Johnson, R;
Bloor, A;
Percival, F;
Sureda, A;
(2017)
Treatment pathways and resource use associated with recurrent Hodgkin lymphoma after autologous stem cell transplantation.
Bone Marrow Transplant
, 52
pp. 452-454.
10.1038/bmt.2016.244.
|
|
|
Radin, M;
Sciascia, S;
Erkan, D;
Pengo, V;
Tektonidou, MG;
Ugarte, A;
Meroni, P;
... APS ACTION; + view all
(2019)
The adjusted global antiphospholipid syndrome score (aGAPSS) and the risk of recurrent thrombosis: Results from the APS ACTION cohort.
Seminars in Arthritis and Rheumatism
, 49
(3)
pp. 464-468.
10.1016/j.semarthrit.2019.04.009.
|
|
Rahman, Sunniyat;
Bloye, Gianna;
Farah, Nadine;
Demeulemeester, Jonas;
Costa, Joana R;
O'Connor, David;
Pocock, Rachael;
... Mansour, Marc R; + view all
(2024)
Focal deletions of a promoter tether activate the IRX3 oncogene in T-cell acute lymphoblastic leukemia.
BLOOD
, 144
(22)
pp. 2319-2326.
10.1182/blood.2024024300.
|
|
|
Rahman, S;
Housein, Z;
Dabrowska, A;
Mayán, MD;
Boobis, AR;
Hajji, N;
(2015)
E2F1-mediated FOS induction in arsenic trioxide-induced cellular transformation: effects of global H3K9 hypoacetylation and promoter-specific hyperacetylation in vitro.
Environ Health Perspect
, 123
(5)
pp. 484-492.
10.1289/ehp.1408302.
|
|
|
Rahman, S;
Magnussen, M;
León, TE;
Farah, N;
Li, Z;
Abraham, BJ;
Alapi, KZ;
... Mansour, MR; + view all
(2017)
Activation of the LMO2 oncogene through a somatically acquired neomorphic promoter in T-cell acute lymphoblastic leukemia.
Blood
, 129
(24)
pp. 3221-3226.
10.1182/blood-2016-09-742148.
|
|
Rahman, S;
Mansour, MR;
(2019)
The role of noncoding mutations in blood cancers.
Disease Models & Mechanisms
, 12
(11)
, Article dmm041988. 10.1242/dmm.041988.
|
|
|
Ramaswami, U;
D'Amore, S;
Finnegan, N;
Hughes, D;
Kazemi, M;
(2021)
Impact of SARS-CoV-2 (COVID-19) pandemic on patients with lysosomal storage disorders and restoration of services: experience from a specialist centre.
Internal Medicine Journal
10.1111/imj.15473.
(In press).
|
|
|
Ramirez, GA;
Mackie, I;
Nallamilli, S;
Pires, T;
Moll, R;
Pericleous, C;
Isenberg, DA;
... Efthymiou, M; + view all
(2021)
Anti-protein C antibodies and acquired protein C resistance in SLE: novel markers for thromboembolic events and disease activity?
Rheumatology
, 60
(3)
pp. 1376-1386.
10.1093/rheumatology/keaa509.
|
|
Ramirez, G;
Cohen, H;
Mackie, I;
Isenberg, D;
Efthymiou, M;
(2018)
Prevalence of anti-protein C antibodies and acquired activated protein C resistance and in systemic lupus erythematosus.
Presented at: British Society for Haemostasis and Thrombosis, Coventry, UK.
|
|
|
Ramirez, GA;
Efthymiou, M;
Isenberg, DA;
Cohen, H;
(2019)
Under crossfire: thromboembolic risk in systemic lupus erythematosus.
Rheumatology
, 58
(6)
pp. 940-952.
10.1093/rheumatology/key307.
|
|
Ramiro, Laura;
García-Berrocoso, Teresa;
Briansó, Ferran;
Goicoechea, Leire;
Simats, Alba;
Llombart, Víctor;
Gonzalo, Ricardo;
... Montaner, Joan; + view all
(2021)
Integrative Multi-omics Analysis to Characterize Human Brain Ischemia.
Molecular Neurobiology
, 58
(8)
pp. 4107-4121.
10.1007/s12035-021-02401-1.
|
|
Rampotas, A;
Sockel, K;
Panitsas, F;
Theuser, C;
Bornhauser, M;
Hernani, R;
Hernandez-Boluda, JC;
... McLornan, DP; + view all
(2023)
Adoptive Immunotherapy via Donor Lymphocyte Infusions following Allogeneic Hematopoietic Stem Cell Transplantation for Myelofibrosis: A Real-World, Retrospective Multicenter Study.
Transplantation and Cellular Therapy
, 29
(11)
687.e1-687.e7.
10.1016/j.jtct.2023.08.020.
|
|
Rampotas, A;
Wilson, MR;
Lomas, O;
Denny, N;
Leary, H;
Ferguson, G;
McKay, P;
... Eyre, TA; + view all
(2021)
Treatment patterns and outcomes of unfit and elderly patients with Mantle cell lymphoma unfit for standard immunochemotherapy: A UK and Ireland analysis.
British Journal of Haematology
, 194
(2)
pp. 365-377.
10.1111/bjh.17513.
|
|
Rampotas, Alexandros;
(2024)
Towards a CAR-T cell therapy approach for Calreticulin mutated Myelofibrosis.
Doctoral thesis (Ph.D), UCL (University College London).
|
|
Rampotas, Alexandros;
Roddie, Claire;
(2025)
It's high TIM-3 for armored CAR-T therapy for B-ALL.
Blood
, 145
(22)
pp. 2538-2540.
10.1182/blood.2025028491.
|
|
Rao, S;
Sclafani, F;
Eng, C;
Adams, RA;
Guren, MG;
Sebag-Montefiore, D;
Benson, A;
... Cunningham, D; + view all
(2020)
International Rare Cancers Initiative Multicenter Randomized Phase II Trial of Cisplatin and Fluorouracil Versus Carboplatin and Paclitaxel in Advanced Anal Cancer: InterAAct.
Journal of Clinical Oncology
, 38
(22)
pp. 2510-2518.
10.1200/JCO.19.03266.
|
|
Rapetto, F;
Taliotis, D;
Chen, Q;
Ttofi, I;
Iacobazzi, D;
Madeddu, P;
Stoica, SC;
... Caputo, M; + view all
(2021)
Allogeneic Mesenchymal Stromal Cell Injection to Alleviate Ischemic Heart Failure Following Arterial Switch Operation.
JACC: Case Reports
, 3
(5)
pp. 724-727.
10.1016/j.jaccas.2021.02.039.
|
|
|
Ravichandran, Sriram;
Mahmood, Shameem;
Wisniowski, Brenden;
Sachchithanantham, Sajitha;
Popat, Rakesh;
Lachmann, Helen;
Rabin, Neil;
... D Wechalekar, Ashutosh; + view all
(2022)
A UK consensus algorithm for early treatment modification in newly diagnosed systemic light-chain amyloidosis.
British Journal of Haematology
, 198
(2)
pp. 328-332.
10.1111/bjh.18216.
|
|
Reading, J;
Foster, K;
Joshi, K;
Chain, B;
(2022)
Tracking down tumor-specific T cells.
Cancer Cell
, 40
(4)
pp. 351-353.
10.1016/j.ccell.2022.03.007.
|
|
Reading, James L;
Caswell, Deborah R;
Swanton, Charles;
(2023)
Tumor heterogeneity impairs immunogenicity in mismatch repair deficient tumors.
Nature Genetics
, 55
(10)
pp. 1610-1612.
10.1038/s41588-023-01492-x.
|
|
Reading, JL;
Roobrouck, VD;
Hull, CM;
Becker, PD;
Beyens, J;
Valentin-Torres, A;
Boardman, D;
... Tree, T; + view all
(2021)
Augmented Expansion of Treg Cells From Healthy and Autoimmune Subjects via Adult Progenitor Cell Co-Culture.
Frontiers in Immunology
, 12
, Article 716606. 10.3389/fimmu.2021.716606.
|
|
|
Reading, JL;
Gálvez-Cancino, F;
Swanton, RC;
Lladser, A;
Peggs, K;
Quezada, S;
(2018)
The function and dysfunction of memory CD8+ T cells in tumor immunity.
Immunological Reviews
, 283
(1)
pp. 194-212.
10.1111/imr.12657.
|
|
Reading, JL;
Quezada, SA;
(2016)
Too Much of a Good Thing? Chronic IFN Fuels Resistance to Cancer Immunotherapy.
Immunity
, 45
(6)
pp. 1181-1183.
10.1016/j.immuni.2016.12.004.
|
|
Recino, A;
Gan, SU;
Sia, KC;
Sawyer, Y;
Trendell, J;
Kay, R;
Gribble, FM;
... Wallberg, M; + view all
(2019)
Immunosuppression overcomes insulin- and vector-specific immune responses that limit efficacy of AAV2/8-mediated insulin gene therapy in NOD mice.
Gene Therapy
, 26
pp. 40-56.
10.1038/s41434-018-0052-5.
|
|
|
RECOVERY Collaborative Group;
(2021)
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial.
The Lancet
, 397
(10289)
pp. 2049-2059.
10.1016/S0140-6736(21)00897-7.
|
|
|
Reed, M;
(2017)
Characterisation of pathogenic pathways within the bone microenvironment of Gaucher Disease which contribute to bone pathology and haematological malignancy.
Doctoral thesis , UCL (University College London).
|
|
|
Reed-Berendt, R;
Shafran, R;
Langdon, D;
Christie, D;
Hough, R;
Coughtrey, A;
(2019)
Experiences of Low Mood in Young People With Cancer: A Qualitative Study.
Journal of Pediatric Oncology Nursing
10.1177/1043454219844232.
(In press).
|
|
|
Reekie, I;
Irish, D;
Ijaz, S;
Fox, T;
Bharucha, T;
Griffiths, P;
Thorburn, D;
... Sekhar, M; + view all
(2018)
Hepatitis E Infection in Stem Cell and Solid Organ Transplantpatients: a Cross-sectional Study the Importance of Hev Rna Screening in Peri-transplant Period.
Journal of Clinical Virology
, 107
pp. 1-5.
10.1016/j.jcv.2018.07.011.
|
|
Rego, RT;
Morris, EC;
Lowdell, MW;
(2019)
T-cell receptor gene-modified cells: past promises, present methodologies and future challenges.
Cytotherapy
, 21
(3)
pp. 341-357.
10.1016/j.jcyt.2018.12.002.
|
|
Reiss, Ulrike M;
Davidoff, Andrew M;
Tuddenham, Edward GD;
Chowdary, Pratima;
McIntosh, Jenny;
Muczynski, Vincent;
Journou, Malo;
... Nathwani, Amit C; + view all
(2025)
Sustained Clinical Benefit of AAV Gene Therapy in Severe Hemophilia B.
The New England Journal of Medicine
, 392
(22)
pp. 2226-2234.
10.1056/NEJMoa2414783.
|
|
|
Rejeski, Kai;
Subklewe, Marion;
Aljurf, Mahmoud;
Bachy, Emmanuel;
Balduzzi, Adriana Cristina;
Barba, Pere;
Bruno, Benedetto;
... Yakoub-Agha, Ibrahim; + view all
(2023)
Immune effector cell–associated hematotoxicity: EHA/EBMT consensus grading and best practice recommendations.
Blood
, 142
(10)
pp. 865-877.
10.1182/blood.2023020578.
|
|
Reyal, Y;
(2013)
The role of the polycomb group gene PCGF2 in human haematopoiesis.
Doctoral thesis , UCL (University College London).
|
|
Reyal, Y;
Kayani, I;
Bloor, AJC;
Fox, CP;
Chakraverty, R;
Sjursen, A-M;
Fielding, AK;
... Peggs, KS; + view all
(2016)
Impact of Pretransplantation F-18-Fluorodeoxyglucose-Positron Emission Tomography on Survival Outcomes after T Cell-Depleted Allogeneic Transplantation for Hodgkin Lymphoma.
Biology of Blood and Marrow Transplantation
, 22
(7)
pp. 1234-1241.
10.1016/j.bbmt.2016.03.034.
|
|
Ricciardelli, I;
Blundell, MP;
Brewin, J;
Thrasher, A;
Pule, M;
Amrolia, PJ;
(2014)
Towards gene therapy for EBV-associated posttransplant lymphoma with genetically modified EBV-specific cytotoxic T cells.
Blood
, 124
(16)
pp. 2514-2522.
10.1182/blood-2014-01-553362.
|
|
|
Ricciardelli, I;
Brewin, J;
Lugthart, G;
Albon, SJ;
Pule, M;
Amrolia, PJ;
(2013)
Rapid Generation of EBV-Specific Cytotoxic T Lymphocytes Resistant to Calcineurin Inhibitors for Adoptive Immunotherapy.
Am J Transplant
, 13
(12)
3244 - 3252.
10.1111/ajt.12475.
|
|
|
Richardson, PG;
Harrison, SJ;
Bringhen, S;
Schjesvold, F;
Yong, K;
Campana, F;
Le-Guennec, S;
... Dimopoulos, MA; + view all
(2021)
Isatuximab for relapsed/refractory multiple myeloma: review of key subgroup analyses from the Phase III ICARIA-MM study.
Future Oncology
, 17
(34)
pp. 4797-4812.
10.2217/fon-2021-0568.
|
|
|
Richardson, S;
Brian, D;
Grandage, V;
Hough, R;
Kottaridis, P;
Mansour, M;
Payne, EMC;
(2019)
Intensive Chemotherapy Is Associated With Poor Overall Survival in Autoimmune Disease-associated Myeloid Malignancies.
HemaSphere
, 3
(1)
, Article e164. 10.1097/HS9.0000000000000164.
|
|
|
Righi, Matteo;
Srivastava, Saket;
Grothier, Thomas;
Robson, Mathew;
Kokalaki, Evangelia;
Gannon, Isaac;
Sillibourne, James;
... Pule, Martin; + view all
(2022)
Enhancing CAR T Cell Therapy Using Fab Based Constitutively Heterodimeric Cytokine Receptors.
Cancer Immunology Research
10.1158/2326-6066.CIR-22-0640.
(In press).
|
|
Rio-Machin, A;
Vulliamy, T;
Hug, N;
Walne, A;
Tawana, K;
Cardoso, S;
Ellison, A;
... Dokal, I; + view all
(2020)
The complex genetic landscape of familial MDS and AML reveals pathogenic germline variants.
Nature Communications
, 11
, Article 1044. 10.1038/s41467-020-14829-5.
|
|
|
ROBERTS, PJ;
PIZZEY, AR;
LINCH, DC;
(1993)
The effect of inhibition of leukotriene synthesis on the activity of interleukin-8 and granulocyte-macrophage colony-stimulating factor.
Mediators of Inflammation
, 2
(3)
211- 216.
10.1155/S0962935193000286.
|
|
|
Robertson, NJ;
Meehan, C;
Martinello, KA;
Avdic-Belltheus, A;
Boggini, T;
Mutshiya, T;
Lingam, I;
... Lowdell, MW; + view all
(2020)
Human umbilical cord mesenchymal stromal cells as an adjunct therapy with therapeutic hypothermia in a piglet model of perinatal asphyxia.
Cytotherapy
10.1016/j.jcyt.2020.10.005.
(In press).
|
|
|
Robin, Marie;
De Wreede, Liesbeth C;
Schroeder, Thomas;
Stoelzel, Friedrich;
Kroeger, Nicolaus;
Koster, Linda;
Platzbecker, Uwe;
... Yakoub-Agha, Ibrahim; + view all
(2023)
Primary Cancer Matters in Therapy-related Myeloid Neoplasm Patients Receiving Allogeneic Hematopoietic Cell Transplantation: A Study From the Chronic Malignancies Working Party of the EBMT.
HemaSphere
, 7
(4)
, Article e851. 10.1097/HS9.0000000000000851.
|
|
|
Robinson, J;
Guethlein, LA;
Cereb, N;
Yang, SY;
Norman, PJ;
Marsh, SGE;
Parham, P;
(2017)
Distinguishing functional polymorphism from random variation in the sequences of >10,000 HLA-A, -B and -C alleles.
PLoS Genetics
, 13
(6)
, Article e1006862. 10.1371/journal.pgen.1006862.
|
|
|
Robinson, J;
Guethlein, LA;
Maccari, G;
Blokhuis, J;
Bimber, BN;
de Groot, NG;
Sanderson, ND;
... Parham, P; + view all
(2018)
Nomenclature for the KIR of non-human species.
Immunogenetics
, 70
(9)
pp. 571-583.
10.1007/s00251-018-1064-4.
|
|
|
Robinson, J;
Halliwell, JA;
McWilliam, H;
Lopez, R;
Marsh, SG;
(2013)
IPD—the Immuno Polymorphism Database.
Nucleic Acids Research
, 41
D1234 - D1240.
10.1093/nar/gks1140.
|
|
|
Robinson, J;
Halliwell, JA;
McWilliam, H;
Lopez, R;
Parham, P;
Marsh, SG;
(2013)
The IMGT/HLA database.
Nucleic Acids Res
, 41
(D1)
D1222 -D1227.
10.1093/nar/gks949.
|
|
|
Robinson, J.;
Waller, M.J.;
Stoehr, P.;
Marsh, S.G.E.;
(2005)
IPD - the Immuno Polymorphism Database.
Nucleic Acids Research
, 33
(Databa)
D523-D526.
10.1093/nar/gki032.
|
|
|
Robles-Zurita, J;
Boyd, KA;
Briggs, AH;
Iveson, T;
Kerr, RS;
Saunders, MP;
Cassidy, J;
... Paul, J; + view all
(2018)
SCOT: a comparison of cost-effectiveness from a large randomised phase III trial of two durations of adjuvant Oxaliplatin combination chemotherapy for colorectal cancer.
British Journal of Cancer
, 119
pp. 1332-1338.
10.1038/s41416-018-0319-z.
|
|
|
Roddie, C;
Dias, J;
O'Reilly, MA;
Abbasian, M;
Cadinanos-Garai, A;
Vispute, K;
Bosshard-Carter, L;
... Peggs, KS; + view all
(2025)
Matched donor allogeneic CAR-T for adult B-ALL: toxicity, efficacy, repeat dosing, and the importance of lymphodepletion.
Blood
, Article blood.2025028790. 10.1182/blood.2025028790.
|
|
Roddie, C;
Dias, J;
O'Reilly, MA;
Abbasian, M;
Cadinanos-Garai, A;
Vispute, K;
Bosshard-Carter, L;
... Peggs, KS; + view all
(2021)
Durable Responses and Low Toxicity After Fast Off-Rate CD19 Chimeric Antigen Receptor-T Therapy in Adults With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia.
Journal of Clinical Oncology
10.1200/jco.21.00917.
(In press).
|
|
|
Roddie, Claire;
Lekakis, Lazaros J;
Marzolini, Maria AV;
Ramakrishnan, Aravind;
Zhang, Yiyun;
Hu, Yanqing;
Peddareddigari, Vijay GR;
... Pule, Martin; + view all
(2023)
Dual targeting of CD19 and CD22 with Bicistronic CAR-T cells in Patients with Relapsed/Refractory Large B Cell Lymphoma.
Blood
, 141
(20)
pp. 2470-2482.
10.1182/blood.2022018598.
|
|
Roddie, Claire;
Neill, Lorna;
Osborne, Wendy;
Iyengar, Sunil;
Tholouli, Eleni;
Irvine, David;
Chaganti, Sridhar;
... Kuhnl, Andrea; + view all
(2023)
Effective bridging therapy can improve CD19 CAR-T outcomes while maintaining safety in patients with large B-cell lymphoma.
Blood Advances
, 7
(12)
pp. 2872-2883.
10.1182/bloodadvances.2022009019.
|
|
Roddie, Claire;
Rampotas, Alexandros;
(2025)
The present and future for CAR-T cell therapy in adult B-cell ALL.
Blood
, 145
(14)
pp. 1485-1497.
10.1182/blood.2023022922.
|
|
Roddie, Claire;
Sandhu, Karamjeet S;
Tholouli, Eleni;
Logan, Aaron C;
Shaughnessy, Paul;
Barba, Pere;
Ghobadi, Armin;
... Jabbour, Elias; + view all
(2024)
Obecabtagene Autoleucel in Adults with B-Cell Acute Lymphoblastic Leukemia.
New England Journal of Medicine (NEJM)
10.1056/NEJMoa2406526.
(In press).
|
|
|
Roddie, C;
(2016)
Targeting interference of CTLA-4 co-inhibition to tumour specific T cells to enhance activity and reduce toxicity.
Doctoral thesis , UCL (University College London).
|
|
Roddie, C;
O'Reilly, M;
Dias Alves Pinto, J;
Vispute, K;
Lowdell, M;
(2019)
Manufacturing chimeric antigen receptor T cells: issues and challenges.
Cytotherapy
, 21
(3)
pp. 327-340.
10.1016/j.jcyt.2018.11.009.
|
|
Roddie, C;
Peggs, KS;
(2017)
Immunotherapy for transplantation-associated viral infections.
Journal Of Clinical Investigation
, 127
(7)
pp. 2513-2522.
10.1172/JCI90599.
|
|
|
Roddy, H;
Meyer, T;
Roddie, C;
(2022)
Novel Cellular Therapies for Hepatocellular Carcinoma.
Cancers
, 14
(3)
, Article 504. 10.3390/cancers14030504.
|
|
|
Roddy, Harriet;
(2024)
Development of a Novel CAR T Cell Strategy for Hepatocellular Carcinoma.
Doctoral thesis (Ph.D), UCL (University College London).
|
|
Rohman, PJ;
Scott, E;
Richfield, L;
Ramaswami, U;
Hughes, DA;
(2016)
Pregnancies and associated events in women receiving Enzyme Replacement Therapy for late onset Glycogen Storage Disease Type II (Pompe disease).
Journal of Obstetrics and Gynaecology Research
, 42
(10)
pp. 1263-1271.
10.1111/jog.13055.
|
|
Rokan, Ahmed;
Diniz, Mariana O;
De Las Heras, Jose I;
Hall, Callum;
Noorsaeed, Somaya;
Bennett, Clare L;
Secrier, Maria;
... Fassati, Ariberto; + view all
(2025)
Evolution of a melanoma that escapes allogeneic rejection.
Cell Reports
, 44
(9)
, Article 116288. 10.1016/j.celrep.2025.116288.
|
|
Ros-Soto, J;
Snowden, JA;
Salooja, N;
Gilleece, M;
Parker, A;
Greenfield, DM;
Anthias, C;
... Transplant Complications Working Party of the EBMT; + view all
(2019)
Current Practice in Vitamin D Management in Allogeneic Hematopoietic Stem Cell Transplantation: A Survey by the Transplant Complications Working Party of the European Society for Blood and Marrow Transplantation.
Biology of Blood and Marrow Transplantation
, 25
(10)
pp. 2079-2085.
10.1016/j.bbmt.2019.06.015.
|
|
Rosenthal, R;
Cadieux, EL;
Salgado, R;
Bakir, MA;
Moore, DA;
Hiley, CT;
Lund, T;
... TRACERx consortium; + view all
(2019)
Neoantigen-directed immune escape in lung cancer evolution.
Nature
10.1038/s41586-019-1032-7.
(In press).
|
|
Rossig, C;
Pule, M;
Altvater, B;
Saiagh, S;
Wright, G;
Ghorashian, S;
Clifton-Hadley, L;
... Amrolia, PJ; + view all
(2017)
Vaccination to improve the persistence of CD19CAR gene-modified T cells in relapsed pediatric acute lymphoblastic leukemia.
Leukemia
, 31
pp. 1087-1095.
10.1038/leu.2017.39.
|
|
Rowe, J.M.;
Buck, G.;
Burnett, A.K.;
Chopra, R.;
Wiernik, P.H.;
Richards, S.M.;
Lazarus, H.M.;
... Goldstone, A.H.; + view all
(2005)
Induction therapy for adults with acute lymphoblastic leukemia: results of more than 1500 patients from the international ALL trial: MRC UKALL XII/ECOG E2993.
Blood
, 106
(12)
pp. 3760-3767.
10.1182/blood-2005-04-1623.
|
|
|
Roy, A;
Vijapurapu, R;
Kurdi, H;
Orsborne, C;
Woolfson, P;
Kalla, M;
Jovanovic, A;
... Steeds, RP; + view all
(2023)
Clinical utilisation of implantable loop recorders in adults with Fabry disease—a multi-centre snapshot study.
Frontiers in Cardiovascular Medicine
, 10
, Article 1323214. 10.3389/fcvm.2023.1323214.
|
|
Royle, KL;
Coulson, AB;
Ramasamy, K;
Cairns, DA;
Hockaday, A;
Quezada, S;
Drayson, M;
... Yong, K; + view all
(2022)
Risk and response adapted therapy following autologous stem cell transplant in patients with newly diagnosed multiple myeloma (RADAR (UK-MRA Myeloma XV Trial): study protocol for a phase II/III randomised controlled trial.
BMJ open
, 12
(11)
, Article e063037. 10.1136/bmjopen-2022-063037.
|
|
Rule, S;
Cook, G;
Russell, NH;
Hunter, A;
Robinson, S;
Morley, N;
Sureda, A;
... Peggs, KS; + view all
(2019)
Allogeneic stem cell transplantation as part of front line therapy for Mantle cell lymphoma.
British Journal of Haematology
, 184
(6)
pp. 999-1005.
10.1111/bjh.15723.
|
|
Rusakiewicz, Sylvie;
(2005)
Development of epitope-based immunotherapy for the treatment of chronic myeloid leukaemia.
Doctoral thesis , UCL (University College London).
|
|
Rushbrook, Simon M;
Kendall, Timothy James;
Zen, Yoh;
Albazaz, Raneem;
Manoharan, Prakash;
Pereira, Stephen P;
Sturgess, Richard;
... Khan, Shahid A; + view all
(2023)
British Society of Gastroenterology guidelines for the diagnosis and management of cholangiocarcinoma.
Gut
10.1136/gutjnl-2023-330029.
(In press).
|
|
|
Russell, LJ;
Jones, L;
Enshaei, A;
Tonin, S;
Ryan, SL;
Eswaran, J;
Nakjang, S;
... Harrison, CJ; + view all
(2017)
Characterisation of the genomic landscape of CRLF2-rearranged acute lymphoblastic leukemia.
Genes, Chromosomes and Cancer
, 56
(5)
pp. 363-372.
10.1002/gcc.22439.
|
|
|
Russell, SJ;
Babovic-Vuksanovic, D;
Bexon, A;
Cattaneo, R;
Dingli, D;
Dispenzieri, A;
Deyle, DR;
... Peng, K-W; + view all
(2019)
Oncolytic Measles Virotherapy and Opposition to Measles Vaccination.
Mayo Clinic Proceedings
, 94
(9)
pp. 1834-1839.
10.1016/j.mayocp.2019.05.006.
|
|
Ryan, SG;
Butler, MN;
Adeyemi, SS;
Kalber, T;
Patrick, PS;
Zaw Thin, M;
Harrison, IF;
... Lythgoe, MF; + view all
(2019)
Imaging of X-Ray-Excited Emissions from Quantum Dots and Biological Tissue in Whole Mouse.
Scientific Reports
, 9
, Article 19223. 10.1038/s41598-019-55769-5.
|
|
|
Ryland, GL;
Jones, K;
Chin, M;
Markham, J;
Aydogan, E;
Kankanige, Y;
Caruso, M;
... Blombery, P; + view all
(2018)
Novel genomic findings in multiple myeloma identified through routine diagnostic sequencing.
Journal of Clinical Pathology
, 71
(10)
pp. 895-899.
10.1136/jclinpath-2018-205195.
|
|
S
|
Sabbah, S;
Liew, A;
Brooks, AM;
Kundu, R;
Reading, JL;
Flatt, A;
Counter, C;
... Tree, TIM; + view all
(2020)
Autoreactive T cell profiles are altered following allogeneic islet transplantation with alemtuzumab induction and re‐emerging phenotype is associated with graft function.
American Journal of Transplantation
10.1111/ajt.16285.
(In press).
|
|
|
Sabry, M;
(2014)
Human natural killer cell responses to tumour-priming.
Doctoral thesis , UCL (University College London).
|
|
Sabry, M;
Lowdell, MW;
(2020)
Killers at the crossroads: The use of innate immune cells in adoptive cellular therapy of cancer.
Stem Cells Translational Medicine
10.1002/sctm.19-0423.
(In press).
|
|
|
Sabry, M;
Lowdell, MW;
(2013)
Tumor-Primed NK Cells: Waiting for the Green Light.
Front Immunol
, 4
, Article 408. 10.3389/fimmu.2013.00408.
|
|
|
Sabry, M;
Zubiak, A;
Hood, SP;
Simmonds, P;
Arellano-Ballestero, H;
Cournoyer, E;
Mashar, M;
... Lowdell, MW; + view all
(2019)
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures.
PLoS One
, 14
(6)
, Article e0218674. 10.1371/journal.pone.0218674.
|
|
|
Sack, BK;
Merchant, S;
Markusic, DM;
Nathwani, AC;
Davidoff, AM;
Byrne, BJ;
Herzog, RW;
(2012)
Transient B cell depletion or improved transgene expression by codon optimization promote tolerance to factor VIII in gene therapy.
PLoS ONE
, 7
(5)
, Article e37671. 10.1371/journal.pone.0037671.
|
|
|
Sado, D;
White, SK;
Piechnik, SK;
Banypersad, SM;
Treibel, TA;
Fontana, M;
Captur, G;
... Moon, J; + view all
(2013)
Native T1 lowering in iron overload and Anderson Fabry disease; a novel and early marker of disease.
Journal of Cardiovascular Magnetic Resonance
, 15
(Suppl 1)
, Article O71. 10.1186/1532-429X-15-S1-O71.
|
|
|
Sage, E;
Davies, A;
Kolluri, K;
Patrick, S;
Weil, B;
Rego, RVTP;
Edwards, A;
... Janes, SM; + view all
(2018)
Targeted stem cells expressing TRAIL as a therapy for lung Cancer TACTICAL: a phase I/II trial.
Lung Cancer
, 115
(Supp. 1)
S87-S87.
10.1016/S0169-5002(18)30222-8.
|
|
Salisbury, Richard A;
Curto-Garcia, Natalia;
O'Sullivan, Jennifer;
Chen, Frederick;
Polzella, Paolo;
Godfrey, Anna L;
Russell, James;
... Innes, Andrew J; + view all
(2021)
Results of a national UK physician reported survey of COVID-19 infection in patients with a myeloproliferative neoplasm.
Leukemia
, 35
pp. 2424-2430.
10.1038/s41375-021-01143-2.
|
|
Samarkanova, Dinara;
Cox, Steven;
Hernandez, Diana;
Rodriguez, Luciano;
Luisa Perez, Maria;
Madrigal, Alejandro;
Vilarrodona, Anna;
... Casaroli-Marano, Ricardo P; + view all
(2021)
Cord blood and amniotic membrane extract eye drop preparations display immune-suppressive and regenerative properties.
Scientific Reports
, 11
, Article 13754. 10.1038/s41598-021-93150-7.
|
|
|
Sammaraiee, Y;
Banerjee, G;
Farmer, S;
Hylton, B;
Cowley, P;
Eleftheriou, P;
Porter, J;
(2019)
Risks associated with oral deferiprone in the treatment of infratentorial superficial siderosis.
Journal of Neurology
, 267
, Article 682. 10.1007/s00415-019-09577-6.
|
|
Samson, A;
Scott, KJ;
Taggart, D;
West, EJ;
Wilson, E;
Nuovo, GJ;
Thomson, S;
... Melcher, AA; + view all
(2018)
Intravenous delivery of oncolytic reovirus to brain tumor patients immunologically primes for subsequent checkpoint blockade.
Science Translational Medicine
, 10
(422)
, Article eaam7577. 10.1126/scitranslmed.aam7577.
|
|
|
Samuel, ER;
(2013)
Novel approaches for the isolation and expansion of cytomegalovirus-specific T cells for adoptive immunotherapy.
Doctoral thesis , UCL (University College London).
|
|
Samuel, ER;
Beloki, L;
Newton, K;
Mackinnon, S;
Lowdell, MW;
(2014)
Isolation of Highly Suppressive CD25+FoxP3+ T Regulatory Cells from G-CSF-Mobilized Donors with Retention of Cytotoxic Anti-Viral CTLs: Application for Multi-Functional Immunotherapy Post Stem Cell Transplantation.
PLoS One
, 9
(1)
, Article e85911. 10.1371/journal.pone.0085911.
|
|
|
San-Miguel, J;
Dhakal, B;
Yong, K;
Spencer, A;
Anguille, S;
Mateos, M-V;
Fernandez de Larrea, C;
... Einsele, H; + view all
(2023)
Cilta-cel or Standard Care in Lenalidomide-Refractory Multiple Myeloma.
New England Journal of Medicine
, 389
(4)
pp. 335-347.
10.1056/NEJMoa2303379.
|
|
|
Sanchez-Paulete, AR;
Teijeira, A;
Quetglas, JI;
Rodriguez-Ruiz, ME;
Sanchez-Arraez, A;
Labiano, S;
Etxeberria, I;
... Melero, I; + view all
(2018)
Intratumoral immunotherapy with XCL1 and sFlt3L encoded in recombinant Semliki Forest Virus-derived vectors fosters dendritic cell-mediated T cell cross-priming.
Cancer Research
10.1158/0008-5472.CAN-18-0933.
|
|
Santos e Sousa, P;
Bennett, CL;
Chakraverty, R;
(2018)
Unraveling the Mechanisms of Cutaneous Graft-Versus-Host Disease.
Frontiers In Immunology
, 9
, Article 963. 10.3389/fimmu.2018.00963.
|
|
|
Santos e Sousa, P;
Ciré, S;
Conlan, T;
Jardine, L;
Tkacz, C;
Ferrer, IR;
Lomas, C;
... Chakraverty, R; + view all
(2018)
Peripheral tissues re-program CD8+ T cells for pathogenicity during graftversus- host disease.
JCI Insight
, 3
(5)
, Article e97011. 10.1172/jci.insight.97011.
|
|
|
Santos e Sousa, P;
Ward, S;
Lomas, C;
Conlan, T;
Shorrock, H;
Means, TK;
Plagnol, V;
... Bennett, CL; + view all
(2016)
A systems immunology approach to GVHD defines skin-autonomous control of donor T cells.
Presented at: 2016 Keystone Symposia Conference: Immunity in Skin Development, Homeostasis and Disease, 28 February - 2 March 2016, Tahoe City, California, USA, Granlibakken, CA.
|
|
|
Sayar, Z;
Moll, R;
Isenberg, D;
Cohen, H;
(2021)
Thrombotic antiphospholipid syndrome: A practical guide to diagnosis and management.
Thrombosis Research
, 198
pp. 213-221.
10.1016/j.thromres.2020.10.010.
|
|
|
Sayar, Z;
Nallamilli, S;
Efthymiou, M;
Lambert, J;
Cohen, H;
(2021)
Coexistent antiphospholipid syndrome and myeloproliferative neoplasm.
Lupus
, 30
(9)
pp. 1502-1508.
10.1177/09612033211021154.
|
|
|
Schiff, ER;
Frampton, M;
Ben-Yosef, N;
Avila, BE;
Semplici, F;
Pontikos, N;
Bloom, SL;
... Levine, AP; + view all
(2018)
Rare coding variant analysis in a large cohort of Ashkenazi Jewish families with inflammatory bowel disease.
Human Genetics
, 137
(9)
pp. 723-734.
10.1007/s00439-018-1927-7.
|
|
|
Schiff, ER;
Frampton, M;
Semplici, F;
Bloom, SL;
McCartney, SA;
Vega, R;
Lovat, LB;
... Levine, AP; + view all
(2018)
A New Look at Familial Risk of Inflammatory Bowel Disease in the Ashkenazi Jewish Population.
Digestive Diseases and Sciences
, 63
(11)
pp. 3049-3057.
10.1007/s10620-018-5219-9.
|
|
Schiffmann, R;
Bichet, DG;
Jovanovic, A;
Hughes, DA;
Giugliani, R;
Feldt-Rasmussen, U;
Shankar, SP;
... Nicholls, K; + view all
(2018)
Migalastat improves diarrhea in patients with Fabry disease: clinical-biomarker correlations from the phase 3 FACETS trial.
Orphanet Journal of Rare Diseases
, 13
(1)
, Article 68. 10.1186/s13023-018-0813-7.
|
|
|
Schiffmann, R;
Goker-Alpan, O;
Holida, M;
Giraldo, P;
Barisoni, L;
Colvin, RB;
Jennette, CJ;
... Hughes, D; + view all
(2019)
Pegunigalsidase alfa, a novel PEGylated enzyme replacement therapy for Fabry disease, provides sustained plasma concentrations and favorable pharmacodynamics: A 1-year Phase 1/2 clinical trial.
Journal of Inherited Metabolic Disease
, 42
(3)
pp. 534-544.
10.1002/jimd.12080.
|
|
|
Schiffmann, R;
Hughes, DA;
Linthorst, GE;
Ortiz, A;
Svarstad, E;
Warnock, DG;
West, ML;
(2017)
Screening, diagnosis, and management of patients with Fabry disease: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference.
Kidney International
, 91
(2)
pp. 284-293.
10.1016/j.kint.2016.10.004.
|
|
|
Schols, S;
Nunn, MA;
Mackie, I;
Weston-Davies, W;
Nishimura, J-I;
Kanakura, Y;
Blijlevens, N;
... Langemeijer, S; + view all
(2019)
Successful treatment of a PNH patient non-responsive to eculizumab with the novel complement C5 inhibitor coversin (nomacopan).
British Journal of Haematology
, 188
(2)
pp. 334-337.
10.1111/bjh.16305.
|
|
Schoser, B;
Fong, E;
Geberhiwot, T;
Hughes, D;
Kissel, JT;
Madathil, SC;
Orlikowski, D;
... Young, P; + view all
(2017)
Maximum inspiratory pressure as a clinically meaningful trial endpoint for neuromuscular diseases: a comprehensive review of the literature.
[Review].
Orphanet Journal of Rare Diseases
, 12
, Article 52. 10.1186/s13023-017-0598-0.
|
|
|
Schreiber, K;
Sciascia, S;
Bruce, IN;
Giles, I;
Cuadrado, MJ;
Cohen, H;
Gordon, C;
... Hunt, BJ; + view all
(2020)
Hydroxychloroquine in patients with rheumatic diseases during the COVID-19 pandemic: a letter to clinicians.
The Lancet Rheumatology
10.1016/S2665-9913(20)30382-9.
(In press).
|
|
|
Schroeder, Jan-Hendrik;
Beattie, Gordon;
Lo, Jonathan W;
Zabinski, Tomasz;
Powell, Nick;
Neves, Joana F;
Jenner, Richard G;
(2023)
CD90 is not constitutively expressed in functional innate lymphoid cells.
Frontiers in Immunology
, 14
, Article 1113735. 10.3389/fimmu.2023.1113735.
|
|
|
Schwarz, G;
Banerjee, G;
Hostettler, IC;
Ambler, G;
Seiffge, DJ;
Ozkan, H;
Browning, S;
... Werring, DJ; + view all
(2022)
MRI and CT imaging biomarkers of cerebral amyloid angiopathy in lobar intracerebral hemorrhage.
International Journal of Stroke
10.1177/17474930211062478.
(In press).
|
|
|
Sciascia, S;
Willis, R;
Pengo, V;
Krilis, S;
Andrade, D;
Tektonidou, MG;
Ugarte, A;
... APS ACTION, .; + view all
(2019)
The comparison of real world and core laboratory antiphospholipid antibody ELISA results from antiphospholipid syndrome alliance for clinical trials & international networking (APS ACTION) clinical database and repository analysis.
Thrombosis Research
, 175
pp. 32-36.
10.1016/j.thromres.2019.01.010.
|
|
Seiffge, DJ;
Wilson, D;
Ambler, G;
Banerjee, G;
Hostettler, IC;
Houlden, H;
Shakeshaft, C;
... Werring, DJ; + view all
(2021)
Small vessel disease burden and intracerebral haemorrhage in patients taking oral anticoagulants.
Journal of Neurology, Neurosurgery & Psychiatry
10.1136/jnnp-2020-325299.
(In press).
|
|
|
Sekhar, M;
Jadhav, S;
(2020)
Why stay? Resilience in haemophilia physicians in the 1980s.
Haemophilia
, 26
(3)
pp. 401-408.
10.1111/hae.13967.
|
|
Sekhar, M;
Pocock, R;
Lowe, D;
Mitchell, C;
Marafioti, T;
Dickinson, R;
Collin, M;
(2018)
Can somatic GATA2 mutation mimic germ line GATA2 mutation?
Blood Advances
, 2
(8)
pp. 904-908.
10.1182/bloodadvances.2017012617.
|
|
Sellar, Rob S;
Sperling, Adam S;
Słabicki, Mikołaj;
Gasser, Jessica A;
McConkey, Marie E;
Donovan, Katherine A;
Mageed, Nada;
... Ebert, Benjamin L; + view all
(2022)
Degradation of GSPT1 causes TP53-independent cell death in leukemia whilst sparing normal hematopoietic stem cells.
Journal of Clinical Investigation
, 132
(16)
, Article e153514. 10.1172/JCI153514.
|
|
Sellar, R;
Gale, R;
Khwaja, A;
Garbowski, M;
Loddo, M;
Stoeber, K;
Williams, GH;
(2018)
Immunophenotypic analysis of cell cycle status in acute myeloid leukaemia: relationship to cytogenetics, genotype and clinical outcome.
British Journal of Haematology
, 181
(4)
pp. 486-494.
10.1111/bjh.15211.
|
|
Sellar, RS;
Fraser, L;
Khwaja, A;
Gale, RE;
Marafioti, T;
Akarca, A;
Hubank, M;
... Linch, DC; + view all
(2016)
Cell cycle status in AML blast cells from peripheral blood, bone marrow aspirates and trephines and implications for biological studies and treatment.
British Journal of Haematology
, 174
(2)
pp. 275-279.
10.1111/bjh.14055.
|
|
Sellar, RS;
Mehra, V;
Fox, TA;
Grigg, A;
Kulasekararaj, A;
Sarma, A;
de Lavallade, H;
... Potter, VT; + view all
(2019)
Comparative analysis of melphalan versus busulphan T-cell deplete conditioning using alemtuzumab in unrelated donor stem cell transplantation for acute myeloid leukaemia.
British Journal of Haematology
, 187
(1)
e20-e24.
10.1111/bjh.16136.
|
|
Sellar, RS;
Rowntree, C;
Vora, AJ;
Furness, CL;
Goulden, N;
Mitchell, C;
Moorman, AV;
(2018)
Relapse in teenage and young adult patients treated on a paediatric minimal residual disease stratified ALL treatment protocol is associated with a poor outcome: results from UKALL2003.
British Journal of Haematology
, 181
(4)
pp. 515-522.
10.1111/bjh.15208.
|
|
Selvadurai, S;
Mann, K;
Mithra, S;
Bridgewater, J;
Malik, H;
Khan, SA;
(2021)
Cholangiocarcinoma miscoding in hepatobiliary centres.
European Journal of Surgical Oncology
, 47
(3)
pp. 635-639.
10.1016/j.ejso.2020.09.039.
|
|
Sepulveda, C.A.G.;
(2005)
Killer cell Immunoglobulin-like Receptor (KIR) polymorphism: Functional implications and clinical relevance.
Doctoral thesis , University of London.
|
|
|
Settakorn, K;
Kongkarnka, S;
Chompupoung, A;
Svasti, S;
Fucharoen, S;
Porter, JB;
Srichairatanakool, S;
(2022)
Effects of green tea extract treatment on erythropoiesis and iron parameters in iron-overloaded β-thalassemic mice.
Frontiers in Physiology
, 13
, Article 1053060. 10.3389/fphys.2022.1053060.
|
|
Sevim, E;
Zisa, D;
Andrade, D;
Sciascia, S;
Pengo, V;
Tektonidou, MG;
Ugarte, A;
... APS ACTION Investigators; + view all
(2022)
Characteristics of Antiphospholipid Antibody Positive Patients in AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking.
Arthritis Care & Research
, 74
(2)
pp. 324-335.
10.1002/acr.24468.
|
|
Shadman, M;
Manzoor, BS;
Sail, K;
Tuncer, HH;
Allan, JN;
Ujjani, C;
Emechebe, N;
... Mato, AR; + view all
(2023)
Treatment Discontinuation Patterns for Patients With Chronic Lymphocytic Leukemia in Real-World Settings: Results From a Multi-Center International Study.
Clinical Lymphoma, Myeloma & Leukemia
10.1016/j.clml.2023.03.010.
(In press).
|
|
|
Shafat, MS;
Mehra, V;
Peggs, KS;
Roddie, C;
(2020)
Cellular Therapeutic Approaches to Cytomegalovirus Infection Following Allogeneic Stem Cell Transplantation.
Frontiers in Immunology
, 11
, Article 1694. 10.3389/fimmu.2020.01694.
|
|
|
Shafat, MS;
Oellerich, T;
Mohr, S;
Robinson, SD;
Edwards, DR;
Marlein, CR;
Piddock, RE;
... Rushworth, SA; + view all
(2017)
Leukemic blasts program bone marrow adipocytes to generate a protumoral microenvironment.
Blood
, 129
(10)
pp. 1320-1332.
10.1182/blood-2016-08-734798.
|
|
|
Shafi, NT;
(2013)
Pulmonary Involvement in Anderson Fabry Disease.
Doctoral thesis , UCL (University College London).
|
|
|
Shah, F.T.;
(2007)
The relationship between non transferrin bound iron and iron overload in thalassaemia and sickle syndromes.
Doctoral thesis , University of London.
|
|
|
Shah, V;
Sherborne, AL;
Johnson, DC;
Ellis, S;
Price, A;
Chowdhury, F;
Kendall, J;
... on behalf of NCRI Haematology Clinical Studies Group; + view all
(2020)
Predicting ultrahigh risk multiple myeloma by molecular profiling:
an analysis of newly diagnosed transplant eligible myeloma XI trial
patients.
Leukemia
10.1038/s41375-020-0750-z.
|
|
|
Sharief, LAT;
Lawrie, AS;
Mackie, IJ;
Halimeh, S;
Kappert, G;
Smith, C;
Peyvandi, F;
(2016)
Plasma factor XIII level variations during menstrual cycle.
Blood Coagulation & Fibrinolysis
, 27
(7)
pp. 786-790.
10.1097/MBC.0000000000000491.
|
|
Sharma, Gargi;
Day, James;
Haldon, Rosemary;
Aradom, Elsa;
Chowdhary, Pratima;
Drebes, Anja;
Gomez, Keith;
... Batty, Paul; + view all
(2025)
Audit of a Multidisciplinary Follow-Up Pathway of Acquired Haemophilia A.
Presented at: 65th Annual Scientific Meeting of the British Society for Haematology, Glasgow, UK.
|
|
|
Sharma, R;
Hughes, D;
Ramaswami, U;
Cole, D;
Roberts, M;
Hendriksz, CJ;
Stepien, KM;
... Jahnke, N; + view all
(2018)
Enzyme replacement therapy for late-onset Pompe disease.
Cochrane Database of Systematic Reviews
, 2018
(4)
, Article CD012993. 10.1002/14651858.CD012993.
|
|
Sharpley, FA;
De-Silva, D;
Mahmood, S;
Sachchithanantham, S;
Ramsay, I;
Garcia Mingo, A;
Worthington, S;
... D Wechalekar, A; + view all
(2020)
Cytomegalovirus reactivation after bortezomib treatment for multiple myeloma and light chain amyloidosis.
European Journal of Haematology
, 104
(3)
pp. 230-235.
10.1111/ejh.13366.
|
|
Shaw, BE;
Mayor, NP;
Szydlo, RM;
Bultitude, WP;
Anthias, C;
Kirkland, K;
Perry, J;
... Marsh, SG; + view all
(2017)
Recipient/donor HLA and CMV matching in recipients of T-cell-depleted unrelated donor haematopoietic cell transplants.
Bone Marrow Transplant
, 52
pp. 717-725.
10.1038/bmt.2016.352.
|
|
Shiltagh, N;
(2013)
Solution structure of the factor VIII binding region on von Willebrand factor.
Doctoral thesis , UCL (University College London).
|
|
|
Sia, KC;
Fu, ZY;
Calne, RY;
Nathwani, AC;
Lee, KO;
Gan, SU;
(2020)
Modification of a Constitutive to Glucose-Responsive Liver-Specific Promoter Resulted in Increased Efficacy of Adeno-Associated Virus Serotype 8-Insulin Gene Therapy of Diabetic Mice.
Cells
, 9
(11)
, Article 2474. 10.3390/cells9112474.
|
|
|
Siddharthan, T;
Grigsby, M;
Miele, CH;
Bernabe-Ortiz, A;
Miranda, JJ;
Gilman, RH;
Wise, RA;
... Checkley, W; + view all
(2017)
Prevalence and risk factors of restrictive spirometry in a cohort of Peruvian adults.
The International Journal of Tuberculosis and Lung Disease
, 21
(9)
pp. 1062-1068.
10.5588/ijtld.17.0101.
|
|
Sillibourne, James E;
Agliardi, Giulia;
Righi, Matteo;
Smetanova, Katerina;
Rowley, Grant;
Speller, Simon;
Dolor, Abigail;
... Pule, Martin; + view all
(2022)
A compact and simple method of achieving differential transgene expression by exploiting translational readthrough.
Biotechniques
, 72
(4)
10.2144/btn-2021-0079.
(In press).
|
|
|
Sillito, Francesca;
Rampotas, Alexandros;
Cheok, Kathleen;
Pomplun, Sabine;
Baker, Robert;
Marafioti, Teresa;
O'Reilly, Maeve;
... Roddie, Claire; + view all
(2025)
Clonal evolution and the risk of secondary myeloid neoplasia
following chimeric antigen receptor T-cell therapy.
Haematologica
10.3324/haematol.2025.287341.
(In press).
|
|
|
Simini, G;
Mackenzie, S;
Gohil, S;
Papanikolaou, X;
Manson, J;
Payne, E;
(2021)
Successful use of allogeneic bone marrow transplantation in a patient with myelodysplastic syndrome presenting with autoimmune manifestations.
British Society of Haematology
, 193
(6)
pp. 1275-1277.
10.1111/bjh.17437.
|
|
Simini, Giulia;
Batty, Paul;
(2025)
The Hepatic Odyssey of AAV: From Gene Delivery to Long-Term Outcomes.
Journal of Thrombosis and Haemostasis
10.1016/j.jtha.2025.08.028.
(In press).
|
|
|
Sinclair, PB;
(2002)
A fluorescence in-situ hybridisation and molecular investigation of leukaemia associated abnormalities of chromosome 6q.
Doctoral thesis , University of London.
|
|
|
Singer, R;
Campbell, P;
Fernandes, C;
Statham, P;
Hochhauser, D;
Bridgewater, J;
(2017)
Time to endoscopic intervention in patients with upper gastrointestinal patients can be improved with pathway provision.
BMC Cancer
, 17
, Article 365. 10.1186/s12885-017-3335-0.
|
|
|
Sirvent, Sofia;
Vallejo, Andres F;
Corden, Emma;
Teo, Ying;
Davies, James;
Clayton, Kalum;
Seaby, Eleanor G;
... Polak, Marta E; + view all
(2023)
Impaired expression of metallothioneins contributes to allergen-induced inflammation in patients with atopic dermatitis.
Nature Communications
, 14
(1)
, Article 2880. 10.1038/s41467-023-38588-1.
|
|
|
Sivakumaran, S;
Henderson, S;
De Ascensao Santos E Sousa, P;
Ward, S;
Chakraverty, R;
Bennett, CL;
(2014)
Depletion of DC drives expansion of a unique population of monocytes poised for innate immune activation.
Presented at: 13th International Symposium on Dendritic Cells (DC 2014), Tours, France.
|
|
Sivakumaran, S;
Henderson, S;
Ward, S;
Santos E Sousa, P;
Manzo, T;
Zhang, L;
Conlan, T;
... Bennett, CL; + view all
(2016)
Depletion of CD11c(+) cells in the CD11c.DTR model drives expansion of unique CD64(+) Ly6C(+) monocytes that are poised to release TNF-α.
European Journal of Immunology
, 46
(1)
pp. 192-203.
10.1002/eji.201545789.
|
|
|
Slyper, M;
Porter, CBM;
Ashenberg, O;
Waldman, J;
Drokhlyansky, E;
Wakiro, I;
Smillie, C;
... Regev, A; + view all
(2020)
A single-cell and single-nucleus RNA-Seq toolbox for fresh and frozen human tumors.
Nature Medicine
, 26
pp. 792-802.
10.1038/s41591-020-0844-1.
|
|
|
Słabicki, M;
Kozicka, Z;
Petzold, G;
Li, Y-D;
Manojkumar, M;
Bunker, RD;
Donovan, KA;
... Ebert, BL; + view all
(2020)
The CDK inhibitor CR8 acts as a molecular glue degrader that depletes cyclin K.
Nature
, 585
(7824)
pp. 293-297.
10.1038/s41586-020-2374-x.
|
|
Smith, D;
Yong, K;
(2016)
Advances in understanding prognosis in myeloma.
British Journal of Haematology
, 175
(3)
pp. 367-380.
10.1111/bjh.14304.
|
|
Smith, L;
McCourt, O;
Heinrich, M;
Paton, B;
Yong, K;
Wardle, J;
Fisher, A;
(2015)
Multiple myeloma and physical activity: a scoping review.
BMJ Open
, 5
, Article e009576. 10.1136/bmjopen-2015-009576.
|
|
Smith, NMG;
Mlcochova, P;
Watters, SA;
Aasa-Chapman, MMI;
Rabin, N;
Moore, S;
Edwards, SG;
... Gupta, RK; + view all
(2015)
Proof of principle for immune control of 1 global HIV1 reactivation in vivo.
Clinical Infectious Diseases
10.1093/cid/civ219.
|
|
|
Snowden, JA;
Greenfield, DM;
Bird, JM;
Boland, E;
Bowcock, S;
Fisher, A;
Low, E;
... UK Myeloma Forum (UKMF) and the British Society for Haematology, .; + view all
(2017)
Guidelines for screening and management of late and long-term consequences of myeloma and its treatment.
British Journal of Haematology
, 176
(6)
pp. 888-907.
10.1111/bjh.14514.
|
|
Solomon, I;
Amann, M;
Goubier, A;
Vargas, FA;
Zervas, D;
Qing, C;
Henry, JY;
... Quezada, SA; + view all
(2020)
CD25-Treg-depleting antibodies preserving IL-2 signaling on effector T cells enhance effector activation and antitumor immunity.
Nature Cancer
, 1
(12)
pp. 1153-1166.
10.1038/s43018-020-00133-0.
|
|
|
Spanswick, VJ;
Craddock, C;
Sekhar, M;
Mahendra, P;
Shankaranarayana, P;
Hughes, RG;
Hochhauser, D;
(2002)
Repair of DNA interstrand crosslinks as a mechanism of clinical resistance to melphalan in multiple myeloma.
BLOOD
, 100
(1)
224 - 229.
|
|
|
Spurr, Liam F;
Martinez, Carlos A;
Katipally, Rohan R;
Iyer, Soumya C;
Pugh, Sian A;
Bridgewater, John A;
Primrose, John N;
... Pitroda, Sean P; + view all
(2022)
A proliferative subtype of colorectal liver metastases exhibits hypersensitivity to cytotoxic chemotherapy.
npj Precision Oncology
, 6
, Article 72. 10.1038/s41698-022-00318-z.
|
|
Stavrou, M;
(2016)
CAR Gene Transfer to Generate Antigen Specific Regulators.
Doctoral thesis , UCL (University College London).
|
|
Stavrou, M;
Philip, B;
Traynor-White, C;
Davis, CG;
Onuoha, S;
Cordoba, S;
Thomas, S;
(2018)
A Rapamycin-Activated Caspase 9-Based Suicide Gene.
Molecular Therapy
, 26
(5)
pp. 1266-1276.
10.1016/j.ymthe.2018.03.001.
|
|
|
Stepien, KM;
Broomfield, A;
Cole, D;
Deegan, PB;
Forshaw-Hulme, S;
Hughes, D;
Jovanovic, A;
... Ramaswami, U; + view all
(2023)
Management of pain in Fabry disease in the UK clinical setting: consensus findings from an expert Delphi panel.
Orphanet Journal of Rare Diseases
, 18
(1)
, Article 203. 10.1186/s13023-023-02796-1.
|
|
Stowe, C;
Pizzey, A;
Kalber, T;
Badar, A;
Lythgoe, M;
Pule, M;
(2015)
Flow-Based Single Cell Deposition for High-Throughput Screening of Protein Libraries.
PLoS One
, 10
(11)
, Article e0140730. 10.1371/journal.pone.0140730.
|
|
|
Stowe, CL;
Burley, TA;
Allan, H;
Vinci, M;
Kramer-Marek, G;
Ciobota, DM;
Parkinson, GN;
... Pule, MA; + view all
(2019)
Near-infrared dual bioluminescence imaging in mouse models of cancer using infraluciferin.
eLife
, 8
, Article e45801. 10.7554/eLife.45801.
(In press).
|
|
|
Straathof, KC;
Pule, MA;
Yotnda, P;
Dotti, G;
Vanin, EF;
Brenner, MK;
Heslop, HE;
... Rooney, CM; + view all
(2005)
An inducible caspase 9 safety switch for T-cell therapy.
BLOOD
, 105
(11)
pp. 4247-4254.
10.1182/blood-2004-11-4564.
|
|
|
Straathof, K;
Flutter, B;
Wallace, R;
Jain, N;
Loka, T;
Depani, S;
Wright, G;
... Anderson, J; + view all
(2020)
Anti-tumor activity without on-target off-tumor toxicity of GD2-Chimeric Antigen Receptor T cells in patients with neuroblastoma.
Science Translational Medicine
, 12
(571)
, Article eabd6169. 10.1126/scitranslmed.abd6169.
|
|
Strauss, VY;
Shaw, R;
Virdee, PS;
Hurt, CN;
Ward, E;
Tranter, B;
Patel, N;
... Mukherjee, S; + view all
(2019)
Study protocol: a multi-centre randomised study of induction chemotherapy followed by capecitabine ± nelfinavir with high- or standard-dose radiotherapy for locally advanced pancreatic cancer (SCALOP-2).
BMC Cancer
, 19
, Article 121. 10.1186/s12885-019-5307-z.
|
|
|
Streck, Christian J;
Zhang, Youbin;
Miyamoto, Ryan;
Zhou, Junfang;
Ng, Catherine Y;
Nathwani, Amit C;
Davidoff, Andrew M;
(2004)
Restriction of neuroblastoma angiogenesis and growth by interferon-α/β.
Surgery
, 136
(2)
pp. 183-189.
10.1016/j.surg.2004.04.014.
|
|
|
Strilchuk, AW;
Hur, WS;
Batty, P;
Sang, Y;
Abrahams, SR;
Yong, ASM;
Leung, J;
... Kastrup, CJ; + view all
(2024)
Lipid nanoparticles and siRNA targeting plasminogen provide lasting inhibition of fibrinolysis in mouse and dog models of hemophilia A.
Science Translational Medicine
, 16
(735)
, Article eadh0027. 10.1126/scitranslmed.adh0027.
|
|
Sudha, Parvathi;
Ahsan, Aarif;
Ashby, Cody;
Kausar, Tasneem;
Khera, Akhil;
Kazeroun, Mohammad;
Hsu, Chih-Chao;
... Walker, Brian A; + view all
(2022)
MGP Panel is a comprehensive targeted genomics panel for molecular profiling of multiple myeloma patients.
Clinical Cancer Research
, 28
(13)
2854-2864..
10.1158/1078-0432.CCR-21-3695.
|
|
Sunderland, MW;
Peggs, KS;
(2018)
Successful translation and future prospects of TALEN editing for leukemia patients.
Expert Opinion on Biological Therapy
, 18
(7)
pp. 725-726.
10.1080/14712598.2018.1484105.
|
|
|
Suzuki, E;
Bridgewater, J;
(2019)
Adjuvant therapy for resected gallbladder cancer.
Chinese Clinical Oncology
, 8
(4)
, Article 39. 10.21037/cco.2019.07.02.
|
|
|
Swanton, C;
Bernard, E;
Abbosh, C;
André, F;
Auwerx, J;
Balmain, A;
Bar-Sagi, D;
... Hanahan, D; + view all
(2024)
Embracing cancer complexity: Hallmarks of systemic disease.
Cell
, 187
(7)
pp. 1589-1616.
10.1016/j.cell.2024.02.009.
|
T
|
Taher, AT;
Origa, R;
Perrotta, S;
Kourakli, A;
Ruffo, GB;
Kattamis, A;
Goh, AS;
... Porter, JB; + view all
(2017)
New film-coated tablet formulation of deferasirox is well tolerated in patients with thalassemia or lower-risk MDS: Results of the randomized, phase II ECLIPSE study.
American Journal of Hematology
, 92
(5)
pp. 420-428.
10.1002/ajh.24668.
|
|
|
Taher, AT;
Origa, R;
Perrotta, S;
Kouraklis, A;
Belhoul, K;
Huang, V;
Han, J;
... Porter, JB; + view all
(2019)
Influence of patient-reported outcomes on the treatment effect of deferasirox film-coated and dispersible tablet formulations in the ECLIPSE trial: A post hoc mediation analysis.
[Letter].
American Journal of Hematology
, 94
(4)
E96-E99.
10.1002/ajh.25408.
|
|
Taher, AT;
Origa, R;
Perrotta, S;
Kouraklis, A;
Ruffo, GB;
Kattamis, A;
Goh, A-S;
... Porter, JB; + view all
(2018)
Patient-reported outcomes from a randomized phase II study of the deferasirox film-coated tablet in patients with transfusion-dependent anemias.
Health and Quality of Life Outcomes
, 16
, Article 216. 10.1186/s12955-018-1041-5.
|
|
|
Taher, AT;
Porter, JB;
Kattamis, A;
Viprakasit, V;
Cappellini, MD;
(2016)
Efficacy and safety of iron-chelation therapy with deferoxamine, deferiprone, and deferasirox for the treatment of iron-loaded patients with nontransfusion-dependent thalassemia syndromes.
Drug Design, Development and Therapy
, 10
pp. 4073-4078.
10.2147/DDDT.S117080.
|
|
|
Taher, AT;
Weber, S;
Han, J;
Bruederle, A;
Porter, JB;
(2019)
Predicting serum ferritin levels in patients with iron overload treated with the film-coated tablet of deferasirox during the ECLIPSE study.
American Journal of Hematology
, 94
(1)
E15-E17.
10.1002/ajh.25322.
|
|
|
Taieb, Julien;
Seufferlein, Thomas;
Reni, Michele;
Palmer, Daniel H;
Bridgewater, John A;
Cubillo, Antonio;
Prager, Gerald W;
... Macarulla, Teresa; + view all
(2023)
Treatment sequences and prognostic/predictive factors in metastatic pancreatic ductal adenocarcinoma: univariate and multivariate analyses of a real-world study in Europe.
BMC Cancer
, 23
(1)
, Article 877. 10.1186/s12885-023-11377-1.
|
|
Taieb, J;
Balogoun, R;
Le Malicot, K;
Tabernero, J;
Mini, E;
Folprecht, G;
Van Laethem, JL;
... PETACC8 investigators, .; + view all
(2016)
Adjuvant FOLFOX +/- cetuximab in full RAS and BRAF wildtype stage III colon cancer patients.
Annals of Oncology
10.1093/annonc/mdw687.
(In press).
|
|
Taieb, J;
Kourie, HR;
Emile, J-F;
Le Malicot, K;
Balogoun, R;
Tabernero, J;
Mini, E;
... Pan-European Trials in Alimentary Tract Cancer (PETACC)-8 Invest; + view all
(2017)
Association of Prognostic Value of Primary Tumor Location in Stage III Colon Cancer With RAS and BRAF Mutational Status.
JAMA Oncology
10.1001/jamaoncol.2017.3695.
(In press).
|
|
Tailor, H;
Mackie, I;
Mellick, A;
Machin, S;
(2017)
Evaluation of the Sysmex XN-550, a Novel Compact Haematology analyser from the XN-L (R) series, compared to the XN-20 system.
International Journal of Laboratory Hematology
, 39
(6)
pp. 585-589.
10.1111/ijlh.12701.
|
|
Tait, A;
Proctor, T;
Hamilton, NJI;
Birchall, MA;
Lowdell, MW;
(2021)
GMP compliant isolation of mucosal epithelial cells and fibroblasts from biopsy samples for clinical tissue engineering.
Scientific Reports
, 11
(1)
, Article 12392. 10.1038/s41598-021-91939-0.
|
|
|
Taj, MM;
Moorman, AV;
Hamadeh, L;
Petit, A;
Asnafi, V;
Alby-Laurent, F;
Vora, A;
... Macintyre, E; + view all
(2022)
Prognostic value of Oncogenetic mutations in pediatric T Acute Lymphoblastic Leukemia: a comparison of UKALL2003 and FRALLE2000T protocols.
Leukemia
, 36
pp. 263-266.
10.1038/s41375-021-01334-x.
|
|
Tamari, Roni;
McLornan, Donal P;
Ahn, Kwang Woo;
Estrada-Merly, Noel;
Hernández-Boluda, Juan Carlos;
Giralt, Sergio;
Palmer, Jeanne;
... Saber, Wael; + view all
(2023)
A simple prognostic system in patients with myelofibrosis undergoing allogeneic stem cell transplantation: a CIBMTR/EBMT analysis.
Blood Advances
, 7
(15)
pp. 3993-4002.
10.1182/bloodadvances.2023009886.
|
|
|
Tan, MH;
Smith, AJ;
Pawlyk, B;
Xu, XY;
Liu, XQ;
Bainbridge, JB;
Basche, M;
... Ali, RR; + view all
(2009)
Gene therapy for retinitis pigmentosa and Leber congenital amaurosis caused by defects in AIPL1: effective rescue of mouse models of partial and complete Aipl1 deficiency using AAV2/2 and AAV2/8 vectors.
Human Molecular Genetics
, 18
(12)
2099 - 2114.
10.1093/hmg/ddp133.
|
|
|
Tanner, Lewis E. S.;
(2022)
Characterising the effect of novel SFK phosphorylation on ADP Ribosylation Factor (ARF) state changes.
Doctoral thesis (Ph.D), UCL (University College London).
|
|
Tayabali, S;
Baker, R;
Nacheva, E;
O’Nions, J;
Gupta, R;
Wilson, AJ;
Xu, K;
(2024)
The use of leukaemia Q-fusion gene screening assay (Q30) in the diagnostic evaluation of acute myeloid leukaemia (AML).
Journal of Hematopathology
, 17
(1)
pp. 37-39.
10.1007/s12308-023-00571-6.
|
|
Taylor, Julia;
Bulek, Anna;
Gannon, Isaac;
Robson, Mathew;
Kokalaki, Evangelia;
Grothier, Thomas;
McKenzie, Callum;
... Thomas, Simon; + view all
(2023)
Exploration of T cell immune responses by expression of a dominant-negative SHP1 and SHP2.
Frontiers in Immunology
, 14
, Article 1119350. 10.3389/fimmu.2023.1119350.
|
|
Taylor, SA;
Mallett, S;
Ball, S;
Beare, S;
Bhatnagar, G;
Bhowmik, A;
Boavida, P;
... Streamline investigators; + view all
(2019)
Diagnostic accuracy of whole-body MRI versus standard imaging pathways for metastatic disease in newly diagnosed non-small-cell lung cancer: the prospective Streamline L trial.
Lancet Respiratory Medicine
10.1016/S2213-2600(19)30090-6.
(In press).
|
|
|
Taylor, SA;
Mallett, S;
Beare, S;
Bhatnagar, G;
Blunt, D;
Boavida, P;
Bridgewater, J;
... Streamline investigators; + view all
(2019)
Diagnostic accuracy of whole-body MRI versus standard imaging pathways for metastatic disease in newly diagnosed colorectal cancer: the prospective Streamline C trial.
The Lancet Gastroenterology & Hepatology
, 4
(7)
pp. 529-537.
10.1016/S2468-1253(19)30056-1.
|
|
|
Taylor, SA;
Mallett, S;
Bhatnagar, G;
Morris, S;
Quinn, L;
Tomini, F;
Miles, A;
... Halligan, S; + view all
(2019)
Magnetic resonance enterography compared with ultrasonography in newly diagnosed and relapsing Crohn's disease patients: the METRIC diagnostic accuracy study.
Health Technol Assess
, 23
(42)
pp. 1-161.
10.3310/hta23420.
|
|
|
Taylor, SA;
Mallett, S;
Miles, A;
Beare, S;
Bhatnagar, G;
Bridgewater, J;
Glynne-Jones, R;
... Halligan, S; + view all
(2017)
Streamlining staging of lung and colorectal cancer with whole body MRI; study protocols for two multicentre, non-randomised, single-arm, prospective diagnostic accuracy studies (Streamline C and Streamline L).
BMC Cancer
, 17
, Article 299. 10.1186/s12885-017-3281-x.
|
|
Taylor, SA;
Mallett, S;
Miles, A;
Morris, S;
Quinn, L;
Clarke, CS;
Beare, S;
... Halligan, S; + view all
(2019)
Whole-body MRI compared with standard pathways for staging metastatic disease in lung and colorectal cancer: the Streamline diagnostic accuracy studies.
Health Technology Assessment
, 23
(66)
10.3310/hta23660.
|
|
|
Teachey, DT;
O'Connor, D;
(2020)
How I treat newly diagnosed T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma in children.
Blood
, 135
(3)
pp. 159-166.
10.1182/blood.2019001557.
|
|
Telfer, P;
De la Fuente, J;
Sohal, M;
Brown, R;
Eleftheriou, P;
Roy, N;
Piel, FB;
... Layton, DM; + view all
(2020)
Real-time national survey of COVID-19 in hemoglobinopathy and rare inherited anemia patients.
Haematologica
, 105
(11)
pp. 2651-2654.
10.3324/haematol.2020.259440.
|
|
|
Thomas, ASB;
(2014)
Vascular events in Fabry and Gaucher disease.
Doctoral thesis , UCL (University College London).
|
|
|
Thomas, MR;
(2016)
The role of antibodies in acquired thrombotic thrombocytopenic purpura.
Doctoral thesis , UCL (University College London).
|
|
|
Thomas, S;
Straathof, K;
Himoudi, N;
Anderson, J;
Pule, M;
(2016)
An Optimized GD2-Targeting Retroviral Cassette for More Potent and Safer Cellular Therapy of Neuroblastoma and Other Cancers.
PLoS One
, 11
(3)
, Article e0152196. 10.1371/journal.pone.0152196.
|
|
|
Tijani, M;
Munis, AM;
Perry, C;
Sanber, K;
Ferraresso, M;
Mukhopadhyay, T;
Themis, M;
... Takeuchi, Y; + view all
(2018)
Lentivector Producer Cell Lines with Stably Expressed Vesiculovirus Envelopes.
Molecular Therapy - Methods & Clinical Development
, 10
pp. 303-312.
10.1016/j.omtm.2018.07.013.
|
|
|
Tilmont, Remi;
Yakoub-Agha, Ibrahim;
Eikema, Diderik-Jan;
Zinger, Nienke;
Haenel, Mathias;
Schaap, Nicolaas;
Arroyo, Concepcion Herrera;
... Manier, Salomon; + view all
(2023)
Carfilzomib, lenalidomide and dexamethasone followed by a second ASCT is an effective strategy in first relapse multiple myeloma: a study on behalf of the Chronic malignancies working party of the EBMT.
Bone Marrow Transplantation
, 58
(11)
pp. 1182-1188.
10.1038/s41409-023-02048-7.
|
|
|
Tinsley, S;
Meja, K;
Shepherd, C;
Khwaja, A;
(2015)
Synergistic induction of cell death in haematological malignancies by combined phosphoinositide-3-kinase and BET bromodomain inhibition.
British Journal of Haematology
, 170
(2)
pp. 275-278.
10.1111/bjh.13283.
|
|
|
Toffoli, M;
Chohan, H;
Mullin, S;
Jesuthasan, A;
Yalkic, S;
Koletsi, S;
Menozzi, E;
... Schapira, AHV; + view all
(2023)
Phenotypic effect of GBA1 variants in individuals with and without Parkinson's disease: The RAPSODI study.
Neurobiology of Disease
, 188
, Article 106343. 10.1016/j.nbd.2023.106343.
|
|
Tohidi-Esfahani, Ibrahim;
Cohen, Hannah;
Ioannou, Yiannis;
Giles, Ian I;
(2025)
Pathogenesis of antiphospholipid antibody syndrome.
In: Wallace, Daniel J and Hahn, Bevra Hannahs and Askanase, Anca and Crow, Mary K and Isenberg, David A and La Cava, Antonio and McMahon, Maureen A and Tsao, Betty P and Venuturupalli, Swamy and Weisman, Michael H, (eds.)
Dubois' Lupus Erythematosus and Related Syndromes.
(pp. 388-401).
Elsevier: Amsterdam, The Netherlands.
|
|
Tomkins, Oliver;
Khwaja, Jahanzaib;
Koay, Shiwen;
Japzon, Nicole;
Hoskote, Chandrashekar;
Gupta, Rajeev;
Baker, Robert;
... D'Sa, Shirley; + view all
(2025)
Bing-Neel Syndrome - A Case Series of 46 Patients from the United Kingdom.
Blood Advances
10.1182/bloodadvances.2025016360.
(In press).
|
|
|
Tostoes, R;
Dodgson, J;
Weil, B;
Gerontas, S;
Mason, C;
Veraitch, FS;
(2017)
A novel filtration system for point of care washing of cellular therapy products.
Journal of Tissue Engineering and Regenerative Medicine
, 11
(11)
pp. 3157-3167.
10.1002/term.2225.
|
|
Townsend, W;
Leong, S;
Hoskin, P;
Diez, P;
Patrick, P;
Linch, D;
Wong, W-L;
... Ardeshna, K; + view all
(2019)
Treatment of classical Hodgkin lymphoma in young adults aged 18-30 years with a modified paediatric Hodgkin lymphoma protocol. Results of a multicentre phase II clinical trial (CRUK/08/012).
British Journal of Haematology
10.1111/bjh.16296.
(In press).
|
|
|
Townsend, WM;
Holroyd, A;
Pearce, R;
Mackinnon, S;
Naik, P;
Goldstone, AH;
Linch, DC;
... Morris, EC; + view all
(2013)
Improved intensive care unit survival for critically ill allogeneic haematopoietic stem cell transplant recipients following reduced intensity conditioning.
Br J Haematol
, 161
(4)
578 - 586.
10.1111/bjh.12294.
|
|
|
Traeger, U;
Andre, R;
Lahiri, N;
Magnusson-Lind, A;
Weiss, A;
Grueninger, S;
McKinnon, C;
... Tabrizi, SJ; + view all
(2014)
HTT-lowering reverses Huntington's disease immune dysfunction caused by NF kappa B pathway dysregulation.
Brain
, 137
pp. 819-833.
10.1093/brain/awt355.
|
|
Tremblay, JP;
Xiao, X;
Aartsma-Rus, A;
Barbas, C;
Blau, HM;
Bogdanove, AJ;
Boycott, K;
... Gao, G; + view all
(2013)
Translating the genomics revolution: the need for an international gene therapy consortium for monogenic diseases.
Molecular Therapy
, 21
(2)
266 - 268.
10.1038/mt.2013.4.
|
|
|
Trudel, S;
Lendvai, N;
Popat, R;
Voorhees, PM;
Reeves, B;
Libby, EN;
Richardson, PG;
... Cohen, AD; + view all
(2018)
Targeting B-cell maturation antigen with GSK2857916 antibody-drug conjugate in relapsed or refractory multiple myeloma (BMA117159): a dose escalation and expansion phase 1 trial.
The Lancet Oncology
, 19
(12)
pp. 1641-1653.
10.1016/S1470-2045(18)30576-X.
|
|
Tsuzuki, S;
Seto, M;
Hong, D;
Gupta, R;
Enver, T;
Matsuo, K;
(2007)
Isoform-specific potentiation of stem and progenitor cell engraftment by AML1/RUNX1.
PLoS Medicine
, 4
(5)
, Article e172. 10.1371/journal.pmed.0040172.
|
|
|
Tuddenham, EG;
(2017)
Platelets are a safe way to deliver factor VIII. After 13 years of preclinical research it is now time for a clinical trial.
Journal of Thrombosis and Haemostasis
, 15
(1)
pp. 96-97.
10.1111/jth.13545.
|
|
Tummala, H;
Walne, AJ;
Williams, M;
Bockett, N;
Collopy, L;
Cardoso, S;
Ellison, A;
... Vulliamy, T; + view all
(2016)
DNAJC21 Mutations Link a Cancer-Prone Bone Marrow Failure Syndrome to Corruption in 60S Ribosome Subunit Maturation.
American Journal of Human Genetics
, 99
(1)
pp. 115-124.
10.1016/j.ajhg.2016.05.002.
|
|
|
Turajlic, S;
Litchfield, K;
Xu, H;
Rosenthal, R;
McGranahan, N;
Reading, JL;
Wong, YNS;
... Swanton, C; + view all
(2017)
Insertion-and-deletion-derived tumour-specific neoantigens and the immunogenic phenotype: a pan-cancer analysis.
The Lancet Oncology
, 18
(8)
pp. 1009-1021.
10.1016/S1470-2045(17)30516-8.
|
|
|
Turati, VA;
Guerra-Assunção, JA;
Potter, NE;
Gupta, R;
Ecker, S;
Daneviciute, A;
Tarabichi, M;
... Enver, T; + view all
(2021)
Chemotherapy induces canalization of cell state in childhood B-cell precursor acute lymphoblastic leukemia.
Nature Cancer
, 2
pp. 835-852.
10.1038/s43018-021-00219-3.
|
U
|
Ulivi, L;
Kanber, B;
Prados, F;
Davagnanam, I;
Merwick, A;
Chan, E;
Williams, F;
... Werring, DJ; + view all
(2020)
White matter integrity correlates with cognition and disease severity in Fabry disease.
Brain
, 143
(11)
pp. 3331-3342.
10.1093/brain/awaa282.
|
|
Ulivi, L;
Squitieri, M;
Cohen, H;
Cowley, P;
Werring, DJ;
(2020)
Cerebral venous thrombosis: a practical guide.
Practical Neurology
, 20
(5)
pp. 356-367.
10.1136/practneurol-2019-002415.
|
|
Underwood, M;
Peyvandi, F;
Garagiola, I;
Machin, S;
Mackie, I;
(2016)
Degradation of two novel congenital TTP ADAMTS13 mutants by the cell proteasome prevents ADAMTS13 secretion.
Thrombosis Research
, 147
pp. 16-23.
10.1016/j.thromres.2016.09.014.
|
|
Underwood, MI;
(2015)
The relationship between ADAMTS13 genotype and phenotype in congenital thrombotic thrombocytopenic purpura and characterisation of ADAMTS13 mutants.
Doctoral thesis , UCL (University College London).
|
|
|
Unlu, O;
Erkan, D;
Barbhaiya, M;
Andrade, D;
Nascimento, I;
Rosa, R;
Banzato, A;
... APS ACTION, .; + view all
(2019)
The Impact of Systemic Lupus Erythematosus on the Clinical Phenotype of Antiphospholipid Antibody–Positive Patients: Results From the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Clinical Database and Repository.
Arthritis Care & Research
, 71
(1)
pp. 134-141.
10.1002/acr.23584.
|
|
Urbani, L;
Camilli, C;
Phylactopoulos, DE;
Crowley, C;
Natarajan, D;
Scottoni, F;
Maghsoudlou, PL;
... De Coppi, P; + view all
(2018)
Multi-stage bioengineering of a layered oesophagus with in vitro expanded muscle and epithelial adult progenitors.
Nature Communications
, 9
, Article 4286. 10.1038/s41467-018-06385-w.
|
|
|
Uttenthal, B;
Martinez-Davila, I;
Ivey, A;
Craddock, C;
Chen, F;
Virchis, A;
Kottaridis, P;
... Morris, EC; + view all
(2014)
Wilms' Tumour 1 (WT1) peptide vaccination in patients with acute myeloid leukaemia induces short-lived WT1-specific immune responses.
Br J Haematol
, 164
(3)
366 - 375.
10.1111/bjh.12637.
|
|
V
|
Valle, JW;
Wasan, H;
Lopes, A;
Backen, AC;
Palmer, DH;
Morris, K;
Duggan, M;
... Bridgewater, JA; + view all
(2015)
Cediranib or placebo in combination with cisplatin and gemcitabine chemotherapy for patients with advanced biliary tract cancer (ABC-03): a randomised phase 2 trial.
Lancet Oncology
, 16
(8)
pp. 967-978.
10.1016/S1470-2045(15)00139-4.
|
|
van de Donk, NWCJ;
Pawlyn, C;
Yong, KL;
(2021)
Multiple myeloma.
The Lancet
, 397
(10272)
pp. 410-427.
10.1016/S0140-6736(21)00135-5.
|
|
van der Veen, SJ;
Vlietstra, WJ;
van Dussen, L;
van Kuilenburg, ABP;
Dijkgraaf, MGW;
Lenders, M;
Brand, E;
... Langeveld, M; + view all
(2020)
Predicting the Development of Anti-Drug Antibodies against Recombinant alpha-Galactosidase A in Male Patients with Classical Fabry Disease.
International Journal of Molecular Sciences
, 21
(16)
, Article 5784. 10.3390/ijms21165784.
|
|
|
Van Emmenis, L;
Mòdol-Caballero, G;
Harford-Wright, E;
Power, A;
Cattin, AL;
White, IJ;
Casal, G;
... Lloyd, AC; + view all
(2025)
Identification of CCL3 as a Schwann cell chemotactic factor essential for nerve regeneration.
Cell Reports
, 44
(2)
, Article 115322. 10.1016/j.celrep.2025.115322.
|
|
|
van Tienhoven, R;
Jansen, DTSL;
Park, M;
Williams, JC;
Larkin, J;
Quezada, SA;
Roep, BO;
(2024)
Induction of islet autoimmunity to defective ribosomal product of the insulin gene as neoantigen after anti-cancer immunotherapy leading to autoimmune diabetes.
Frontiers in Immunology
, 15
, Article 1384406. 10.3389/fimmu.2024.1384406.
|
|
Vargas, FA;
Furness, AJS;
Litchfield, K;
Joshi, K;
Rosenthal, R;
Ghorani, E;
Solomon, I;
... Quezada, SA; + view all
(2018)
Fc Effector Function Contributes to the Activity of Human Anti-CTLA-4 Antibodies.
Cancer Cell
, 33
(4)
pp. 649-663.
10.1016/j.ccell.2018.02.010.
|
|
|
Vargas, FA;
Furness, AJS;
Solomon, I;
Joshi, K;
Mekkaoui, L;
Lesko, MH;
Rota, EM;
... Quezada, SA; + view all
(2017)
Fc-Optimized Anti-CD25 Depletes Tumor-Infiltrating Regulatory T Cells and Synergizes with PD-1 Blockade to Eradicate Established Tumors.
Immunity
, 46
(4)
pp. 577-586.
10.1016/j.immuni.2017.03.013.
|
|
|
Venkatesan, S;
Rosenthal, R;
Kanu, N;
McGranahan, N;
Bartek, J;
Quezada, SA;
Hare, J;
... Swanton, C; + view all
(2018)
APOBEC mutagenesis in drug resistance and immune escape in HIV and cancer evolution.
Annals of Oncology
, 29
(3)
pp. 563-572.
10.1093/annonc/mdy003.
|
|
|
Venturelli, Veronica;
Maranini, Beatrice;
Tohidi-Esfahani, Ibrahim;
Isenberg, David A;
Cohen, Hannah;
Efthymiou, Maria;
(2024)
Can complement activation be the missing link in antiphospholipid syndrome?
Rheumatology
, Article keae178. 10.1093/rheumatology/keae178.
(In press).
|
|
Vesely, C;
Childs, A;
Wong, YNS;
Ogunbiyi, O;
Gander, A;
Luong, T;
Thirlwell, C;
... Meyer, T; + view all
(2018)
Systematic Evaluation of the Immune Microenvironment of Neuroendocrine Tumors (NET).
Presented at: 15th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Barcelona, Spain.
|
|
Vicencio, JM;
Evans, R;
Green, R;
An, Z;
Deng, J;
Treacy, C;
Mustapha, R;
... Ng, T; + view all
(2022)
Osimertinib and anti-HER3 combination therapy engages immune dependent tumor toxicity via STING activation in trans.
Cell Death & Disease
, 13
(3)
, Article 274. 10.1038/s41419-022-04701-3.
|
|
|
Vijapurapu, R;
Roy, A;
Demetriades, P;
Warfield, A;
Hughes, DA;
Moon, J;
Woolfson, P;
... Steeds, RP; + view all
(2023)
Systematic review of the incidence and clinical risk predictors of atrial fibrillation and permanent pacemaker implantation for bradycardia in Fabry disease.
Open Heart
, 10
(2)
, Article e002316. 10.1136/openhrt-2023-002316.
|
|
Vijapurapu, R;
Baig, S;
Nordin, S;
Augusto, JB;
Price, AM;
Wheeldon, N;
Lewis, N;
... Steeds, RP; + view all
(2020)
Longitudinal Assessment of Cardiac Involvement in Fabry Disease Using Cardiovascular Magnetic Resonance Imaging.
JACC: Cardiovascular Imaging
, 13
(8)
pp. 1850-1852.
10.1016/j.jcmg.2020.03.004.
|
|
Vijapurapu, R;
Geberhiwot, T;
Jovanovic, A;
Baig, S;
Nordin, S;
Kozor, R;
Leyva, F;
... Steeds, RP; + view all
(2019)
Study of indications for cardiac device implantation and utilisation in Fabry cardiomyopathy.
Heart
, 105
(23)
10.1136/heartjnl-2019-315229.
|
|
|
Vijapurapu, R;
Kozor, R;
Hughes, DA;
Woolfson, P;
Jovanovic, A;
Deegan, P;
Rusk, R;
... Steeds, RP; + view all
(2019)
A randomised controlled trial evaluating arrhythmia burden, risk of sudden cardiac death and stroke in patients with Fabry disease: the role of implantable loop recorders (RaILRoAD) compared with current standard practice.
Trials
, 20
, Article 314. 10.1186/s13063-019-3425-1.
|
|
|
Vijapurapu, R;
Nordin, S;
Baig, S;
Liu, B;
Rosmini, S;
Augusto, J;
Tchan, M;
... Kozor, R; + view all
(2019)
Global longitudinal strain, myocardial storage and hypertrophy in Fabry disease.
Heart
, 105
(6)
pp. 470-476.
10.1136/heartjnl-2018-313699.
|
|
|
Vila Cuenca, M;
Marchi, G;
Barqué, A;
Esteban-Jurado, C;
Marchetto, A;
Giorgetti, A;
Chelban, V;
... Sanchez, M; + view all
(2020)
Genetic and Clinical Heterogeneity in Thirteen New Cases with Aceruloplasminemia. Atypical Anemia as a Clue for an Early Diagnosis.
International Journal of Molecular Sciences
, 21
(7)
, Article 2374. 10.3390/ijms21072374.
|
|
|
Vinchi, F;
Porto, G;
Simmelbauer, A;
Altamura, S;
Passos, ST;
Garbowski, M;
Silva, AMN;
... Muckenthaler, MU; + view all
Atherosclerosis is aggravated by iron overload and ameliorated by dietary and pharmacological iron restriction.
European Heart Journal
10.1093/eurheartj/ehz112.
(In press).
|
|
Vithayathil, M;
Bridgewater, J;
Khan, SA;
(2021)
Medical therapies for intra-hepatic cholangiocarcinoma.
Journal of Hepatology
, 75
(4)
pp. 981-983.
10.1016/j.jhep.2021.04.004.
|
|
Vlachodimitropoulou, E;
Garbowski, M;
Anne Solomon, S;
Abbasi, N;
Seaward, G;
Windrim, R;
Keunen, J;
... Ryan, G; + view all
(2022)
Outcome predictors for maternal red blood cell alloimmunisation with anti-K and anti-D managed with intrauterine blood transfusion.
British Journal of Haematology
, 196
(4)
pp. 1096-1104.
10.1111/bjh.17956.
|
|
Vlachodimitropoulou, E;
Chen, Y-L;
Garbowski, M;
Koonyosying, P;
Psaila, B;
Sola-Visner, M;
Cooper, N;
... Porter, J; + view all
(2017)
Eltrombopag: a powerful chelator of cellular or extracellular iron(III) alone or combined with a second chelator.
Blood
, 130
(17)
pp. 1923-1933.
10.1182/blood-2016-10-740241.
|
|
Vogel, A;
Bridgewater, J;
Edeline, J;
Kelley, RK;
Klümpen, HJ;
Malka, D;
Primrose, JN;
... ESMO Guidelines Committee; + view all
(2023)
Biliary tract cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.
Annals of Oncology
, 34
(2)
pp. 127-140.
10.1016/j.annonc.2022.10.506.
|
|
Vos, JM;
Notermans, NC;
D'Sa, S;
Lunn, MP;
van der Pol, WL;
Kraan, W;
Reilly, MM;
... Minnema, MC; + view all
(2017)
High prevalence of the MYD88 L265P mutation in IgM anti-MAG paraprotein-associated peripheral neuropathy.
[Letter].
Journal of Neurology, Neurosurgery & Psychiatry
, 89
(9)
pp. 1007-1009.
10.1136/jnnp-2017-316689.
|
|
W
|
Wagner, AK;
Alici, E;
Lowdell, MW;
(2019)
Characterization of human natural killer cells for therapeutic use.
Cytotherapy
, 21
(3)
pp. 315-326.
10.1016/j.jcyt.2018.11.001.
|
|
Walf-Vorderwülbecke, V;
Pearce, K;
Brooks, T;
Hubank, M;
Van den Heuvel-Eibrink, MM;
Zwaan, CM;
Adams, S;
... Williams, O; + view all
(2018)
Targeting acute myeloid leukemia by drug-induced c-MYB degradation.
Leukemia
, 32
pp. 882-889.
10.1038/leu.2017.317.
|
|
Wall, EC;
Wu, M;
Harvey, R;
Kelly, G;
Warchal, S;
Sawyer, C;
Daniels, R;
... Bauer, DL; + view all
(2021)
AZD1222-induced neutralising antibody activity against SARS-CoV-2 Delta VOC.
The Lancet
10.1016/S0140-6736(21)01462-8.
(In press).
|
|
|
Wall, EC;
Wu, M;
Harvey, R;
Kelly, G;
Warchal, S;
Sawyer, C;
Daniels, R;
... Bauer, DLV; + view all
(2021)
Neutralising antibody activity against SARS-CoV-2 VOCs B.1.617.2 and B.1.351 by BNT162b2 vaccination.
The Lancet
10.1016/s0140-6736(21)01290-3.
(In press).
|
|
|
Wallace, Eric L;
Goker-Alpan, Ozlem;
Wilcox, William R;
Holida, Myrl;
Bernat, John;
Longo, Nicola;
Linhart, Aleš;
... Warnock, David G; + view all
(2023)
Head-to-head trial of pegunigalsidase alfa versus agalsidase beta in patients with Fabry disease and deteriorating renal function: results from the 2-year randomised phase III BALANCE study.
Journal of Medical Genetics
10.1136/jmg-2023-109445.
(In press).
|
|
|
Wanner, C;
Arad, M;
Baron, R;
Burlina, A;
Elliott, PM;
Feldt-Rasmussen, U;
Fomin, VV;
... Hilz, MJ; + view all
(2018)
European expert consensus statement on therapeutic goals in Fabry disease.
Molecular Genetics and Metabolism
, 124
(3)
pp. 189-203.
10.1016/j.ymgme.2018.06.004.
|
|
|
Wanner, C;
Feldt-Rasmussen, U;
Jovanovic, A;
Linhart, A;
Yang, M;
Ponce, E;
Brand, E;
... Ortiz, A; + view all
(2020)
Cardiomyopathy and kidney function in agalsidase beta-treated female Fabry patients: a pre-treatment vs. post-treatment analysis.
ESC Heart Failure
, 7
(3)
pp. 825-834.
10.1002/ehf2.12647.
|
|
|
Waters, AM;
Asfahani, R;
Carroll, P;
Bicknell, L;
Lescai, F;
Bright, A;
Chanudet, E;
... Beales, PL; + view all
(2015)
The kinetochore protein, CENPF, is mutated in human ciliopathy and microcephaly phenotypes.
J Med Genet
, 52
(3)
147 - 156.
10.1136/jmedgenet-2014-102691.
|
|
|
Wawrzyniecka, PA;
Ibrahim, L;
Gritti, G;
Pule, MA;
Maciocia, PM;
(2021)
Chimeric antigen receptor T cells for gamma-delta T cell malignancies.
Leukemia
10.1038/s41375-021-01385-0.
(In press).
|
|
|
Weil, B;
Hanley, PJ;
Lowdell, M;
(2019)
Proposal for the International Society for Cell & Gene Therapy position statement on assays for the quality control and potency assessment of adoptive cellular immunotherapies.
Cytotherapy
, 21
(3)
pp. 367-375.
10.1016/j.jcyt.2019.02.001.
|
|
Weil, BD;
(2017)
Purification Of Progenitor Photoreceptors Derived From The Directed Differentiation Of Human Pluripotent Stem Cells.
Doctoral thesis , UCL (University College London).
|
|
|
Weil, BD;
Jenkins, MJ;
Uddin, S;
Bracewell, DG;
Wellings, D;
Farid, SS;
Veraitch, F;
(2017)
An integrated experimental and economic evaluation of cell therapy affinity purification technologies.
Regenerative Medicine
, 12
(4)
pp. 397-417.
10.2217/rme-2016-0156.
|
|
West, HC;
Bennett, CL;
(2018)
Redefining the role of Langerhans cells as immune regulators within the skin.
Frontiers in Immunology
, 8
, Article 1941. 10.3389/fimmu.2017.01941.
|
|
|
Westerland, OA;
Pratt, G;
Kazmi, M;
El-Najjar, I;
Streetly, M;
Yong, K;
Morris, M;
... British Society of Haematology Imaging Practice Guidelines Worki; + view all
(2018)
National survey of imaging practice for suspected or confirmed plasma cell malignancies.
British Journal of Radiology
, 91
(1092)
10.1259/bjr.20180462.
(In press).
|
|
|
Westwood, J-P;
(2015)
The Role of Complement Anaphylatoxins in Systemic Disease.
Doctoral thesis , UCL (University College London).
|
|
Westwood, JP;
Langley, K;
Heelas, E;
Machin, SJ;
Scully, M;
(2013)
Complement and cytokine response in acute Thrombotic Thrombocytopenic Purpura.
British Journal of Haematology
, 164
(6)
858- 866.
10.1111/bjh.12707.
|
|
|
Wilson, AJ;
Troy-Barnes, E;
Subhan, M;
Clark, F;
Gupta, R;
Fielding, AK;
Kottaridis, P;
... Khwaja, A; + view all
(2020)
Successful remission induction therapy with gilteritinib in a patient with de novo FLT3-mutated acute myeloid leukaemia and severe COVID-19.
[Letter].
British Journal of Haematology
, 190
(4)
e189-e191.
10.1111/bjh.16962.
|
|
Wilson, D;
Ambler, G;
Banerjee, G;
Shakeshaft, C;
Cohen, H;
Yousry, TA;
Al-Shahi Salman, R;
... Werring, DJ; + view all
(2018)
Early versus late anticoagulation for ischaemic stroke associated with atrial fibrillation: multicentre cohort study.
Journal of Neurology, Neurosurgery & Psychiatry
, 90
(3)
pp. 320-325.
10.1136/jnnp-2018-318890.
|
|
Wilson, D;
Ambler, G;
Lee, K-J;
Lim, J-S;
Shiozawa, M;
Koga, M;
Li, L;
... Microbleeds International Collaborative Network, .; + view all
(2019)
Cerebral microbleeds and stroke risk after ischaemic stroke or transient ischaemic attack: a pooled analysis of individual patient data from cohort studies.
Lancet Neurology
10.1016/S1474-4422(19)30197-8.
(In press).
|
|
|
Wilson, D;
Ambler, G;
Shakeshaft, C;
Banerjee, G;
Charidimou, A;
Seiffge, D;
White, M;
... CROMIS-2 collaborators, .; + view all
(2019)
Potential missed opportunities to prevent ischaemic stroke: prospective multicentre cohort study of atrial fibrillation-associated ischaemic stroke and TIA.
BMJ Open
, 9
(7)
, Article e028387. 10.1136/bmjopen-2018-028387.
|
|
|
Wilson, D;
Ambler, G;
Shakeshaft, C;
Brown, MM;
Charidimou, A;
Salman, RA-S;
Lip, GYH;
... Werring, DJ; + view all
(2018)
Cerebral microbleeds and intracranial haemorrhage risk in patients anticoagulated for atrial fibrillation after acute ischaemic stroke or transient ischaemic attack (CROMIS-2): a multicentre observational cohort study.
The Lancet Neurology
, 17
(6)
pp. 539-547.
10.1016/S1474-4422(18)30145-5.
|
|
|
Wilson, D;
Charidimou, A;
Shakeshaft, C;
Ambler, G;
White, M;
Cohen, H;
Yousry, T;
... Werring, DJ; + view all
(2015)
Volume and functional outcome of intracerebral hemorrhage according to oral anticoagulant type.
Neurology
, 86
(4)
pp. 360-366.
10.1212/WNL.0000000000002310.
|
|
|
Wong, WJ;
Emdin, C;
Bick, AG;
Zekavat, SM;
Niroula, A;
Pirruccello, JP;
Dichtel, L;
... Chen, WM; + view all
(2023)
Clonal haematopoiesis and risk of chronic liver disease.
Nature
, 616
(7958)
pp. 747-754.
10.1038/s41586-023-05857-4.
|
|
Wong, YNS;
Joshi, K;
Khetrapal, P;
Ismail, M;
Reading, JL;
Sunderland, MW;
Georgiou, A;
... Quezada, SA; + view all
(2018)
Urine-derived lymphocytes as a non-invasive measure of the bladder tumor immune microenvironment.
Journal of Experimental Medicine
, 215
(11)
pp. 2748-2759.
10.1084/jem.20181003.
|
|
|
Wong, YNS;
Joshi, K;
Pule, M;
Peggs, KS;
Swanton, C;
Quezada, SA;
Linch, M;
(2017)
Evolving adoptive cellular therapies in urological malignancies.
Lancet Oncology
, 18
(6)
E341-E353.
10.1016/S1470-2045(17)30327-3.
|
|
|
Wood, G;
Grenader, T;
Nash, S;
Adams, R;
Kaplan, R;
Fisher, D;
Maughan, T;
(2017)
Derived neutrophil to lymphocyte ratio as a prognostic factor in patients with advanced colorectal cancer according to RAS and BRAF status: a post-hoc analysis of the MRC COIN study.
Anti-Cancer Drugs
, 28
(5)
pp. 546-550.
10.1097/CAD.0000000000000488.
|
|
Woodruff, Rosie;
Parekh, Farhaan;
Lamb, Katarina;
Mekkaoui, Leila;
Allen, Christopher;
Smetanova, Katerina;
Huang, Jasmine;
... Pule, Martin; + view all
(2023)
Large-scale manufacturing of base-edited chimeric antigen receptor T cells.
Molecular Therapy: Methods & Clinical Development
, 31
, Article 101123. 10.1016/j.omtm.2023.101123.
|
|
|
Woolston, A;
Khan, K;
Spain, G;
Barber, LJ;
Griffiths, B;
Gonzalez-Exposito, R;
Hornsteiner, L;
... Gerlinger, M; + view all
(2019)
Genomic and Transcriptomic Determinants of Therapy Resistance and Immune Landscape Evolution during Anti-EGFR Treatment in Colorectal Cancer.
Cancer Cell
, 36
(1)
35-50e9.
10.1016/j.ccell.2019.05.013.
|
|
|
Work, LM;
Baker, AH;
Graham, T;
McIntosh, J;
Nathwani, A;
(2008)
Performance of AAV8 vectors expressing human factor IX from a hepatic-selective promoter following intravenous injection into rats.
Genetic Vaccines and Therapy
, 6
, Article 9. 10.1186/1479-0556-6-9.
|
|
|
Wu, Yin;
Biswas, Dhruva;
Usaite, Ieva;
Angelova, Mihaela;
Boeing, Stefan;
Karasaki, Takahiro;
Veeriah, Selvaraju;
... Swanton, Charles; + view all
(2022)
A local human Vδ1 T cell population is associated with survival in nonsmall-cell lung cancer.
Nature Cancer
, 3
pp. 696-709.
10.1038/s43018-022-00376-z.
|
X
|
Xu, K;
Gupta, S;
Kaffo, E;
Baker, R;
Nacheva, E;
O’Nions, J;
Wilson, AJ;
(2024)
The use of targeted ribonucleic acid (RNA)–sequencing assay in the diagnostic evaluation of acute myeloid leukaemia (AML).
Journal of Hematopathology
, 17
(3)
pp. 167-169.
10.1007/s12308-024-00594-7.
|
|
Xu, K;
Kyriakou, C;
(2024)
Extramedullary myeloma progressed to plasmablastic myeloma.
Clinical Hematology International
, 6
(1)
pp. 13-15.
10.46989/001c.92050.
|
|
|
Xu, K;
Nacheva, E;
(2024)
Secondary plasma cell leukaemia (PCL) with plasmablastic morphology.
Journal of Hematopathology
, 17
(2)
pp. 117-119.
10.1007/s12308-024-00583-w.
|
|
Xu, K;
Nacheva, E;
(2024)
Acute myeloid leukaemia (AML) with KMT2A rearrangement presented with haemophagocytic lymphohistiocytosis (HLH).
International Journal of Laboratory Hematology
, 46
(2)
pp. 214-215.
10.1111/ijlh.14183.
|
|
Xu, K;
Nacheva, E;
(2023)
Chronic myeloid leukaemia (CML) presenting in B-lymphoblastic crisis: a diagnostic challenge.
Journal of Hematopathology
, 16
(4)
pp. 243-245.
10.1007/s12308-023-00560-9.
|
|
Xu, K;
Vistsaras, E;
Gupta, R;
(2025)
Chronic Myeloid Leukaemia (CML) in T-Lymphoblastic Blast Crisis With Near Early T Cell Progenitor (ETP) Immunophenotype.
International Journal of Laboratory Hematology
, 47
(3)
pp. 376-377.
10.1111/ijlh.14383.
|
|
Xu, Ke;
Abusalim, Enas;
Vitsaras, Evan;
Orfinada, Karen;
Baker, Robert;
Nacheva, Elisabeth;
Wilson, Andrew;
... Gupta, Rajeev; + view all
(2025)
Diagnosis and treatment of T/myeloid mixed phenotype acute
leukaemia (T/M-MPAL).
EJHAEM
, 6
(1)
, Article e1075. 10.1002/jha2.1075.
|
|
|
Xu, Ke;
Agbuduwe, Charles;
Kanellias, Nickolaos;
Wilson, William;
McMillan, Annabel;
Papanikolaou, Xenofon;
Lee, Lydia;
... Kyriakou, Charalampia; + view all
(2024)
Bone-independent extramedullary disease is associated with inferior overall survival in multiple myeloma patients: a single center, real-world experience.
Haematologica
10.3324/haematol.2024.286409.
(In press).
|
|
|
Xu, Ke;
Childerhouse, Anna;
Al-Hassani, Ahmed;
Kyriakou, Charalampia;
(2021)
Plasmablastic myeloma progressed to plasma cell leukaemia.
eJHaem
, 2
(4)
pp. 869-870.
10.1002/jha2.331.
|
|
|
Xu, Ke;
Childerhouse, Anna;
Gupta, Rajeev;
(2023)
Mast cell leukaemia progressed from myelodysplastic syndrome after acquiring KIT mutation.
International Journal of Laboratory Hematology
10.1111/ijlh.14174.
(In press).
|
|
Xu, Ke;
Childerhouse, Anna;
Gupta, Rajeev;
(2022)
Burkitt leukaemia with B-cell precursor immunophenotype.
eJHaem
, 3
(3)
pp. 1044-1045.
10.1002/jha2.450.
|
|
Xu, Ke;
Kaffo, Eleanor;
Baker, Robert;
Nacheva, Elisabeth;
McMillan, Annabel;
Lee, Lydia;
Papanikolaou, Xenofon;
... Gupta, Rajeev; + view all
(2024)
Myeloid neoplasm post cytotoxic treatment in patients with multiple myeloma.
eJHaem
, 5
(5)
pp. 1089-1091.
10.1002/jha2.1017.
|
|
|
Xu, Ke;
Kamuriwo, Lucy;
Anderson, Claire;
Jasani, Parag;
(2022)
IgG kappa multiple myeloma with isolated central nervous system relapse.
eJHaem
, 3
(3)
pp. 1082-1083.
10.1002/jha2.469.
|
|
|
Xu, Ke;
Maharaj, Carolyn;
Kaffo, Eleanor;
Vitsaras, Evan;
Orfinada, Karen;
Baker, Robert;
Nacheva, Elisabeth;
... Gupta, Rajeev; + view all
(2025)
Diagnosis and treatment of early T-cell precursor acute lymphoblastic leukaemia.
British Society for Haematology
10.1111/bjh.20163.
|
|
Xu, Ke;
Mellios, Zois;
Hyun, June;
Childerhouse, Anna;
O'Nions, Jenny;
Wilson, Andrew;
Proctor, Ian;
... Gupta, Rajeev; + view all
(2025)
Diagnosis and management of acute erythroid leukemia (AEL).
Leukemia and Lymphoma
10.1080/10428194.2025.2553166.
(In press).
|
|
Xu, Ke;
Vitsaras, Evan;
Boneva, Temenuzhka;
Nacheva, Elisabeth;
Gupta, Rajeev;
(2025)
HLA-DR positive acute promyelocytic leukaemia (APML) with cryptic PML::RARA fusion.
Journal of Hematopathology
, 18
, Article 15. 10.1007/s12308-025-00631-z.
|
|
Xu, Ke;
Vitsaras, Evan;
Childerhouse, Anna;
Boneva, Temenuzhka;
Nacheva, Elisabeth;
Gupta, Rajeev;
(2025)
CD45-Positive Small Lymphocyte-Like Myeloma with IGH::CCND1 Fusion and TP53 Mutations.
Indian Journal of Hematology and Blood Transfusion
10.1007/s12288-025-02063-2.
(In press).
|
|
|
Xu, Ke;
Vitsaras, Evan;
Gupta, Rajeev;
(2025)
CD34 and HLA-DR Double Positive Microgranular Acute Promyelocytic Leukaemia With Multiple T- and B-Cell Markers Expression.
eJHaem
, 6
(4)
, Article e70106. 10.1002/jha2.70106.
|
|
Y
|
Yakoub-Agha, Ibrahim;
Greco, Raffaella;
Onida, Francesco;
de la Camara, Rafael;
Ciceri, Fabio;
Corbacioglu, Selim;
Dolstra, Harry;
... Sanchez-Ortega, Isabel; + view all
(2023)
Practice harmonization workshops of EBMT: an expert-based approach to generate practical and contemporary guidelines within the arena of hematopoietic cell transplantation and cellular therapy.
Bone Marrow Transplantation
, 58
(6)
pp. 696-700.
10.1038/s41409-023-01958-w.
|
|
|
Yang, J;
Milasta, S;
Hu, D;
AlTahan, AM;
Interiano, RB;
Zhou, J;
Davidson, J;
... Davidoff, AM; + view all
(2017)
Targeting Histone Demethylases in MYC-Driven Neuroblastomas with Ciclopirox.
Cancer Research
, 77
(17)
pp. 4626-4638.
10.1158/0008-5472.CAN-16-0826.
|
|
|
Yang, JHM;
Cutler, AJ;
Ferreira, RC;
Reading, JL;
Cooper, NJ;
Wallace, C;
Clarke, P;
... Tree, TIM; + view all
(2015)
Natural Variation in Interleukin-2 Sensitivity Influences Regulatory T-Cell Frequency and Function in Individuals With Long-standing Type 1 Diabetes.
Diabetes
, 64
(11)
pp. 3891-3902.
10.2337/db15-0516.
|
|
|
Yelnik, CM;
Erton, ZB;
Drumez, E;
Cheildze, D;
de Andrade, D;
Clarke, A;
Tektonidou, MG;
... Erkan, D; + view all
(2024)
Thrombosis recurrence and major bleeding in non-anticoagulated thrombotic antiphospholipid syndrome patients: Prospective study from antiphospholipid syndrome alliance for clinical trials and international networking (APS ACTION) clinical database and repository (“Registry”).
Seminars in Arthritis and Rheumatism
, 65
, Article 152347. 10.1016/j.semarthrit.2023.152347.
|
|
Yeo, GHT;
Juez, O;
Chen, Q;
Banerjee, B;
Chu, L;
Shen, MW;
Sabry, M;
... Gifford, DK; + view all
(2021)
Detection of gene cis-regulatory element perturbations in single-cell transcriptomes.
PLoS Computational Biology
, 17
(3)
, Article e1008789. 10.1371/journal.pcbi.1008789.
(In press).
|
|
|
Yip, HM;
Yong, K;
De-Silva, D;
Rabin, N;
(2020)
Assessing the safety of autologous stem cell transplant pathway via ambulatory care for patients with multiple myeloma.
Hematology/Oncology and Stem Cell Therapy
10.1016/j.hemonc.2020.01.001.
(In press).
|
|
|
Yong, K;
Wilson, W;
de Tute, RM;
Camilleri, M;
Ramasamy, K;
Streetly, M;
Sive, J;
... Popat, R; + view all
(2022)
Upfront autologous haematopoietic stem-cell transplantation versus carfilzomib–cyclophosphamide–dexamethasone consolidation with carfilzomib maintenance in patients with newly diagnosed multiple myeloma in England and Wales (CARDAMON): a randomised, phase 2, non-inferiority trial.
The Lancet Haematology
, 10
(2)
e93-e106.
10.1016/S2352-3026(22)00350-7.
|
|
Yong, KL;
Hinsley, S;
Auner, HW;
Bygrave, C;
Kaiser, MF;
Ramasamy, K;
De Tute, RM;
... Brown, SR; + view all
(2021)
Carfilzomib or bortezomib in combination with cyclophosphamide and dexamethasone followed by carfilzomib maintenance for patients with multiple myeloma after one prior therapy: results from a multi-centre, phase II, randomized, controlled trial (MUKfive).
Haematologica
, 106
(10)
pp. 2694-2706.
10.3324/haematol.2021.278399.
|
|
Yong, K;
Cavet, J;
Johnson, P;
Morgan, G;
Williams, C;
Nakashima, D;
Akinaga, S;
... Cavenagh, J; + view all
(2016)
Phase I study of KW-2478, a novel Hsp90 inhibitor, in patients with B-cell malignancies.
British Journal of Cancer
, 114
(1)
pp. 7-13.
10.1038/bjc.2015.422.
|
|
Yong, K;
Delforge, M;
Driessen, C;
Fink, L;
Flinois, A;
Gonzalez-McQuire, S;
Karlin, L;
... Cavo, M; + view all
(2016)
Multiple myeloma: patient outcomes in real-world practice.
British Journal of Haematology
, 175
(2)
pp. 252-264.
10.1111/bjh.14213.
|
|
|
Yong, K;
van de Donk, N;
(2019)
Oral proteasome inhibitor maintenance for multiple myeloma.
The Lancet
, 393
(10168)
pp. 204-205.
10.1016/S0140-6736(18)33128-3.
|
|
Yoo, Changhoon;
Javle, Milind M;
Verdaguer Mata, Helena;
de Braud, Filippo;
Trojan, Jörg;
Raoul, Jean-Luc;
Kim, Jin Won;
... Borad, Mitesh J; + view all
(2023)
Phase 2 trial of bintrafusp alfa as second-line therapy for patients with locally advanced/metastatic biliary tract cancers.
Hepatology
, 78
pp. 758-770.
10.1097/HEP.0000000000000365.
|
|
Yoon, Jongwon;
(2025)
Immunocompetent in vivo CRISPR screening to
identify key transcription factors which enhance
persistence and efficacy of CAR-T cells in cancer.
Doctoral thesis (Ph.D), UCL (University College London.
|
|
Young-Gqamana, B;
Brignol, N;
Chang, H-H;
Khanna, R;
Soska, R;
Fuller, M;
Sitaraman, SA;
... Benjamin, ER; + view all
(2013)
Migalastat HCl Reduces Globotriaosylsphingosine (Lyso-Gb(3)) in Fabry Transgenic Mice and in the Plasma of Fabry Patients.
PLOS ONE
, 8
(3)
, Article e57631. 10.1371/journal.pone.0057631.
|
|
|
Yuan, Z;
Lourenco, SDS;
Sage, EK;
Kolluri, KK;
Lowdell, MW;
Janes, SM;
(2016)
Cryopreservation of human mesenchymal stromal cells expressing TRAIL for human anti-cancer therapy.
Cytotherapy
, 18
(7)
pp. 860-869.
10.1016/j.jcyt.2016.04.005.
|
|
Z
|
Zambetti, L.P.;
(2012)
Preparation and characterization of engineered antigen presenting cells (APCs) for the generation of cytotoxic response for transplantation-related immunotherapy.
Doctoral thesis , UCL (University College London).
|
|
|
Zelenay, S;
van der Veen, AG;
Boettcher, JP;
Snelgrove, KJ;
Rogers, N;
Acton, SE;
Chakravarty, P;
... Reis e Sousa, C; + view all
(2015)
Cyclooxygenase-Dependent Tumor Growth through Evasion of Immunity.
Cell
, 162
(6)
pp. 1257-1270.
10.1016/j.cell.2015.08.015.
|
|
Zhao, Y;
Fu, X;
Lopez, JI;
Rowan, A;
Au, L;
Fendler, A;
Hazell, S;
... Litchfield, K; + view all
(2021)
Selection of metastasis competent subclones in the tumour interior.
Nature Ecology & Evolution
, 5
pp. 1033-1045.
10.1038/s41559-021-01456-6.
|
|
|
Zhou, C;
O'Connor, J;
Backen, A;
Valle, JW;
Bridgewater, J;
Dive, C;
Jayson, GC;
(2022)
Plasma Tie2 trajectories identify vascular response criteria for VEGF inhibitors across advanced biliary tract, colorectal and ovarian cancers.
ESMO Open
, 7
(2)
, Article 100417. 10.1016/j.esmoop.2022.100417.
|
|
|
Zhu, AX;
Macarulla, T;
Javle, MM;
Kelley, RK;
Lubner, SJ;
Adeva, J;
Cleary, JM;
... Abou-Alfa, GK; + view all
(2021)
Final Overall Survival Efficacy Results of Ivosidenib for Patients With Advanced Cholangiocarcinoma With IDH1 Mutation: The Phase 3 Randomized Clinical ClarIDHy Trial.
JAMA Oncology
10.1001/jamaoncol.2021.3836.
(In press).
|
|
|
Ziff, Monica;
Lawson, Gabrielle;
De-Silva, Dunnya;
Cheesman, Simon;
Kyriakou, Charalampia;
Mahmood, Shameem;
Papanikolaou, Xenofon;
... Popat, Rakesh; + view all
(2021)
Ixazomib with lenalidomide and dexamethasone for patients with relapsed multiple myeloma: impact of 17p deletion and sensitivity to proteasome inhibitors from a real world data-set.
Leukemia & Lymphoma
, 62
(5)
pp. 1243-1246.
10.1080/10428194.2020.1864356.
|
|
Zuily, S;
Cohen, H;
Isenberg, D;
Woller, SC;
Crowther, M;
Dufrost, V;
Wahl, D;
... Devreese, KMJ; + view all
(2020)
Use of direct oral anticoagulants in patients with thrombotic antiphospholipid syndrome: Guidance from the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis.
J Thromb Haemost
, 18
(9)
pp. 2126-2137.
10.1111/jth.14935.
|
|
Zuily, S;
Clerc-Urmes, I;
Bauman, C;
Andrade, D;
Sciascia, S;
Pengo, V;
Tektonidou, MG;
... Erkan, D; + view all
(2020)
Cluster analysis for the identification of clinical phenotypes among antiphospholipid antibody-positive patients from the APS ACTION Registry.
Lupus
, 29
(11)
pp. 1353-1363.
10.1177/0961203320940776.
|
|
|
Zuo, Y;
Navaz, S;
Tsodikov, A;
Kmetova, K;
Kluge, L;
Ambati, A;
Hoy, CK;
... Lockshin, M; + view all
(2023)
Anti–Neutrophil Extracellular Trap Antibodies in Antiphospholipid Antibody–Positive Patients: Results From the Antiphospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking Clinical Database and Repository.
Arthritis & Rheumatology
10.1002/art.42489.
(In press).
|
|
|
Zwi-Dantsis, L;
Wang, B;
Marijon, C;
Zonetti, S;
Ferrini, A;
Massi, L;
Stuckey, DJ;
... Stevens, MM; + view all
(2019)
Remote Magnetic Nanoparticle Manipulation Enables the Dynamic Patterning of Cardiac Tissues.
Advanced Materials
, Article e1904598. 10.1002/adma.201904598.
(In press).
|
|
|
Zwi-Dantsis, L;
Winter, CW;
Kauscher, U;
Ferrini, A;
Wang, B;
Whittaker, TE;
Hood, SR;
... Stevens, MM; + view all
(2020)
Highly purified extracellular vesicles from human cardiomyocytes demonstrate preferential uptake by human endothelial cells.
Nanoscale
10.1039/d0nr04278a.
(In press).
|
|
Ś
|
Śledzińska, A;
Vila de Mucha, M;
Bergerhoff, K;
Hotblack, A;
Demane, DF;
Ghorani, E;
Akarca, AU;
... Quezada, SA; + view all
(2020)
Regulatory T Cells Restrain Interleukin-2- and Blimp-1-Dependent Acquisition of Cytotoxic Function by CD4⁺ T Cells.
Immunity
, 52
(1)
151-166.e6.
10.1016/j.immuni.2019.12.007.
|
